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Antimycobacterial activity of pyrimido[4,5-b]diazepine
derivatives
J.G. Bueno Sánchez1,∗, A. Garcia2, B. Insuasty2, J. Quiroga2
1 Instituto Nacional de Salud, Bogotá, Colombia
2 Grupo de Investigación de Compuestos Heterocíclicos,
Departamento de Química, Universidad de Valle, Cali,
Colombia
Background: Human tuberculosis is a contagious-
infectious disease mainly caused by Mycobacterium tuber-
culosis, which is an aerobic pathogenic bacterium that
establishes its infection usually in the lungs. About one
third of the world’s population is currently infected with
M. tuberculosis; 10% of those infected will develop clinical
disease, particularly those who also have the human immun-
odeﬁciency virus (HIV) infection. This problem is further
compounded by a dramatic increase in multidrug-resistant
strains of M. tuberculosis which demands the search
for alternative antimycobacterial drugs. In this effort,
diazepine derivatives, which showed a broad spectrum of
biological activity especially antitumoral is presented as
a promising source of new compounds-leaders. Using the
existing capacity that posses the Colombian National Insti-
tute of Health (NIH) for to develop reproducible in vitro tests
against mycobacteria species and the research trajectory
of Grupo de Investigación de Compuestos Heterocíclicos,
the aim of this study was to determine the activity against
15 Mycobacterium spp strains and clinical isolates of 12
diazepine derivatives.
Methods: The synthesis of pyrimidodiazepines by
microwave irradiation (200 ◦C, 300W) during 2-8minutes
of equimolar mixture of 2-R-4,5,6-triamino-pyrimidines and
chalcones in DMF (0.5mL) and catalytic amount of BF3.OEt2
(0.5mL. The minimum inhibitory concentration (MIC) was
determined by colorimetric broth microdilution method.
The activity was evaluated against ﬁve M. tuberculosis ATCC
strains, 5 isolates of Beijing genotype and 5 clinical isolates
of nontuberculous mycobacteria. Isoniazid and rifampicin
were used as control drugs.
Results: In total six diazepine derivatives showed mod-
erate activity at concentrations in a range between
16-32g/mL (Good activity CMI <10g/ mL), three were
active against 13 microorganisms; the rest just inhibited the
growth of M. tuberculosis strains.
Conclusion: Diazepine derivatives scaffolds over the
years have gained an ongoing interest for biological
activities as anticancer, anti-bacterial, psychotropics, anti-
convulsant, anti-viral, and herbicidal. This is the ﬁrst
report of antimycobacterial activity of diazepine compounds
developed entirely in Colombia, in addition, also includes
multidrug-resistant isolates classiﬁed in the national resis-
tance studies conducted in the Colombian National Institute
of Health (NIH).
doi:10.1016/j.ijid.2010.02.1912ts e191
8.002
ive-year trend of antimicrobial susceptibility rates
nd daptomycin activity among Staphylococcus aureus
solates collected in Latin American medical eenters
2005-2009)
.J. biedenbach, R.N. jones, H. Sader ∗
JMI Laboratories, North Liberty, IA, USA
Background: Daptomycin is lipopeptide with a unique
echanism of action and rapid bactericidal activity against
ram-positive cocci. Daptomycin is approved for the treat-
ent of Gram-positive pathogen associated complicated
kin and skin structure infections (cSSSI) and S. aureus (SA)-
ssociated bacteremia and endocarditis and in the United
tates, Europe and some Latin American (LA) countries. The
n vitro activity of daptomycin and comparator agents was
valuated against clinical isolates of SA collected in four LA
ountries over ﬁve years.
Methods: 6,031 SA isolates were collected in 10 med-
cal centers located in Argentina (1,075), Brazil (2,637),
hile (1,345) and Mexico (974). Isolates were mainly from
loodstream (42.1%) and cSSSI (28.6%). Susceptibility (S)
as determined by the CLSI broth microdilution method
n cation-adjusted Mueller-Hinton broth supplemented to
0mg/L of calcium for daptomycin tests.
Results: The overall oxacillin resistance (MRSA) rate in LA
as 41.1% and ranged from 32.1-39.0% in Brazil and Mexico
o 51.7-51.9% in Argentina and Chile. MRSA rates increased
ontinuously from 34.7 (2005) to 48.4% (2009). Daptomycin
as highly active against SA in all LA countries with MIC50
nd MIC90 values of 0.25 and 0.5mg/ml, respectively. Over-
ll, daptomycin was highly active against MRSA (100.0%
, see table) as was vancomycin (MIC50/90, 1/1mg/ml;
00% S) and linezolid (MIC50/90, 1/2mg/ml; >99.9% S).
rythromycin resistance was higher in Chile and Mexico
46.5-54.5%) than in Argentina and Brazil (38.2-39.4%). Over-
ll constitutive clindamycin resistance was 78.8% in LA.
MP/SMX and tetracycline resistance was much higher in
razil (20.6-23.6%) compared to other countries (1.5-6.2%).
evoﬂoxacin and gentamicin resistance was highest in Chile
t 52.1% and 42.8%, respectively.
ation (no. of
SA strains)
Cumulative % inhibited at daptomycin MIC
(g/ml) of:
≤0.06 0.12 0.25 0.5 1 2
rgentina
(1,075)
0.0 2.3 62.1 98.5 100.0 -
razil (2,637) 0.1 2.1 61.1 98.4 100.0 -
hile (1,345) 0.2 2.8 57.3 97.9 100.0 -
exico (974) 0.5 3.9 74.6 99.2 99.9 -
ll regions
Methicillin- 0.2 3.3 77.3 99.1 >99.9 100.0MRSA
(2479)
0.1 1.5 41.6 97.5 100.0 -
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Conclusion: Signiﬁcant resistance variations among SA
nd several classes of antimicrobial agents were observed
n LA countries. Daptomycin showed consistent potency
gainst recent clinical isolates of SA collected in LA medical
enters, including MDR strains. Resistance to other com-
ounds did not adversely inﬂuence daptomycin potency and
ith S rates at over 99.9% during the past ﬁve years sug-
ests that daptomycin has maintained in vitro activity in LA
ountries.
oi:10.1016/j.ijid.2010.02.1913
8.003
n vitro activity of new compound YF-13-1 against gram-
ostive and gram-negative bacteria strains of clinical
solates in chain
. Zhang1,∗, Y. Liu2
Sichuan industral Institue antibiotics, Chengdu, Sichuan,
hina
Sichuan Industral Institute of Antibiotical, chengdu,
ichuan, China
Background: The Present study is undertaken to evaluate
nd compared the activity of the new compound YF-13-1
lone and with eight antibiotics against gram — positive and
ram — negative. Bacterial strains. The majority of bacterial
trains evaluated in this study were recent clinical isolates
btained from several hospital sources in China.
Methods: Determination of antibacterial activity in vitro:
inimum inhibitory concentrations (MICs) were determined
ccording to CLSI(formerly NCCLs guidelines using cation —
djusted Mueller-Hinton agar.) by the agar dilution method
ith a Multiple innoculator replicator (steers-folty repli-
ator) serialtwofold dilutions of the compounds will be
repared 10-fold in agar, ranged from 128 to 0.008 ug/ml (for
xtremely sensitive organisms, further dilutions).the lowest
oncentration which allowed the growth of no more than
hree colonies is considered to be the MICs.
Results: The results showed that YF-13-1 was a broad-
pectrum Antibiotics. MIC50, MIC90 values for YF-13-1 were
ach 0.25mg/L and 1mg/L against ciproﬂoxacin-susceptible
nd levoﬂoxacin- susceptible S.aureus strains. It inhib-
ted 90% tested Ciproﬂoxacin and levoﬂoxacin- resistant
. aureus strains at less than 16mg/L. MIC 90 values
gainst S. aureus MRSA, MSSA was 4mg/L, 0.25mg/L respec-
ively. YF-13-1 was more active against coagulose-negative.
taphylococci and S.epidermidis MRSE, MSSE, MIC90 were
mg/L, 8mg/L; 2mg/L and 0.25mg/L respectively. MIC90
as)4mg/L against S.pyogenes, S.pneumoniae and Entero-
occcus. MIC 90 4, 8, 0.5mg/L against Branhemella bacteria,
nﬂuengae and Gonococcal respectively. Whereas, the YF-
s
a
c
dternational Congress on Infectious Diseases (ICID) Abstracts
3-1 MIC range for E.coli, K. peumoniae, Proteus, Serratia
arcescens, E. aerogenes and cloacae were 0.008- 32mg/L.
IC50, MIC90 was 2mg/L and 8mg/L against P. aerogenes
espectively, But, it less active against acinetobacter bau-
annii, MIC50, MIC90 was 8mg/L, 128mg/L respectively.
Conclusion: The results showed that YF-13-1 was a broad-
pectrum Antibiotics.
oi:10.1016/j.ijid.2010.02.1914
8.004
0-hydroxy-2-decenoic acid induce dispersion of Strepto-
occus mutans bioﬁlms
. Shoae Hassani1,∗, N. Ordouzadeh2
Islamic Azad University (IAU), Fars Science & Research,
ran, Islamic Republic of
Azad University, Fars, Iran, Islamic Republic of
Background: Hydroxy decenoic acid is a bioactive com-
onent of royal jelly that occupies its 10% of the total
eight. Bioﬁlms progress through multiple developmental
tages, beginning with reversible attachment to a surface,
ollowed by irreversible attachment and development of
icrocolonies, when dispersion occurs, releasing cells into
he bulk liquid. Colonization and Bioﬁlm formation of Strep-
ococcus mutans is the causative agent of dental plaques
nd subsequently dental caries.
Methods: 10-hydroxy decenoic acid was puriﬁed by
eans of HPLC. Glass slides were used for bioﬁlm for-
ation in treated media with each slide in a total area
f 6 cm2. Microtiter plate dispersion bioassays were used
o test various preparations for their ability to exoge-
ously induce Streptococcus mutans ATCC 25175 bioﬁlm
ispersion.
Results: Hydroxy decenoic acid is capable of inducing the
ispersion of established bioﬁlms and of inhibiting bioﬁlm
evelopment. When added exogenously to Streptococcus
utans bioﬁlms at a native concentration of 2.5 nM, it was
hown to induce the dispersion of bioﬁlm microcolonies.
hese dispersion events were observed to originate at the
enter of microcolonies near the substratum, but only within
icrocolonies that had attained a minimum diameter of 40
nd a minimum thickness of 10m.
Conclusion: Active at nanomolar concentrations,
ydroxy-2-decenoic acid appears to be functionally and
tructurally related to the class of short-chain fatty acid
ignaling molecules such as diffusible signal factor, which
ct as cell-to-cell communication molecules in bacterial
olonies.
oi:10.1016/j.ijid.2010.02.1915
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an effect of this kind of pumps was observed. Additionally
presence of transferable quinolone-resistance mechanisms
has been detected in the area.
doi:10.1016/j.ijid.2010.02.191714th International Congress on Infectious Diseases (ICID) Abs
48.005
In vitro activity of biapenem against Burkholderia pseu-
domallei
V. Thamlikitkul ∗, S. Trakulsomboon
Siriraj Hospital, 10700, Thailand
Background: Burkholderia pseudomallei, a gram-
negative bacterium, causes in humans and animals a
disease called melioidosis. Biapenem has a broad spectrum
of in vitro antibacterial activity against many gram negative
and gram-positive aerobic and anaerobic bacteria, including
those producing $-lactamases. The objective of the study
was to determine in vitro activity of biapenem against
Burkholderia pseudomallei
Methods: 110 clinical isolates of B. pseudomallei from
different patients were selected from our collection. In vitro
susceptibility of biapenem was determined by agar dilution
method and Kirby-Bauer disc diffusion. Paper discs contain-
ing biapenem 10g per disk (Eiken Chemical Co. Ltd., Japan)
and the standard powder of biapenem (Meiji Seika Kaisha
Ltd. Pharmaceutical Division, Japan) were provided by Meiji
Pharmaceuticals (Thailand). The methodology used for sus-
ceptibility testing was direct colony suspension according
to guidelines suggested by CLSI. The proposed breakpoints
for inhibition zone diameter of biapenem recommended by
the manufacture are >20mm for susceptible, 15-19mm for
intermediate and <14mm for resistant.
Results: All strains of B. pseudomallei had inhibition zone
diameter greater than 39mm. The MIC50 and MIC90 of bia-
penem against B. pseudomallei were <0.125 and 0.25g/ml
respectively. All strains of B. pseudomallei had biapenem
MIC less than 0.64g/ml.
Conclusion: Biapenem is very active against B. pseudo-
mallei and biapenem could be analternative therapy for
melioidosis.
doi:10.1016/j.ijid.2010.02.1916
48.006
Role of Efﬂux pumps in the development of quinolone-
resistance in Peruvian Escherichia coli isolates
S. Mosquito1,∗, M.J. Pons2, T.J. Ochoa3, R.C. Maves4, J.
Ruiz5
1 Universidad Peruana Cayetnao Heredia, Lima, Peru
2 CRESIB, Barcelona, Spain
3 Universidad Peruana Cayetano Heredia, Lima, Peru
4 U.S. Naval Medical Research Center Detachment, Lima,
Peru
5 Centre de Recerca en Salut Internacional de Barcelona,
Hospital Clinic/Institut d’Investigacions Biomèdiques
August Pi i Sunyer, Barcelona, Spain
Background: Active efﬂux pumps are important in the
development of antibiotic-resistance. Inhibitor efﬂux pumpsts e193
re under investigation because the possibility to be used
n the future together with antimicrobial agents. Phe-Arg-
- naphthylamide (PAN) is a broad spectrumefﬂux pump
nhibitor on quinolone susceptibilities in microorganisms
uch as Escherichia coli. The objective of this study is to
etermine the effect of PAN in the MIC of quinolones, to
elate its effect with the presence of mutations in gyrA and
arC genes and with the presence of transferable mecha-
isms of quinolone-resistance (qnr and aac(6’)Ib-cr genes)
n Escherichia coli peruvian isolates.
Methods: MICs for nalidixic acid (NAL) and ciproﬂoxacin
CIP) were determined in the presence or absence of PAN
20mg/L) by agar dilution in 67 Nalidixic Acid resistant E.coli
solates. Quinolone resistance mechanisms were investi-
ated by PCR ampliﬁcation of gyrA, parC, qnrA, qnrB, qnrS
nd aac (6‘)lb genes. Ampliﬁed fragments of gyrA and parC
ere sequencied to detect the presence of mutations.
Results: The typical mutations in gyrA (Ser83 1 Leu; Asp87
Asn) were found in 38 and 9 isolates respectively, in the
arC mutations (Ser80 1 Ile; Glu84 1 Val, Gly) were found
n 15, 4 and 1 isolates respectively. Seven strains were PCR
ositives for QnrB and eight for aac (6‘)lb. No QnrA or QnrS
ositives were found. In 30 isolates, the effect of the PAN
n the MIC of NAL was higher than 4 folds, in the half of
hem (n = 15) the effect was higher than 8 folds, while no
ffect in the MIC of CIP was observed. In 6 isolates the NAL
esistance was associated exclusively to the effect of PAN-
nhibible efﬂux pumps.
Conclusion: PAN posses a high effect in the NAL MIC, sug-
esting a high relevance of PANinhibible efﬂux pumps in
he development of quinolone-resistance. This fact has also
een supported by the presence of isolates in which only
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when given as 600mg twice daily. The optimal dosage of line-
zolid requires further delineation through balancing efﬁcacy
and toxicity.
doi:10.1016/j.ijid.2010.02.1919194 14
ntibiotics: Pharmacology and Clinical Studies
Poster Presentation)
9.001
murine gastritis model to study antibacterial effect of
amellia sinensis (Green Tea) against H.pylori infection
. Sherwani1,∗, F. Aziz2, T. Siddiqui3, S. Akhter4, W.
hmed3, S.S.U.K. Kazmi5
Federal Urdu University, Karachi, Pakistan
Karachi University, Karachi, Pakistan
Pakistan Medical and Research Council, Jinnah Postgradu-
te Medical College, Karachi Pakistan, Karachi, Pakistan
Department of Medicine and Department of Surgery, Dow
edical College and, Karachi, Pakistan
University of Karachi, Karachi, Pakistan
Background: Research studies reveal that green tea con-
ains catechins, polyphenols and related compounds possess
ariety anti-tumor effects and bactericidal properties. This
tudy is meant to evaluate the antimicrobial potential of
queous crude extract of dried leaves of Camellia sinensis
Green Tea) against H.pylori in vivo and in vitro conditions.
Methods: A total of 250 biopsies were collected from
he patients of gastro-duodenal pathology from govern-
ent sector hospitals in Karachi, Pakistan. All these biopsies
ere processed for detection of H.pylori by rapid Heli-
ourease, culture and polymerase chain reaction (PCR) for
he 16S ribosomal gene of H.pylori. All the isolates were
creened for their susceptibility against antibiotics and
queous extract of Camellia sinensis (Green Tea) by agar
ell diffusion as well as micro-broth dilution. In-vivo stud-
es were carried out by developing Gastritis Models (divided
nto 4 groups and each has got 3 test mice and 1 control
ouse) in BALB/c mice by infecting orally with sub-lethal
oses of 100 !l of 10 7ml of H pylori culture. The gastritis
odel was developed after inoculation H.pylori for about
days, 14 days, 21 days, 28 days and 34 days with subse-
uent doses of 5% aqueous extract of geen tea whose MIC
as 28mg/ml.
Results: In this study, a total of 88, clinical H pylori iso-
ates were isolated and identiﬁed by rapid and molecular
ethods and our isolates showed a high level resistance
owards Tetracyclin (60%), Metronidazole (80%), and Amox-
cillin (60%), Erythromycin (40%), Clarithromycin (30%),
ﬂoxicin (8%).A signiﬁcantly large zone of an average 21mm
as found on most of the isolates in case of in-vitro studies.
oreover, 4 fold reductions of Cfu/ g was noted in 7 days, 14
ays and 21 days, but fairly moderate CFU/g was observed
n control upon organ culture. The results were also found in
greement to the histopathological ﬁndings of the stomach
ndicating successful establishment of infection and gastritis
nd upon treatment by the green tea, the reduction in the
io-load
Conclusion: Owing to the exorbitantly high resistance like
n Metronidazole that is a cause of the failure of treatment
n combined therapy, the results of the current study provide
seful insights to the developments of new antimicrobial
gent like green tea as a therapeutic intervention tool.
oi:10.1016/j.ijid.2010.02.1918ternational Congress on Infectious Diseases (ICID) Abstracts
9.002
arious dosages of linezolid in treatment of difﬁcult
ultidrug-resistant tuberculosis
.W. Yew
Grantham Hospital, Hong Kong, China
Background: Linezolid has a potential role in treatment of
omplicated multidrug-resistant tuberculosis (MDR-TB) and
xtensively drug-resistant tuberculosis (XDR-TB). However,
ore clinical experience is desirable regarding its dosing and
olerance.
Methods: All patients treated with linezolid plus other
econd-line drugs in a tertiary tuberculosis center for
uoroquinolone-resistant MDR-TB or XDR-TB from May 2004
o January 2009 were identiﬁed. Their clinical records were
eviewed through October 2009.
Results: Twelve patients with ﬂuoroquinolone-resistant
DR-TB and 7 patients with XDR-TB (including one probable
ase) were enroled. They were given levoﬂoxacin 600-
00mg daily together with linezolid and other second-line
gents. Linezolid was administered in 600mg twice-daily
osing in 14 patients for a median of 56 days [interquar-
ile range (IQR) 42-56 days], and 800mg once-daily dosing
n 5 patients for a median of 84 days (IQR 42-112 days). Of
hese 19 patients, 8 (42%) achieved sputum culture conver-
ion before receiving linezolid and other second-line agents
nd culture negativity persisted; 7 (37%) had culture con-
erted to negative after a median of 12 weeks (IQR 8-12
eeks) of treatment; 3 (16%) had transient bacteriological
onversion to negativity followed by reversion to positivity
fter withdrawal of linezolid; and 1 (5%) failed to achieve
ny sputum culture conversion.
Among the 14 patients who received 600mg twice-daily
osing, 4 (29%) had signiﬁcant gastrointestinal distur-
ance and 9 (64%) patients developed anemia (hemoglobin)
0 g/dL). Two (14%) tolerated treatment well without any
ide-effect. Among the 5 patients who received 800mg
nce-daily dosing, 2 (40%) had no adverse events, 2 (40%)
atients had anemia, and 2 (40%) experienced mild limb
aresthesia.
A total of 6 (32%) patients completed treatment with
elapse in one. Four (21%) defaulted from treatment. Two
11%) patients died, one from lung carcinoma and the other
rom TB. Seven (37%) patients were continuing treatment
ith one still on linezolid.
Conclusion: Complicated MDR-TB or XDR-TB may require
rolonged linezolid therapy. Linezolid administered as
00mg once daily appeared to be better tolerated than
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gies for this antibiotic in order to maximize clinical efﬁcacy,
reduce patient risk of developing bacterial resistance and
minimize adverse effects.
doi:10.1016/j.ijid.2010.02.192114th International Congress on Infectious Diseases (ICID) Abs
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Intravaginal pentamycin for the treatment of bacterial
vaginosis
C. Winnips1,∗, J.A. Balmer2
1 Lumavita AG, Basel, Switzerland
2 Gynäkologie und Geburtshilfe, Spiez, Switzerland
Background: Pentamycin 3mg vaginal tablets
(FemiFect®, Lumavita AG, Basel, Switzerland) is effective
in the treatment of vaginal infections caused by Tri-
chomonas vaginalis, Candida albicans and mixed ﬂora (Clin.
Ter. 92: 137-142, 1980; Internet Journal of Gynecology
and Obstetrics 11(1), 2009). While pentamycin has shown
in-vitro activity against some pathogenic bacteria, it is
inactive against the lactobacilli that colonize the healthy
vagina, making it an ideal therapeutic candidate for the
treatment of bacterial vaginoses. The objective of this
study was to investigate the efﬁcacy, safety and tolerability
of intravaginal pentamycin in women with symptomatic
bacterial vaginosis.
Methods: This open-label clinical trial included 92
women, aged 15-78 years, who attended the gynaecol-
ogy clinic for symptoms of vaginitis and had a diagnosis
of bacterial vaginosis on the basis of the history, com-
plete gynaecological examination, wet mount evaluation
and microbiological analysis. The causative agent was pri-
marily Gardnerella vaginalis in 43 patients, while diverse
bacteria were found in the vaginal secretions of the other
49 women.
Twenty-ﬁve patients had previously received other
antimicrobial therapies without beneﬁt. Patients were
treated with intravaginal pentamycin (6mg daily for 5 days,
n = 58; 3mg daily for up to 10 days, n = 34), either alone
(73.9% of cases) or in combination with other therapies.
The gynaecological examination and microbiological anal-
ysis were repeated at the end of the treatment period,
when the occurrence of systemic or local adverse events
was also recorded and patient’s satisfaction was assessed
by using a questionnaire. Efﬁcacy endpoints were resolution
of symptoms and eradication of the causative agents.
Results: Resolution of symptoms and eradication of the
causative agents were demonstrated in 74.4% and 69.8%,
respectively, of patients with bacterial vaginoses primarily
caused by G. vaginalis and in 87.8% and 75.5%, respectively,
of patients with bacterial vaginoses caused by diverse bac-
teria. Irrespective of the dose of pentamycin administered,
treatment acceptance was rated as ‘‘good’’ by 69.8% of
patients with bacterial vaginoses primarily sustained by G.
vaginalis and 79.6% of those with a disease caused by diverse
bacteria. The therapeutic regimen was well-tolerated in all
cases.
Conclusion: Intravaginal pentamycin, either alone or in
combination with other therapies, is effective in the treat-
ment of bacterial vaginoses. The drug exhibits a favourable
tolerability proﬁle and is well-accepted by patients.
doi:10.1016/j.ijid.2010.02.1920ts e195
9.004
ntravenous colistin therapy for infections caused by
ultidrug-resistant gram-negative bacteria in critically ill
atients
. Cusato
Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Background: The increasing incidence of infections
aused by multidrug-resistant (MDR) Pseudomonas aerugi-
osa, Acinetobacter baumannii and Klebsiella pneumoniae
s a worldwide problem, particularly among patients with
mmune deﬁciency, burns or neutropenia. The signiﬁcant
esistance of these bacteria to the commonly used antibi-
tics and the expected lack of new agents available in the
ear future lead the clinicians to test the efﬁcacy and safety
f colistin, an old antibiotic whose use decreased because
f suspected toxicity and which is now used as the last ther-
peutic resort.
Methods: Thirteen (10 M, 3F; mean [SD] age 45.3
18.3] years; mean [SD] estimated body weight, 82.8 [21.9]
g;) critically ill patients with different conditions were
nrolled. SAPS II and SOFA scores were used to predict mor-
ality in the intensive care unit. All patients were treated
ith colistin sulphomethate sodium (CMS) intravenously (2M
.U.) every 8 h. After at least three days of therapy, blood
amples were collected before and at 1,2,3,4,6,8 h after the
nd of the 30-minute IV infusion. Colistin was measured
ith a speciﬁc high-performance liquid chromatography
ethod. Pharmacokinetic parameters were determined by
oncompartmental analysis using the Kinetica InnaphaseTM
.0 software.
Results: Patients received 2.19± 0.38mg/kg (range 1.58-
.49) of CMS per dose. At the steady-state, plasma
olistin had a mean [± S.D.] AUC (0-8 h), Cthrough,
max, t½, CrCL of 11.54± 6.20g h/ml, 1.02± 0.69g/ml,
.21± 1.08g/ml, 5.87± 2.56 h and 142.9± 57.8mL/min,
espectively. A clinical response was observed in 92% of
atients; treatment failed in one patient with severe
nderlying conditions (cerebral cancer, pneumonia). The
ntibacterial effect of colistin was evaluated by the
max/MIC and AUC/MIC ratios; ratios differed according to
he considered bacteria.
Conclusion: Based on our pharmacokinetic results, the
aximum concentrations of colistin achieved were proba-
ly sufﬁcient to ensure optimal Cmax/MIC ratios for all the
ramnegative bacteria under study.
However, we need to redeﬁne appropriate dosing strate-
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9.005
harmacodynamic proﬁling of intravenous antibiotics
gainst gram-negative bacteria collected during the Track-
ng Resistance in the United States Today (TRUST)
urveillance program
. Koomanachai, D.P. Nicolau ∗, J.L. Kuti, C.C. Bulik
Hartford Hospital, 06106, CT, USA
Background: Antibiotic resistance in Gram-negative bac-
illi (GNB) is escalating globally; thus achieving optimal
ntimicrobial exposures has become considerably more
hallenging. We used data from ‘‘Tracking Resistance in
he United States Today (TRUST) surveillance program’’ to
ompare the probabilities of attaining requisite antibiotic
xposures against Escherichia coli, Klebsiella pneumoniae,
cinetobacter baumannii, and Pseudomonas aeruginosa.
Methods: Using Monte Carlo simulation, pharma-
odynamic proﬁling was performed for standard and
rolonged infusions of cefepime 1&2gq12 h, 2gq8h(0.5h&3h
nfusions); ceftazidime 1&2gq8h(0.5&3 h); ceftriax-
ne; 1&2gq24h(0.5 h); ciproﬂoxacin 0.4gq8&12h(1 h);
oripenem 0.5, 1&2gq8h(1&4 h); ertapenem 1gq24h(0.5 h);
mipenem 0.5gq6&8h(0.5 h), 1gq8h(0.5&3 h); lev-
ﬂoxacin 0.75gq24h(1 h); meropenem 0.5gq6&8h(0.5 h)
hen 1&2gq8h(0.5&3 h); piperacillin/tazobactam
.375&4.5gq6h(0.5 h), 3.375gq8h(4 h), 4.5gq6h(3 h).
IC data were incorporated from the 2008 TRUST program.
harmacodynamic targets were deﬁned as fT>MIC >40% for
arbapenems, 50% for penicillins and cephalosporins. A
otal AUC/MIC ≥87 and ≥125 was applied for levoﬂoxacin
nd ciproﬂoxacin, respectively. The cumulative fraction of
esponse (CFR) was determined for each regimen against
ach population of organisms. Optimal CFR was deﬁned a
riori as ≥90%.
Results: The ﬂuoroquinolones displayed the lowest sus-
eptibilities against all organisms. All cephalosporins, car-
apenems and piperacillin/tazobactam had susceptibility
ates >90% for Enterobacteriaceae. Against P. aerugi-
osa, piperacillin/tazobactam portrayed the highest per-
ent susceptibility(90%), followed by meropenem(89.8%),
efepime(88%), and ceftazidime/doripenem(86%). All $-
actam regimens achieved optimal CFR against E. coli,
nd all but piperacillin/tazobactam 3.375 g q6h achieved
ptimal CFR against K. pneumoniae. The ﬂuoroquinolones
chieved the lowest CFRs against all organisms. Against P.
eruginosa, high dose, prolonged infusion doripenem and
eropenem achieved CFRs of 97.2% to 98.8%, followed
y high dose, prolonged infusion ceftazidime(93.3%) and
efepime(93.2%). No regimens achieved optimal CFR against
. baumannii. Prolonged infusion regimens increased CFR for
ll $-lactams against the non-fermenting GNB.
Conclusion: Standard intravenous doses of many com-
only $-lactam regimens have a high probability of
chieving optimal exposure against Enterobacteriaceae. For
on-fermenting-GNB, higher dose, prolonged infusions of
efepime, ceftazidime, doripenem, and meropenem offered
he highest probabilities of achieving bactericidal exposure.
oi:10.1016/j.ijid.2010.02.1922
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ral Ceﬁxime is beneﬁcial in acute uncomplicated
almonella gastroenteritis in children with mucoid or
loody diarrhea — Do indications of antibiotics therapy
eed reassessment?
.-Y. Lee1,∗, T.-Y. Lin2, C.-T. Wu3, C.-H. Chiu3, Y.-C. Huang3
Chang Gung Memorial Hospital and Chang Gung University,
weishan, Taoyuan, Taiwan, R.O.C
Chang-Gung Memorial Hospital, Linkou, Taiwan, R.O.C
Taoyuan, China
Background: Conventional antibiotics not only pro-
ided no beneﬁt to pediatric patients with uncomplicated
almonella enterocolitis but also increased the rate of
elapse and duration of fecal excretion. This study was
esigned to evaluate the role of ceﬁxime, an oral
ephalosporine with excellent activity against Salmonella,
n the treatment of uncomplicated nontyphoid Salmonella
nteritis in children.
Methods: In a randomized, prospective, double-blind,
wo-center study, children with uncomplicated Salmonella
astroenteritis and mucoid/bloody diarrhea were treated
ith oral ceﬁxime (10mg/kg/day divided twice daily) or
lacebo for 5 days. There was no signiﬁcant difference
etween these two groups in their characteristics, sever-
ty of disease and distributions of serogroups (Table 1). The
uration of fever and diarrhea were recorded by hours. Stool
amples were sent for culture weekly until three consecutive
egative results were obtained. Subsequent follow-up visits
ere at any time when diarrhea happened or at two-week
ntervals for the ﬁrst two months, three-month interval for
he following one year and two-year interval for the follow-
ng six years.
Results: Sixty-eight patients with acute, uncompli-
ated culture-proved Salmonella enteritis were enrolled.
erogroup B was the most commonly isolated serogroup
n both oral ceﬁxime group and placebo group (26/37,
4/31), followed by serogroup C (6/37, 3/31) and D
4/37, 4/31). The susceptibility rate of ceﬁxime in vitro
100%) was equal to that of ceftriaxone (100%), and
igher than those of ciproﬂoxacin (97.06%), ceftizoxime
97.06%), sulfamethoxazole-trimethoprim (51.47%), ampi-
illin (42.65%), and chloramphenicol (41.18%).The duration of diarrhea or mucoid diarrhea was signif-
cantly reduced by antibiotic treatment (mean 55.8 hours
s 79.2 hours, p = 0.009; 49.5 hours vs 73.0 hours, p = 0.036)
Table 2). Time to defervescence was signiﬁcantly short-
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ened in the group receiving ceﬁxime (mean 15.0 hours vs
29.3 hours, p = 0.028). However, there was no signiﬁcant dif-
ference with respect to the rate of clearance of Salmonella
from stool (p = 0.843). All followed-up samples after com-
pleting therapy, remained sensitive in vitro to ceﬁxime.
There was no relapse of the same pathogen found.
Conclusion: The clinical trial showed that ceﬁxime could
shorten the time to defervescence and the duration of
diarrhea signiﬁcantly. Prolonging the period of carriage or
increasing the risk of relapse was not found in this study.
Ceﬁxime could be considered in acute, uncomplicated,
Salmonella enteritis in children with mucoid/bloody diar-
rhea.
doi:10.1016/j.ijid.2010.02.1923
49.007
Evaluation of the pharmacodynamics of Daptomycin
(DAP)-Rifampin (RIF) combinations with Staphylococcus
aureus using various in vitro methods
S. Zinner1,∗, M. Smirnova2, E. Strukova2, A. Firsov2
1 Mount Auburn Hospital, Harvard Medical School, MA, MA,
USA
2 Gause Institute for Antibiotics, Moscow, Russian Federa-
tion
Background: The evaluation of antibiotic combinations
is often based on traditional checkerboard techniques (CT)
that might or might not provide optimal interpretations. In
this study, DAP plus RIF combinations were tested with S.
aureus using CT as well as time-kill curves at constant and
changing antibiotic concentrations – static studies (SS) and
dynamic studies (DS), respectively.
Methods: A clinical isolate S. aureus 866 (MIC of DAP
0.5mg/L, MIC of RIF 0.016mg/L) was tested using CT at DAP
concentrations ranging from 0 to 2mg/L and RIF concentra-
tions ranging from 0 to 0.06mg/L. In SS, the same organism
was exposed to DAP (0.5, 1, 2, 4, 8 and 6mg/L), alone and in
combination with RIF (DAP/RIF 1:1.5) over a 24-hour period.
In DS, S. aureus was exposed to daily administered DAP and
DAP+RIF for 5 consecutive days; the simulated ratios of area
under concentration-time curve (AUC) to the MIC were 50
and 50+75, respectively. The antimicrobial effects observed
in SS and DS were expressed by areas between the bacte-
rial concentration — time curves with and without antibiotic
(ABBCs).
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Results: Based on the CT data, DAP+RIF combinations
ere additive or indifferent (FIC index = 1). Based on ABBC
nalysis of the SS data, DAP+RIF was synergistic at relatively
ow AUC/MICs of DAP (24-96) or additive at higher AUC/MICs
f DAP (192-770). For example, the 24-hour ABBC of DAP
AUC/MIC 48) + RIF (AUC/MIC 72) was 9-fold greater than
hat of DAP (AUC/MIC 48). Similar differences in the effects
f DAP+RIF and DAP were established in DS: the 120-hour
BBC was 13 times greater in simulations of the combination
han DAP alone.
Conclusion: These data suggest that (1) checker-
oard technique-based evaluations of daptomycin+rifampin
ombinations can be misleading, and (2) in vitro pharmaco-
ynamic data obtained in static systems are predictive of
hose in dynamic studies.
oi:10.1016/j.ijid.2010.02.1924
9.008
he effectiveness of oral suppression in high risk pros-
hetic joint infections after total knee arthroplasty
. McBroom1,∗, D.J. Barbaro2
University of North Texas Health Science Center, Fort
orth, TX, USA
Tarrant County Infectious Disease Associates, Fort Worth,
X, USA
Background: Prosthetic joint infection (PJI) is a rare but
erious complication of total knee arthroplasty (TKA) and is
frequent reason for failure to retain the prosthesis. Recent
tudies have reported success rates of >80 percent with
ebridement and retention of prosthesis between 2 to 5-year
ollow-up periods. Lack of consensus on deﬁnitions of PJI
nd risk factors between centers makes evaluation of true
isk factors and outcomes a challenge. Though improved suc-
ess rates have been reported for the conservative approach
f debridement, intravenous (IV) antimicrobial therapy, and
rosthesis retention, little data exists on combining the use
f oral suppressive therapy with this treatment option.
Methods: Nine year retrospective study of 28 high risk PJI
atients after TKA who had been treated with debridement,
ix weeks IV antimicrobial therapy and prosthesis retention,
r the same treatment with oral suppressive therapy and had
two to ﬁve year follow-up to ascertain the effectiveness
f oral suppressive therapy, excluding potential confound-
ng factors such as chemotherapy, HIV treatment, or steriod
herapy. Statististical analysis involved estimation of cumu-
ative probability of treatment failure using Kaplan Meier
ethod and total curve comparison was obtained by using
he Mantel-Cox logrank method. Fisher’s exact test and the
ilcoxon rank sum test were used for univariate analysis.
Results: The 2-year cumulative probability of failure for
ral suppressive therapy was 7% (95% CI: 0.04 to 27.5)
ompared to 42% (95% CI: 17.7 to 66.07) for the control
roup. Oral suppressive therapy was signiﬁcantly differ-
nt than control (P = 0.033).Conclusion: Treating high risk
atients with only six weeks IV antimicrobial therapy and
ebridement, especially in early postoperative infections,
ould lead to treatment failure sooner than when treating
atients with oral suppressive therapy. The effectiveness
f this treatment could reﬂect the importance of using
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ifampin/vancomycin or similar combinations during the six
eeks preceding the baseline of this study.
oi:10.1016/j.ijid.2010.02.1925
9.009
opulation pharmacokinetics of meropenem in pediatric
atients: a concurrent analysis of the plasma and urine
oncentration data
. Ikawa ∗, N. Morikawa, K. Ikeda, M. Miki, M. Kobayashi
Hiroshima University, Hiroshima, Japan
Background: This study aimed to develop a population
harmacokinetic model for meropenem in Japanese pedi-
tric patients, speciﬁcally focusing on the drug urinary
xcretion process. This study also aimed to use this model
o assess the pharmacodynamics of meropenem regimens
gainst common bacterial populations.
Methods: Pharmacokinetic data (229 plasma samples and
1 urine samples) were collected from 40 infected children
age, 0.2—14.8 years; body weight, 3.8—64.0 kg) in nine
eparate studies. The data were concurrently ﬁtted into
multi-compartment model using the NONMEM program.
he developed model was then used for a pharmacody-
amic Monte Carlo simulation to estimate the probabilities
f attaining the bactericidal target (40% of the time for
hich the free drug concentration remains above the MIC
or the bacterium).
Results: In the ﬁnal population pharmacokinetic model,
ody weight (BW, kg) was the most signiﬁcant covariate
s follows: CLr (L/h) = 0.254 3 BW, CLnr (L/h) = 3.45, Vc
L) = 0.272 3 BW, Q (L/h) = 1.65 and Vp (L) = 0.228 3 BW,
here CLr and CLnr are the renal and non-renal clearances,
p and Vc are the volumes of distribution of the central and
eripheral compartments, and Q is the intercompartmen-
al (central—peripheral) clearance. The pharmacodynamic
ssessment based on this model showed that regimens of
0—40mg/kg, three times a day (0.5-h infusions), achieved
target attainment probability of >80% against clinical
solates of Escherichia coli (MIC90 = 0.03mg/L), Streptococ-
us pneumoniae (MIC90 = 0.5mg/L), methicillin-susceptible
taphylococcus aureus (MIC90 = 0.12mg/L), Haemophilus
nﬂuenzae (MIC90 = 0.25mg/L) and Pseudomonas aeruginosa
MIC90 = 1mg/L), in most typical patients (BW = 10, 20 and
0 kg).
Conclusion: These results provide a better understand-
ng of the pharmacokinetics of meropenem in Japanese
ediatric patients. They are also useful in the choice of a
eropenem regimen based on the BW of the patient and
he susceptibility of the causative bacteria.
oi:10.1016/j.ijid.2010.02.1926
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ppropriate use of ﬂuoroquinolones in a Lebanese ter-
iary medical center
. Kabbara ∗, P. Rahbany, S. Al-Natour
Lebanese American University, Byblos, Lebanon
Background: Fluoroquinolones are among themost widely
rescribed antibiotics especially for respiratory and urinary
ract infections. However, concerns about increasing resis-
ant micro-organisms associated with the use of these agents
ave emerged in both community and hospital settings. This
as been particularly a rising major problem in Lebanon
s the resistance to ﬂuoroquinolones has reached 30-40%
y 2008 (for E.coli and Klebsiella species). The primary
bjective of this study is to assess the appropriate use of
uoroquionolones in a Lebanese tertiary medical center by
valuating the appropriate indication, dose, dosage adjust-
ent in renal impairment, and the duration of treatment.
Methods: We conducted a prospective observational
tudy at Raﬁc Harriri University Hospital in Beirut, Lebanon
etween January and June 2009. We identiﬁed 118 patients
eceiving broad spectrum ﬂuoroquinolones (levoﬂoxacin,
iproﬂoxacin and moxiﬂoxacin). The majority of patients
ere in internal medicine ﬂoors or in the intensive care unit.
data collection form inculding all pertinent information
as used. Patients were followed from initiation of ﬂuoro-
uinolone therapy to the discharge date. The assessment
or the appropriate use was based on relevant guidelines
rom the Infectious Disease Society of America, manufac-
urer package inserts and clinical judgment. Monitoring of
lood glucose levels with ﬂuoroquinolone therapy was also
valuated.
Results: The patient population was predominantly male
62.7%) and the mean age was 62.8 years. About one third
f the patients (29.6%) had decreased renal function neces-
itating dosage adjustment of ciproﬂoxacin or levoﬂoxacin.
he main indications were community acquired pneumonia
nd diabetic foot infections. Cultures were taken in only
9.3% of patients. Of the positive cultures, the most com-
on isolated micro-organisms were E. coli and Pseudomonas
eruginosa. The ﬁnal percentage of ﬂuoroquinolone appro-
riate indication, dose and duration of therapy was 93.2%,
4.5% and 57.6% respectively (which were also calculated
or each drug separately). 57.1% of patients did not receive
he appropriate dose adjustment according to the level of
enal dysfunction (calculated by using Cockcroft-Gault equa-
ion). Baseline blood glucose was monitored in only 21.5% of
atients.
Conclusion: The major clinical interventions that need
mprovement in our tertiary medical center are adequate
enal adjustment of the dose of ﬂuoroquinolones and the
uration of therapy.
oi:10.1016/j.ijid.2010.02.1927
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Impact of restriction policy as part of an antimicrobial
stewardship program in a university hospital of a devel-
oping country
P. Titanti, V. Berdin˜as, J. Ramos, L. Manevich, L. Barcelona,
P. Rios, G. Lopardo ∗
Hospital B Houssay, Buenos Aires, Argentina
Background: In an era of growing concern about bacte-
rial resistance and hospital costs, limiting the use of broad
spectrum antibiotics is important. The purpose of this study
is to evaluate the impact of restriction policy as part of an
antimicrobial stewardship program.
Methods: The study was conducted in a 140-bed univer-
sity hospital of a developing country. Tools of the program
were development of guidelines of antimicrobial therapy
for common community and hospital-acquired infections and
education to improve antimicrobial prescription. During the
ﬁrst period of the program we implemented a policy of
prior approval for selected antibiotics. Every day pharma-
cists reviewed prescriptions and the team discussed with
prescribing physicians to accomplish with hospital guide-
lines. After one year of implementation of the program,
we stopped the restriction policy and we kept on working
with the other tools of the program. To assess if cessation
of restriction was associated with an increase in antimi-
crobial consumption, we measured antibiotic consumption
during the ﬁrst year (period 1) and during one year after
we stopped restriction (period 2). Antimicrobial consump-
tion was measured by Deﬁned Daily Dose (DDD) normalized
by 1000 bed-days.
Results: During the period 2 antibiotic consumption
of ceftriaxone, ceftazidime and vancomycin decreased;
it remained unchanged for piperacillin-tazobactam while
cefepime, imipenem and colsitin increased
Period 1 Period 2 Percentage
of Increase/
Decrease (%)
P value
Antibiotic DDD per
1000
beddays
Cefepime 53,73 80,97 +50,7 <0.01
Ceftazidime 17,56 12,57 -28,4 <0.01
Ceftriaxone 40,00 32,07 -19,8 <0,01
Colistin 9,25 19,50 +110,8 <0,01
Imipenem 14,11 21,65 +53,4 <0,01
Piperacillint-
azobactam
30,36 30,19 -0,05 0,9
Vancomycin 44,31 36,98 -16,5 <0,01
Conclusion: Antibiotic consumption of 4 out of 7 agents
did not increased after we stopped restriction policy, while
some agents suffered an increased; these agents were those
mainly prescribed in intensive care unit associated to an
increase in isolation of multidrug resistant Acinetobacter sp.
Programs aimed to improve antibiotic prescription accom-
panied by measurement of antibiotic consumption may help
to focus the program in some particular agents and areas of
the hospital, and also to reinforce other infection control
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easures.
oi:10.1016/j.ijid.2010.02.1928
0.003
tilization of activated protein C (Xigris) in a large teach-
ng hospital- Possible overuse and complications
.R. Wallace, C. Arinyedokiari ∗, B. Dattani
Orlando Health, Orlando, FL, USA
Background: The role of drotrecogin alpha (Xigris) in the
reatment of septic shock remains controversial. The recent
iterature suggests there is little or no beneﬁt, and deﬁnite
isk, for patients whose APACHE II scores are less than 25.
2007 Cochrane analysis stated that the beneﬁt of Xigris
n patients with higher APACHE II scores was supported only
y ‘‘very weak evidence’’. We reviewed our institutional
xperience with this agent.
Methods: Retrospective evaluation of the records of 73
atients receiving Xigris at an 808-bed teaching hospital
rom April 2003 to June 2008. APACHE II scores, demographic
ata, clinical outcomes, 28-day mortality, and incidence of
leeding complications were assessed.
Results: Forty-ﬁve of 73 (61%) patients had an APACHE
I score ≥25. The overall incidence of bleeding was 18 of
3 (25%); in 8 cases, severe or life-threatening bleeding
ccurred. Six of 18 (33%) patients with bleeding during the
nfusion had APACHE II scores < 25, with 4 of those 6 cases
escribed as severe. The 28-daymortality among all patients
as 25 of 73 (34%), with 19 of 25 (76%) having APACHE II
cores ≥25 and 6 of 25 (24%) having APACHE II scores < 25.
elative to the APACHE II scores, the 28-day mortality was
9 of 45(42%) among patients with an APACHE II score ≥25
nd 6 of 28 (21%) among patients with an APACHE II score <
5.
Conclusion: Thirty-nine percent of patients receiving
igris had APACHE II scores less than 25; its value in these
atients is unproven. The incidence of bleeding during infu-
ion of this drug is signiﬁcant and is associated with higher
PACHE II scores, but severe bleeding occurred even among
hose with lower APACHE II values, who were less likely to
erive any beneﬁt from its use. Xigris may be signiﬁcantly
ver utilized, and its use is not without risk.
oi:10.1016/j.ijid.2010.02.1929
0.004
ntimicrobial prophylaxis for transrectal ultrasound
uided biopsy of prostate: a comparative study between
ingle dose of Gentamicin vs. Oﬂoxacin
. Chazan ∗, G. Zelichenko, Y. Shental, H. Edelstein, R. Raz
Ha Emek Medical Center, Afula, Israel
Background: Prostate cancer is the most common malig-
ancy in men, and has been increasing in incidence in the
estern world. The gold standard for diagnosing prostate
ancer is a transrectal US-guided biopsy. One of the com-
lications of this procedure is the development of urinary
ract infections. It has been shown that treatment with pro-
hylactic antibiotics prior to the procedure reduces the rate
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importance of this study is that tigecycline may be a
therapeutic option for chronic osteomyelitis resistant Acine-
tobacter sp, under which treatment options are very limited.
doi:10.1016/j.ijid.2010.02.1932200 14
f infections. The widespread use of quinolones for this and
ther reasons has led to an increase in resistant bacteria.
ims of this study: to evaluate the efﬁcacy of single-dose
entamicin in comparison with single dose of oﬂoxacin in
atients underwent transrectal ultrasound guided biopsy of
rostate.
Methods: 109 patients undergoing a prostate biopsy were
andomly assigned to two groups: the ﬁrst group was treated
ith a single dose of oﬂoxacin (400mg) prior to the biopsy
nd the second with a single dose of gentamicin (3mg/kg).
linical signs and symptoms, and urine tests and cultures
ere followed 2 and 7 days after procedure.
Results: 57 patients received Oﬂoxacin and 52 Gentam-
cin. 3 patients in the Oﬂoxacin group (5.2%) and 4 in the
entamicin group (7.6%) developed urinary tract infections
N.S). No diferences were seen in the clinical outcome
etween the groups.
Conclusion: The development of quinolone resistant
acteria has led us to examine alternative options for pro-
hylactic treatment before prostate biopsies. Gentamicin,
as as efﬁcient as quinolones in the prevention of urinary
ract infections. A single dose prior to the procedure is suf-
cient and longer treatment duration is unnecessary.
oi:10.1016/j.ijid.2010.02.1930
0.005
educing inappropriate antibiotic usage and costs in
n academic Hematology-Oncology unit via antimicrobial
tewardship
.L. Yeo ∗, T.S. Wu, R. Lim, P.A. Tambyah, L.Y. Hsu
National University Health System, Singapore, Singapore
Background: Rising consumption of broad spectrum
ntimicrobials and increasing prevalence of resistant
athogens have raised concerns about antimicrobial use
n recent years. Antimicrobial stewardship programs have
een reported to improve patient and institutional outcomes
hile potentially reducing cost and resistance rates. In the
ight of these ﬁndings, an antimicrobial stewardship program
ASP) was initiated in a tertiary care hospital in Singapore.
Methods: The program was initiated in July 2009
nd piloted in the haematology-oncology department. A
rospective audit and feedback mechanism was employed
or review of patients on selected broad spectrum antimi-
robials. Appropriateness for use was assessed based on
ndication of therapy, dose of antimicrobials used, and dura-
ion of therapy. Recommendations were made by infectious
isease physicians to the primary team in writing. Appropri-
teness of use, recommendations made, patient savings and
linical outcomes were analyzed for a period of four months
fter initiation of the program.
Results: A total of 462 cases were reviewed of which 64%
f them were appropriate. The most commonly prescribed
ntimicrobials were piperacillin/tazobactam, ceftazidime
nd imipenem, making up 19%, 16% and 15% of the cases
udited respectively. Among the recommendations made,
e-escalation and discontinuation of antimicrobials were the
ost common, eachmaking up 27% of the recommendations.
his was followed by recommendations for IV-to-PO switch
nd advice on treatment duration, which made up 11% ofternational Congress on Infectious Diseases (ICID) Abstracts
he recommendations each. The overall acceptance rate of
he recommendations was 89%. An estimate of the potential
atient savings due to the accepted recommendations came
p to $24, 590 over the four months period. There was no
igniﬁcant negative impact on clinical outcomes following
he recommendations.
Conclusion: ASP has demonstrated its impact in reduc-
ng unnecessary use of broad spectrum antimicrobials and
ost to patients. Extension of the program is likely to reduce
election pressure for drug-resistant pathogens in the insti-
ution and decrease antimicrobial expenditure.
oi:10.1016/j.ijid.2010.02.1931
0.006
igecycline usage in osteomielitis caused by multidrug-
esistent acinetobacter: A report of 10 cases from a single
nstitution
.M. Ruiz1, E. Gayoso2,∗, Y. Vasquez3
Hospital militar, Caracas, DC, Venezuela
Hospital Millitar, caracas, DC, Venezuela
Hospital Militar Dr. carlos Arvelo, Caracas, DC, Venezuela
Background: Acinetobacter infectious has been identiﬁed
n soldiers who participated in wars as Korean, Vietnam and
iddle Orient, by now the therapeutics options are limited
or this type of multidrug resistant microorganism, we know
hat the use is not approved for de treatment a bone infec-
ious, so we found necessary to evaluate the efﬁcacy of
igecycline in the treatment of this entity.
Methods: We identiﬁed 10 patients with chronic
steomielitis during 2007-2008, this study of cases is
rospective, descriptive analytical, we use the microbio-
ogical method of Kirby-Bauer and the criteria of inclusion
ere patients with clinical diagnosis, microbiology isolation,
maging and bone biopsy. Exclusion criteria: inmunocompro-
ised and pregnant woman.
Results: 10 patients completed the study; the 88% were
ales, age 19 to 72 years, mean 39 years. The more com-
on location were: hip, femur, tibia, sacrum and calcaneus.
he risk factors identiﬁcated were: open fracture, vascular
ompromise, prolong use of antibiotic, long stay and re-
nterventions. Positive cultures for A. baumannii 100%. They
eceived different regimens of antibiotics without success,
t this time we began with tigecycline IV 100mg the ﬁrst
ay and then 50mg IV q 12hs for 6-7 weeks, all the patients
ncluded a combined surgical and medical management.
Conclusion: 90% showed clinical improvement, and the
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Tetanus immunity among intravenous drug users in Upp-
sala County, Sweden
S. Sylvan
Uppsal University Hospital, Uppsala, Sweden
Background: Lately, an upsurge in cases of Clostridium
tetani infections among injecting drug users (IDUs) has
occurred in the USA and the United Kingdom. The majority
of tetanus cases occurred among persons inadequately vac-
cinated or with unkown vaccination history who sustained
an acute injury. This increased susceptibility may, in part,
explain the disproportionate occurrence of tetanus among
IDUs. The aim of our study was to evaluate the levels of
antibody to tetanus toxoid among IDUs in Uppsala County,
Sweden
Methods: Blood samples obtained from 37 IDUs were
determined for the level of anti-tetanus antibodies with EIA
(Enzyme Immuno Assay). Titers >IgG 0.3 IU/ml were con-
sidered protective with long lasting immunity whereas IgG
0.03-0.3 IU/ml was considered low and protective. Lower
or absent levels of antibody (<0.01 IU/ml) was considered
non-protective antibody activity in serum.
Results: Among IDUs aged 26-45 years, 88% of the tested
individuals had anti-tetanus titers >IgG 0.3 IU/ml and 12%
had titers between 0.03-0.3 IU/ml. Among older IDUs (>45
years), 75% had long lasting immunity (>0.3 IU/ml) whereas
25% had titers between 0.3 — 0.03 IU/ml. None of the tested
IDUs lacked protective antibodies in serum.
Conclusion: IDUs in Uppsala County are sufﬁciently pro-
tected against tetanus at the moment. Because all wounds,
even minor and relatively clean wounds, confer a risk for
tetanus, health-care providers should review the vaccina-
tion status of all IDUs and administer indicated tetanus
toxoid vaccine to keep them fully protected.
doi:10.1016/j.ijid.2010.02.1933
51.002
Three-year surveillance of community-acquired and
health care-associated Methicillin-Resistant staphylococ-
cus aureus infections in Uppsala County, Sweden
S. Sylvan1,∗, B. Christenson2, B. Ardung2
1 Uppsal University Hospital, Uppsala, Sweden
2 Uppsala County Council, Uppsala, Sweden
Background: The purpose of this three-year prospective
surveillance was to recognize risk factors and spread of
Community-Acquired (CA) and Health Care-Associated (HCA)
MRSA infections in Uppsala County and to calculate the cost
by identiﬁcation of patients with MRSA infections.
Methods: MRSA was isolated between 2004-2006 by sys-
tematic screening, regardless of symptoms, from all patients
that had been treated in hospitals abroad or in the Stock-
holm area. During the study, 17 634 isolates were collected
from 7967 patients attending two hospitals and 37 primary
care clinics. A combination of molecular typing methods was
used, including pulsed-ﬁeld electrophoresis (PFGE) and mul-
w
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ilocus sequence typing (MLST) to determine the prevalence
f major clones. Clones were characterized by sequencing
f Staphylococcus protein A gene (spa typing). The viru-
ence factor the Panton Valentine Leukocidin (PVL) gene was
etermined. Themajority of the MRSA isolates were grouped
nto resistance proﬁles of seven antibiotics.
Results: 82 cases of MRSA infections were identiﬁed, 24
CA and 58 CA. The total cost for bacterial isolation of MRSA
as 7.2 million SEK (1.14 million USD)) which amounts to 86
05 SEK (13 870 USD) per identiﬁed patient. A majority of the
RSA infections originated outside Sweden (65%). Domestic
ases showed certain risk factors as alcohol or drug abuse,
mmunosuppression, chronic diseases and high age. Domes-
ic MRSA infections decreased during the period whereas
solates originating from patients infected abroad increased.
he isolates could be assigned into 9 clonal complexes.
ost frequent clonal complexes were CC8 (34%) isolates and
C80 (23%). Two clones, CC45 (6 cases) and CC1 (2 cases)
ere only domestic. None of the HCA isolates carried the
irulence determinant PVL gene whereas 52% of CA-cases
arboured the gene. Resistance to antibiotics, other than $-
actams was rare in domestic MRSA-infections (3%) whereas
6% of patients infected abroad were resistant to several
ntibiotics.
Conclusion: Sweden is a low endemic country. There was
o spread of MRSA in the community or in hospital during the
urveillance. Patients with family relations or travel in Mid-
le East or Asia were highly overrepresented. To save costs
elected screening of patients at risk should be advised.
oi:10.1016/j.ijid.2010.02.1934
1.003
ne-year epidemiology of febrile diseases on the
mergency Department of a Caribbean island: the
urac¸ao-experience
. Limper1,∗, I. Gerstenbluth2, A. Duits3, E. Van Gorp1
Slotervaart Hospital, Amsterdam, Netherlands
Medical & Public Health Service (GGD) of Curac¸ao, Cura-
ao, Netherlands
Red Cross Blood Bank Curacao, Curacao, Netherlands
Background: Fever is one of the most frequent causes
f attendance at emergency departments (EDs) worldwide.
he etiology of febrile diseases in tropical countries often
emains poorly characterized. Curac¸ao is a small tropical
sland in the Caribbean Sea with a semi-arid climate. The
urpose of this study is to describe the etiology and outcome
f febrile illnesses on the ED in Curac¸ao, during a one-year
eriod.
Methods: From April 2008 to April 2009, all febrile
atients (T > 38.5 ◦C) between 18 and 80 years who pre-
ented at the ED of the St. Elisabeth Hospital, Curac¸ao,
etherlands Antilles, were included. Clinical data were
ecorded, routine laboratory measurements and blood cul-
ures were taken. Supplementary diagnostics were ordered
t the discretion of the attending physician. Final diagnoses
ere made at discharge by an independent physician and
gain in retrospect by the main investigator, using all avail-
ble clinical data.
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Results: Between April 2008 and April 2009, 403 patients
ith fever were identiﬁed (207 males, 51.4%). Mean age was
1.4 yrs (SD 21.2 yrs). 223 Patients (55.6%) were hospital-
zed, 32 patients (7.9%) died and 18 patients (4.5%) were
dmitted to the Intensive Care Unit. In 129 febrile patients
32.0%), infection was proven. 84.4% of patients had bacte-
ial (29.0% urinary tract infection (UTI), 23.2% pneumonia),
.6% viral and 10.0% parasitic or fungal infection. In 34
atients (8.4%), dengue fever was suspected; dengue was
erologically proven in one patient. 21 Patients (5.2%) were
ischarged with a non-infectious diagnosis, most frequently
alignancy. 172 Patients (42.7%) were discharged without a
lear diagnosis.
inal diagnoses of febrile patients on the
mergency department, Curacao
onclusion: A high mortality rate of 7.9% was observed
n this cohort. We found a high prevalence of bacterial
nfections, with pneumonia and urinary tract infections as
ost common causes of fever. Not many typical tropical
nfections were seen, although many patients were diag-
osed with probable dengue fever during the rain season,
hich could not be corroborated serologically. One in 20
atients presenting with fever did not have an infectious
isease.
oi:10.1016/j.ijid.2010.02.1935
1.004
ransmission risk and predictability of invasive meningo-
occal disease
. Racloz1,∗, L. Da Silva2
Swiss Tropical Institute, Basel, Switzerland
Novartis Vaccines and Diagnostics, Cambridge, MA, USA
Background: In light of the media coverage concerning
ecent infectious disease outbreaks such as the ongoing
nﬂuenza pandemic as well as previous ones involving Severe
cute Respiratory Syndrome (SARS), the public domain has
ecome more conscience of infectious diseases as well
s the effect of travel aiding their spread. Meningococcal
eningitis has been a disease which among other fac-
ors such as age, climate and life style, is facilitated by
ravel. The causative bacterial agent, Neisseria meningi-
idis, being spread through aerosol respiratory droplets
an cause Invasive Meningococcal Disease (IMD), and is
p
(
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widely distributed, complex human disease affecting
ll age categories. Forecasting models exist for diseases
ased on vector-borne or wind related movement, as well
s climate derived assessments, and recently travel ori-
nted detection. Hence a combination of several factors
anging from meteorological to molecular level infor-
ation should aid in determining likely occurrences of
eningococcal meningitis epidemics in spatial and temporal
eans.
Methods: A systematic review was conducted in order to
dentify the different risks and models available in terms
f IMD spread. Varying risk stratiﬁcation was used to clas-
ify risk factors such as: travel related spread, respiratory
o-infections, the effect of new meningococcal clones into a
usceptible population, low humidity, high temperatures and
ifestyle based aspects. These data will be used to create an
arly warning system generated through various technolo-
ies and transmission models in order to highlight risk areas
nd periods of ongoing IMD.
Results: As other studies have shown, travel patterns
uch as destination, duration and timing during the year
ffect risk of IMD development and spread among travel-
rs, whilst climate, geography and factors such as virulence
f circulating strain are more important in determining the
everity of an outbreak in terms of local occurrence and
otential epidemic developments.
Conclusion: Meningococcal meningitis is not only a well
stablished threat in terms of epidemic or endemic occur-
ences, but also for travelers. Hence the development
f more accurate and timely detection and forecast-
ng methods are required to help in decision making
rocesses involving prevention and early warning pur-
oses.
oi:10.1016/j.ijid.2010.02.1936
1.005
ospitalizations due to pneumonia and case-fatality rates
n Brazil between 2003 and 2007
. Cássio de Moraes1,∗, E. Berezin1, J. Markowitz2, T.
ong3, P. Seljan4
Santa Casa University Hospital, São Paulo SP, Brazil
Health Data Analytics, Princeton Jct., NJ, USA
Pﬁzer Inc., Collegeville, PA, USA
Pﬁzer Inc, Collegeville, PA, USA
Background: In emerging countries, pneumonia is a lead-
ng cause of hospitalization and death, particularly among
oung children and older adults. Between 2000 and 2003,
3% of all deaths in children under 5 years of age living in
razil were due to pneumonia. Overall, deaths in Brazil due
o pneumonia averaged 4% between 1979 and 2001.
Methods: This was a retrospective study to quantify
he rate of hospitalizations due to pneumonia (HDTP) and
ases-fatality rates (CFR) in age groups ranging from <1
ears old to 80 years and older. An online, interactive web-
ased database of individuals hospitalized during the 5-year
eriod, 2003-2007 covered by the Integrated Health System
DATASUS) in Brazil was used to identify cases. The Insti-
uto Brasileiro de Geograﬁa e Estatística database served as
he source of the population/denominator statistics used for
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the incidence rate calculations. Case-fatality rates are the
percentage of HDTP cases who died.
Results: Overall, the observed rate of HDTP in Brazil has
shown a downward trend averaging 4.5 per 1000 residents
in 2003, and 3.9 in 2007. Children <1 year old had the high-
est reduction in rates of HDTP, from 47 per 1000 in 2003 to
36.4 in 2006. Brazilians 80+ years old had the next highest
incidence rates, averaging about 23 to 27 HDTPs per 1000
residents during the study period. CFRs related to HDTP have
increased steadily over time, averaging 2.9% in 2003, and 4%
in 2007. With the exception of the <1 year old age-group,
CFRs increased with age, and in the 80+ age group averaged
between 16% and 18%. In age groups under 5 years, CFRs
have declined slightly beween 2003 and 2007. In all other
age-groups, particularly the ones 30 years and older, CFRs
have generally risen.
Conclusion: As expected, the highest rates of HDTP were
observed in the extremes of age, very young and old. While
a slight reduction has been observed in HDTP rates, CFRs
have progressively risen during this same period particularly
for adults aged 80+. Pneumonia remains an important health
problem in Brazil.
doi:10.1016/j.ijid.2010.02.1937
51.006
Meningococcal meningitis epidemic in Arua district North
West of Uganda
M. Busuulwa
Medical Epidemiologist, Kampala, US, Uganda
Background: Meningitis due to Neisseria meningitidis has
an epidemic potential and a high case fatality rate. On
3rd September 2008, a meningitis epidemic was reported
in Arua district health ofﬁce, in north western Uganda. The
objective of the investigation was to conﬁrm the menin-
gitis epidemic, identify the causative agent, risk factors
and assess the district response capacity to handle the epi-
demic.
Methods: Community based cross-sectional study. We
purposively selected cases, their families, District health
team & local leaders for interview. Cerebral spinal ﬂuid sam-
ples were drawn from cases and sent to Central Public Health
Laboratory of Ministry of Health to isolate the causative
agent. Frequencies and distributions of cases with respect
to age groups and affected communities with EPIINFO 2006
were done.
Results: A total of 44 cases were detected and 10 deaths
occurred to meningitis. The Case Fatality Rate was 22.7%:
highest CFR (46.2%) occurred in those above 30years.Age
range was 3months to 65years. The causative agent for this
meningitis epidemic was identiﬁed to be Neisseria meningi-
tides type A with latex rapid test. 70.5% of the cases were
Years 2003 2004 20
No of cases 16 or10.89% 36 or 24.5% 61<30 years and the male to female ratio was 1:2. Charac-
teristically, it was discovered that the epidemic occurred
in the area which had missed vaccination against menin-
s
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itis in the previous outbreak of meningitis. Sleeping in
oorly ventilated huts and overcrowding: 3-5 huts with 7-
0 people/family cluster were risk factors to this mening-
tis.
Conclusion: Highest case fatality rate occurred amongst
ersons who are over 30 yrs old. Overcrowding, staying in
oorly ventilated huts and lack of previous vaccination were
hought to be predisposing factors to this meningitis epi-
emic.
oi:10.1016/j.ijid.2010.02.1938
1.007
he study of epidemiological data of the mumps and the
ffect of MMR vaccine in the Albanian children
. Hoxha1,∗, A. Simaku2, E. Kallfa-Foto3, G. Lito3, R.
etrela3, E. Thartori 1
University Hospital Center ‘‘Mother Theresa’’, Tirana,
lbania
Institute Public Health, Tirana, Albania
University Hospital Center Mother Theresa Tirana, Alba-
ia, Tirana, Albania
Background: Up to March 2005 in our country mumps was
ndemic diseases with every year epidemic and the chil-
ren were unvaccinated for these diseases. From March to
eptember 2005 was made a massive MMRII vaccination for
he children under 7 years and from this year this vaccine
as included in our routine national program vaccination.
he incidence of this diseases in years 2003 was 72.9/100000
abitants and in 2007,2008 were respecti vely 26.9 and
.6/100000
The aim of the study: was to show the epidemiological
ata of the mumps and his complications in Albanian chil-
ren and to show the effect of the MMRII vaccine in the
ecrease of the incidence of this diseases in Albania.
Methods: This is a retrospective study .In this study were
nrolled 147 children admitted in our hospital from January
003 to December 2008.The children were the age from 18
onths to 14 years old. For each children were studied the
ex, the age, the season, origin, complications, length of
he hospitalization and the status of the vaccination. All the
atients admitted in the hospital before March 2005 were
nvaccinated.
Results: The average age was 6.3, 96 cases or 65.3%
ere 5-14 years old followed by 1-4years old with 47 cases
r 31.9%,predominantly male patients with 112 cases or
6.19%, 105 cases or 71,43% were admitted in the spring
nd summer seasons, there is not any difference for origin.
e saw these complications: neurological manifestations in
1 cases or 41.5%, pancreatitis 24 cases or 16.3%, orchitis 18
ases or 12.2% manly in the patients up 12 years old, tonsil-
itis and maxillitis 28 cases19.1%.The spread of the patients
y years was shown in the following table:
2006 2007 2008
1.5% 23 or 15.6% 9 or 6.12% 2 or 1.36%Conclusion: The majority of the cases was happen in the
ummer and spring, the male suffer more often from this
iseases and the neurological manifestation were seen more
ften as othermanifestations. In the last 2 years, the vaccine
e th In
a
d
d
5
P
D
t
h
t
w
o
e
P
t
a
w
b
c
m
d
3
d
p
1
(
6
(
r
g
t
w
a
8
a
t
o
a
p
s
d
p
d
5
S
A
L
d
s
c
t
r
w
s
v
d
v
c
i
A
r
o
t
A
c
c
c
t
s
c
n
F
r
t
A
o
o
A
o
s
s
B
i
d
5
S
d
M
t
t
F
4
i
d
e
d204 14
gainst mumps have reduce very much the incidence of this
iseases in our country.
oi:10.1016/j.ijid.2010.02.1939
1.008
ertussis in Brazil: An overview from 1988 to 2009
. Leite ∗, L.C.V. Melo, T.M.I. Vaz, K. Irino
Instituto Adolfo Lutz, São Paulo, Sao Paulo, Brazil
Background: The introduction of pertussis vaccination in
he past decades reduced substantially the number of cases;
owever, despite the high vaccination coverage rates, per-
ussis is still a major threat to public health all over the
orld including Brazil. In this study we present an overview
f pertussis in Brazil in the last two decades.
Methods: Between 1988 and 2009, the National Refer-
nce Laboratory for Pertussis, Instituto Adolfo Lutz, São
aulo, Brazil, received a total of 985 presumptively iden-
iﬁed Bordetella spp strains, isolated from sporadic cases
nd/or some pertussis outbreaks. The strains were for-
arded by the Regional Laboratories in São Paulo State and
y the Central Public Health Laboratories throughout the
ountry. Identiﬁcation of the species was done by standard
ethods. Detection of O1 antigen, and the serotyping were
one by slide agglutination test using O1, and Fim 2 and Fim
antibodies, respectively. Molecular characterization was
one by Pulsed Field Gel Electrophoresis (PFGE).
Results: All the 985 strains were conﬁrmed as Bordetella
ertussis and the most of them belonged to the serotype
,3. Strains from southeastern states accounted for 67%
660/985), most of them from São Paulo State (646/985;
5.6%). The remaining 325 strains were from south region
147/985, 15%), northeastern states (87/985, 8.8%), north
egion (48/985, 5%) and central area (43/985, 4.4%). The
reat majority (81.1%, 799/985) was from children under
welve years of age, and among them 84.4% (675/799)
as from infants aged less than six months. Strains from
dolescents and adults accounted for 3.2% (32/985) and
% (78/985), respectively. The age group was unknown in
pproximately 7.7%. Strains belonging to several PFGE pat-
erns were identiﬁed and some were prevalent.
Conclusion: Different B. pertussis clones circulate all
ver the country. These data do not cover all the country,
nd may represent only a fraction of the actual number of
ertussis cases due to the underreporting, despite pertus-
is is, in Brazil, a reportable disease since 2001. Data on age
istribution of pertussis cases may contribute to develop the
olicy of booster doses of vaccine in adolescents and adults.
oi:10.1016/j.ijid.2010.02.1940
1.009
erogroup B epidemiology in the southern cone of South
merica. A literature review
. Da Silva ∗, M.H. KyawNovartis Vaccines and Diagnostics, Cambridge, MA, USA
Background: The epidemiology of meningococcal disease
iffers greatly by country and time period. Only passive
b
W
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urveillance systems for meningococcal disease exist in
ountries in South America. Thus, little is known about
he pattern of serogroup distribution by country in this
egion. Existing data showed that serogroup B is prevalent
orldwide, with various strains and clones causing endemic,
poradic and epidemic disease. Several of these clones are
ery virulent. Understanding the local and national seroepi-
emiology of group B meningococcal disease is critical for
accine formulations and vaccine policies.
Methods: We examined the current disease burden
aused by serogroup B in the southern cone of South Amer-
ca, comprised of Brazil, Uruguay, Paraguay, Chile, and
rgentina. Clinical data were retrieved following systematic
eview of the literature by country. The 2008 SIREVA report
n invasive disease was also consulted.
Results: Until the late twentieth century, countries in
he southern cone had similar disease epidemiology to Latin
merica as a whole. However, in recent years, this has
hanged. In Brazil, signiﬁcant differences in epidemiology
an be identiﬁed between areas close to other southern cone
ountries and areas bordering Andean or Caribbean coun-
ries. Fluctuations in the proportion of serogroup B versus
erogroup C disease have been observed in southern cone
ountries, yet serogroup B consistently accounted for a sig-
iﬁcant disease burden throughout the early 21st century.
or example, 100% of serotypable meningococcal disease
eported in Chile between 1990 and 2003 was attributed
o serogroup B, as was 40% to 65% of disease in Brazil. In
rgentina, serogroup B consistently accounts for about 60%
f invasive meningococcal disease. Even with the emergence
f disease caused by Serogroups Y and W-135 in Brazil and
rgentina since 2000, serogroup B has remained the cause
f a consistent and ongoing public health problem.
Conclusion: Invasive disease caused by meningococcal
erogroup B remains an important public health issue in the
outhern cone countries. An effective vaccine against group
meningococcal is needed to reduce the burden of disease
n South America.
oi:10.1016/j.ijid.2010.02.1941
1.010
tatus of bloodborne pathogen education for injection
rug users in Indiana hospital emergency departments
. Wenger
Indiana State Department of Health, Indianapolis, IN, USA
Background: The problem of the study was to determine
he status of bloodborne pathogen education for injec-
ion drug users in Indiana hospital emergency departments.
orty-six instruments were returned for a response rate of
3.8%.
Methods: The study was designed to answer the follow-
ng research questions: (a) Do Indiana hospital emergency
epartments have written policies on bloodborne pathogen
ducation for injection drug users? (b) To what extent
o Indiana hospital emergency departments provide blood-
orne pathogen education for injection drug users? and (c)
hat are the major barriers for Indiana hospital emergency
epartments in providing bloodborne pathogen education
or injection drug users? A valid instrument was developed
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Uruguay, were assessed and followed up. Rivera is a north-
ern department of Uruguay with 78.000 inhabitants and have
3 community hospitals. Annual incidence rates were calcu-
lated for age and sex strata. Denominators were obtained
from National Institute of Statistics.14th International Congress on Infectious Diseases (ICID) Abs
and sent to 110 Indiana hospital emergency department
nurse managers.
Results: The results indicated only three (7.1%) respond-
ing hospital emergency departments had written bloodborne
pathogen educational policies. Ten (20.8%) emergency
departments provided some form of bloodborne pathogen
education for injection drug users. Major barriers indicated
for not providing patient education consisted of insufﬁcient
monetary resources, injection drug users denying a drug
history, and emergency department nurses being unable to
identify injection drug usage.
Conclusion: On the basis of the ﬁndings and within the
limitations of the study, the following conclusions were
drawn: Indiana hospital emergency departments do not
provide bloodborne pathogen education for injection drug
users.
doi:10.1016/j.ijid.2010.02.1942
51.011
Neighborhood urban environmental quality conditions
probably drive malaria and diarrhea mortality in Accra,
Ghana
J. Fobil 1,∗, J. Fobil 2, A. Kraemer3, J. May1
1 Bernhard Nocht Institute for Tropical Medicine, Hamburg,
Germany
2 School of Public Health, University of Ghana, Legon, Accra,
Ghana
3 University of Bielefeld, Bielefeld, Germany
Background: Urbanization is an urban change process
which alters the structure and function of urban environ-
ment. The alteration in the quality of urban environmental
quality conditions has signiﬁcant implications for urban
health both in terms of change of vector ecology and infec-
tious disease transmission.
Methods: Study objectives: To investigate the relation-
ship between infectious disease (malaria and diarrhea)
mortality and spatial change in neighborhood urban envi-
ronmental quality in a rapidly urbanizing area in a low
income economy. Design: A time-point spatial analysis of
cluster-level environmental and mortality data using Princi-
pal Component Analytic (PCA) and multiple linear regression
models. Methods: Environmental variables were extracted
from the Ghana Census 2000 database and mortality data
were obtained and pooled together from the Ghana Births
and Deaths Registry in Accra over the period 1998-2002.
Results: While there was a very strong evidence of a dif-
ference in the risk of urban malaria mortality across urban
environmental zones of differing neighborhood environmen-
tal quality conditions, no such evidence of a difference in
urban diarrhea mortality risk was observed across these
zones. Additionally, whereas bivariate analyses showed a
weak to very strong evidence of association between the
environmental variables and malaria mortality, not the least
evidence of association was observed between urban diar-
rhea mortality and the environmental variables.ts e205
Conclusion: We conclude that environmental manage-
ent initiatives intended for infectious disease control
ight substantially reduce and/or lower the neighborhood
rban environmental quality attributable fraction of the risk
f urban malaria mortality more than that for urban diar-
hea mortality in rapidly urbanizing areas in a low income
etting.
oi:10.1016/j.ijid.2010.02.1943
1.012
ncidence of hospital- and ICU-admitted community-
cquired pneumonia: A population-based study in
ruguay
. Goleniuk1, H. Albornoz2,∗
Hospital Departamental de Rivera, Cooperativa de Asis-
encia Medica de Rivera-FEMI and Cooperativa Medica de
ivera, Intensive Care Unit, Rivera/UY, Rivera, Uruguay
Hospital Departamental de Rivera and Cooperativa de
sistencia Medica de Rivera-FEMI., Intensive Care Unit,
ontevideo/UY, Intensive Care Unit, Montevideo/UY, Mon-
evideo, Uruguay
Background: Community-acquired Pneumonia (CAP) is
till an important health problem with high mortality and
ntensive care unit (ICU) requirement. Basal requirement
ates of hospital and ICU (intensive care unit) admission are
elated to age, social condition, comorbidities and clinical
everity and are important background for requirements in
nﬂuenza pandemic period.
Objetive: to estimate the incidence rates of CAP requir-
ng hospital- and ICU-admission in the department of Rivera,
ruguay, in non inﬂuenza pandemic period.
Methods: a prospective cohort of all CAP patient’s >
5 years admitted between 1st May 2005 and 30th April
007 to all hospitals and their respective ICU in Rivera,
e th International Congress on Infectious Diseases (ICID) Abstracts
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R te of ICU-admitted (n)
M les Females Total
1 85 (29) 0.06 (1) 0.12 (2) 0.09 (3)
2 76 (21) 0.30(4) 0.35(5) 0.33(9)
3 17 (34) 0.14 (2) 0.20 (3) 0.17 (5)
4 10 (50) 0.59 (7) 0.17 (2) 0.38 (9)
5 29 (94) 1.07 (9) 0.96 (9) 1.01 (18)
6 45 (101) 2.95 (18) 1.21 (9) 1.99 (27)
7 .48 (109) 4.60 (14) 1.56 (7) 2.79 (21)
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Results: 495 (63 ± 19 years, male 53.9%) and 99 patients
ere admitted to hospital and ICU, respectively. Annual inci-
ence rates are showed in table.
ate of hospital admitted (n) Ra
ales Females Total Ma
5 - 24 y 0.82 (14) 0.89 (15) 0.
5 - 34 y 0.68 (9) 0.83 (12) 0.
5 - 44 y 0.99 (14) 1.35(20) 1.
5 - 54 y 2.37 (28) 1.83 (22) 2.
5 — 64 y 6.31 (53) 4.37 (41) 5.
5 — 74 y 10.15 (62) 5.24 (39) 7.
5 — 84 y 21.37 (65) 9.81 (44) 14
85 y 30.86 (22) 22.24 (35) 24
otal 3.58 (267) 2.82 (228) 3.
episodes/1000 inhabitants-year.
Conclusion: Incidence of hospital and ICU-admitted CAP
as 3.18 and 0.64 episodes/1000 inhabitants-year, respec-
ively. The incidence increased with age and were higher in
en.
oi:10.1016/j.ijid.2010.02.1944
1.013
he Survey of leptospirosis in Mazandaran province, north
f Iran by Microscopic agglutination test, 2006-2007
.P. Ziapour1,∗, B. Esfandiari 1, G. Abdollahpour2, M.
ssmar3, M.R. Yousseﬁ4, G. Amirbozorgi 1, B. Amini
avaie1, S. Sattari Tabrizi 2, M. Alipour Espeh-kolaie5
Pastuer Institute of Iran, Amol Researh Center, Amol,
azandaran, Iran, Islamic Republic of
Tehran University, Faculty of Veterinary Medicine, Karaj,
ehran, Iran, Islamic Republic of
Pasteur Institute of Iran, Tehran, Tehran, Iran, Islamic
epublic of
Azad Islamic University, Babol Unit, Babol, Mazandaran,
ran, Islamic Republic of
Babol University Medical Sciences, Yahya-nejad Hospital,
abol, Mazandaran, Iran, Islamic Republic of
Background: Leptospirosis, a septicemic zoonosis with
ultisystemic involvement, is caused by the pathogenic
trains of Leptospira interrogans. Rural farm workers are at
igh risk for leptospirosis, and it can be a signiﬁcant public
ealth problem when water and food safety are not ensured.
ince, the incidence of leptospirosis is signiﬁcantly high in
emperate regions, rice ﬁeld workers and livestock animals,
t will be necessary to evaluate condition of leptospirosis in
azandaran Province (north of Iran) and recognize common
erotypes for use in vaccine production.
Methods: In this survey, 127 serum samples of suspected
uman were collected from different parts of Mazandaran
rovince during Nov 2006- Aug 2007 and were tested by
icroscopic agglutination test (MAT) with cut-off ≥1:100
n Leptospira Research Laboratory, Faculty of Veterinary
edicine, University of Tehran.
Results: Prevalence rate of leptospirosis in Mazandaran
rovince using MAT was 52.75%. In this survey, 67 samples
ere positive which 80.6% of them were belonged to male
nd 19.4% to female. Rice ﬁeld workers showed the most
m
a
s
i57) 5.61 (4) 1.91 (3) 3.06 (7)
95) 0.79 (59) 0.49 (40) 0.64 (99)
requent occurrence of infection, so among positive cases
1.21% were belonged to rice ﬁeld workers and showed
igniﬁcant variance with other occupations (P)0.01). There
as no signiﬁcant variance between genus and leptospirosis
P > 0.05). Living place (urban/rural) and contact of person
o animals did show no signiﬁcant variance with leptospirosis
P’’0.05). The most positive cases were found in age range
f 30-40 years (25.4%). Seven common serotypes which were
ecognized in Mazandaran Province using MAT, included, Bal-
um (16.77%), Sejroe (14.29%), Tarassovi (13.64%), Australis
11.69%), Pyrogenes (7.79%), Javanica (6.5%) and Ictero-
aemorrhagiae (6.5%). Among all serotypes which were
ecognized in region, male and female reacted to 81.81%
nd 18.19% of them, respectively.
Conclusion: Because in Mazandaran Province, men and
omen work together at rice ﬁeld, also urban peoples still
elate to agriculture, it’s acceptable that genus and living
lace have not signiﬁcant variance with prevalence of lep-
ospirosis. In order to as certain that the effect of contact
ith animals has no signiﬁcant variance with the prevalence
f leptospirosis, it needs more investigations, direct sam-
ling from animals or their urine and comparison of them to
he results of this study.
oi:10.1016/j.ijid.2010.02.1945
1.014
ncidence of mycobacteria and fungi in clinically sus-
ected urinary tract infection of immunocompromised
atients — A tertiary care hospital study
. Jain ∗, V. nag, R.S.K. Marak, N. prasad, T. Dhole
Sanjay Gandhi Postgraduate Institute of Medical Sciences,
ucknow, Uttar Pradesh, India
Background: Urinary tract infections are among the most
ommon infections especially in hospital settings. Most of
hese infections are caused by bacterial agents. Mycobac-
erial and fungal agents of urinary tract infections although
ess frequent in immunocompetent individuals but they are
ore common and severe in immunocompromised individu-
ls.
Objectives Detection of Mycobacteria and Fungi in urine
pecimens of clinically suspected urinary tract infection of
mmunocompromised patients and evaluation of different
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tests for detection of Mycobacteria and Fungi in urine spec-
imens.
Methods: Study was done in Department of Microbi-
ology, Sanjay Gandhi Postgraduate Institute of Medical
Sciences, Lucknow, India, from October 2005 to September
2007. Urine samples of 50 patients with clinical suspicion
of Tubercular and Fungal etiology of Urinary tract infec-
tion of immunocompromised patients [Diabetes mellitus
(14), AIDS (13), Renal transplant recipient (09), Malignan-
cies (07), End stage renal disease/ Chronic renal failure
(06), Systemic lupus erythematosus (01)] & 50 apparently
immunocompetant patients were taken as diseased control.
For Mycobacteria microscopy (Ziehl-Neelsen staining), Cul-
ture (Lowenstein Jensen Medium and BACTEC medium), PCR
and NAP test were done. For Fungus microscopy (Direct
wet mount, Gram’s stain), Culture (Sabouraud’s Dextrose
Agar), Germ tube test, Corn meal agar, Sugar Fermentation
& assimilation test were done. Culture was considered as
gold standard.
Results: Out of 50 immunocompromised patients, 7(14%)
were positive for mycobacteria [MTBC 5(10%), MOTT 2(4%)]
and 10(20%) were positive for fungi [C. albicans 4(8%), C.
glabrata 4(8%) and C. tropicalis 2(4%)]. Out of 50 appar-
ently immunocompetant patients (diseased control), 4(8%)
were positive for mycobacteria [MTBC 3(6%), MOTT 1(2%)]
and 3(6%) were positive for fungi [C. albicans 2(4%) and C.
tropicalis 1(2%)]. Sensitivity and speciﬁcity were 71.42%,
90.69% of Ziehl-Neelsen stain, 88%, 100% of Lowenstein
Jensen culture, 57%, 100% of PCR for Mycobacteria, 80%,
100% respectively for wet mount for fungi.
Conclusion: Incidence of mycobacterial/fungal infec-
tion in immunocompromised patients is more then to
immunocompetent individuals and with immunocompro-
mised conditions, urinary tract infection should be screened
for mycobacterial and fungal pathogens.
doi:10.1016/j.ijid.2010.02.1946
51.015
Molecular analysis and risk factors for nasal colonization
with methicillin-resistant Staphylococcus aureus among
community individuals attending a Family Health Care
Program in Rio de Janeiro, Brazil
T. Miranda1, T. Brust1, N.H.T. Miyazaki1, H. Kang2, L.
Isaias2, O. Fernandes1, F. Aguiar-Alves3,∗
1 Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro,
Brazil
2 Universidade Federal Fluminense, Niterói, Rio de Janeiro,
Brazil
3 Universidade Federal Fluminense, Nova Friburgo, Rio de
Janeiro, Brazil
Background: Staphylococcus aureus has been the most
prevalent pathogen in hospital infections worldwide,
including Brazil. Many factors contribute to the world dis-
semination of hospital endemic multiresistant MRSA strains,
enabling the recent emergency of Community Acquired
Methicillin-Resistant S. aureus (CA-MRSA) infections. Molec-
ular methods have been used to investigate its role in
community infections to address the emergency of out-
breaks of new CA-MRSA clones.
l
r
t
ots e207
Methods: We selected subjects with diabetes and/or
ypertension and their relatives, from different areas of
he city of Niterói, in Rio de Janeiro, attending the Fam-
ly Health Care program by Health Foundation of Rio de
aneiro, Brazil. A total of 519 subjects from the communi-
ies underwent swabbing of both nares. Colonies of interest
ere phenotyped and all methicillin resistant S. aureus iso-
ates were genotyped to search for mecA gene, characterize
ulsed-ﬁeld gel electrophoresis proﬁle and SCCmec type.
Results: Among all subjects, 357 were colonized with S.
ureus (68.79%). Of S. aureus isolates, 37 (10.36%) were
ethicillin resistant. Women and men presented a preva-
ence of approximately 68%. However, when this isolates
ere compared for MRSA colonization, women presented
higher prevalence (11.11%) than men (7.24%). Individuals
ged 60 years or more, had higher estimated probabilities
f nasal S. aureus colonization (75.76%). However, subjects
ged from 12 to 19 years and 40 to 59 years presented the
ighest methicillin resistant prevalence rates (10.57%). In
ddition, regions with poor sanitation conditions showed the
ighest level of S. aureus colonization. The analysis also
evealed that 67% of the individuals carrying some metabolic
yndrome were colonized by S. aureus.
Conclusion: The study suggests, corroborated by many
uthors, that subjects presenting diabetes and hyperten-
ion are found to be more colonized by S. aureus then other
ubjects. Hitherto, factors such as increase of the cost of
reatment, the potential loss of productivity of infected
atients, the possibility of untreatable infections and the
ncreased mortality, indicate the need for a prevention of
RSA infections.
oi:10.1016/j.ijid.2010.02.1947
1.016
he prevalence of Staphylococcus aureus nasal coloniza-
ion among Korean children attending day care centers
.-H. Lee1,∗, Y.M. Kim2, E.Y. Cho1, K.B. Hong1, J. Lee1,
.H. Choi1, H.J. Lee1
Seoul National University College of Medicine, Seoul,
orea, Republic of
Dong Kang General Hospital, Ulsan, Korea, Republic of
Background: There is an increasing incidence of
ommunity-acquired methicillin-resistant Staphylococcus
ureus (MRSA) infection worldwide. Nasal colonization with
. aureus is a known risk factor for subsequent infection.
he aim of this study was to investigate the prevalence
nd antimicrobial resistance of S. aureus colonizing anterior
ares of children attending day care centers in Korea
Methods: Nasal swabs were obtained from both nostrils
f the 425 children attending 7 day care centers located
n Seoul, Korea. Nasal swab specimens were cultured in
nrichment broth, and plated on mannitol salt agar to grow
. aureus. Antimicrobial susceptibilities were determined
y disk diffusion method according to CLSI guidelines. The
-zone test was performed to detect inducible macrolide-
incosamide-streptogramin B (MLSBi) resistance. To identify
isk factors for acquisition of MRSA, a standardized ques-
ionnaire was completed by the caregivers at the time of
btaining the specimens.
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on the mode of transmission of the disease, its signs and
symptoms and encourage community participation in health
education and environmental sanitation.
doi:10.1016/j.ijid.2010.02.1950208 14
Results: Of the 425 children, 124 (29.2%) and 40
9.4%) children were colonized with methicillin-sensitive
nd methicillin-resistant S. aureus, respectively. Only 2 out
f the 40 children colonized with MRSA had been hospitalized
ithin 1 year. S. aureus isolates were resistant to peni-
illin (98.2%), erythromycin (43.9%), clindamycin (1.2%),
iproﬂoxacin (0.6%), gentamicin (7.3%), chloramphenicol
1.2%), and tetracycline (3.7%). Inducible MLSBi resistance
as found in 41.5% of S. aureus isolates by the D-zone test.
ll isolates were susceptible to vancomycin, trimethoprim-
ulfamethoxazole, and rifampin.
Conclusion: MRSA carriage rates among Korean children
ttending day care centers were high. These ﬁndings neces-
itate the continued surveillance of the carriage rate and
ntimicrobial resistance patterns of S. aureus.
oi:10.1016/j.ijid.2010.02.1948
1.017
eptospirosis: analysis of the notiﬁcation records and
nvestigation on the year of 2007, of the municipal district
f Salvador-Bahia-Brazil, 2009
. Cerqueira ∗, J.F. Silva
Federal University of Bahia, Salvador, Bahia, Brazil
Background: The leptospirosis is an acute infectious
isease that attacks men and animals. It is caused by
icroorganisms belonging to the gender leptospirose. Lep-
ospirose is endemic in Brazil and the largest incidence
ommonly occur in areas with larger precipitation rainfall
ubject to the occurrence of inundations and of precarious
ocioeconomic conditions. It is a disease of compulsory noti-
cation in Brazil and it feeds the System of Information of
ffences of Notiﬁcation - SINAN. The notiﬁcation is accom-
lished by the assistant units through the completion of a
ecord that contains the patients personal data, and postepi-
emic investigation. It collects important data such as race,
ccupation, disease related to the work, signs and symp-
oms, risk factors and data regarding the hospitalization,
nal classiﬁcation of the disease, conﬁrmation criterion and
volution among others
Methods: Study is grown throug quantitative type -
escriptive with the objective of identifying the ﬁelds that
requently left out in the notiﬁcation records and investi-
ation of the leptospirosis to discover the consequences of
hose actions for the evaluation of the data in the munici-
al district of Salvador-Bahia-Brazil. The completeion of the
isted feilds were analyzed regarding partner-demographic
ata, occupation, pregnant, disease related to the work,
ospitalization, ﬁnal classiﬁcation, conﬁrmation criterion
nd evolution.
Results: It was veriﬁed that the data related to the
onditions partner - demographic, beginning of the symp-
oms, investigation date and closing of the case frequently
hey were ﬁlled out accuratly and correctly. The ﬁelds
hat presented smaller percentile of completion are: race,
ccupation, work-relaed diseases, hospitalization, ﬁnal
lassiﬁcation, conﬁrmation criterion and evolution.
Conclusion: The lack of registrations in the ﬁelds disables
he description of the epidemic proﬁle of the population
eached by the leptospirose and as consequence the epi-ternational Congress on Infectious Diseases (ICID) Abstracts
emic surveillance can’t take measures to control and
revent it efﬁciently.
oi:10.1016/j.ijid.2010.02.1949
1.018
assa fever awareness and practices in a nigerian rural
ommunity
. Asogun1,∗, P. Okokhere1, S. Okogbenin1, G. Akpede1, S.
unther2, C. Happi3
Irrua Specialist Teaching Hospital, Irrua, Edo, Nigeria
Bernhard-Nocht-Institute for Tropical Medicine, Hamburg,
ermany
UCH Ibadan, Ibadan, Nigeria
Background: Lassa fever is one of the causes of morbidity
nd mortality in Nigeria. The knowledge, attitude and prac-
ice by the people is largely undetermined. This information
s an important requirement for the design of a strategic
lan for the control of the disease. This necessitated the
tudy in Ebhodiza, Uhiele-Ekpoma, a community of about
00 persons.
Methods: By means of a cluster sampling technique, one
undred and sixty (160) interviewer administered structured
uestionnaires were distributed to the respondents while
ne hundred and forty seven (147) of them were retrieved,
iving a response rate of 91.9%.
Results: Farming was predominant occupation (61%).
nly 32% had up to primary school level of education. Thirty-
ix percent (36%) of the respondents have heard about the
isease, mainly through the electronic media. Fifty-one per-
ent (51%) identiﬁed rats as the main source of infection of
assa fever, while 14% of respondents said that the disease
an be spread from person to person.
The study revealed that only 31% of the people had a
orrect knowledge of Lassa fever, and 32% had poor attitude
nd engage in practices that favor transmission of the dis-
ase. Most (72%) of the respondents do not use any means
o control rats in their households. Fortythree percent (43%)
f respondents encouraged bush- burning.
There was a signiﬁcant relationship between the level
f education of respondents and knowledge of Lassa fever
X = 3.4, P < 0.05). However, the relationship between the
ccupation of respondents and practices was not signiﬁcant
x = 3.2, P > 0.05).
Conclusion: It is therefore recommended that the three
iers of government and nongovernmental organizations
NGOs) in Nigeria should intensify effort in adequately edu-
ating the populace through enlightenment campaigns most
specially through the mass media and religious groups
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51.019
Serological update of the Chikungunya epidemic outbreak
in Italy
P. Gaibani1,∗, A. Pierro1, F. CAVRINI2, G. Rossini 3, M.P.
Landini 3, C. Manisera4, V. Sambri5
1 S.Orsola-Malpighi, Bologna, Italy
2 S. Orsola-Malpighi Hospital, BOLOGNA, Italy
3 S.Orsola-Malpighi Hospital, section of Microbiology,
BOLOGNA, Italy
4 S.Orsola-Malpighi Hospital, Microbiology, Bologna, Italy
5 University of Bologna, Bologna, Italy
Background: Chikungunya (CHIKV) is an arthropod-borne
virus belonging to the Alphavirus genus in the Togaviridae
family. Epidemic Chikungunya virus (CIKV) infections result
common limited to several countries of the tropical areas.
The only epidemic of CHIKV that aroused outside the trop-
ical areas was the small epidemic outbreak occurred in the
Emilia Romagna region, Italy, during summer of 2007. Local
transmission has been made possible by the enormous pop-
ulation of Aedes albopictus. On the basis of these facts,
a serological screening of chikungunya fever was initiated
by Centro Riferimento Regionale Emergenze Microbiologiche
(CRREM) of Bologna to determine the speciﬁc CHIKV IgG and
IgM titres in conﬁrmed CHIKV case.
Methods: Serum obtained from the 172 CHIKV infected
persons were collected and tested for the presence of CHIKV
antibodies. Speciﬁc antibodies titres were analyzed by an
indirect immunoﬂuorescence assay for the detection of anti-
CHIKV IgG and IgM by using a commercial EUROIMMUN assay.
Results: During the outbreak occurred in Emilia-Romagna
on 2007, all serum from laboratory conﬁrmed CHIKV infec-
tions were collected and tested as follows. Of these samples,
108 (62,8%) were CHIKV positive both in IgM and IgG, 27
(15,6%) were only IgM positive, 12 (6.9%) were IgG positive
only. In opposite, 25 (14,5%) were negative both for IgM and
IgG, but tested PCR positive. Moreover the 71,4% of the IgM
positive samples had a titre comprised between 1/100 and
1/1600. In addition the 85,8% of the IgG positive samples
had a titre ranging from 1/100 to 1/6400.
Conclusion: Here we report the ﬁrst sero-prevalence
study for speciﬁc CHIKV-antibodies in a population outside
the tropical geographic areas. In addition, this study was
performed on all the autochthonous CHIKV infected persons.
The results obtained clearly demonstrated the high level of
antibody response to CHIKV in the acute phase, or immedi-
ately after, infection. Studies are presently on going in order
to deﬁne the persistence of CHIKV speciﬁc antibodies.
doi:10.1016/j.ijid.2010.02.1951
51.020
Sero-prevalence of West Nile virus in north-eastern Italy
A. Pierro1,∗, P. Gaibani1, F. CAVRINI2, C. Manisera3, G.
Rossini 4, M.P. Landini 5, V. Sambri61 S.Orsola-Malpighi, Bologna, Italy
2 S. Orsola-Malpighi Hospital, BOLOGNA, Italy
3 S.Orsola-Malpighi Hospital, Microbiology, Bologna, Italy
2
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Gts e209
Centro Riferimento Regionale Emergenze Microbiologiche
CRREM), Bologna, Italy
S.Orsola-Malpighi Hospital, section of Microbiology,
OLOGNA, Italy
University of Bologna, Bologna, Italy
Background: West Nile virus (WNV) is a member of the ﬂa-
ivirus family and is transmitted in natural cycles between
irds and mosquitoes, particularly Culex spp. Human and
orses are susceptible but dead-end hosts. Firstly identi-
ed in tropical Africa, WNV infection has been evidenced in
orthern Africa, Israel, India and Australia. WNV spread in
merica since 1999 and has been the cause of outbreaks
nd sporadic cases in central eastern and Mediterranean
urope for more than 45 years. Of people infected with
osquito-borne WNV, 80% develop asymptomatic infections,
0% develop symptomatic infections and <1% develop severe
euro-invasive disease. The ﬁrst human cases of neuro-
nvasive WNV infection was identiﬁed in 2008 near Ferrara
rovince where had been identiﬁed several WNV-positive
orses and birds. After this ﬁrst case of WNV infection in
milia-Romagna, a sero-epidemiological survey was started
o ascertain the sero-prevalence of speciﬁc antibodies in the
lood donor population and the relative risk in population.
Methods: Serum obtained from 10.000 blood donors
esident in Ferrara province were collected between
eptember 2008 to April 2009, and tested for speciﬁc WNV.
irus-speciﬁc IgG were detected in serum specimens by
nzyme-linked immunosorbent assay (ELISA). To conﬁrm
esults of positive IgG samples and to determine the effec-
ively titers in the serum, an Immuno Fluorescent assay (IFA)
as performed.
Results: Between a period of 8 months, since autumn
008, 10.000 serum obtained by blood donors in Ferrara
rovince were collected and tested as described in previ-
usly. 70 of the 10.000 serum analyzed resulted positive in
gG. This data showing an incidence of 0.7% in a blood donors
opulation.
Conclusion: After the outbreak of WNV infections in Italy
uring the 2008, a sero-prevalence study was performed to
etermine the WNV mosquitoes-related infections in a blood
onors in Italy. We report the ﬁrst study of human sero-
revalence in Europe involving a high number of persons.
he ﬁrst data of the study show an incidence of 0,7% and
uggest the large diffusion of WNV in the area studied. In
ddition, the high incidence prospect a necessary surveil-
ance in blood and organ donors, performed by NAAT in this
art of Italy.
oi:10.1016/j.ijid.2010.02.1952
1.021
retrospective laboratory analysis of clinically diagnosed
assa fever cases in a tertiary hospital in Nigeria
. Ehichioya1,∗, D. Asogun2, M. Hass3, B. Becker-Ziaja4, S.
unther5, S. Omilabu6University of Lagos, Lagos, Nigeria
Irrua Specialist Teaching Hospital, Irrua, Edo, Nigeria
Bernhard-Nocht-Institute for Tropical Medicine, Bernhard-
ocht-Strasse 74, D-20359 Hamburg, Germany, Hamburg,
ermany
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Bernhard-Nocht-Institute for Tropical Medicine, Hamburg,
ermany, Hamburg, Germany
Bernhard-Nocht-Institute for Tropical Medicine, Hamburg,
ermany
College of Medicine, University of Lagos, Idi-araba, P.M.B.
2003, Lagos, lagos, Nigeria
Background: Lassa fever (LF) is associated with a wide
pectrum of clinical manifestations and its clinical diagnosis
s often complicated by the fact that the initial symptoms
f the disease are indistinguishable from a number of other
nfections seen in endemic areas. Over the years, many out-
reaks and deaths from LF have been reported in Nigeria
ostly associated with no or inadequate laboratory testing.
onsequently, the accuracy of clinical diagnosis is therefore
f interest.
Methods: Data including blood specimens and background
nformation were collected from 267 consented in- and
ut-patients clinically diagnosed to have LF at the Irrua
pecialist Teaching Hospital, Nigeria. Blood specimens were
ested for Lassa virus RNA using Reverse transcriptase poly-
erase chain reaction (RT-PCR). Data derived were analyzed
sing EpiInfo 6.04a version.
Results: Comparison of clinical diagnoses with laboratory
est results showed a low speciﬁcity of clinical judgement.
f the 267 clinically diagnosed cases, LF was laboratorycon-
rmed in 62 (23.2%), of which 35 (56%) were rightly treated
ith Ribavirin. On the other hand, 57 (28%) of the 205 LF
egative patients were erroneously treated with Ribavirin.
owever 35 (56%) of these patients recovered, 18 (29%) died
nd 1(2%) was referred to another hospital for further atten-
ion. Patients that tested positive to LF were more likely
o report vomiting, bleeding and have fever, sore throat,
eadache, abdominal pain and malaise than those that did
ot (p < 0.05).
Conclusion: Until now, the diagnosis of LF is mainly clini-
al, and was considered sufﬁcient for treatment decision.
nfortunately, clinical diagnosis of LF by health workers
s hardly achievable especially in the absence of haemor-
hage. Ribavirin can only help if it is administered early in
he course of illness. In the above elucidated challenge,
rompt diagnosis is clearly needed for early commence-
ent of treatment. The place of appropriate laboratory
upport in the effective and prompt diagnosis cannot be
ver-emphasized in the management of LF in all endemic
ountries of West Africa.
oi:10.1016/j.ijid.2010.02.1953
1.022
yphilis among young women: a population based survey
n central Brazil
.L.B. Garcia1, M. Turchi2,∗, E.M.B. Guimaraes2, N.
arvalho2, C.T. Ribeiro3, M.N.G. Reis2, M.F.C. Alves2
Brazilian Ministry of Health, Brasilia, Brazil
Federal University of Goias, Goiania, Brazil
Catholic University of Goias, Goiania, Brazil
Background: Syphilis remains an important public
ealth problem worlwide, despite preventive measure and
ffective treatment available for decades. The evolving epi-
o
A
a
aternational Congress on Infectious Diseases (ICID) Abstracts
emiology, changing risk groups, and social environments
resent challenges for syphilis control and further elimina-
ion. Population based syphilis prevalence studies are scarce
mong adolescent and youth, considered a vulnerable group
or sexually transmitted diseases (STD). To estimate the
revalence of syphilis in adolescents and young females,
exually active in central part of Brazil.
Methods: The study was a population-based cross sec-
ional study conducted among 15 to 24 years old sexually
ctive females attending Family Health Program (∼ 14.000
amilies registered at FHP), in three medium sized cities
∼10.650 to 75.600 inhabitants) of Goias State- Central
razil, from 2007 to 2009. Potential participants were ran-
omly selected from a nominal list of youth registered at
ocal FHS. Community health agents invited the participants
or an interview at the local health center. The demographic
ata and sexual behavior proﬁle were investigated by conﬁ-
ential interview. For those sexually active, a serum sample
as collected for syphilis diagnosis using two screening tests
VDRL and ELISA) followed by a conﬁrmatory test (FTA Abs).
Results: 1073 participants were interviewed, among
hem 698 (65.0%) were sexually active. The median age
f the ﬁrst sexual relation was 15.9 years (dp = 2.1), 73.5%
f the participants referred inconsistent condom use, and
8.8% had at least one previous pregnancy. Eleven women
ere positive on screening test (VDRL or ELISA) for syphilis.
ne sample was positive on screening and on the conﬁr-
atory test, yielding a syphilis prevalence of 0.14% (CI95%
.00-0.79).
Conclusion: The overall prevalence of syphilis was lower
han the expected for pregnant women and blood donors,
n Brazil. However, adolescents and young women, of the
valuated cities, reported high risk sexual behavior for SDT,
ointing out for the need of preventive strategies towards
yphilis control and future elimination. Financial support:
NESCO and Brazilian Health Ministry
oi:10.1016/j.ijid.2010.02.1954
1.023
linical features of Plasmodium malariae in Venezuela
. Villegas1,∗, M.E. Guevara2, N. Hernandez2, V. Pacheco2,
. Fuenmayor2, B. Salazar2, M. Giron2, M. Pacheco2, J.
oreno3
ASOCIS, Paramaribo, Suriname
ASOCIS, Tumeremo, Venezuela
Instituto de Altos Estudios en Salud Publica Dr. Arnaldo
abaldon, Tumeremo, Venezuela
Background: Despite the increased mass of knowledge in
ifferent aspects of malaria, P. malariae is the least studied
f the four species that infect humans; in part because of
ts low prevalence. There is evidence that P. malariae infec-
ions are vastly underreported. We undertook a prospective
ohort study to investigate the clinical features of P. malar-
ae infections in endemic areas in Venezuela.
Methods: National malaria parasite data per year was
btained from the national malaria surveillance system.
prospective cohort study assessing the clinical and par-
sitological proﬁles of malaria infections was conducted
mong patients attending the malaria post at the Centro
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de Investigación de Campo Francisco Vitanza (CICFV) in
Tumeremo, Sifontes Municipality, Bolivar State, Venezuela.
A pre-piloted clinical record form was used to capture
information on each malaria episode. Malaria blood ﬁlms
were stained with 4% Giemsa and read using microscopy
(1000X). 100 microscopic thick ﬁlm ﬁelds were inspected
before a slide was being declared malaria negative. For
malaria-positive smears parasite species were identiﬁed and
densities recorded as number of parasites per 200 WBC.
Results: Between 2005 and 2007, there were 120 cases
of Pm reported in Venezuela - CICFV diagnosed 71. Detailed
clinical data was available among 59 cases (83%). All
Pm cases occurred in communities located along the
Venezuelan-Guyanan border. Mean age was 28 years (1-79).
All cases reported fever and/or history of fever in the last
2 days (100%), other signs/symptoms included: headache
(92%), chills (86.4%), sweating (83.1%), osteomuscular pain
(78%), weakness (66%), and poor appetite (64%). Cough and
difﬁcult to breath was reported in 61% and 37%, respectively.
No nephritic syndrome was found. Median parasitemia was
660 parasites/uL (range 48-17604 uL).
Conclusion: For our knowledge, this is the ﬁrst report
on the clinical features of P. malariae in Venezuela. Fever,
chills and headaque were the most common signs/symptoms
reported. Interestingly, as seen in P. falciparum in Africa,
respiratory symptomatology was present among Pm cases.
Nephrotic syndrome was not reported. Parasitological pro-
ﬁles and socioeconomical data were collected, describing a
case with high parasitemia. Further research is necessary in
order to describe the full clinical spectrum of Pm infections
in the Amazon basin.
doi:10.1016/j.ijid.2010.02.1955
51.024
Severe malaria surveillance and treatment delays in
Canada
C. Prematunga1,∗, A. McCarthy2
1 The University of Ottawa, K1H 8M5, ON, Canada
2 the Ottawa Hospital, Ottawa, ON, Canada
Background: Malaria remains the principle life-
threatening infection for travellers to endemic regions
and severe malaria has a 20% case fatality rate. The
Canadian Malaria Network (CMN) provides intravenous
anti-malarial therapy and collects surveillance data on all
malaria cases utilizing parenteral therapy.
Methods: Examines epidemiological features and treat-
ment delays associated with cases of malaria reported to
CMN between June 2001 and July 2009.
Results: Over the eight years 131 malaria cases were
reported (an average of 15 reports per annum). Species
distribution: P. falciparum 90%, P. vivax 3%, P. malariae
<1% and 4% unknown. 87% of cases were acquired in Africa
and a majority of cases presented in Ontario (51%) and
Quebec (30%). Overall, there was an equal distribution of
gender. Only 31% of the cases reported seeking pre-travel
advice and 28% indicated any chemopropholaxis use. 55%
of cases were non-Canadian born, 63% adults, 30% minors.
Most indicated immigration as the reason for travel. 45%
of cases were Canadian born, 76% adults and 20% minors.
f
p
wts e211
isiting friends/relatives was the major reason for travel.
edian delay between arrival in Canada and symptoms was
days; between symptoms and ﬁrst physician visit was 3
ays. The Median delay between the1st physician visit and
iagnosis or between diagnosis and request for malarial
reatment/administration was found to be 0 days. In 41%
f the cases, a delay of one or more days occurred between
iagnosis and treatment.
Conclusion: The time delay in consulting a physician
nd the low rate of individuals seeking pre-travel advice
ndicates gaps of knowledge among persons arriving to, or
eturning from endemic regions. The inappropriate use of
hemoprophylaxis and delays in treatment requests indi-
ates gaps of knowledge with respect to the treatment
rovider. Canadians who plan to visit endemic regions should
e instructed to seek pre-travel advice regarding malaria.
on-Canadians immigrating to Canada should be instructed
o seek medical attention if they experience fever to ensure
arly diagnosis and treatment.
oi:10.1016/j.ijid.2010.02.1956
1.025
eptospirosis in Mazandaran province, northern Iran,
008-2009
. Esfandiari 1,∗, S.P. Ziapour1, M. Assmar2, M.R. Yousseﬁ3,
. Amirbozorgi 1, B. Amini Navaie1, Z. Farzaneh-nejad2, M.
lipour Espeh-kolaie4
Pastuer Institute of Iran, Amol Researh Center, Amol,
azandaran, Iran, Islamic Republic of
Pasteur Institute of Iran, Tehran, Tehran, Iran, Islamic
epublic of
Azad Islamic University, Babol Unit, Babol, Mazandaran,
ran, Islamic Republic of
Babol University Medical Sciences, Yahya-nejad Hospital,
abol, Mazandaran, Iran, Islamic Republic of
Background: Leptospirosis is one of infectious diseases
ause by pathogenic leptospira. This is an important
oonotic disease. Most of human morbidities occur by con-
act with patient animals’ urine contaminant water and soil.
his disease in special occupation (such as rice and cane
arm workers, veterinarian, laboratories staff, slaughter
ouse personal and herdsmen) is seen more. This evaluation
ccomplished to determine morbidity rate of this disease in
atient who referred to Mazandaran Province leptospirosis
iagnostic center in Pasteur institute of Iran, Amol Research
enter, Dept. of Parasitology.
Methods: Suspect patient blood samples along with ﬁlled
ut questionnaires by infection disease specialists from dif-
erent hospitals of Mazandaran Province (such cities as Sari,
abol, Qaemshahr, Amol and . . ..) were send to Pasteur insti-
ute of Iran, Amol Research Center, Dept. of Parasitology
uring March 2008-March 2009. After separating samples
era, serologic study was done by Indirect Immunoﬂuores-
ent Antibody Assay (IFA) and Cut-off for this method was’’
/80.Results: From 157 suspect samples, 36 (22.93%) were
emale and 121 (77.07%) were male. From 36 female
atients, of them 2 farmer and 4 housekeepers who also
ork in farms, were serological positive. From 121 male
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atients, 32 of them, 18 (78.26%) farmers, 2 (8.69%) employ-
es, 2 (8.69%) self employees and 1 (4.36%) herdsman were
erological positive.
Conclusion: Analyses of questionnaires showed that lep-
ospirosis had a high prevalence in farmers and herdsmen. So
t can be considered as an occupational disease. More occur-
ence of leptospirosis in male than female is explainable
uct a working of more men than women in farms.
oi:10.1016/j.ijid.2010.02.1957
1.026
pidemiologic comparison of Human Brucella suis and
rucella melitensis infections
. Stanek1,∗, P. Nicoletti 2, D. Harrell 3, G. churchwell 4, P.
ee4, C. Blackmore5
Florida Department of Health, Tallahassee, FL, USA
University of Florida College of Veterinary Medicine,
ainesville, FL, USA
USDA VS, Gainesville, FL, USA
FL DOH, Jacksonville, FL, USA
FL DOH, Tallahassee, FL, USA
Background: Brucella suis is endemic in feral swine across
he state of Florida, and with the eradication of Brucella
bortus in cattle, has emerged as the primary cause of
uman and animal Brucellosis in the state. Brucella meliten-
is is not present in Florida but is endemic in Mexico.
any Mexican immigrants return to visit friends and family
n Mexico regularly, where they may be exposed to Bru-
ella through consumption of unpasteurized milk products
r domestic animal contact. Although B. suis has a world-
ide distribution, most epidemiologic case studies describe
emographics, clinical presentation and other epidemio-
ogic information from patients infected with B. melitensis
nd B. abortus. This study provides an epidemiologic com-
arison of 36 B. suis and 11 B. melitensis infected patients
eported to Florida Department of Health.
Methods: Human surveillance data from 1997-2008 were
eviewed including clinical symptoms and signs, time
rom symptom onset to treatment and prescribed treat-
ent. Thirty-six patients culture positive for B. suis (32
atients), epidemiologically linked to a conﬁrmed patient
1 patient) or serologically conﬁrmed per national guide-
ines (3 patients) were compared to 11 B. melitensis culture
ositive patients reported during the same timeframe.
Results: Most B. suis patients were male (92%), white
94%) and non-Hispanic (81%) with an average age of 43 years
range 18-78). Endocarditis or aneurysm was reported in 4
11%) of B suis patients, two with fatal results. Of the 22
atients with medical treatment information all were pre-
cribed doxycycline, 14 (66%) rifampicin and 13 (62%) an
minoglycoside; 4 (11%) patients relapsed. Brucella meliten-
is patients were 55% male, 55% white and 73% Hispanic.
verage age was 37 (range 4-76). Gastrointestinal signs
nd/or abdominal pain were reported in 4 (36%) of patients,
s was single joint or bone pain. Only 4 (44%) of patients
ere prescribed doxycycline, 2 (22%) rifampicin and 1 (11%)
nd aminoglycoside; 3 (27%) patients relapsed.
Conclusion: Patient demographics, clinical presentation
nd clinical management were different for infections with
o
w
S
S
pternational Congress on Infectious Diseases (ICID) Abstracts
ifferent Brucella species and warrant further study to
mprove disease prevention strategies and treatment rec-
mmendations. Physician education, standardized guidance
or convalescent monitoring, and improved testing to reduce
ncidence of disease relapse are needed.
oi:10.1016/j.ijid.2010.02.1958
ram-negative Bacterial Infections (Poster Presen-
ation)
2.001
higellosis in Central American countries
. Achí ∗, K. Barrantes
University of Costa Rica, San José, Costa Rica
Background: Shigellosis is an important cause of mor-
idity and mortality around the world. Shigella spp is
ransmitted person to person through the faecal-oral route,
lso by contaminated food and water. The infection is con-
idered as a childhood disease but it also represents an
mportant cause of diarrhea in adults, particularly among
ourists who travel to endemic areas. The symptoms range
rom mild watery diarrhea to severe bacillary dysentery with
ever, abdominal pain, blood and mucus in stool samples.
he indiscriminate use of antimicrobial drugs is responsi-
le for the increasing resistance among Shigella spp. strains
orldwide. Even though shigellosis could be a prevalent
nfection in the region, there are insufﬁcient studies from
entral America.
Methods: Fecal specimens from 3045 children up to
0 years old from San José, León, San Salvador and
anama, hospitalized due to severe diarrhea were col-
ected and analyzed at local laboratories using standardized
acterial culture. Samples were inoculated in selective
edia and analyzed by biochemical tests and serology.
ntibiotic susceptibility test was performed to Shigella
ositive strains by the Kirby-Bauer Method (Costa Rica,
icaragua and El Salvador) and the Biomeriaux Vitek Systems
Panama).
Results: The frequency of Shigella in Central American
ountries was 9.4%(16/170) in Costa Rica, 3.5%(18/508) in
icaragua, 8.9% (95/1071) in El Salvador and 8.4%(109/1296)
n Panama. Eight strains of S.dysenteriae (4 from El
alvador y 4 from Panama), 165 of S.ﬂexneri (8 from
osta Rica, 14 from Nicaragua, 95 from El Salvador
109 from Panama), 55 of S.sonnei (5 from Costa
ica, 4 from Nicaragua, 20 from El Salvador and 26
rom Panama) and 7 of S. boydii (El Salvador) were
ound. Resistance of the Shigella isolates to 7 out of
2 antibiotics tested such as Ampicillin, Cephalotin, Gen-
amicin, Erythromycin, Chloramphenicol, Tetracycline and
rimetroprim-sulfamethoxazole was observed.
Conclusion: Shigella spp is a common pathogen in the
entral American region. S.sonnei and S.ﬂexneri species
ere the most common agents. In Costa Rica and Nicaragua
nly S. ﬂexneri and S. sonnei species were isolated mean-
hile in El Salvador and Panama S. dysenteriae and El
alvador S.boydii were also found. Emergence of resistant-
higella strains to common antibiotics was observed, in
articular with Trimethroprim-sulfamethozaxole (more than
trac
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transmitted by oral route and oral cavity may act as a good
source of keeping and re-infecting of stomach of dyspeptic
patients after antibiotic therapy
doi:10.1016/j.ijid.2010.02.196114th International Congress on Infectious Diseases (ICID) Abs
60% of strains), Ampiciline, Tetracycline, Erythromycin and
Cephalotine.
doi:10.1016/j.ijid.2010.02.1959
52.002
Detection and molecular characterization of verotoxin
gene in non-O157 diarrheagenic Escherichia coli isolated
from Miri hospital, Sarawak, Malaysia
M.N.H. Maziz1,∗, S. ismail 2, H. Jamal2, A. Ansary3
1 Universiti Teknologi MARA, Shah Alam, Selangor, Malaysia
2 University of Malaya, Kuala Lumpur, Kuala Lumpur,
Malaysia
3 Open University Malaysia, Kuala Lumpur, Malaysia
Background: Non-O157 diarrheagenic Escherichia coli
are typical Escherichia coli. Infections with non-O157
Escherichia coli are now increasingly recognized in many
countries. The virulence proﬁles of most of the non-O157 E.
coli are unknown. Therefore, easy detection, isolation, and
characterization of non-O157 Escherichia coli isolates are
essential for improving our knowledge of these organisms.
Methods: A total of 32 non-O157 diarrheagenic
Escherichia coli isolated (Miri hospital, Sarawak, Malaysia,
2001) from the patients with diarrhea were examined for
the detection of verotoxin (VT) gene. For this purpose, two
sets of primers (VT1 and VT2) were used for PCR method.
VT1 probe was prepared which was used for the Southern
hybridization study. Bacteriophage induction was carried
out using mitomycin C. Nucleotide sequencing was made
from the VT1 gene fragment isolated from an E. coli isolates
using PCR protocol.
Results: The PCR protocol used here produced a fragment
of 348 bp of VT1 gene and 584 bp of VT2 gene, respectively.
It was shown that 13 E. coli isolates (40%) carried VT1 gene
whereas none was found to carry VT2 gene using PCR proto-
cols. Plasmids were detected in all the VT1-positive isolates.
From the Southern hybridization study, VT1 probe showed
homology with the chromosome of all 13 VT1-positive iso-
lates indicating the VT1 gene to be located on chromosome.
Bacteriophage induction as carried out using mitomycin C
showed that none of the VT1-positive isolates harbor any
lysogenic bacteriophage. However, nucleotide sequencing
made from the VT1 gene fragment isolated from an E. coli
isolates using PCR protocol showed 97% homology with the
known VT1 gene which proves to be the similar gene carried
by E. coli O157 and other ancestors.
Conclusion: The PCR method used here was sensitive,
speciﬁc and reliable. VT1 was found to be the most common
verotoxin among the E. coli strains isolated from clinical
sources in Malaysia and this VT1 gene is located in the chro-
mosome of the E. coli isolates. This study improves the
knowledge of a highly signiﬁcant emerging pathogen non-
O157 E. coli.
doi:10.1016/j.ijid.2010.02.1960ts e213
2.003
solation and characteristic distribution pattern of cagA+
elicobacter pylori in dental plaque of dyspeptic patients
. karbalayi 1,∗, S. Khodadad2
Tarbiat Modares University, 14113, Iran, Islamic Republic
f
National Institure of Genetic and Biotechnology research,
ehran, Iran, Islamic Republic of
Background: Helicobacter pylori is one of the most com-
on human pathogens which colonize in stomach. Recently
he oral cavity has been proposed as a reservoir for H. pylori
ut not much evidence from the presence of cagA+ H. pylori
n dental plaque is available. The aim of this study was to
nvestigate the possibility of isolation of cagA+ H. pylori in
ental plaque of dyspeptic patients and to study the distri-
ution pattern of cagA+H. pylori in different areas of oral
avity.
Methods: One hundred (100) patients with dyspepsia,
ttending the routine endoscopy were examined and sam-
les from sub gingival plaque of molar and incisor areas
f patients were taken, placed in suitable transport media
nd immediately sent to lab before 4 h. All samples cul-
ured on modiﬁed brucella blood agar and all the susceptible
olonies were tested by urease, catalase, oxidase and
ram stains. Also after DNA extraction process, two sets
f primers, highly speciﬁc for ureC and cagA were used for
CR.
Results: H. pylori was detected in dental plaque sam-
les of 40 (40%) of patients by culture on enriched brucella
gar media, 100% of these samples were positive by PCR
f ureC gene and 25 samples (62.5%)were also positive for
agA gene. Results of PCR for ureC gene on different areas
f dental plaque, also showed that sub gingival plaque of
olar areas had the most microbial load of H. pylori (73%,
9 cases) in comparison of incisor sites (27%, 10 cases).
Conclusion: According to our ﬁndings, it’s estimated that
ental plaque, especially sub gingival plaque of molar areas,
an be a suitable reservoir for H. pylori. Being out of reach
f oxygen and difﬁcult access of this site for cleaning tools
f oral cavity can conﬁrm this thesis. Also it was shown in
his study that cagA + H. pylori can be isolated from den-
al plaque of dyspeptic patients, so maybe H. pylori can be
e th In
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2.004
ultiresistant Acinetobacter spp in a burn unit in
rgentina
.T. Rosanova1,∗, G. Mudryck1, A. Monaco1, H. Lopardo2,
. Villasboas3, G. Berberian1
Hospital Garrahan, Buenos Aires, Argentina
Hospital de Pediatria Dr. Juan P. Garrahan, Buenos Aires,
rgentina
Hospital garrahan, Bs as, Argentina
Background: Multiresistant Acinetobacter spp has
merged as an important microorganisms in critical areas
ike burn units.
Objetives: Infections caused by multiple drug resistant
MDR) Acinetobacter spp was studied in our burn unit to
valuate epidemiological, clinical features, outcome, use of
olistin and adverse effects related with this antibiotic.
Methods: A prospective chart review of pediatric patients
dmitted to our tertiary burn unit between January 2005 and
ecember 2006 with isolation of multiresistant Acynetobac-
er spp was performed. During the study period, 26 p were
valuated with isolation of Acinetobacter spp.
Results: The mean age of the patients was 66.5 months
range: 2 to 168 m), 17 patients (65%) were male. The burnt
urface was between 10% and 87% (median 42.5%). Full thick-
ess was present in 10 p (39%). Burn wound sepsis was the
ost frequent focus in 10 patients (39%). In 8 patients (30%),
urn wound infection occurred without sepsis. Intravascu-
ar catheter-related bacteremia was found in three patients
11%) and bacteremia in one (4%). Two patients had pneu-
onia (8%), and two urinary tract infection (8%). All patients
ere treated with colistin.according susceptibility test. The
ime of colistin treatment was between 10 and 71 days
median 21days). None of the children developed adverse
ffects attributable to colistin. The outcome was favorable
n all patients.
Conclusion: Multiresistant Acinetobacter spp has
merged as a new threat in burn units. Burn wound sepsis
as the most common foci. Colistin was a safe drug for the
reatment. The outcome was favorable in all patients.
oi:10.1016/j.ijid.2010.02.1962
2.005
nvestigation of Helicobacter pylori in dyspeptic patients
nd its relationship with Iranian life style
. Shokrzadeh ∗, K. Baghaei, D. Mirsattari, R. Mashayekhi,
. Zojaji, M.R. Zali
Research Center for Gastroenterology and Liver Diseases,
ehran, Iran, Islamic Republic of
Background: Helicobacter pylori infection is recognized
s an important player in the development of chronic gas-
ritis, peptic ulcers, and gastric carcinoma. The aim of this
tudy was to evaluate the association between H. pylori
nfection and clinical symptoms in patients referred to a
eferral academic hospital (Shahid Beheshti hospital).
Methods: A total of 303 patients with dyspeptic symptoms
nderwent endoscopy in the academic hospital. Clinical data
ere collected for each patient and gastrointestinal symp-
w
d
(
uternational Congress on Infectious Diseases (ICID) Abstracts
oms were evaluated by using the Gastrointestinal Symptom
ating Scale Questionnaire. During endoscopy two biopsy
pecimens were taken from the antrum for histological eval-
ation.
Results: Among the 303 patients, 263 (86.8%) were found
o be positive for H. pylori, of whom 43% were male and 57%
emale. The prevalence of H. pylori infection in patients
ith anorexia, nausea, heart burn and belching was 98
32.3%), 89 (29.4%), 132 (43.6%) and 171(56.4%), respec-
ively. Likewise, we found 112 patients with abrupt pain and
6 with pain by consumption of tea were H. pylori-positive.
lso 98 (32.3%) patients with a positive family history of gas-
roduodenal diseases had H. pylori infection. Among them,
0 of 41 patients with a family history of gastric cancers and
0 from 73 with a family history of gastroduodenal ulcers
ere infected by H. pylori.
Conclusion: There was an increased risk ofH. pylori infec-
ion in 60-69 aged patients (OR = 0.27, 95%CI, 0.086-0.87)
ompared to young people with aged 20-29. H. pylori was
ot associated with, marital status, education and ethnic
roup of the patients (P > 0.05). We found no signiﬁcant dif-
erence in the prevalence of H. pylori infection according
o ethnicity (P > 0.05). Also we did not observe any rela-
ionship between H. pylori infection and family history. It
as observed that some symptoms such as belching, patients
ith abrupt pain and pain with consumption of tea was sig-
iﬁcantly associated with H. pylori infection, whereas there
as no difference between consumption of other foods and
ther clinical symptoms.
oi:10.1016/j.ijid.2010.02.1963
2.006
ytokine proﬁle in patients with severe gram negative
epsis
. Jain ∗, S. Agrawal, V. Dhawan, N. Sharma, S. Varma
PostGraduate Institute of Medical Education and Research,
handigarh, India
Background: Cytokine-related systemic intravascular
nﬂammation may represent a common pathogenic link
etween initial insult and multisystem organ failure. Inter-
ctions between different cytokines in sepsis are complex
nd not well understood.The primary aim was to study the
ffect of standard therapy on serum levels of IL1$, IL-6, IL-
6, and TNF-& and CRP levels in patients with severe gram
egative sepsis/septic shock.
Methods: In a prospective study, 60 patients with severe
ram negative sepsis or septic shock (as per ACCP/SCCM Con-
ensus Conference deﬁnitions) were studied for 28 days or
urvival. All standard therapy was given as per the hospital
rotocol. Samples for cytokine estimation were drawn at
nrolment and again at the end of 4 weeks. Serum cytokine
evels were assayed using commercially available immunoas-
ay kits for IL1$, IL-6, TNF-&, IL-16 and hsCRP, as per the
peciﬁcation of the kit.
Results: In the study group 40 (66.7%) patients survived
hile 20 (33.3%) patients had expired before completing 28
ays of follow up. Diabetes (26.7%), chronic kidney disease
13.3%) and hypertension (11.7%) were the most frequent
nderlying diseases. 43 patients (71.6%) were culture posi-
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tive for gram negative organisms.E.coli (35%), Acinetobacter
(18%) and Klebsiella (13%) were amongst the commonest
isolated organisms. Stepwise regression analysis revealed
that metabolic acidosis alone accounted for a 11.7% risk
and in combination with nervous system dysfunction a 20.6%
risk of death (p = 0.014). Levels of cytokines — IL1$, TNF&,
IL-6, IL-16 and hsCRP were signiﬁcantly higher than the
normal range at the time of admission. Statistically sig-
niﬁcant decline in the day 28 cytokine levels was seen
in IL-6 and IL-16 (p < 0.05) while there was no change in
IL1$, TNF& and hsCRP. There was no correlation between
cytokine levels and individual organ dysfunction, although
IL1$, TNF alpha and CRP levels were signiﬁcantly elevated
in patients with multisystem organ failure. There was poor
correlation between serum cytokines and survival except for
hsCRP.
Conclusion: Serum proinﬂammatory cytokines are
markedly elevated in severe sepsis/septic shock due to
gram negative sepsis. However a cause and effect relation-
ship between cytokine levels and outcome could not be
established.
doi:10.1016/j.ijid.2010.02.1964
52.007
Burkholderia pseudomallei musculoskeletal infections
(Melioidosis) in India: Are the orthopaedic surgeons
aware?
V. Pandey1, S. RAO2,∗, S. rao3, K.K.V. Acharya4
1 Katurba Medical College and Hospital, Madhav Nagar, India
2 Kasturba Medical college,Manipal University, Manipal, Kar-
nataka, India
3 kasturba Medical College & Hospital ,Manipal, Karnataka,
India
4 Kasturba Medical College and Hospital, Madhav Nagar,
Manipal, India
Background: Melioidosis, an infection due to gram neg-
ative Burkholderia pseudomallei, is an important cause of
sepsis in East Asia especially Thailand and northern Aus-
tralia. It usually causes abscesses in lung, liver, spleen,
skeletal muscle and parotids especially in patients with
diabetes, chronic renal failure and thalassemia. Muscu-
loskeletal melioidosis is not common in India even though
sporadic cases have been reported mostly involving soft tis-
sues.
Methods: During a two-year-period, we had ﬁve patients
with musculoskeletal melioidosis. All patients were diag-
nosed on the basis of positive pus culture.
Results: All patients presented with multifocal
osteomyelitis, recurrent osteomyelitis or septic arthri-
tis. One patient died early because of septicemia and
multi-organ failure. All patients were treated by surgical
debridement followed by a combination of antibiotics;
(ceftazidime, amoxy-clavulanic acid, co-trimoxazole and
doxycycline) for six months except for one who died due
to fulminant septicemia. All other patients recovered
completely with no recurrences.
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Conclusion: With increasing awareness and better diag-
ostic facilities, probably musculoskeletal melioidosis will
e increasingly diagnosed in future.
oi:10.1016/j.ijid.2010.02.1965
2.008
pectrum of hepatic dysfunction in enteric fever
. Bhatia1,∗, M. Prabhu2, K. saravu1, M. docherla1, B.
hastry1
Kasturba Medical College, Karnataka, India
KMC Manipal, Manipal, Karnataka, India
Background: Liver involvement in enteric fever can be in
he form of asymptomatic biochemical alterations or hep-
titis like presentation. This condition has been described
s ‘‘Typhoid/Salmonella Hepatitis’’. In India, where enteric
ever is endemic, hepatic involvement either clinical or bio-
hemical is not uncommon. This study was undertaken in
rder to observe the hepatic manifestations in enteric fever
nd their clinical signiﬁcance.
Methods: A prospective study was done from November
005 — April 2007 at Kasturba Hospital, Manipal (Karnataka),
ndia. Patients diagnosed to have enteric fever based on the
solation of S typhi or S. paratyphi in blood or bone marrow
ultures or a rising (four fold) titer of Widal agglutinins on
erial estimation were studied with particular reference to
iver function abnormalities.
Patients satisfying any 3 of the following criteria were
lassiﬁed as Salmonella hepatitis;
. Jaundice
. Hepatomegaly
. Elevated liver enzymes > 2 times normal.
. Prolonged Prothrombin Time
. Abnormal histopathology
Results: 111 patients with enteric fever were included
n the study, of which 56 patients (50%) were diagnosed
ith typhoid fever and 55 patients (50%) were found to have
aratyphoid fever. The most common abnormality observed
as deranged liver enzymes more notably in patients pre-
enting beyond the second week of illness; AST levels were
bnormal in 93 patients (82%), range (16 - 757 U/L), average
alue 118.8 U/L.
ALT levels were abnormal in 80 patients (72%), range (7
500 U/L), average value 100.3 U/L.
ALP levels were abnormal in 21 patients (20%), range (25
1153 U/L).
Hyperbilirubinemia was present in 13 patients (11%).
We observed 13 cases of Typhoid hepatitis (11.7%).Jaun-
ice, hepatomegaly and abnormal biochemical tests were
resent in all of these patients.
The antibiotic sensitivity patterns were similar in both
epatitis and non hepatitis group of patients with all hep-
titis patients showing a good response and normalization
f liver functions with treatment.
Conclusion: Liver involvement is common in enteric fever
ith elevated transaminases as the most common abnormal-
ty noticed. Hepatitis with jaundice is a rare presentation of
nteric fever; however in tropics recognition of Salmonella
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epatitis in patients presenting with fever and jaundice is
mportant and should be differentiated from common ail-
ents presenting in a similar manner like viral hepatitis,
alaria and leptospirosis.
oi:10.1016/j.ijid.2010.02.1966
2.009
erotoxin gene in non-O157 diarrheagenic Escherichia
oli can be plasmid-mediated
.N.H. Maziz
Universiti Teknologi MARA, Shah Alam, Selangor, Malaysia
Background: Infections with diarrheagenic non-O157
scherichia coli are now increasingly recognized in many
ountries. Verotoxins was ﬁrst identiﬁed in Shigella dysen-
eriae, where it is chromosomally encoded but the genes
or its production are readily transmitted between E. coli
trains by toxin encoding bacteriophages. VT1 and VT2 genes
re encoded on two different lysogenic lambdoid temperate
acteriophages inserted into the chromosome in E. coli.
Methods: A total of 30 non-O157 diarrheagenic
scherichia coli isolated (University Hospital, Kuala
umpur, Malaysia, 2003) from the patients with diarrhea
ere examined for the detection of verotoxin (VT) gene.
or this purpose, two sets of primers (VT1 and VT2) were
sed for PCR method. VT1 probe was prepared which was
sed for the Southern hybridization study. Bacteriophage
nduction was carried out using mitomycin C. Nucleotide
equencing was made from the VT1 gene fragment isolated
rom a 7.2 kb plasmid of an E. coli isolate using PCR
rotocol.
Results: The PCR protocol produced a fragment of 348 bp
f VT1 gene and 584 bp of VT2 gene, respectively. Twelve
. coli isolates (40%) carried VT1 gene whereas none was
ound to carry VT2 gene. Plasmids were detected in all
he VT1-positive isolates. VT1 probe showed homology with
he chromosome of 10 VT1-positive isolates after Southern
ybridization indicating the VT1 gene to be located on chro-
osome. Interestingly, VT1 probe also showed homology
ith the 7.2 kb plasmid of 2 VT1-positive isolates indicat-
ng the VT1 gene to be located on a plasmid. Bacteriophage
nduction as carried out using mitomycin C showed that none
f the VT1-positive isolates harbor any lysogenic bacterio-
hage. However, nucleotide sequencing made from the VT1
ene fragment isolated from the 7.2 kb plasmid of an E. coli
solates using PCR protocol showed 97% homology with the
nown VT1 gene.
Conclusion: In this study, we believe to report for the
rst time in the world that VT1 gene to be located on a 7.2-
b plasmid of non-O157 E. coli and there is no evidence of
lysogenic phage present in it. VT1 was found to be the
ost common verotoxin among the E. coli strains. The PCR
ethod used here was sensitive, speciﬁc and reliable.
oi:10.1016/j.ijid.2010.02.1967
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2.010
ertebral column damage due to brucellosis
. Leka
University Hospital Center ‘‘Mother Tereza’’, Tirana, Alba-
ia, N/A, Albania, Albania
Background: Brucellosis is zoonotic infection very
ommon in Albania (and Balkans region), because of uncon-
rolled infection of animals, especially in sheeps and goats.
he evaluation of clinical, laboratory and vertebral imaging
ndings is important to assess the efﬁcacity of the treatment
pplied.
Methods: The author has studied 12 patients, 20-74 years
ld, hospitalized in Infectious Diseases Department of UHC
uring the period Jan. 2002 - Oct. 2009. They were all
iagnosed with Brucellosis conﬁrmed by serological tests:
B, Wright and ELISA (IgM, IgG). They all, had also, verte-
ral lesions seen in MRI or CT examination. The treatment
rotocol consists of a combination of three antibiotics and
teroidal and non steroidal antiinﬂamatories administered
ver a three months period. Then the MRI or CT examination
as repeated.
Results: Totally, 11 cases (91%) were considered to be
n the subacute form of the disease, while 1 case (9%) in
he acute form. All of them had back pain and difﬁculties
n walking. According to CT or MRI ﬁndings in 3 cases (25%)
he region affected was the L2-L3 level, in 5 cases (41%) the
3-L4 level, in 2 cases (16%) the L4-L5 level and only in one
ase (8%) the damage was seen in C2-C3 level. Also, in one
ase there were simultaneously lesions in T11-T12 and L2-L4
ertebral levels. In 3 cases (25%) oedema of paravertebral
oft tissue was observed, without abscess formation. Nar-
owing of intervertebral spaces was seen in 11 cases (91%),
ssociated with a destruction of vertebral bodies surfaces,
ut the spinal cord was intact.
Pain was considerably relieved after treatment in 11
ases (91%) (the patients with lesion in one vertebral level)
nd partially relieved in 1 case (9%) (the patient with two
ertebral level lesions)
According to the second MRI or CT examination, in all
ases ﬁbrotic changes in vertebral bodies were seen associ-
ted with discal space reduction.
Conclusion: The author draws special attention to verte-
ral column lesions due to Brucellosis; adequate treatment
mproves clinical signs and symptoms and imaging ﬁndings.
oi:10.1016/j.ijid.2010.02.1968
2.011
arbapenem-resistant Enterobacteriaceae in a tertiary
are cancer hospital
. biswas
tata memorial hospital, mumbai, India
Background: Background. Infection with carbapenem-
esistant Enterobacteriaceae (CRE) or carbapenemase-
roducing Enterobacteriaceae is emerging as an important
hallenge in health-care settings. Carbapenem-resistant
lebsiella pneumoniae (CRKP) is the species of CRE most
ommonly encountered. CRKP strains are resistant to many
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which may be due to a very high use of co-trimoxazole here
is similar to those reported from this region (Microb Drug Res
7:403-411, 2001).14th International Congress on Infectious Diseases (ICID) Abs
available antimicrobial agents, and infections with CRKP
have been associated with high rates of morbidity and
mortality, particularly among persons with prolonged hos-
pitalization and those who are critically ill and exposed
to invasive devices (e.g., ventilators or central venous
catheters).. The most important mechanism of resistance
for CRKP is the production of a carbapenemase enzyme,
blakpc. The gene that encodes the blakpc enzyme is carried
on a transposon, which increases the risk for dissemination.
Detection of CRE is difﬁcult because some strains that har-
bor blakpc have minimal inhibitory concentrations (MICs)
that are elevated but still within the susceptible range for
carbapenems.
This study was undertaken to assess the presence of
carbapenem-resistant
Enterobacteriaceae in immunocompromised patients
who are more vulnerable to infections.
Methods: Material & Methods: A total of 5121 clinical
samples received during the study period in the Dept. of
Microbiology, were included in the study. All the samples
were processed, identiﬁed and antimicrobial susceptibility
testing performed as per standard microbiological proce-
dures. Imipenem resistance in E.coli and K.pneumoniae was
conﬁrmed by E-test, Modiﬁed Hodge test and double disk
synergy test.
Results: Results: Of the 5121 clinical samples received,
there were 275 isolates of E.coli and 154 isolates
of K.pneumoniae. A total of 23 carbapenem-resistant
Enterobacteriaceae were isolated from 12 patients. Of
the 23 isolates, 14(61%) were E.coli and 9(39%) were
K.pneumoniae.
Conclusion: Conclusions: The emergence and spread of
CRKP and other types of CRE is an important event in a series
of worrisome public health developments in antimicrobial
resistance among gram-negative bacteria and underscores
the immediate need for aggressive detection and the imple-
mentation of urgent control strategies.
doi:10.1016/j.ijid.2010.02.1969
52.012
Infections due to Haemophilus inﬂuenzae encountered in
Jamaica: Analysis of 286 cases at the University Hospital
of the West Indies
N. Bodonaik, R. Willis ∗, L. Rainford
University of the West Indies, Kingston, Jamaica
Background: Infections due to and antibiotic susceptibil-
ity of Haemophilus inﬂuenzae (HI) varies in different areas.
There are a large number of reports on HI infections from
many developed countries. Published data from developing
countries, however, are few and far between. There are
very few such reports from countries in the Caribbean. In
this report, we examine 286 cases of HI infections encoun-
tered in 3 years (2000-2002) at the University Hospital of
the West Indies (a 534 bed Tertiary Care Teaching Hospital)
in Kingston, Jamaica.Methods: The isolates were identiﬁed by standard
methodology including tests for requirement for X and
V factors (Manual Clin Microbiol, 6th ed. p 556-565).
Antimicrobial susceptibilities were determined by CLSI disc
dts e217
iffusion method. The disc susceptibility results were fur-
her validated by test for MIC by E-test using Haemophilus
nﬂuenzae ATCC 49217 as control with some isolates. Nitro-
eﬁn discs (BBL) were used to test for betalactamase
roduction.
Results: There were 286 patients with HI infections dur-
ng the period, 127 (44.4%) males and 159 (55.6%) females.
he age ranged from 1 day to 89 years and the mean age was
6.8 years. There were 28 invasive (sterile site) infections
mostly meningitis and bacteraemia) all of which were due
o type b strains and 258 non-invasive infections, the vast
ajority of which were conjunctivitis (148) and pneumonia
88). Pneumonia was the most common infection in adults
nd conjunctivitis the most common in children. These two
nfections together accounted for over 80% of all HI infec-
ions in the hospital during the period. The rate of resistance
o front-line antibiotics were: ampicillin 14.3%, chloram-
henicol 1.5%, amoxicillin-clavulanate (augmentin) 2.6%,
rythromycin 12.7% and cotrimoxazole 44.2%. All ampicillin
esistant isolates were betalactamase producers.
Pattern of infection due to Haemophilus inﬂuenzae in
arious age groups at UHWI 2000 - 2002
Conclusion: The changing epidemiology of HI infection in
ecent years underlines the need for periodic surveillance
f both invasive and non-invasive HI infections especially in
eveloping countries where Haemophilus inﬂuenzae contin-
es to remain a major cause of morbidity and mortality. The
igh prevalence of cotrimoxazole resistance in this hospitaloi:10.1016/j.ijid.2010.02.1970
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2.013
ncidence of human Brucellosis in Gevgelia region, Mace-
onia
. Petkov1,∗, Z. MIlenkovic2, M. Toshev3
General Hospital-Gevgelia, Gevgelia, Macedonia
Clinical Center-Scopje, Scopje, Macedonia
DSZI-PO Gevgelia, Negotino, Macedonia
Background: In Macedonia of 2008 year to enroll 9500
iseased sheeps and goats of Brucellosis.That is too much
otential to appear of human Brucellosis.The same year to
ecords 213 new diseased peoples of human Brucellosis who
s signiﬁcant health problem many years ago.
Methods: It used descriptive-epidemiological
ethod,biochemical and serological analysis
BAB,Wight,Coombs) to follow up a ten years period to dis-
asse (1998-2008) in General hospital-Gevgelia,Macedonia.
Results: In the department of Infectious disseases-
evgelia for period of ten years are treated totally
35 diseased persons.The last year to appear one out-
reak of human Brucellosis to one lifestock farm with
5 diseased peoples.In the season(march-september)
o enroll 108(80.0%)patients.The structure of diseased
eoples moreover was sheep-breeders and theirs own
amily,farmers,housewifes and veterinary surgeons.Most
requently age group was 35-45 years of 62 (45.0%)
atients).The smallest number of patients to enroll
005 year (6).The last year have to biggest number
f patients (20).Clinical manifestation of illness was
ains at knees,hips,shoulders e.t.c.Not often clinical
anifestations was high temperature, night perspira-
ion,weakness,exhausting.More frequently complications
as hepatitis brucellogenes (22,2%),orhyepidydymi-
is (5,9%),endocarditis (1,5%) and bronchopneumonia
0,7%).Therapeutical treatmen was introduced during of
ix weeks with dual therapy with(Rifampicin,Doxiciklin/Co-
rimoxsol).
Conclusion: The very much numbers of diseased ani-
als (sheeps and goats) to 9500 of last year subsequently
o introduce very high infectious potential to appear of
uman Brucellosis at Republic of Macedonia.Risk group
o obtaining human Brucellosis was farmeres and theirs
wn family, house- wifes whos to handles whit animal
roducts,veterinary surgeons e.t.c. Most frequently compli-
ation was hepatits brucellogenes (22.2%) with auspicious
ourse. To preventing to this zoonosis should complete vac-
ination and eradication to diseased stock.
oi:10.1016/j.ijid.2010.02.1971
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2.014
isk factors for death amongst children of ﬁve years and
ounger, with invasive non-typhoidal Salmonella infec-
ion, 2004 — 2008, South Africa
. Dermaux ∗, A. Sooka, S. Meiring, N. Govender, J. Moyes,
. Cohen, K. Keddy
National Institute for Communicable Diseases for GERMS-
A, Sandringham, South Africa
Background: In Sub-Saharan Africa, non-typhoidal
almonellae (NTS) are an important cause of bacteraemia,
ith case-fatality ratios (CFR) amongst hospitalized children
anging from 4%-27%.
Methods: NTS isolated from normally-sterile sites from
anuary 2004 through December 2008 were reported to a
ational, laboratory-based surveillance system. In-hospital
utcome, HIV infection status and other clinical data were
ollected at sentinel sites. Incidence rates for 2007 amongst
IV-infected and—uninfected children) 5 years were cal-
ulated, assuming that the age-speciﬁc HIV prevalence
mongst tested children was similar to those not tested
or HIV. Risk factors for death were evaluated using logistic
egression. Nosocomial infection was deﬁned as infection
dentiﬁed from specimens collected > 2 days after admis-
ion.
Results: The highest incidence of NTS was amongst chil-
ren aged < 1 year (19.8 per 100,000) and 1 year old children
6.2 per 100,000) as compared to older children (1.1 per
00,000 for 2 to 5 years old age group). The overall inci-
ence was 88.3 (per 100,000) amongst HIV-infected children
nd 2.7 (per 100,000) amongst HIV-uninfected children. HIV-
nfected children with invasive NTS infection had a 3.4-fold
ncreased odds (95% conﬁdence interval [CI95%] 1.9—6.3) of
ying compared to HIV-uninfected children (30%, (50/166)
IV-infected versus 9%, (10/112) HIV-uninfected, p < 0.001).
he CFR was higher amongst patients aged < 1 year (22%,
8/399) compared to those aged 1-5 years (16%, 40/248)
OR 1.5 CI95% 1.00—2.2, p = 0.066).
CFR varied by province: 6% (7/111) Western Cape, 20%
64/319) Gauteng, 24% (31/128) KwaZulu-Natal and 29%
26/91) other provinces, p < 0.001.
Nosocomial infections accounted for 19% (96/496) of
nfections and were associated with a 1.8-fold (CI95% 1.1—
.0) higher risk of death compared to community-acquired
nfections (CFR 29% (27/94) nosocomial versus 19% (73/392)
ommunity-acquired, p = 0.030). On multivariable analysis,
ontrolling for province, HIV-infected children with invasive
TS had a 3 times greater odds of death as compared to
IV-uninfected children p = 0.002 (OR 3.0 CI95% 1.7—5.5).
Conclusion: The incidence of NTS was highest in chil-
ren aged < 1 year and HIV-infected children. HIV-infected
hildren were also at increased risk of death. Access to
revention of mother-to-child transmission, HIV testing and
ighly active antiretroviral therapy should be prioritised.
oi:10.1016/j.ijid.2010.02.1972
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52.015
Changes in the epidemiology of Haemophilus inﬂuenzae
invasive disease, in Portugal, after the introduction of the
Hib vaccine
M.P. Bajanca-Lavado ∗, C. Betencourt
National Institute of Health Dr. Ricardo Jorge, Lisbon, Por-
tugal
Background: Haemophilus inﬂuenzae (Hi) is responsi-
ble for a number of human diseases ranging from chronic
infections to meningitis. Most of the isolates are non-
encapsulated (NC), although it is known until now six
serotypes (a-f). Hi serotype b (Hib) vaccine was adopted
in Portugal since 1994 and obligated since the year 2000
to children less than ﬁve years old. Our aim is to analyse
the serotypes of Hi invasive strains in parallel with possible
changes in antimicrobial susceptibility, before and after the
introduction of vaccine.
Methods: We collected 104 invasive Hi isolates (50 CSF,
52 blood cultures and 2 pleural ﬂuids) from 1989 to 2000,
and 111 (22 CSF, 81 blood cultures and 8 pleural ﬂuids) from
2001 to 2008, from several Hospital Laboratories in Por-
tugal. Fifty two strains (50%) were isolated from children
(<18 years old) in the ﬁrst period and 34 (32.7%) after the
vaccination period. Identiﬁcation of Hi was conﬁrmed by
standard procedures. Susceptibility testing was performed
by a microdilution assay, according to the CLSI guidelines.
$-lactamase production was determined with nitroceﬁn.
Serotyping was performed by PCR.
Results: In relation to ampicillin resistance, $-lactamase
producing was detected in 28.8% of the strains in the period
1989—2000, and 12.6% between 2001-2008. Five strains
(5.2%), all isolated in the pos vaccine period, had MIC values
to ampicillin and clavulanic acid of 2mg/L, which indicates
BLNAR possible. In relation to serotype characterization, in
the pre-vaccine period, 68.3% of the strains were Hib and
31.7% were NC; after the introduction of the vaccine, 12.6%
were Hib, 79,3% NC, and 8.1% non-b-type (2.7% a and 5.4%
f).
Conclusion: Considering the two periods 1989—2000 and
2001—2008 we observe a rise in NC strains and a decline
in serotype b, in invasive disease in Portugal. Non-b-type
strains were characterized only after the introduction of
the vaccine. In this way, we document changes in invasive
infections following the introduction of the vaccine in Portu-
gal, with an emergence of NC and an increase of serotypes
other than b. We also expect a new rule in the virulence
mechanisms of these strains.
doi:10.1016/j.ijid.2010.02.1973
52.016
Analysis of clinical outcome in patients with multidrug-
resistant Acinetobacter baumannii bacteremia
M.W. Kang ∗, Y.J. Kim, K.-W. Hong, S.I. Kim, Y.R. Kim, Y.-J.
ParkThe catholic University of Korea, Seoul, Korea, Republic of
Background: Multidrug-resistant Acinetobacter bauman-
nii (MDRAB) has been increasing reported worldwide, and
d
t
t
its e219
he therapeutic options are limited. The aim of this study
as to investigate clinical characteristic, risk factors for
ortality and outcome among patients with MDRAB bac-
eremia.
Methods: A retrospective study was performed at a ter-
iary care hospital in Korea from January 2005 to July 2009.
nly ﬁrst bacteremic episode from one patient was included
n the study. Antibiotic therapy was considered to be appro-
riate if the isolated strain was sensitive, in vitro, to initial
ntibiotic, which were administered within 48 hours after
lood culture sample obtained. Multidrug-resistant Acineto-
acter baumannii (MDRAB) was deﬁned as resistance to all
ommercially available antibiotics except colistin.
Results: Seventy-seven patients (40 male, 37 female)
ith Acinetobacter baumannii bacteremia were included.
he presumed sources of bacteremia that caused bac-
eremia were lung (n = 24,31.2%), catheter (n = 21, 27.3%),
ntraabdomen (n = 13, 17%), postoperative wound (n = 6,
.8%), urinary tract (n = 5,6.5%), and unknown (n = 8, 10.4%).
orty—three patients(55.8%) were infected with MDRAB. The
verall 30-day mortality in patients with Acinetobacter bau-
annii bacteremia was 33.7%(26/77), and was higher in
DRAB patients than non-MDRAB (62.5% vs 20.8%, p < 0.05).
ccording to univariate analysis, diabetes mellitus, central
enous catheter, mechanical ventilation, hospital day until
acteremia, inappropriate antimicrobial therapy, resistance
o imipenem and resistance to multidrug except colistin
ere associated with 30-day mortality (p < 0.05). Multivari-
te analysis using logistic regression model showed that
igniﬁcant risk factors for 30-day mortality were mechan-
cal ventilator (OR = 5.6, 95% CI 1.24-.24.83, p = 0.02), and
esistance to multidrug (OR = 40.77, 95% CI 3.95-420.85,
= 0.001).
Conclusion: Patients with MDRAB bacteremia showed
igher mortality rate than non-MDR bacteremia, although
nderlying status play an important role in clinical outcome.
he efforts to minimize the emergence of antimicrobial
esistance should be important.
oi:10.1016/j.ijid.2010.02.1974
2.017
linical proﬁle and antimicrobial resistance pattern of
nteroaggregative E.coli isolated from patients with diar-
hoea, using a multiplex PCR assay in a tertiary care
ospital in North India
. Pahil ∗, N. Taneja, G. Singh, M. Sharma
Post Graduate Institute of Medical Education and Research,
handigarh, India
Background: Enteroaggregative Escherichia coli (EAEC)
s an increasingly recognized enteric pathogen which
an cause both acute and persistent diarrhoea in chil-
ren,traveller’s diarrhoea and diarrhoea in immunocompro-
ised patients. The identiﬁcation of EAEC by conventional
echniques is technically demanding and time consuming.
he genetic and phenotypic heterogeneity also makes the
iagnosis of EAEC difﬁcult. Therefore a single assay mul-
iplex polymerase chain reaction (PCR) can be useful for
he identiﬁcation of enteroaggregative Escherichia coli. To
dentify both typical and atypical EAEC with a high sensitiv-
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ty and speciﬁcity we selected three targets including aggR,
VD432 and astA. The EAEC plasmid gene regulator, aggR
as 27.5—82% EAEC detection rate. The antiaggregation pro-
ein transporter gene, CVD432 (now aat), has a sensitivity of
5—89% and speciﬁcity of 99%. The enteroaggregative heat-
table enterotoxin gene astA has been reported in 29.8—44%
AEC strains and is most frequently detected among atypical
AEC.
Methods: Multiplex PCR was established for three genes
ggR(254 bp), CVD432(194 bp) and astAgene(94 bp). Antimi-
robial susceptibility was performed on the conﬁrmed
solates by Kirby Bauer method as recommended by CLSI.
Results: Out of a total of 185 isolates of E.coli 29%
53/185) showed presence of Enteroaggregative E.coli. Vir-
lence gene such as aggR was present in 69.8% (37/53)
solates. Genes such as east were positive in 43.3% (23/53)
f isolates and CVD was present in 56.6% (30/53) of iso-
ates.Majority of the strains were resistant to most ﬁrst line
ntibiotics showing high resistance for cotrimoxazole(84%),
moxycillin(81%) and norﬂoxacin(77%).
Conclusion: Diarrhoeagenic E.coli is a well established
ause of signiﬁcant morbidity and mortality worldwide. The
dentiﬁcation of EAEC by conventional techniques is techni-
ally demanding and time consuming. Multiplex PCR assays
argeting various virulence genes of EAEC can easily be
dopted for the routine diagnosis. In our study, 29% of cases
ere found to be caused by EAEC which were conﬁrmed
y multiplex PCR. Such a rapid technique can be extremely
seful in investigation of acute diarrhoea outbreaks due to
AEC. Drug resistance in EAEC is an increasing cause of con-
ern and most of isolates were resistant to all ﬁrst line
ntibiotics.
oi:10.1016/j.ijid.2010.02.1975
2.018
henotypic and molecular characterization of Pseu-
omonas aeruginosa isolates expressing high-level beta-
actamic resistance in cystic ﬁbrosis patients
.D.C. Batlle ∗, J. Ayala
Academy of Sciences, Havana, Cuba
Background: Most cystic ﬁbrosis (CF) patients suffers
rom chronic and fatal pulmonary infections caused by
trains of Pseudomonas aeruginosa (Ps. aeruginosa). Resis-
ance to extended spectrum Cephalosporin in this pathogen
s associated in most cases with the over production
f Cephalosporinase. The b-lactamases of Ps. aeruginosa
estroy antimicrobials with: carboxipenicilin, aminopeni-
ilin and cephalosporin The purpose of this study was to
etermine the presence of b lactamases genes (bla pse–
, ampC and bla oxa) in strains resistant. The nucleotide
equences by theses gene were determined in three resis-
ant strains to beta lactam antibiotic.
Methods: In our study 65 Ps. aeruginosa isolations were
btained from 15 cystic pediatric patients attending in
illiam Soler, in Havana during ﬁve years. Were character-zed by Micro dilution broth (MIC), Api System, Phagotyping
nd serotyping and Pulse Field gel Electrophoresis. High
evel Ceftazidime resistant isolate were conﬁrmed by PCR
etection of bla pse–1, ampC and bla oxa gene. Ampliconsternational Congress on Infectious Diseases (ICID) Abstracts
esulting from PCR determining regions of these genes were
uriﬁed with a Quia Quick spin PCR puriﬁcation kit. The
ucleotide sequences were determined with an automatic
equencer ABI PRISM 377 DNA SECUENCER.
Results: Mutations in the beta lactam resistance deter-
ining region of the ampC gene were detected in 3 strains
eftazidime resistant. Higth level by MIC to Ticarcillin,
ztreonam and Ceftazidime was associated with mutations
t codon 180 and 195 of the AmpC gene. The codon 180
mino acid change Pro to Arg and the codon 195 the
minoacid change Glu to Lys in the three strains. The
pidemiological date indicated that such resistant strains
robably emerge independently, possibly following selection
uring treatment with beta lactam drug.
Conclusion: Two main clusters were detected by PFGE
n our study, with common clonal relation among strains
iperacillin, Tobramicin and Meropenem were active against
ost of the strains tested, and is a good choice of antibac-
erial drug for treating CF infections. The results this work
ill be very helpful to guide empirical antimicrobial therapy
nd the implementation of infection control in cystic ﬁbrosis
atients in our country.
oi:10.1016/j.ijid.2010.02.1976
2.019
pigenetic regulation of lymphocytes response to LPS
. Melo1,∗, M. Camargo2, R. Curi 2, I. Velasco1, F. Soriano1
Medicine school University of Sao Paulo, Sao Paulo, Sao
AULO, Brazil
ICB University of Sao Paulo, Sao Paulo, Sao PAULO, Brazil
Background: Recent evidence suggests that many inﬂam-
atory genes are regulated by epigenetic modiﬁcations to
ndividual promoters. This level of control allows a single
ene to be expressed or silenced according to its func-
ion and to the previous conditions suffered, irrespective
f other genes induced by the same receptor, and therefore
s ‘‘gene-speciﬁc’’. The aim of the study is analyze in LPS
olerance the epigenetic via used to regulate gene expres-
ion (demethylation or hypermethylation) in lymphocytes
esponse.
Methods: Lymphocytes were cultured in DMEM (con-
rol C). Tolerance was reproduced in culture lymphocytes
xposed to LPS (T group) (24 and 48 h). NAB or 5aza were
dded once (NAB1 and 5aza1) for 24 h. After this period
PS was added to the media. The production of IL-6, IL-
0, IL-1, TNF, and MIP-2 were measured by enzyme-linked
mmunosorbent assay (ELISA). RT-PCR was performed to ver-
fy the differential mRNA expression. Primer sequences were
esigned using GenBank (www.ncbi.nlm.nih.gov).
tracts e221
AB1 NAB2 AZA1 AZA2
1000 pg/ml* ±1000 pg/ml# ±2000 pg/ml& ±10000 pg/ml$
4000 pg/ml ±5000 pg/ml ±4000 pg/ml& ±2000 pg/ml$
3000 pg/ml ±5000 pg/ml ±4000 pg/ml ±1000 pg/ml$
3000 pg/ml* ±6000 pg/ml ±4500 pg/ml& ±3000 pg/ml$
1500 pg/ml* ±4000 pg/ml ±1500 pg/ml& ±4500 pg/ml
8900† ±70000‡ ±20000 ±71000
3000 ±4500 ±5300 ±60004
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Results: Control LPS high dose Tolerant N
ELISA
TNF ±500 pg/ml ±20000 pg/ml ±1000 pg/ml ±
MIP ±50 pg/ml ±3000 pg/ml ±100 pg/ml ±
IL-1 ±70 pg/ml ±6000 pg/ml ±200 pg/ml ±
IL-6 ±58 pg/ml ±9000 pg/ml ±40 pg/ml ±
IL-10 ±50 pg/ml ±2000 pg/ml ±100 pg/ml ±
RT-PCR
TNF ±100 ±40000 ±1000 ±
IL-1 ±150 ±30000 ±2500 ±
ELISA
NAB1, * p < 0.05 compared to NAB2
NAB2, # p < 0.05 compared to LPS high dose
AZ1 & p< 0.05 compared to AZ2
AZ2, $ p < 0.05 compared to LPS high dose
RT-PCR
NAB1, † p < 0.05 compared to NAB2
NAB2, ‡p < 0.05 compared to LPS high dose
AZ2, 4 p < 0.05 compared to LPS high dose
Results are expressed as means± SEM. Comparisons among the group
were performed by using paired t-test.
Conclusion: Tolerance is regulating the expression of the
inﬂammatory genes differentially: 1-the epigenetic mech-
anism involved in regulating the expression of the genes:
MIP2 and IL1 is the demethylation of histones, 2- however,
the epigenetic regulation of IL6 and IL10 is through hyperme-
thylation and 3-the gene: TNF is regulated by demethylation
and hypermethylation.
doi:10.1016/j.ijid.2010.02.1977
52.020
Clinical and phylogenetic characteristics of Escherichia
coli urinary tract infections
S.Y. Lee ∗, J.H. Kim, J.K. Hur, J.H. Kang
The Catholic university of Korea, Seoul, Korea, Republic of
Background: We aimed to investigate the clinical and
phylogenetic characteristics of Escherichia coli Urinary Tract
Infections (E. coli UTI).
Methods: We enrolled patients with culture-proven E.
coli UTI, who were admitted at the study hospital from
September 2008 to August 2009. We investigated clinical
data of patients with E. coli UTI and characteristics of iso-
lated E. coli strains. The phylogenetic groups were classiﬁed
using triplex polymerase chain reaction (PCR), and the dis-
tribution of nine virulent genes was determined by multiplex
PCR.
Results: A total of 47 patients have participated in this
study. Thirty (63.8%) were under 6 months; eight (17.0%)
were between 6-12 months; and nine (19.1%) were over 12
months. We compared two age groups between under 6-
month and over 6-month. In the age group under 6-month,
higher proportion of male (P = 0.002) and group B2 strains
(P = 0.020) were observed. In contrast, higher proportion of
female and group non-B2 strains were observed in age group
over 6-month. In the comparison of phylogenetic groups,
group B2 showed higher distribution of virulent genes,
while group D included more strains resistant to trimetho-
prim/sulfamethoxazole (TMP/SMZ) than other groups.
C
S
1
3Conclusion: We showed the age group-speciﬁc difference
n the distribution of phylogenetic groups; more male and
roup B2 strains in age group under 6-month, while more
emale and group non-B2 in age group over 6-month. How-
ver, further evaluation including larger number of patients
ill be necessary to conﬁrm above thesis in future molecular
pidemiological studies.
oi:10.1016/j.ijid.2010.02.1978
2.021
erogroup W135 meningococcal invasive disease in
rgentina
.R. Agosti 1, C. Vescina2, J.C. Morales1, R.S. Oderiz3,
.M. Greco4,∗, D.M. Cecchini 5, S.E. González Ayala1
School of Medicine, National University of La Plata and Sor
aria Ludovicaˇıs Children Hospital, La Plata, Argentina
Laboratory of Microbiology, Sor Maria Ludovicaˇıs Children
ospital, La Plata, Argentina
Laboratory of Microbiology, Sor Maria Ludovicaˇıs Children
ospital, La Plata, Argentina
School of Medicine, National University of La Plata and
span˜ol Hospital, La Plata, Argentina
Department Infectious Diseases, Dr. C. Argerich Hospital,
uenos Aires, Argentina
Background: Meningococcal invasive disease (MID) is
ndemic/ hyperendemic/ epidemic at La Plata city, Buenos
ires, Argentina and its surrounding areas. First isolation
f N. meningitids W135 (NmW135) in Argentina was made
n 1981 in this location and, since then, sporadic cases
ccurred. MID is a rare disease in persons older than 15 years
f age in our country. The aim of this study is to describe
he clinical presentation, age group and fatality rate for
mW135 MID.
Methods: We prospectively studied 707 inpatients with
ID in a 13-year period; children accounted for 99.4%
n = 703). Blood and CSF cultures and isolation were made
y standard methods, identiﬁcation with DIFCO serum, and
or the last three years PCR gen (crgA) by M. Taha method (J
lin Microbiol 2000; 38:855-857) at Microbiology Laboratory,
or María Ludovica Childrenˇıs Hospital, La Plata, Argentina.
Results: First period (1996-2001): 419 MID total cases and
.2% (n = 5) were caused by NmW135. Age group (range):
months-9 years old. Clinical presentation: sepsis and
e th In
p
(
c
(
(
b
t
s
p
o
5
N
N
I
f
i
n
c
m
c
r
d
5
S
e
R
M
a
d
a
l
i
a
i
d
l
t
a
B
T
a
d
o
u
a
P
o
S
m
s
d
5
G
E
f
C
O
1
2
H
A
3
4
U
a
t
d
s
F
g
u
r
a
w
i
p
b
r
g
i
r
P
d
o
w
8
X
c
a
i
p
strains was observed. The characteristics as sample type
(diarrhea or control), date and EPEC type do not observed
closely related in the dendogram.
doi:10.1016/j.ijid.2010.02.1981222 14
urulent meningitis; no fatalities occurred. Second period
2002-2008): 288 MID total cases and 5.9% (n = 17) were
aused by NmW135. This serogroup emerged in the year 2007
n = 6) and the peak occurred in 2008 (n = 10). Age group
range): 1 month-58 years old. Clinical presentation was
acteremia (5.9%), bacteremia and pneumonia (5.9%), bac-
eremia and arthritis (5.9%), fulminant sepsis (23.5%), and
epsis with purulent meningitis (58.8%). Considering both
eriods, 4 adults were affected; age (range): 21 to 58 years
ld. The global fatality rate was 17.6% but in adults it was
0%.
Conclusion: We alert for the emergence of MID caused by
mW135with an unusual frequency in 2007. According to the
ational Reference Laboratory at the National Institute of
nfectious Diseases Dr. Carlos G. Malbran, NmW135 increased
rom 1.3% (1998-1999) to 11.6% (2006-2007), achieving 38.9%
n 2008. Clinical and microbiological laboratory data are
ecessary for epidemiological surveillance to detect early
hanges in frequency and Nm serogroup incidence. The
echanism by which a strain causes sporadic or epidemic
ases and the importance of a change in serogroup strains
emain unknown.
oi:10.1016/j.ijid.2010.02.1979
2.022
almonella prosthetic joint infections: An uncommon
ntity
. Gupta ∗, S.M. Boger, L.R. Leddy, H.D. Schutte, C.E.
arculescu, H.A. Demos
Medical University of South Carolina, Charleston, SC, USA
Background: Salmonella Prosthetic Joint Infection (PJI) is
rare entity, with twenty cases reported in the literature to
ate. S. typhimurium is themost commonly isolated species.
Methods: We conducted a medline search for all cases
nd series of Salmonella prosthetic joint infections pub-
ished between 1967-2008.We found twenty cases reported
n the literature, which are summarized in Table I.
Results: We present two cases of Salmonella PJI seen
t our institution between 1995-2009. Both cases had an
nvolvement of a total hip arthroplasty (THA). A preceding
iarrheal illness was only identiﬁed in one case. Salmonella
ivingstone was isolated from intraoperative cultures in
his case; S.enteritidis from the second patient. Symptoms
t presentation in both cases were fever and hip pain.
oth cases presented in the late post-operative period.
he surgical therapy included resection of prosthesis in one
nd, debridement with retention in the other, followed by
irected prolonged intravenous antimicrobial therapy. The
utcome in one patient is favorable at two months of follow-
p. The other patient died from an unrelated complication
fter eight weeks of therapy.
Conclusion: Salmonella spp is an uncommon cause of
JI. To our knowledge, this is the ﬁrst reported case
f Salmonella livingstone PJI. Identiﬁable risk factors for
almonella PJI are uncommon. A combination of surgical and
edical modalities is required for successful management of
uch infections
oi:10.1016/j.ijid.2010.02.1980ternational Congress on Infectious Diseases (ICID) Abstracts
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enetic analysis by pulsed-ﬁeld gel electrophoresis of
nteropathogenic Escherichia coli (EPEC) strains isolated
rom Peruvian children
.A. Contreras1,∗, J. Ruiz2, C.F. Lanata3, T.G. Cleary4, T.J.
choa1
Universidad Peruana Cayetano Heredia, Lima, Peru
Centre de Recerca en Salut Internacional de Barcelona,
ospital Clinic/Institut d’Investigacions Biomèdiques
ugust Pi iSunyer, Barcelona, Spain
Instituto de Investigación Nutricional, Lima, Peru
University of Texas School of Public Health, Houston, TX,
SA
Background: Enteropathogenic Escherichia coli (EPEC)
re a leading cause of infantile diarrhea in developing coun-
ries.The aim of this study was to determine the genetic
iversity of EPEC isolated.
Methods: 182 EPEC strains isolated from a cohort diarrhea
tudy in Peruvian children were characterized for the Pulse
ield Gel-Electrophoresis (PFGE). The strains were distin-
uished between typical (tEPEC) and atypical (aEPEC) EPEC
sing PCR for bfpA gene.
Results: A dendogram of 182 EPEC strains (98 from diar-
hea cases and 84 from controls; 35 were tEPEC and 147 were
EPEC) based of XbaI-digested DNA pattern was created
ith the InfoQuest (Bio Rad) software using Dice similar-
ty indices. PFGE, which revealed 171 distinct pulsed-ﬁeld
atterns (PP) based on a difference of a single band as a
asis for discrimination between isolates, were arranged in
evealed 28 clusters (I-XXVII; 1-44 strains per group) with
eneral similarity of 80% according to the Dice similarity
ndex. Four strains were not typeable by PFGE because it
epeatedly produced only a smear of degraded DNA after
FGE. Each cluster gathered strains belonging to different
ate of isolated, sample type (isolated from diarrhea cases
r control) or EPEC type (tEPEC or aEPEC). Two exceptions
ere cluster IX and XIX, which gathered only strains (6 and
respectively) isolated from diarrhea cases. The clusters
XVI, XXVII and XXVIII shown the most divergent pattern and
onstituting a separated groups from other strains analyzed
nd are formed exclusively by one strains each group (aEPEC
solated from diarrhea in all cases).
Conclusion: The 182 strains showed 28 different PFGE
atterns. A high degree of polymorphism among different
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52.024
Antibody subclasses as a tool for Helicobacter pylori anti-
gen characterization
F. Martinez1,∗, G. Castillo Rojas2, Y. López3
1 Universidad Nacional Autonoma de Mexico, Mexico City,
Mexico
2 Universidad Nacional Autonoma de Mexico, Mexico, Mexico
3 Universidad Nacional Autonoma de Mexico, D.F., Mexico
Background: Helicobacter pylori is a bacteria that colo-
nizes about 50% of the world population. H. pylori infection
is associated with severe disease including peptic ulcer
and gastric cancer. Several factors have been proposed as
important for this variability. Among the factors that pos-
sibly participate in this variable disease outcome is the
host’s immune response. Antibody subclass markers could be
important markers for disease outcome and could be used
as interesting markers of the development and polarization
of immune response. Therefore, we characterized the dif-
ferences in subclass antigenic recognition according to H.
pylori associated disease and source of antigen.
Methods: IgG1 and IgG2 titres were determined by ELISA
in 44 sera of patients with different H. pylori associated dis-
eases (Gastric cancer, peptic ulcer and dyspepsia). H. pylori
antigens were obtained from 12 different clinical isolates
from similar associated diseases.
Results: When the IgG1 and IgG2 titres were analyzed, we
found higher IgG2 titres across all titre determinations unre-
strictive of pathology. In particular, peptic ulcer patients
showed higher IgG2 /gG1 titre ratios. Source of antigen also
had an effect on these determinations, as dyspepsia derived
antigens revealed higher IgG1 titres across all screened sera.
Conclusion: There was an increase in IgG2 titres in all
sera, in concordance with a Th1 response. This increase is
more represented in peptic ulcer patients. Antigen source
was found to be a variable in these determinations, which
represents a novel characteristic of subclass-associated
antigenic analysis.
doi:10.1016/j.ijid.2010.02.1982
Hepatitis (Poster Presentation)
53.001
Age-speciﬁc seroprevalence of hepatitis A in SARI (north-
ern part of IRAN)
R. Ghasemian1,∗, S. Alian2
1 Mazandaran Universtiy of Medical Sciences, 48167-13319,
Iran, (Islamic Republic of)
2 Sari, Iran, (Islamic Republic of)
Background: Hepatitis A virus (HAV) is an enteric, viral,
infectious disease still endemic in many developing coun-
tries such as Iran. Improved sanitary condition has generally
resulted in a signiﬁcant decline in the incidence of hepatitis
A. However, a low incidence of infection results in increased
HAV susceptibility. The present study investigates the sero-
prevalence of hepatitis A virus antibodies in relation to age
to clarify the current HAV status and HAV susceptibility in
the city of Sari, northern part of Iran.
D
D
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Methods: A total of 1034 Serum samples collected dur-
ng 2007 from Iranian urban and rural individuals ranging in
ge from 1- 25 years, were tested for anti-HAV IgG antibody
sing a commercial enzyme immunoassay kit. Subjects were
nvestigated using a standardized social and medical history
uestionnaire. In data analysis, we use X2 (chi-square) and
sher exact test.
Results: 1034 subjects were enrolled including 620 urban
nd 414 rural people. The overall seroprevalence rate was
8.8%. There were 192 children under 5 years old and
30 subjects between 5 and 15 years and 512 subjects
etween 15 to 25 years old.. There was signiﬁcant corre-
ation between ages, parent’s educational levels and home
ondition with anti HAV antibody levels.
Conclusion: The surveillance of anti-HAV antibody preva-
ence is useful for implementing preventive measures and
or controlling the spread of HAV. It seems that immunization
gainst HAV will be needed in early future in our Population.
oi:10.1016/j.ijid.2010.02.1983
3.002
ssociation of polymorphism of HLA-DRB1 13 and HLA-A
3 alleles with outcome of hepatitis B virus infection
. Ramezani1,∗, A. Aghakhani1, E. Kalantar2, A. Eslamifar1,
. Banifazl 3
Pasteur Institute of Iran, Tehran, Iran, (Islamic Republic
f)
Iran medical university, Tehran, Iran, (Islamic Republic of)
Iranian society for support patients with infectious dis-
ase, Tehran, Iran, (Islamic Republic of)
Background: Hepatitis B virus (HBV) infection is a major
ublic health problem worldwide. The mechanism of sus-
eptibility to chronic persistent HBV infection is not well
lariﬁed, while the outcome of HBV infection mainly
epends on the host immune response. Different HLA class 1
nd 2 alleles may play roles in HBV infection outcome. The
urrent study aimed to determine association between HBV
nfection outcome and HLA-A and DRB1 genotyping in North
art of Iran.
Methods: Ninety-four HBV infected patients were
nrolled in this study. First HLA-A and DRB1 alleles were ana-
yzed by using low resolution PCR sequence-speciﬁc-primer
PCRSSP) and then we used high resolution PCR-SSP method
or subtyping HLA-A*33 and DRB1*13 alleles which were sig-
iﬁcantly related to the outcome of HBV infection.
Results: The frequency of A*33 allele in persistent group
as higher than in recovered group (9.37% vs. 0%, P < 0.008)
nd sub typing showed HLA-A*3303 and HLA-A*3301 in 75%
allele frequency: 7.3) and 25% (allele frequency: 2.34) of
ersistent HBV infected cases respectively. The frequency
f DRB1*13 allele was lower in persistent group than in
ecovered group (3.13% vs. 11.67%, P < 0.03, OR = 0.22, 95%CI
.06-0.82), and HLADRB1* 1301 and HLA-DRB1*1303 were
ound in 66.7%(allele frequency: 4.89) and 33.3% (allele
requency: 3.45) of cases respectively. HLA-A*3303 and
RB1*1301 were the predominant subtypes of HLA-A*33 and
RB1*13 at high resolution PCR-SSP method.
Conclusion: Host HLA polymorphism is an important
actor to determining the outcome of HBV infection. HLA-
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*3303 and DRB1*1301 were the predominant subtypes
f HLA-A*33 and DRB1*13 alleles in Iranian HBV infected
atients.
oi:10.1016/j.ijid.2010.02.1984
3.003
epatitis A epidemiology in a Brazilian ﬁre department
. Borghi1,∗, R.P. Igreja2, M.D. Canetti 1, R.C.
asconcellos1, C.L. Vitral 3, D.R.L. Santos3
Fire Department, Rio de Janeiro, Brazil
Universidade Federal do Rio de Janeiro, Rio de Janeiro,
razil
Instituto Oswaldo Cruz, Rio de Janeiro, Brazil
Background: In developing countries, the ﬁrst contact
ith hepatitis A virus (HAV) occurs early in life. In recent
ears, the improvement on sanitation conditions in some
eveloping areas resulted in an increase of proportion of the
opulation that reaches adulthood without acquired immu-
ity. In Brazil, although hepatitis A is considered an endemic
isease, data published in recent investigations carried out
n the State of Rio de Janeiro revealed a shift in the hepati-
is A epidemiological pattern. Consequently studies must be
onducted to deﬁne the seroprevalence of anti-HAV antibod-
es in different populations and a programme to vaccinate
on immune people must be created.
Methods: To ﬁnd out the seroprevalence of anti-HAV
ntibodies in a population professionally exposed to water
ontact (ﬂooding, sea and fresh water) living in Rio de
aneiro, Brazil. A secondary objective was to evaluate the
ost-beneﬁt of performing serological screening prior to
accination. Participants were military ﬁreman from the
tate of Rio de Janeiro, that ﬁlled in a socioeconomic
uestionnaire. Blood specimens were obtained for anti-HAV
erological test (ELISA). The results were analyzed using t-
tudent test and 2 test, as well as a logistic regression.
Results: Nine hundred and thirty one participants were
nrolled in the study. The median age of the population was
8 years and the overall seroprevalence of anti-HAV was
8.5%. The distribution of positive tests according to age
roups were 47,8% in 20—25 years, 53,4%% in 26—30 years,
9,4% in 31—35 years, 87,2% in 36—40 years, 88,6% in 41—45
ears and 91% in > 46 years.
Conclusion: Military ﬁreman from Rio de Janeiro have a
igh level of immunity against HAV. The results of cost bene-
t showed that the population which has a prevalence of up
o 27%, should be vaccinated without serological screening.
s the lower prevalence of this group was 47.8%, everyone
hould undertake serology before being vaccinated.
oi:10.1016/j.ijid.2010.02.1985
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3.004
ssociation of exon 9 but not intron 8 VDR polymorphisms
ith occult HBV infection in southeastern Iranian patients
. Hassanshahiraviz
Faculty of medicine, rafsanjan, kerman, Iran (Islamic
epublic of)
Background: Occult hepatitis B infection (OBI) is charac-
erized as a form of hepatitis in which despite of absence of
etectable hepatitis B surface antigen (HBsAg), HBV-DNA is
resent in patient’s peripheral blood. Investigators believe
hat divergent genetics and immunological parameters are
arying in resistant individuals from patients. Vitamin D3 and
t’s known receptor seem to be involved in anti-viral immune
esponses. Therefore, because OBI is a form of viral infec-
ion, the aim of this study was to investigate the association
etween polymorphisms in intron 8 and exon 9 of vitamin D
eceptor (VDR) with OBI.
Methods: In this experimental study, the plasma sam-
les of 3700 blood donors were collected and tested for
BsAg and anti-HBs using ELISA. The HBsAg-/anti-Hepatitis
core+(anti-HBc) samples were selected and screened for
BV-DNA using PCR. HBV-DNA positive samples assigned as
BI cases and PCR-RFLP was performed to examine the poly-
orphisms in intron 8 and exon 9 of VDR.
Results: Results of the current study demonstrated that
52 (9.5%) of 3700 blood samples were HBsAg−/anti-HBc+.
BV-DNA was detected in 57/352 (16.1%) of HBsAg-/anti-
Bc+ samples. Our results showed signiﬁcant difference in
/T allele of exon 9 of VDR but any differences were also
bserved in the other examined alleles.
Conclusion: The polymorphisms in T/T allele of exon 9 of
DR is possibly associated with OBI thus it can be concluded
hat VDR and its functional polymorphisms can probably
ave a relation with sensitivity and resistance of immune
ystem to HBV in OBI patients.
oi:10.1016/j.ijid.2010.02.1986
3.005
L-12 +1188 and IFN-g +874 polymorphisms is not asso-
iated with these cytokines serum level in occult HBV
nfected patients
. Abousaidi
Faculty of medicine, rafsanjan, kerman, Iran, (Islamic
epublic of)
Background: Occult hepatitis B infection (OBI) is identi-
ed as a form of hepatitis in which despite of absence of
etectable HBsAg, HBV-DNA is observed in peripheral blood
f patients. The main aim of this study was to investigate
he association between polymorphisms in +874 of IFN-g and
1188 of IL-12 with their serum level in patients suffering
rom OBI.
Methods: In this experimental study, plasma samples of
700 blood donors were tested for HBsAg and anti-HBc by
LISA. The HBsAg-/anti-HBc+ samples were selected and
creened for HBV-DNA by PCR. HBV-DNA positive samples
ssigned as OBI cases and ARMS-PCR techniques was per-
ormed to examine the polymorphisms in IL-12 and IFN-g.
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The serum level of IL-12 and IFN-g was also detected by
ELISA.
Results: Results of this study demonstrated that, 352
(9.5%) out of 3700 blood samples were HBsAg-/anti-HBc+
and HBV-DNA was detected in 57/352 (16.1%) of HBsAg-
/anti-HBc+ samples. Our results showed that groups showed
signiﬁcant difference in CC allele of +1188 region of IL-
12 and no difference was observed in the other evaluated
genes. Our results also showed that the alleles of +1188
region of IL-12 and alleles of +874 of IFN-g were also not
associated with serum level of cytokines.
Conclusion: According to the results of this study it may
be concluded that the polymorphisms in +1188 region of IL-
12 and +874 region of IFN-g would not affect the expression
of both cytokines at serum level in OBI patients.
doi:10.1016/j.ijid.2010.02.1987
53.006
Occult hepatitis B virus infection in ART-naive HIV-
infected Indian patients
S. Singh
All India Institute of Medical Sciences, New Delhi, India
Background: Hepatitis viruses are frequently found as a
co-infection with HIV due to shared routes of transmission.
Globally the most common method of diagnosis is serology,
which can only detect active HBV infection while the occult
HBV infection may be missed. We estimated the burden of
HBV infection in patients who were tested positive for HIV
at a tertiary care centre in north India. We also attempted
to determine the prevalence and clinical characteristics of
occult HBV among these treatment-naïve patients and com-
pare their demographics features with other HIV patients.
Methods: During a period of 6 years between January
2002 to December 2007 837 HIV positive patients were
tested for serological markers of HBV (HBsAg) and HCV IgM
in our laboratory. For comparison 428 apparently healthy,
HIV-negative organ donors were also included in the study.
Data on demographics, sexual behaviour, medical history,
laboratory tests viz., serum ALT and CD4 count of these
patients were recorded. A sub-group of 53 HBsAg negative
samples from HIV positive patients were randomly selected
and assessed for anti-HBs, anti-HBc total (IgG+IgM) and HBV-
DNA using a highly sensitive qualitative PCR and analysed
retrospectively.
Results: Overall, 7.3% of HIV positive patients showed
presence of HBsAg as compared to 1.4% in the HIV negative
control group. The prevalence was higher (8.55%) in males
than females (3.39%). Overall occult HBV with detectable
HBV-DNA was found in 37.5% patients; being 45.5% in anti-
HBs positive patients and 30.7% in patients positive for anti-
HBc antibodies alone.
Conclusion: High prevalence of HIV-HBV co-infection was
found in our patients. The most reliable method to diagnose
occult HBV co-infection in HIV seropositive patients is the
detection of HBV DNA.
doi:10.1016/j.ijid.2010.02.1988
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3.007
reatment of chronic hepatitis C: The efﬁcacy and pre-
ictors of response to therapy
. Bozic
Institute for Infectious and Tropic Diseases, Belgrade, SER-
IA, Serbia
Background: The current standard for therapy of chronic
epatitis C (CHC) is combination of pegylated interferon
lpha (PEG IFN-&2a or PEG IFN-&2b) and ribavirin (RBV). It
s universally accepted that achievement of Sustained Viro-
ogical Response (SVR) means successful treatment. Certain
actors are good predictors of treatment outcome and they
rovide optimal, individual therapeutic approach.
Objectives: Evaluation of efﬁcacy of CHC treatment and
redictors of treatment response.
Methods: 194 patients with CHC were treated with
ombination therapy (PEG IFN-&2a + RBV).Virological exam-
nations: anti-HCV antibodies (ELISA), serum HCV RNK levels
nd HCV genotypes (PCR technique). Liver biopsy specimens
ere staged in accordance with the Metavir score. Predic-
or with inﬂuence on treatment outcome were estimated by
ultivariable logistic regression analysis.
Results: There were more patients of male gender
59.3%), older then 40 years (58.2%), with high basal HCV-
NA level (> 800.000 IU/ml, 63%), with G1 HCV (67%) in
reated group of patients with CHC. Bridging ﬁbrosis and cir-
hosis (F3, F4) were found in 54 (27.8%) of patients. SVR was
chieved in 69.2%, relapse was found in 11.9% of patients.
9.8% of patients had no response on therapy. Predictors for
chievement of SVR were: non-1 HCV genotype p = 0.002,
R 5.9 95% CI (1.9—18.0), achievement of early virologi-
al response (EVR) p = 0.000, OR 0.92, 95% CI (2.73—35.97),
nd patients younger the 40 years p = 0.005, OR 3.66 95% CI
1.48-9.0). Predictors for failure of therapy for patients who
idn’t respond to treatment were: G1 HCV p = 0.005, OR 3.9,
5 CI (1.5—10.3), high basal viral load p = 0.013, OR 3.45,
5% CI (1.29—9.19) and interupted continuity of treatment
= 0.002, OR 4.49, 95% CI (1.72—11.76).
Conclusion: The current standard antiviral therapy was
fﬁcient in 127/194 (69.2%) of our patients. The most impor-
ant predictors for successful treatment (SVR) were: non-1
CV genotype, achievement of EVR for G1 HCV and patients
ge. Predictors for failure of treatment were: G1 HCV, high
asal viral load, older age (>40 years), presence of cirrhosis
nd discontinuity of treatment.
oi:10.1016/j.ijid.2010.02.1989
3.008
ccult hepatitis C virus infection among chronic liver dis-
ase patients in the United Arab Emirates
. Al-Moslih
University of Sharjah, P.O.Box 27272, Sharjah, United Arab
miratesBackground: Viral Hepatitis C (HCV) is one of the major
orld wide health problems. WHO estimates that about 3%
f the world’s population has been infected with HCV and
hat some 170 million are chronic carriers at risk of develop-
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ng liver cirrhosis and/or liver cancer. Occult hepatitis C virus
OCV) infection is characterized by presence of HCV infec-
ion with undetectable hepatitis C antibodies or/and RNA
n serum. Scanty information is available about the etiology
f viral chronic liver diseases in the United Arab Emirates
UAE). Therefore a study was carried out for detecting and
enotyping of HCV & OCV in patients with chronic liver dis-
ase (CLD) in UAE.
Methods: A total of 142 serum samples from CLD patients
nd 139 healthy individuals were tested by polymerase chain
eaction (PCR) & (RT-PCR) in determining HCv RNA&HBVDNA
n serum samples. ELISA tests were used to detect HCV & HBV
arkers in patient sera. Liver biopsies were taken from CLD
atients for immunohistochemistry((IHC) staining.
Results: The results indicated the prevalence of HCV,
ccult HCV, dual (HBV &HCV) and HBV infections at a
ate of 43.7%, 27.5%, 19.0% and 12.7% in CLD patients
espectively. Were as Healthy subjects were positive for
nti body HCV and HBV-DNA at a rate of 3.6% and 2.2%
espectively (P = 0.001). The most prevalent genotypes and
ubtypes of of HCV infection in CDL patients were genotype 4
28.3%),Where as the prevalence of other genotypes,3a,1a,
nd 3b,1b, 5, 2, 3a & 3b, 2a and 1a & 1b were in the range of
5.3 to 1.3%. IHC results for HCV in biopsy tissues revealed
hat 84.6 (11/13) were positive. Histopathological studies of
iver biopsies revealed that patients with HCV infection were
ore likely to have necroinﬂammatory activity and ﬁbrosis
han patients without HCV infection.
Conclusion: Occult HCV is relatively frequent among
atients with CLD in the UAE. Phylogenetic tree showed that
enotype 4 appears to be the dominant genotype Where as
he prevalence of other genotypes that circulating in UAE
opulation.(1b, 5, 2, 3a & 3b, 2a and 1a &1b) were less
ominant than genotype 4.
oi:10.1016/j.ijid.2010.02.1990
3.009
linical features of acute viral hepatitis A complicated
ith acute renal failure
. Choi ∗, B.S. Chin, S.Y. Shin, S.J. Jin, Y.T. Chae, S.H. Han,
.-H. Baek, J.Y. Choi, C.O. Kim, J.M. Kim
Yonsei University College of Medicine, Seoul, Korea, Repub-
ic of
Background: Although acute hepatitis A is usually self-
imited, the clinical manifestations can vary from mild to
evere liver dysfunction. However, little is known about risk
actors and outcome predictors for acute renal failure (ARF)
n acute hepatitis A. The objective of this study was to iden-
ify the simple clinical predictors for acute renal failure
ARF) and its clinical course.
Methods: The study and control groups consisted of
atients who did or did not develop acute renal failure,
espectively, after acute hepatitis A from January 2006 to
une 2009. A total of 396 patients were enrolled in this
tudy. We conducted a retrospective analysis of the inci-
ence, risk factors, and outcomes of patients with acute
epatitis A complicated with ARF.
Results: Thirty patients (7.6%) developed ARF. Older
atients and males were more likely to ARF during hepati-
a
a
tternational Congress on Infectious Diseases (ICID) Abstracts
is A. ARF patients were more likely obese, heavy alcoholics
nd having fulminant course. The ARF patients had a higher
hite blood cell count, higher levels of AST, ALT, total
ilirubin and CRP, lower levels of albumin, more frequent
oagulopathy, and lower platelet count compared with the
thers. On multivariate analysis, male gender [Odds ratio
OR) 9.616, 95% conﬁdence interval (CI) 1.307—70.000,
= 0.026], the presence of hypertension [OR 5.91, 95%
I 1.407-24.824, P = 0.015] and fulminant hepatitis [OR
7.95, 95% CI 10.399—322.928, P < 0.001] were indepen-
ent risk factors of hepatitis A-associated ARF. Of the 30
atients with ARF, 23 (76.7%) patients fully recovered; 14
46.7%) patients recovered with conservative care only,
nd nine (30%) patients required short-term hemodialysis.
he two groups of spontaneous recovery from ARF (n = 14)
nd hemodialysis/death (n = 16) showed signiﬁcant differ-
nces in platelet count at its worst value, creatinine at
ts worst value, albumin at admission, INR at admission
nd fulminant hepatic failure. Albumin level at admission
igher than 3.6mg/dL [OR 13.183, 95% CI 1.064-163.403,
= 0.045] and INR at admission less than 1.6 [OR 14.969,
5% CI 1.346-166.447, P = 0.028] were independent predic-
ors of spontaneous recovery of ARF during acute hepatitis
.
Conclusion: Acute renal failure associated with acute
epatitis A is not a rare complication. Male gender and
ypertension are risk factors of ARF. Patients complicated
ith ARF, higher albumin level and shorter INR at admission
ould a favorable prognostic factor.
oi:10.1016/j.ijid.2010.02.1991
3.010
revalence of isolated hepatitis B core antibody among
njection drug users in Central Province of Iran
. Soﬁan1,∗, A. Rostampour2, N. Izadi3, F.S. Mahdaviani3,
.A. Farazi 1, A. Ramezani4, N. Zarinfar5, H. Sarmadian6,
. Aghakhani7, M. Banifazl 7
Arak University of Medical Sciences, Arak, Iran, (Islamic
epublic of)
Islamic Azad University of Arak Branch, Arak, Iran, (Islamic
epublic of)
Iranian Blood Transfusion Research Center, Arak, Iran,
Islamic Republic of)
Pasteur Institute of Iran, Tehran, Iran, (Islamic Republic
f)
Arak medica university, Arak, Iran, (Islamic Republic of)
Arak University of Medical science, Arak, Iran, (Islamic
epublic of)
Tehran, Iran, (Islamic Republic of)
Background: Prevalence of hepatitis B virus (HBV), hep-
titis C virus (HCV) and co-infection of HBV and HCV are high
mong injection drug users. Hepatitis B may be presented
nly with isolated Hepatitis B core antibody (anti-HBc). This
tudy aimed to determine the prevalence of isolated anti-
Bc among injection drug users in central province of Iran
nd comparison of its prevalence with healthy blood donors.
Methods: A total of 531 voluntary blood donors with mean
ge of 36± 10.18 years (range 16—60 years) and 153 injec-
ion drug users with mean age of 30.66± 5.92 years (range
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20—50 years) were enrolled in this study. All of the injec-
tion drug users were prisoners. Hepatitis B surface antigen
(HBsAg), hepatitis B surface antibody (anti-HBs), anti-HBc,
Anti-HIV and hepatitis C antibody (anti-HCV) were tested in
all subjects.
Results: Of the 531 blood donors, 11 subjects (2.1%) had
isolated anti-HBc and of 153 injection drug users, 12 cases
(7.84%) showed isolated anti-HBc. All of 12 injection drug
users with isolated anti-HBc were also HCV positive. Sero-
logic proﬁle of 2 groups was shown in Table 1.
Variable Blood donors Injection drug users P value
HBsAg 0.4% 7.2% 0
Anti-HBs 31.8% 43.8% 0
Anti-HBc 11.5% 35% 0
Anti-HCV 0.2% 59.5% 0
Anti-HIV 0% 5.9% 0
Conclusion: Our study showed that prevalence of isolated
anti-HBc among injection drug users was 3.73 fold in com-
parison with blood donors. This study supports that injection
drug use and incarceration is contributing to increase preva-
lence of isolated anti-HBc.
doi:10.1016/j.ijid.2010.02.1992
53.011
Persistence of protective antibodies against Hepatitis B
virus among vaccinated health workers, Al-Hussein Hos-
pital, Salt, Jordan, 2008
S. Sheikh Ali 1,∗, M. Jaghbir2
1 MOH, Amman, Jordan
2 Dean Faculty of Medicine, Hashemite University, Zarka Jor-
dan, Amman, Jordan
Background: Health workers (HWs) have occupational
exposure to blood or body ﬂuids; unvaccinated HWs or those
vaccinated with low hepatitis-B surface antibodies‘‘(anti-
HBs) <10UI’’ are at higher risk of Hepatitis-B infection they
could be focus for dissemination of infection. Duration of
protection after fully vaccination is not known. The objec-
tive is to assess the immunogenicity ‘‘anti-HBs ‘‘10mIU/ml’’
post vaccination among HWs.
Methods: Two stage study; cross-sectional and follow-up
prospective-cohort. Voluntary HWs who met the inclusion
criteria were surveyed and tested primary for hepatitis-B
core antibodies and hepatitis-B surface antigen, only those
with negative results were tested for ‘‘anti-HBs’’; fully vac-
cinated HWs with negative anti-HBs were voluntary enrolled
in the second stage,retested for anti-HBs after 45 days from
a booster dose.
Results: 252 HWs participate in the study; 10% of those
don’t meet the inclusion criteria, primary study sample was
226 HWs, 81% were fully and 19% were partially vaccinated.
There was a signiﬁcant association between the number of
vaccine doses and the presence of anti-HBs, p-value-0.0002.
There is a signiﬁcant difference regarding the presence of
anti-HBs among fully or partially vaccinated HWs; P-value-
0.003. To verify ‘‘persistence’’, statistics were limited to
182 fully vaccinated HWs; was found signiﬁcant associa-
tion between the time period from the last administrated
doses, age at vaccination, duration of practice and the per-
i
o
e
(ts e227
istence of antibodies, P-value-0.00004, 0.040, and 0.010
espectively. There were no signiﬁcant differences regard-
ng the vaccination site, Fisher exact: 0.7018. There is no
ssociation between the ‘‘place of working, profession, and
requency of exposure to blood or needle stick injury’’ and
he persistence of antibodies. 8% of participants in second
tage didn’t response by reforming the anti-HBs. 65% of
Ws who were exposed to a needle stick injury report no
ost exposure preventive measures was taken after they had
eported the injury.
Conclusion: The Hepatitis-B prevalence among HWs was
0%; the non-response rate to vaccine was 8%; the prob-
bility for antibodies-persistence is declining by time;
robability of antibodies persistence is highly signiﬁcant if
he period from the last administrated dose is less than three
ears and increases with a booster dose. The older age the
accine was administrated the higher was the risk to non
esponse to vaccine.
oi:10.1016/j.ijid.2010.02.1993
3.012
egional and ethnical aspects of viral hepatitis B in preg-
ant women in Slovakia
. Kristian, I. Schreter, Z. Paralicova, P. Jarcuska ∗, L.
iegfried, S. Porubcin
Faculty of Medicine, University of P.J.Safarik, Kosice, Slo-
akia
Background: The estimated prevalence of HBsAg in Slo-
ak population is <2% with supposed regional differences
nd higher prevalence of HBV infection in Roma popula-
ion. Pregnant women constitute a special subgroup, that
s subject to routine HBsAg screening because of the risk
f vertical transmission, and also pregnancy can modify the
ourse of hepatitis B infection. The aim of this study was
o determine the prevalence of HBV infection in pregnant
omen in districts of eastern Slovakia with diverse preva-
ence of Roma population and to determine the subset of
omen with chronic hepatitis B and increased risk of vertical
ransmission.
Methods: We have analyzed data from 9 regional Depart-
ents of Clinical Microbiology from January 2008 till June
009. We have evaluated the portion of HBsAg positive ﬁnd-
ngs from the overall examined samples and among pregnant
omen. Available sera from HBsAg positive pregnant women
ere also screened for ALT, HBeAg and HBV DNA.
Results: Overall, 44,912 sera samples were examined,
ith 10,739 from pregnancy screening. The number of HBsAg
ositive samples overall and during pregnancy was 803
1.79%) and 251 (2.34%) respectively. Comparing districts
ith higher (>4%) and lower (<3%) prevalence of Roma popu-
ation, there was no notable difference in the overall HBsAg
revalence (1.85% vs. 1.68%), however in the subgroup of
regnant women (2.69% vs. 1.25%) this difference was highly
igniﬁcant (p < 0.001). HBV DNA was evaluated in 158 preg-
ant women, 19 patients had viral load >105 copies/ml, 27
n the range of 104-105 copies/ml and 112 patients < 104
r negative. HBeAg positivity was conﬁrmed in 17 of 146
xamined samples (11.6%) and elevated ALT in 11 of 69 cases
15.9%). Twelve out of 58 patients with normal ALT (21%) had
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showed that the prevalence of HCV infection in Kerman is
more than other provinces of Iran.
Conclusion: In contrast with other studies HBV-DNA in
these patients could not be detected, hence, it seems that228 14
iral load >104 copies/ml, 3 of them were simultaneously
BeAg positive.
Conclusion: The prevalence of HBV infection in pregnant
omen in eastern Slovakia exceeds the overall estimated
lovak prevalence, and in districts with higher Roma popula-
ion conﬁrms presumed higher prevalence of HBV infection
n this population. Majority of infected women are HBsAg
arriers, but we have conﬁrmed several cases of pregnant
omen with high viral load and increased risk of vertical
ransmission. We consider evaluation of ALT in pregnancy as
nsufﬁcient for ruling out chronic hepatitis B. This study was
upported by VEGA grant No.1/0050/08.
oi:10.1016/j.ijid.2010.02.1994
3.013
ew approaches in in-vitro diagnosis of Hepatitis C infec-
ions: The diagnostic performance of new hepatitis C virus
ore antigen detection test
. Kocazeybek1, P. Yuksel1,∗, S. Saribas1, R. Caliskan1, S.
rgin1, M. Aslan1, A. Yalcıner2, M.M. Torun1
Istanbul University Cerrahpasa Faculty of Medicine,
urkey, Turkey
Duzen Laboratory, Istanbul, Turkey
Background: There are problems currently in the diag-
osis of hepatitis C infections We aimed to investigate the
iagnostic performance of new HCV Ag (Abbott Diagnostic,
ermany.
Methods: All of the study cases were applied to the
stanbul University Microbiology and Clinical Microbiology
epartment and to the Düzen laboratory between February
008-March 2009. Molecular (real-time PCR) and serological
ethods (Micro-ELISA) were applied to the all of the cases,
23 HCV RNA-positive and anti-HCV positive cases, 48 HCV
NA negative and anti-HCV negative cases were included
s the study and negative control groups, respectively. We
valuated sensitivity, speciﬁcity, positive predictive (PPV)
nd negative predictive (NPV) values, accuracy and kappa
alues of antigen detection HCV Ag kit which includes mon-
clonal anti-HCV antibodies against HCV core antigen coated
n the solid phase.
Results: Sensitivity, speciﬁcity, PPV, NPV, accuracy and
appa values were evaluated as 94.3%, 97.9%, 99.1%, 87%,
5.3% and 88%, respectively for HCV Ag kit.
Viral load distrubition and HCV Core Ag results of HCV
NA Positive Patients
CV RNA (IU/ml) HCV RNA Positive Patients
—1000 4
001—2000 2
001—10000 2
0001—100000 13
00001 and upper 102
otal 123Conclusion: As a result, the diagnostic performance
arameters of recently developed HCVAg kit have not satis-
actory results because false negative ratio was 5% and NPV
as 87%. We suggest that this situation is related with unsuf-ternational Congress on Infectious Diseases (ICID) Abstracts
cient analytic sensitivity especially for HCV cases which
ave a 2000 IU/ml and below viral load. We suggest that the
e-evaluation of the sensitivity of this kit will be usefull for
lood screening.
oi:10.1016/j.ijid.2010.02.1995
3.014
o detected hepatitis B virus-DNA in thalassemic patients
nfected by hepatitis C virus in Kerman province of Iran
. Hassanshahiraviz
Faculty of medicine, rafsanjan, kerman, Iran, (Islamic
epublic of)
Background: Occult hepatitis B infection (OBI) is charac-
erized as a form of hepatitis in which despite of absence
f detectable hepatitis B surface antigen (HBsAg), HBV-DNA
s present in patient’s peripheral blood. This project was
imed to investigate the prevalence and clinical impact of
ccult HBV infection in thalassemic patients with chronic
CV infection.
Methods: In this cross-sectional study we have totally
xamined 60 patients suffering HBV and HCV infections by
CR and RT-PCR methods, respectively, in Kerman province
f Iran. ELISA technique (RADIM, Italy) was used to detect
nti-HBc, anti-HBs and HBsAg. The serum level of liver
nzymes (SGOT, SGPT, DB, TB and ALK) were analyzed in
he HCV infected patients (MAN, IRAN). Statistical analyses
erformed using t-test and Chi-square.
Results: We found that 27 cases (out of 60) were infected
y HCV but HBV-DNA was not seen in HCV infected patients.
ur ﬁndings also showed that none of samples were HBsAg
ositive but 9 (33%) (out of 27) HCV-RNA positive patients
ere anti-HBc positive and 11 (40.7%) were positive for
nti-HBs. We found that SGOT, SGPT, DB, TB and ALK are
bove normal in 27 (100%), 19 (70.3%), 12 (44.5%), 15 (55.5%)
nd 15 (55.5%) RNA-HCV positive patients, respectively. The
revalence of hepatitis C infection is very high in tha-
assemic patients and based on other studies our results
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risk factor for the development of signiﬁcant and advanced
ﬁbrosis. Their alterations during antiviral treatment allow
monitoring the progression of liver ﬁbrosis.
doi:10.1016/j.ijid.2010.02.199814th International Congress on Infectious Diseases (ICID) Abs
occult HBV infection isn’t frequent in Iranian thalassemic
patients who suffering from chronic HCV infection.
doi:10.1016/j.ijid.2010.02.1996
53.015
Genotypes and reverse transcriptase variability in asymp-
tomatic chronic hepatitis B virus
M. Basaras1,∗, E. Arrese1, S. Blanco2, P. Ruiz2, R. Cisterna3
1 University of Basque Country, Bilbao, Spain
2 Basurto Hospital, Bilbao, Spain
3 Basurto Hospital. University of Basque Country, Bilbao,
Spain
Background: Genomic mutations presented during hep-
atitis B virus (HBV) reverse transcription could explain its
genetic diversity and account for genetically distinct eight
genotypes which show distinctive geographically distribu-
tion. The main objectives of this study were to determinate
the prevalence of hepatitis B virus genotypes in asymp-
tomatic chronic hepatitis B patients without treatment,
and to identify mutations associated to nucleos(t)ides ana-
logues.
Methods: Twenty two serum samples from asymptomatic
chronic hepatitis B patients without treatment were ana-
lyzed using INNO-LIPA HBV Genotyping assay and INNO-LIPA
HBV DRv2 assay (Innogenetics). Nucleic acid was isolated
and quantiﬁed using real time PCR assay COBAS Taqman HBV
test. HBsAg, anti-HBs, HBeAg and anti-HBe were determined
by ADVIA Centaur.
Results: Genotype D was the most prevalent (45.5%) fol-
lowed by genotype A (27.3%) and genotype E (9%). There
were four coinfection cases (18.2%) (two D/H, one E/F and
one A/D genotypes). Both patients infected with genotype
E were from sub-Saharan area. In our study, all the patients
were positive for HBsAg and negative for HBeAg. HBV-DNA
levels were quantiﬁed and themean was 3.4 log10 copies/ml
(minimum 1.07 and maximum 7.04). Among the twenty two
HBV chronic inactive carriers, in only one case was detected
a single mutation in rtV214A position, which has been asso-
ciated to adefovir dipivoxil treatment. In this case, patient
was infected with genotype D. In the remaining patients no
mutations were identiﬁed at reverse transcriptase domain.
Risk factors for HBV acquisition were as follow: vertical
(27.3%), transfusion (13.6%), sexual (9.1%), tattoos (4.5%),
interfamilial (4.5%) and unknown (41%).
Conclusion: INNO-LIPA is a convenient tool for detec-
tion HBV genotype and resistance mutation. Genotype D
was the most prevalent accompanied with genotype A in
asymptomatic patients, but also coinfection genotypes are
frequent. A resistant mutation is rare in asymptomatic
patients but it was detected in one patient, indicating a
possible predisposition to adefovir dipivoxil therapy resis-
tance. HBV reverse transcriptase gene sequencing analysis
provides additional insight as part of monitoring program
that includes genotypic analysis and quantiﬁcation of circu-
lating virus.
doi:10.1016/j.ijid.2010.02.1997ts e229
3.016
ntiviral treatment with interferon alpha and ribavirin
nﬂuences serum markers of liver ﬁbrosis in children with
hronic hepatitis C
. Mania, W. Sluzewski ∗, P. Kemnitz, M. Figlerowicz, A.
owala-Piaskowska
University of Medical Sciences, Poznan, Poland
Background: Liver ﬁbrosis largely inﬂuences the course
nd prognosis of chronic hepatitis C (CHC). Although per-
utaneous liver biopsy is a valuable tool in the evaluation
f liver injury, it posses signiﬁcant drawbacks that limit
epeated use of this technique. The aim of this study was
o assess chosen serum markers of liver ﬁbrosis — laminin
LAM), hyaluronic acid (HA) and transforming growth factor
eta 1 (TGF-beta-1) with their relation to histopathological
ndings as well as their alterations after antiviral treatment
ith recombinant interferon alpha (IFN-alpha) and ribavirin
Rib) in children with CHC.
Methods: Study group included 68 children, age range
—18 years (mean 13,34± 3,27 years) with diagnosed CHC.
istory data were analysed. Diagnosis was conﬁrmed by the
resence of HCV-RNA in serum by RT-PCR. All children under-
ent histopathological evaluation of liver biopsy specimen
ccording to Ishak scoring system. Serum sample and liver
iopsy specimen were collected the same day. LAM, HA
nd TGF-beta-1 were measured in serum by enzyme linked
mmunosorbent assay kits. Children were treated with IFN-
lpha (3 MU/m2 3 x/week in s.c. injections) and Rib (orally,
wice daily) for 48 weeks. Serum markers of ﬁbrosis were
lso assessed at the end of the treatment.
Results: Length of infection was 7.34± 4.03 years (range
—13.5 years). Mean ALT activity was 60,82± 65,02 IU/l.
ncreasing mean serum TGF-beta-1 (p = 0.029) and decreas-
ng mean LAM level (p = 0.039) was found in the groups of
hildren with increasing stage of ﬁbrosis. Level of LAM was
eﬁned a risk factor of signiﬁcant ﬁbrosis (95%CI 18.05;
7.87, p = 0.001), while level of TGF-beta -1 of signiﬁ-
ant (95%CI: -33.51;-1.73, p = 0.030) and progressed liver
brosis (95%CI -36.09; -3.37, p = 0.019). Conducted antivi-
al treatment with IFN-alpha and Rib resulted in signiﬁcant
ecrease of TGF-beta-1 (51.42± 30.68 vs. 35.24± 31.50
g/ml, p = 0.032) and increase of LAM (60.26± 52.38 vs.
3.70± 46.25 ng/ml, p = 0.002) in serum. No signiﬁcant
lterations were detected in the control group of untreated
hildren.
Conclusion: Level of liver injury in children with CHC
aries in severity. TGF-beta-1 and LAM are not only propor-
ional to the stage of ﬁbrosis but also seem to be a good
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3.017
ncidence of HBeAg/anti-HBe and HBs/anti-HBs serocon-
ersion after sntiviral treatment in children with chronic
epatitis B
. Kemnitz, W. Sluzewski ∗, A. Mania, M. Figlerowicz, A.
owala-Piaskowska, M. Michalak
University of Medical Sciences, Poznan, Poland
Background: Chronic hepatitis B (CHB) is still a signiﬁcant
linical problem In the whole Word. It is estimated that 2
illiard people had contact with hepatitis B virus (HBV) and
00 millions suffer from CHB or its remote consequences.
he study was aimed at remote analysis of the incidence
f seroconversion in HBeAg/anti- HBe and HBsAg/anti-HBs
fter antiviral treatment and their relation to age at infec-
ion as well as evaluation of aminotransferase activity and
hosen biochemical parameters.
Methods: The study included 310 children (220 boys and
0 girls) with diagnosed CHB who underwent antiviral treat-
ent with interferon-alpha (IFN-alpha) or lamivudine. 177
hildren were treated with IFN-alpha, 25 with lamivudine
nd 107 children were treated with lamivudine after prior
ack of response to IFN-alpha treatment. Mean age at HBV
nfection diagnosis was 4.14± 3.23 years. Mean age At the
eginning of observation was 6.93± 3.69 years. Mean length
f follow-up was 7.11± 2.39 years.
Results: In 222 children (71.6%) seroconversion in
BeAg/anti-HBe was present - on the average 6.69± 3.02
fter the diagnosis and 2.19± 1.47 after the introduction
f antiviral treatment. The group of children treated with
FN-alpha was introduced 3.72± 2.12 years and lamivu-
ine 6.38± 3.71 years after the diagnosis of HBV infection.
everse relation was found between the incidence of sero-
onversion and the age at diagnosis (r =−0,30; p < 0,001).
LT and AST activity at HBV diagnosis was compared in
hildren with and without seroconversion. Children with
BeAg/anti-HBe seroconversion had higher aminotrasferase
t the diagnosis of HBV infection in comparison with patients
ithout seroconversion. Viral load in children with sero-
onversion revealed signiﬁcant alterations in the following
ears of the follow-up period in children with seroconversion
p < 0.0089). Similar changes were not present in children
ithout seroconversion.
Conclusion: Age at infection seem to be a signiﬁcant fac-or inﬂuencing the incidence of seroconversion. ALT and
ST activity at the diagnosis is a good prognostic factor of
BeAg/anti-HBe and HBsAg/anti-HBs seroconversion.
oi:10.1016/j.ijid.2010.02.1999
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eroprevalence and associated risk factors of hepatitis B
irus among street children in Isfahan, Iran (2005—2007)
. Ataei1,∗, Z. Nokhodian1, A. Babak2, P. Shoaei2, N.
assaian1, M. Ataie3
Isfahan University of Medical Sciences, Isfahan, Iran,
Islamic Republic of)
Isfahan University of Medical Scienses, Isfahan, Iran,
Islamic Republic of)
Azad Islamic Najaf Abad University, Isfahan, Iran, (Islamic
epublic of)
Background: Millions of children throughout the world
ive on the street. They are at higher risk of viral diseases
eg.hepatitis B virus) because of physical, sexual and drug
buse. The aim of this study was to evaluate the prevalence
f hepatitis B virus (HBV) and its risk factors in Isfahan street
hildren.
Methods: In a cross-sectional study, we selected 399
treet children by simple sampling method in June 2005-
arch 2007 from correctional centers in Isfahan,Iran.
fter getting information and giving concept form,data on
ociodemographic characteristics and life time risk factors
ere obtained during a structured interview and a venous
lood sample was taken for HBV testing.The tests for HBs
g, HBs Ab and HBc Ab were doen by ELISA method and data
ere analyzed by SPSS software version 15 used t-test, 62,
ann Whitney and logistic regression.
Results: We studied 271 (68%) boys and 128 (32%) girls.
heir mean age was 12.74± 3.27 years. In our study, poverty
as the main motivation for street children (68% of par-
icipants). 91.7%, 94.7% and 96.7% of the participants had
o history of smoking, drinking alcoholic beverages or
rug abuse, respectively. 34.4% of girls and 4.4% of boys
P = 0.001) were sexually abused and 68% of girls and 17.3% of
oys (P = 0.001) were involved in physical ﬁghting. HBs Ag,
Bs Ab and HBc Ab seroprevalence were 3.3%, 14.4% and
.1% respectively. No signiﬁcant statistical difference was
etween HBV-seroprevalence and its probable risk factors.
Conclusion: According to prevalence of HBV markers in
he same age group in Isfahan general population,it seems
hat street children have had more HBV infection and
ess protection. Educational programs for safer behaviors,
mprove quality of life, and hepatitis B vaccination in those
ho are non-immune are recommended for them.
oi:10.1016/j.ijid.2010.02.2000
3.019
revalence of HBeAg positive cases and abnormal amino-
ransferase tests in HBV chronic carriers in Kashan, Iran
. Momen Heravi
Kashan University of Medical sciences, Kashan, Isfahan,
ran, (Islamic Republic of)
Background: Hepatitis B virus (HBV) infection and its
equelae are major global health problems. It is estimated
hat 400 million people worldwide are HBV carriers. The nat-
ral history of hepatitis B is complex and is inﬂuenced by
any factors, including age at infection, viral factors (HBV
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genotype, viral mutations, level of HBV replication), host
factors (gender, age, and immune status), and exogenous
factors such as concurrent infection with other hepatotropic
viruses or alcohol.this study was conducted to evaluate
HBsAg persistence, related risk factors of HBV infection and
detect of HBeAg positive cases and abnormal liver enzyme
tests among chronic HBV carriers in Kashan.
Methods: This descriptive study was performed in HBsAg
positive blood donors. They were invited to retest HBsAg
.A questionnaire consisting demographic and history of risk
factors of HBV infection were ﬁlled by interviewing and then
5cc blood was taken and HBsAg was measured by ELISA
method. Who had HBsAg positive test without history of
acute hepatitis during the previous year, were known as
chronic carriers. and HBeAg, hepatic aminotranferases and
alkaline phosphatase were measured.
Results: Of 150 HBsAg positive blood donors 124(83.7%)
were male and 26(17.3%) female. Persistence and clear-
ance of HBsAg was seen in 132(88%) and18(12%). No
signiﬁcant statistical correlation between sex, age,marital
status, history of icther, endoscpy, tattoo. transfusion, with
persistence of HBsAg was found. In 132 HBsAg +chronic car-
riers the prevalence of HBeAg positive cases was 18.2%.
There was abnormal aminotransferase level including: 35
(26.3%)AST,16(12%)ALT,26(19.5%)ALKP Signiﬁcant statistical
correlation was seen between ALT and HBeAg but there was
no statistical correlation between AST and ALKP with HBeAg.
Conclusion: Considering the lower chance of clearance of
HBsAg and detect of correlation between HBeAg positive and
abnormal ALT,and also detect of suspected cases of chronic
hepatitis, follow up seems to be essential in HBeAg positive
cases.
doi:10.1016/j.ijid.2010.02.2001
53.020
Positive association of high risk behaviors and Hepatitis B
infection
A. Nejatizadeh, F. Abedi ∗, A. Madani
Hormozgan university of Medical sciences, Bandar Abbas,
Iran, (Islamic Republic of)
Background: Hepatitis B is one the most infectious dis-
eases, without seasonal distribution, accounting for more
than one million deaths annually due to chronic hepatitis,
cirrhosis and hepatocellular carcinoma. We aimed to inves-
tigate the seroprevalence of the HBV infection in Bandar
Abbas, Iran and determine the association of respective risk
factors with its occurrence.
Methods: We conducted a cross sectional community-
based study of 1152 apparently healthy individuals aged
8—65 years for the serological HBsAg screening. A standard
questionnaire was administered to all subjects. Unpaired t-
test for continuous data and the #2 test for categorical data
were performed.
Results: A total of 1152 individuals were assessed for
hepatitis B surface antigen (HBsAg), which was 2.1% in over-
all. There was no signiﬁcant difference between males and
p
a
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emales with respect to HBsAg seropositivity (male, 2.2%
s female, 2.1%, P > 0.05). Singles showed a prevalence of
.7%, while HBsAg seropositivity in married participants was
.3%. Subjects with tattooing practices reﬂected signiﬁcant
igher prevalence (7.5%) compared to those without tat-
ooing (1.7%, P < 0.0002). History of drug abuse remained
igniﬁcantly associated with HBsAg seropositivity (4.9% vs.
.4%, P < 0.0001).
Conclusion: HBsAg seropositivity was found 2.1%. High
isk behaviors associated signiﬁcantly with seroprevalence
f HBsAg. Of these, tattooing emerged more crucial com-
ared to the risk factors identiﬁed in out in other regions.
oi:10.1016/j.ijid.2010.02.2002
3.021
iodynamics of HCV infection in haemodialysis patients in
ahang
. Mustafa ∗, M.S. Abdul Majid, H.A. Binti Hamzah, M.H. bin
asmaini
Faculty of Medicine, International Islamic University
alaysia, Kuantan, Pahang, Malaysia
Background: Hepatitis C is a global disease, WHO has
escribed it as a ‘‘viral time bomb’’. In Malaysia, the sero-
revalence is 1.6%. HCV infection is frequent in patients
ndergoing maintenance haemodialysis, with prevalence
etween 8 and 10%. Hepatitis C has an adverse effect on
oth patient and graft survival in those who get renal trans-
lants. There are relatively scarce reports on the natural
uctuation in viral load and alpha interferon (&-IFN) level
n patients on chronic hemodialysis.
Methods: A longitudinal short-term three months study
here 27 chronic hemodialysis patients infected with known
CV genotypes were recruited from seven hemodialysis cen-
ers in Pahang. Serum samples were collected monthly,
oth pre- and post-hemodialysis sessions, over a period of
hree months. Viral RNA was extracted from serum using
IAamp Viral RNA Extraction kit (Qiagen). The HCV viral load
as measured using one step reverse transcriptase qPCR
Applied Biosystems) targeting the 5‘HCV non-coding region.
he serum &-IFN level was measured using commercial ELISA
it (Amersham, UK). Six biochemical liver function tests
AST, ALP, TP, albumin, ALT and TB) were also done for all
re-hemodialysis samples.
Results: All patients showed persistant low level viral
oad that varied signiﬁcantly over the study period
P = 0.001). HCV genotype 1 viral load was signiﬁcantly
igher than that of genotype 3. The difference between
re- and post-haemodialysis viral load was statistically
nsigniﬁcant. No signiﬁcant correlation between viral load
nd liver function status was noted. No correlation was
bserved between pre-haemodialysis serum &-IFN level and
rehaemodialysis viral load. The difference between pre
nd post-haemodialysis plasma &-IFN levels was statistically
nsigniﬁcant.
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iral load variation in three batches of sera taken one
onth apart.
Conclusion: HCV infected haemodialysis patients expe-
ience signiﬁcant ﬂuctuation in viral load with time but no
orrelation with biochemical evidence of liver injury. HCV
enotype 1 is associated with higher viral load as compared
o genotype 3. Single-step rt qPCR assay has the potential
or rapid HCV genotyping.
oi:10.1016/j.ijid.2010.02.2003
3.022
uns test and linear trend test of the time series of pri-
ary hepatocellular carcinoma mortality in Haimen City,
969—2007
.-X. Huang ∗, H.-B. Lu, W.-Y. Lin
Haimen City Center for Disease Prevention and Control,
iangsu Province, Haimen, China
Background: To evaluate the trend and contributing fact-
rs of time series changes of primary hepatocellular carcin-
ma (HCC) mortality between 1969 and 2007 in Haimen City.
Methods: A ﬁve-year retrospective survey was conducted
n Haimen City in 1973 to verify the cause of death among
ll city population between 1969 and 1973. The birth/death
eporting system was also established and was deﬁned as
ne of the nation’s pilot city for vital statistics by Ministry of
ealth and Ministry of Public Security. In 2006 it was accep-
ed by the International Union Against Cancer (UICC) as a
ember institute. This paper describes the time series chan-
es of HCC mortality in Haimen City between 1969 and 2007.
uns test was performed as stability test for the time series
nd linear trend test was performed as signiﬁcance test.
Results: HCC mortality increased from 33.18 per 100,000
n 1969 to 49.32 per 100,000 in 1979, with an annual increas-
ng rate of 4.04%. Between 1979 and 1989 the mortality
ncreased from 49.32 to 70.64 per 100,000, with an annual
ncreasing rate of 3.66%. Between 1989 and 1999 the mor-
ality decreased from 70.64 to 54.94 per 100,000, with an
nnual increasing rate of -2.28%. Between 1999 and 2007 the
ortality decreased from 54.94 to 50.09 per 100,000, with
n annual increasing rate of -1.15%. The runs test showed
n instable time series, and the linear trend test indicated
statistical signiﬁcant decreasing trend of HCC mortality
ince 1990. It is unlikely that this decreasing trend is caused
y random.
u
p
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Conclusion: The decreasing trend of HCC mortality in
aimen City since 1990 is related with the intervention of
nvironmental factors including ‘changing drinking water,
hanging staple food and prevention of HBV infection’ as
ajor components.
oi:10.1016/j.ijid.2010.02.2004
3.023
redictive factors for sustained virological response in the
reatment of patients with chronic hepatitis C
. Svirtlih1,∗, D. Delic1, J. Simonovic1, A. Radovanovic1,
. Mitrovic1, L. Nikitovic1, E. Gvozdenovic1, S. Zerjav1, I.
oricic2
Clinic for Infectious and Tropical Diseases Clinical Centre
f Serbia, Belgrade, Serbia
Institute for Pathology, Medical Faculty University of Bel-
rade, Belgrade, Serbia
Background: The goal of antiviral therapy in patients with
hronic hepatitis C is to prevent progression of the dis-
ase. The most important treatment response is the absence
f viral RNA six months after discontinuation the therapy,
eﬁned as the sustained virological response (SVR). Success-
ul therapy depends on many factors that are in association
ith the virus itself and/or infected person. The aim of
he investigation was identifying some characteristics of the
atients and hepatitis C virus as pre-treatment predictive
actors for achieving SVR.
Methods: Total of 364 treatment-naïve patients was
nrolled in the study (60.4% were males; age from 16 yr-
5 yr, mean 42.18, SD± 11.71). Liver cirrhosis had 21.7%
f patients. Patients were treated with standard doses of
egylated interferon alpha and ribavirin during 6 to 12
onths depending on the genotype in the period from Jan-
ary, 2004 to January, 2009. Source of infection was blood
ransfusion, intravenous drug abuse, accidental injury and
nknown in 26.5%, 19.5%, 12%, and 42% of patients, respec-
ively. Genotype distribution revealed genotype 1, 3, and
in 56.8%, 26.7% and 5% of patients, respectively. The
inority of patients had genotype 2 and/or mixed genotypes
1b3a, 1b4). Detection and quantiﬁcation of viral RNA with
ommercial assay (Cobas Amplicor HCV Monitor v2, Roche
olecular Systems) was evaluated before treatment, after
reatment and six months later. Electronic data base (SPSS
or Windows V11.0) was used for statistical analysis.
Results: Total of 82.8% of patients were negative (HCV
NA< 50 IU/mL) after treatment while SVR was achieved
n 68.8% of patients. Binary logistic regression analysis
evealed intravenous drug abuse (p = .005) and genotype 3
p = .003) as positive, whereas age older than 40 (p = .000),
resence of cirrhosis (p = .039), and genotype 1 (p = .000)
ere negative predictor factors for SVR. In multivari-
te analysis, age older than 40 (p = .001) and genotype 1
p = .000) were signiﬁcant variables (Exp(B) = .351 vs. .233).
Conclusion: Successful virological response to therapy is
xpected in patients with genotype 3 and intravenous drug
sers. Presence of genotype 1 is the most important negative
redictor for treatment of patients with chronic hepatitis C.
oi:10.1016/j.ijid.2010.02.2005
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53.024
Is there any association between chronic Hepatitis C virus
and celiac disease?
M. Rostami Nejad1,∗, S.R. Mohebbi2, K. Rostami3, K.
Cheraghipour4, M.R. Zali 5
1 Centers for Gastroenterology and Liver Diseases, Shahid
Beheshti University, M.C., Tehran, Iran, (Islamic Republic
of)
2 Center of Gastroenterology and Liver disease, Shaheed
Beheshti University, M.C, Tehran, Iran, (Islamic Republic of)
3 School of Medicine, University of Birmingham, Birming-
ham, United Kingdom
4 Department of Parasitology, Hamedan Medical University,
Hamedan, Iran, (Islamic Republic of)
5 Tehran, Iran, (Islamic Republic of)
Background: Celiac disease (CD) is an immune-mediated
disorder associated with some autoimmune liver diseases,
including primary biliary cirrhosis, autoimmune hepatitis
and primary sclerosing. In addition, there are contradictory
reports on association of chronic hepatitis C (HCV) and celiac
disease. The aim of this study was to determine the preva-
lence of untreated celiac disease and Hepatitis C Virus in
Iranian pregnant women and assess the outcome of preg-
nancy compared to non-celiac cases.
Methods: In this cross sectional study, 827 pregnant
women were recruited for this study during the period of
January 2007- February 2009. The mean age was 26.07
and SD 5.35 and mean pregnancy 5.4 months. Data were
obtained through questionnaires distributed during preg-
nancy. The questionnaire included questions about GI
symptoms and infections during pregnancy. They underwent
a total IgA test and antihuman IgA class antitissue transglu-
taminase (tTGA) antibodies for celiac disease and samples
also screened for anti- HCV antibodies by Third generation
enzyme linked immunosorbent assay.
Results: From 827 pregnant women 27 (3.26%) had a
positive serology for tTGA. Only two samples (0.24%) were
anti-HCV positive and one of them had positive tTG-IgA.
Eleven cases from 827 had IgA deﬁciency and none of them
were positive for IgG-tTG. Out of the 27 diagnosed women,
three had low birth weight babies and four had a history of
miscarriage.
Conclusion: Routine screening of HCV in CD patients is
not recommended, however, the presence of CD should be
considered in the setting of clinical deterioration during the
pregnancy.
doi:10.1016/j.ijid.2010.02.2006
53.025
Prevailing HCV genotypes and subtypes among HIV
infected patients in Georgia
M. Karchava ∗, L. Sharvadze, L. Gatserelia, L. Dzigua, N.
Dvali, T. TsertsvadzeInfectious Diseases, AIDS and Clinical Immunology Research
Center, Tbilisi, Georgia
Background: Recent analysis of ART program data in
Georgia showed that end-stage liver disease is leading cause
E
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f death among HIV/HCV co infected patients on ART after
nitiation of ART program in 2005. Therefore, treatment of
epatitis C among HIV infected individuals is essential for
ustaining success of ART in Georgia and to improve sur-
ival rates of HIV infected patients. HCV treatment response
ate and sustained viral suppression after antiviral treat-
ent largely depends on the HCV genotypes along with the
nﬂuence of HIV co- infection itself. The objective of this ret-
ospective study was to study the prevailing genotypes and
ubtypes of HCV virus in a cohort of HIV infected patients in
rder to obtain the preliminary data.
Methods: We analyzed 1490 HIV infected patients co
nfected with HCV virus. Among them 59% were HCV coin-
ected. Measurement of HCV RNA viral load was done by
OBAS TaqMan HCV-2.0 Test and HCV genotyping by reverse
ybridization line probe assay using VERSANT HCV Genotype
it 2.0 respectively.
Results: Detectable HCV RNA was found among 680
atients (91.%). Less than 10 Iu/ml was found among among
7 (9%). This numbers indicate low rate of self clearance
f the virus among HIV persons. Greater HCV RNA levels
ere associated with a greater chance to be infected with
CV genotypes 1. Most prevalent genotypes were genotype 1
ccounting for (41.6%), followed by genotype 3 (34.7%) and
(17.6%), inter genotype recombinants were found among
.8%.
Conclusion: Study demonstrated high prevalence of HCV
nfection among HIV-infected patients and reveals 1 as
redominant genotype. The differences of prevailing HCV
enotypes among general population and HIV co infected
roup was probably attributed to the different methods
or sample selection used. Another option can be possi-
le inﬂuence of diverse transmission networks among HIV
nfected group. The high number of intergenotype recom-
inants might be results of continues parenteral exposure
o different HCV genotypes during drug injection parapher-
alia. Study highlights and strengthens the need for careful
ollow-up of HCV/HIV co infected patients, effective man-
gement and therapies against HCV in order to reduce liver
elated death rates in patients on ART.
oi:10.1016/j.ijid.2010.02.2007
3.026
epatitis B Virus (HBV) mutations during long-term ther-
py in chronic hepatitis B patients
. Arrese1, M. Basaras2, S. Blanco3, P. Ruiz3, R. Cisterna4,∗
University of Basque Country, Vitoria-Gasteiz, Spain
University of Basque Country, Bilbao, Spain
Basurto Hospital, Bilbao, Spain
Basque Country / Basurto Hospital, Bilbao, Spain
Background: Long-term lamivudine (LAM), adefovir (ADV)
nd entecavir (ETV) treatment has been found to induce
he emergence of drug-resistant hepatitis B virus (HBV) in a
igniﬁcant number of patients with chronic hepatitis B infec-
ion. The aim of our study was to evaluate the LAM, ADV and
TV mutations detected in our patient group.
Methods: Fifteen patients diagnosed with chronic hepati-
is B were enrolled in this study. The patient group consisted
f those who had received two years of treatment with
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ucleos(t)ide analogues. Patients were evaluated based on
irologic and serologic response to therapy, and were clas-
iﬁed as patients with a detectable level of HBV DNA and
ndetectable HBV DNA (<1.08 log copies/ml). The muta-
ions associated with HBV drug resistance were investigated
n patients with detectable HBV DNA. Due to resistance, in
his group of patients treatment was change.
Results: In our study group, four patients devel-
ped LAM-associated mutations (rtL180M+rtM204V,
tL180M+rtM204V/I, and 2 present rtM204I), three patients
eveloped ADV-associated mutations (rtA181V+rtN236T;
tN236T and rtA181V), one patient developed ADV+LAM
ssociated mutations (rtL180M+rtA181V+rtN236T) and
ther patient developed ETV-associated mutations
rtL180M+rtT184A+rtS202G+rtM204V). Beside the primary
esistant mutations, various combinations of secondary
nd compensatory mutations conferring resistance to
ucleos(t)ide analogues were detected in 5 (33%) patients.
Conclusion: HBV treatment with nucleoside analogues
esults in the development of mutants strains, leading
o drug resistance. These data suggest an early develop-
ent of ETV resistance in patients with prior LAM and ADV
esistance. Therefore genotypic resistance is important in
onitoring HBV treatment. In conclusion, optimization of
herapy combining LAM and ADV may be a good choice for
atients with hepatitis B who have resistance mutations to
DV or LMV.
oi:10.1016/j.ijid.2010.02.2008
3.027
ong term virological follow up of Hepatitis C (VHC)
onoinfected patients who achieved end of treatment
esponse (ETR)
. Vujacich1,∗, P. Rodriguez Iantorno2, G. Vidiella3, E.
oggi 1, P. Titanti 1, P. Canda1, E. Sturba1, D. Stamboulian4
FUNCEI, BUENOS AIRES, Argentina
FUNCEI, Bs. As., Argentina
Maternidad Suizo Argentina Y Sanatorio Agote, Buenos
ires, Buenos Aires, Argentina
FUNCEI; Clinical Director, Ciudad Autonoma de Buenos
ires, Argentina
Background: Over the last few years a new concept
as intoduced a possibility a SVR may indicate cure. VHC-
RN clearence at 6 months after therapy discontinuation
VR (sustained virologic response) is generally assumed as
robable cure. The medical literature shows a signiﬁcative
eduction in the rate of progression to cirrosis and Hep-
tocarcinoma development in patients who achieved SVR
ompared to non responders and relapsers.
Methods: We retrospectively analysed a group of VHC
atients that fulﬁlled histologic criteria for antiviral treat-
ent from 1998 to 2009. We performed VHC ARN PCR
eterminations at baseline, during treatment, in the last
eek of antiviral treatment, every 6 months’ until the 2◦
ear after therapy discontinuation. and once a year further
n. We deﬁned ETR as negative or undetectable ARN VHC
CR in the last week of antiviral treatment.
Results: In our study 38 patients achieved ETR (nega-
ive VHC PCR during the ﬁnal week of IFN treatment). Only
e
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patients that achieved ETR showed early relapse in the
ext six months after stopping therapy (so they not achieved
VR). The rest of the patients are not detectable up to the
ast control., in the long term follow up.
Conclusion: In this small group of patients we didn‘t ﬁnd
elapses after 6 months following discontinuation of therapy,
ith a mean follow up of nearly 10 years The period of higest
isk of relapses was the next 12 months after the end of
reatment. The rate of relapses after 24 months of the end
f treatment was very low, as estimated in different studies
etween 1 and 2%.
oi:10.1016/j.ijid.2010.02.2009
3.028
eroprevalence of hepatitis A among children and adoles-
ent from south and southeast region of Brazil
. Figueiredo1,∗, M.R. Cardoso2, R. Moreira3, L. Pereira4,
. Montarroyos4, C. Braga5, A. Stein6, G. Coral6, R.
imenez4
Secretaria de Estado de Saúde de São Paulo, SãO Paulo,
ão Paulo, Brazil
Universidade de São Paulo, São Paulo, Brazil
INSTITUTO ADOLFO LUTZ, São Paulo, SP, Brazil
Universidade Estadual de Pernambuco, Recife, Brazil
Centro de Pesquisas Aggeu Magalhaes - FIOCRUZ, Recife,
ernambuco, Brazil
Santa Casa de Porto Alegre, Porto Alegre, Brazil
Background: The objectives were to estimate the preva-
ence of hepatitis A among children and adolescents from
outh and southeast region of Brazil and to identify
ndividual-, household- and area-levels factors associated
ith hepatitis A infection.
Methods: This population-based survey was conducted
n 2007—2008 and covered individuals aged between 5 and
9 years. A stratiﬁed multistage cluster sampling technique
ith probability proportional to size was used to select
.054 individuals aged between 5 and 19 years living in
he State capitals of 7 states in the study regions. The
ample was stratiﬁed according to age (5—9 and 10- to
9-years-old) and capital within each region. Individual-
nd household-level data were collected by interview at
he home of the individual. Variables related to the area
ere retrieved from census tract data. The outcome was
otal antibodies to hepatitis A virus detected using com-
ercial EIA. The associations between HAV infection and
ndependent variables were assessed using the odds ratio
nd corrected for the random design effect and sampling
eight. Multilevel analysis was performed by GLLAMM using
tata 9.2.
Results: The prevalence of hepatitis A infection in the
—9 and 10—19 age-group was 20,6 and 37,7%, respec-
ively for the Southeast and, 18,9 and 34,5%, respectively
or the South. A trend for the prevalence of HAV infec-
ion to increase according to age was detected in all sites.
ultilevel modeling showed that variables relating to differ-
nt levels of education were associated with HAV infection
n all sites. The multilevel model showed that individual,
ousehold- and area-level variables are independently asso-
iated with HAV infection. Age is an important predictor of
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outcome. Additionally, education and sewage disposal ser-
vice variables that were collected through household-level
interviews or retrieved from IBGE census tract data were
associated with HAV infection in all sites.
Conclusion: The study sites were classiﬁed as areas with
low endemicity area for hepatitis A infection. This multilevel
model allowed for quantiﬁcation of contextual predictors of
hepatitis A infection in urban areas.
doi:10.1016/j.ijid.2010.02.2010
53.029
Household survey of hepatitis B infection and risk fac-
tor assessment in the from South and Southeast region of
Brazil
G. Figueiredo1,∗, R. Moreira2, L. Pereira3, M.R. Cardoso4,
G. Coral5, A. Stein5, U. Montarroyos3, C. Braga6, R.
Ximenez3
1 Secretaria de Estado de Saúde de São Paulo, SãO Paulo,
São Paulo, Brazil
2 2Instituto ADOLFO LUTZ, São Paulo, SP, Brazil
3 Universidade Estadual de Pernambuco, Recife, Brazil
4 Universidade de São Paulo, São Paulo, Brazil
5 Santa Casa de Porto Alegre, Porto Alegre, Brazil
6 Centro de Pesquisas Aggeu Magalhaes - FIOCRUZ, Recife,
Pernambuco, Brazil
Background: In 1989, the Brazilian government ﬁrst
implemented immunization against hepatitis B for infants
and children in the western Amazon region and gradually
expanded this to other regions. Vaccination of risk groups
for the whole country started in 1992, and new groups have
been successively added to the original list. Since 1998,
the HBV vaccine has been incorporated into the immuniza-
tion schedule for infants as a national policy and, in 2001,
this was broadened to include children and adolescents.
Ppopulation-based survey was conducted in Brazil to esti-
mate the prevalence of and risk factors for HBV infection
from South and Southeast region of Brazil.
Methods: Random multistage cluster sampling was used
to select individuals aged 13-69 years. Outcomes indicat-
ing HBV infection were anti-HBc and HBsAg. HBsAg-positive
samples were tested for HBV-DNA and genotyped. Univariate
and multivariate analyses were performed.
Results: Overall, 10.496 individuals were included; the
prevalence of anti-HBc was: South 1,58% for 10—19 and 11,3
for 20—69 years old; Southeast 0,61% for 10—19 and 7,9 for
20—69 years old. HBsAg positivity was less than 0,5% in all
areas. Genotypes 3A, 1b,1a and 2b were identiﬁed. Age were
associate with HBV infection in all region and male were
independently associated with HBV infection in Southeast.
Conclusion: Our survey classiﬁed the South and Southeast
region of Brazil as low HBV endemicity areas. Our ﬁndings
that age is risk factors for HBV reinforce the need for exten-
sive HBV vaccine coverage among adolescents to prevent
viral infection. All individuals belonging to the risk groups
identiﬁed by our survey should be considered candidates for
HBV vaccine and educational measures. Therefore, vaccina-
tion upon request for individuals without speciﬁc risk should
be considered, in accordance with the current CDC recom-
mendations. This survey shows the importance of generating
r
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opulation-based information to facilitate comprehensive
accination and of developing educational strategies that
ddress regional differences.
oi:10.1016/j.ijid.2010.02.2011
3.030
ge-dependent, differentiated prevalence of anti-HAV
nd anti-HBc antibodies among patients with chronic
epatits C (CHC): New aspect of future vaccination per-
pectives against hepatitis A Virus
. Bialkowska1,∗, W. Mazur2, J. Slusarczyk3, M. Jablkowski1
Medical University of Lodz, Lodz, Poland
Medical University of Katowice, Katowice, Poland
Medical University of Warsaw, Warsaw, Poland
Background: Hepatitis A is an acute, usually self-limiting
isease of the liver, caused by hepatitis A virus. Patients
ith chronic liver disease are at increased risk of severe
omplications, related to hepatitis A, which, in some
ircumstances, may even lead to death. Therefore, it
s postulated that HAV susceptible individuals (anti-HAV
eronegative subjects) should be vaccinated against HAV to
revent or diminish morbidity and mortality of the disease.
im: Evaluation of the prevalence of anti-HAV antibodies
mong patients in different age groups with chronic hepati-
is C.
Methods: 133 patients (the mean age: 38.3 yrs) with CHC
ere divided into two groups, according to age (Table 1).
he control group consisted of 150 healthy young medical
tudents (the mean age: 25.3 yrs). The presence of anti-
AV and addition of HBV infection viral markers: anti HBc
nd HBsAg in blood sera of the patients and of the control
roup were assessed, using the standard EIA method (Cobas
oche).
Results: The prevalence of anti HAV antibodies and HBV
nfectionmarkers among the evaluated groups are presented
n Table 1.
roup Age
years
Pt n anti HAV Anti-HBc HBsAg
n % n % n %
HC 18—30 33 5 15.5 6 18.8 0 0
31—73 100 47 47.0 27 27.0 2 2
ontrol
24—26
150 15 10.0 8 5.3 2 1.33
In the study groups, age-dependent, differentiated
revalence of anti-HAV and anti-HBc was observed among
ounger (< 31 years) and older (> 30 years) patients with CHC
15.5% vs. 47.0%; p = 0.05 and 18.8% vs. 27%, p = 0.05, respec-
ively), which was higher than in healthy controls (10.0% and
.3%, respectively).
Conclusion: Patients below 31 with CHC present signif-
cantly lower anti-HAV and anti-HBc prevalence than older
nes, what creates a substantial risk for fulminant liver fail-
re and even death in case of HAV or HBV infection. Thus
accination programmes against HAV and HBV are strongly
ecommended in these groups of patients.
oi:10.1016/j.ijid.2010.02.2012
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3.031
ltrasonography changes of the liver of patients infected
ith hepatitis C met in the Foundation of Tropical
edicine of Amazonas
.R.D.T. Leao1,∗, M. Brock2, R.A.C. Carvalho3, W.S.M.
raga4
Universidade do Estado do Amazonas - Fundac¸ão de Medic-
na Tropical do Amazonas, Manaus, AM, Brazil
Universidade do Estado do Amszonas - Fundac¸ão de Medic-
na Tropical do Amazonas, Manaus, AM, Brazil
Universidade do Estado do Amazonas - Fundac¸ão de Medic-
na Tropical do Amazonas, manaus, Brazil
Fundac¸ão de Medicina Tropical do Amazonas, Amazonas,
razil
Background: 50% to 85% of the patients infected by hep-
titis C virus will develop a chronic infection, 20% of them
ill suffer from cirrhosis and 1% to 4% will develop hepa-
ocellular carcinoma. Morfologic and hemodynamic changes
hich occur in the liver and in the portal system can be
valuated by Doppler ultrasonography at an early stage and
n a non-invasive way.The main purpose of this paper was
o study alterations detected by ultrasonography examina-
ions in hepatitis C patients assisted at Fundac¸ão de Medicina
ropical do Amazonas.
Methods: In an 8-month period, 50 patients anti-HCV pos-
tive whose ages ranged from 18 to 69 were submitted to
oppler ultrasonography examinations.
Results: Most of the patients were males (74%) at an
verage age of 47,1. Morfologic alterations were detected,
uch as increase of the volume of the liver (12%) mainly
n the left liver lobe, increase of liver ecogenicity (24%),
splenomegaly (14%) and increase of ecogenicity and gall-
ladder wall thicknen (4%).
Conclusion: Hemodynamic alterations were noticed,
ostly a reduction on the portal vein velocity (26%), alter-
tions on the congestion index (12%), on the vascular hepatic
ndex (16%) and impedance of hepatic and splanchinic arte-
ial index.
oi:10.1016/j.ijid.2010.02.2013
3.032
etection of acute HCV infection among different risk
roups
. Gatserelia ∗, L. Sharvadze, M. Karchava, N. Dvali, L.
zigua, N. Badridze, T. Tsertsvadze
Infectious Diseases, AIDS and Clinical Immunology Research
enter, Tbilisi, Georgia
Background: To investigate acute HCV infection from the
ery ﬁrst days of the infection among blood donors, inject-
ng drug users (IDUs), health care workers and persons who
ad ﬁrst life time sexual intercourse with the chronic HCV
nfected persons in orders to asses clinical laboratory vari-
nts of infection, viral replication kinetic, disease outcome.Methods: Study was performed among ELISA negative
ersons in four groups: 7500 blood donors, 3200 IDUs, 70
xposed health care workers and 45 persons who had ﬁrst
ife time sexual intercourse with the chronic HCV infected
m
H
e
aternational Congress on Infectious Diseases (ICID) Abstracts
ersons. All groups were investigated on HCV RNA by Real
ime PCR (COBAS TaqMan Roche) using pool method and
enotyped by line probe assay (Innolipa, Versant, Bayer)
ccording to the manufacturer’s instructions. The results
ere analyzed by age, sex, duration of infection, modes of
ransmission and other variables.
Results: Total of 21 patients with acute HCV infection
ere identiﬁed: 7 from blood donors, 9 from IDUs, 1 from
ealth care workers and 4 from persons who had ﬁrst
ife time sexual intercourse with the chronic HCV infected
atients. All HCV RNA positive persons revealed within the
tudy were followed on viral load dynamic at detection
oment and at 2, 4 and 8 weeks and after 3 and 6 months
rom their possible exposure. Among them: 5 were symp-
omatic and 16 asymptomatic. Among 21 subjects: 10 had
enotype - 1b, 5 - 2a/2c and 6 - 3a. Out of 21 patients 7
leared the virus (5 were symptomatic: 1 - genotype 1b, 2
genotype 2a/2c, 2 - genotype 3a, and 2 asymptomatic:
- genotype 1b, 1 - genotype 3a), while 14 developed
hronic infection. In all patients viremia increased rapidly
nd reached a peak by week 4. After week 10 the viremia
apidly decreased. It became either undetectable by weeks
6-18 (viral clea rance), or virus was not eliminated (chronic
nfection).
Conclusion: We found that HCV viral clearance was cor-
elated with high viral titers, symptomatic form of disease
nd sexually transmitted HCV infection in female subjects.
tudy revealed no correlations between viral genotype and
iral clearance rates.
oi:10.1016/j.ijid.2010.02.2014
3.033
fﬁcacy of 96 weeks adefovir dipivoxil treatment in
BeAg positive chronic hepatitis B patients with various
aseline biochemical levels
. Zhuang1,∗, J. You2, L. Kong1, H. Lei1, R.-D. Yang2, X.
hang2, Q.-Q. Wang2
Third Municipal People’s Hospital of Kunming, Kunming,
hina
The First Afﬁliated Hospital of Kunming Medical Univer-
ity, Kunming, China
Background: Adefovir dipivoxil (ADV) has shown efﬁcacy
nd safety in a broad range of populations with chronic
epatitis B over 48 to 96 weeks. This study reports the
6-week long-term efﬁcacy data with ADV treatment in
ucleoside-naive HBeAg-positive chronic hepatitis B patients
ith various baseline biochemical levels.
Methods: Ninety-eight HBeAg-positive patients who had
ever received nucleoside treatment received 96-week ADV
0mg/d therapy. All patients had serum level of HBV load
ver 105 copies/ml and increased serum alanine aminotrans-
erase (ALT) level. Based on serum ALT levels at baseline,
ll patients were divided into two groups, A (48 patients
ith serum ALT level less than 200U/L) and B (50 patients
ith ALT level more than 200 U/L). Serum HBV load was
easured with quantitative real-time-PCR. ALT activity,
BeAg, anti-HBeantibodies, HBV-DNA level in serum were
valuated at baseline, week 12, 24, 48 and 96 during ther-
py.
trac
e
p
o
T
D
g
c
o
P
c
i
H
o
c
d
5
P
R
R
M
M
L
S
1
2
B
3
4
5
P
6
7
8
9
1
1
1
1
n
1
B
c
i
p
b
a
b
P
l
n
s14th International Congress on Infectious Diseases (ICID) Abs
Results: After 24 weeks of therapy, mean reduction of
HBV-DNA level, the percentage of patients with HBV-DNA
lower than 5 log10 copies/ml and the percentage of patients
with HBV-DNA level decrease of more than 2 log10 copies/ml
in group B were signiﬁcantly higher than those in group A
(P < 0.05, respectively). At the end of 24, 48 and 96 weeks,
the patients in group B had higher rates of undetectable
serum HBV-DNA levels and ALT normalization than those in
group A (46% vs 25%, 74% vs 54.2%, 88% vs 70.8%; 52% vs
31.3%, 66% vs 43.8%, 82% vs 62.5%; P < 0.05, respectively).
HBeAg seroconversion rate was signiﬁcant hihger in group B
than those in group A (48% vs 27.1%, P < 0.05). There was no
evidence of adverse effect in patients treated for up to 96
weeks.
Conclusion: Adefovir dipivoxil is an effective treatment
option for nucleoside-naive patients with HBeAg-positive
chronic hepatitis B, especially for those with high serum ALT
levels at baseline. Adefovir dipivoxil treatment through 96
weeks was well tolerated and resulted in continued beneﬁt
for patients with HBeAg-positive chronic hepatitis B.
doi:10.1016/j.ijid.2010.02.2015
53.034
The relationship between HBV precore region muta-
tion and the variation of T-lymphocyte subpopulations in
chronic HBV-infected individuals with normal liver func-
tion tests
J. You1,∗, Y.-H. Chen1, H.-Y. Chen1, H.-Q. Yang1, R.-D.
Yang1, Y.-F. Zhang1, J.-Y. Qu1, L. Zhuang2, Q.-Q. Wang1, X.
Zhang1, B.-Z. Tang1, J.-H. Huang3
1 The First Afﬁliated Hospital of Kunming Medical Univer-
sity, Kunming, China
2 Department of Hepatology, Third Municipal People’s Hos-
pital of Kunming, Kunming, China
3 Yunnan General Hospital of The Chinese People’s Armed
Police Forces, Kunming, China
Background: To investigate peripheral T-lymphocyte sub-
population proﬁle and its correlation with HBV precore
region 1896 mutation in chronic HBV-infected (CHI) individ-
uals with normal liver function tests.
Methods: HBV precore region 1896 mutation and distri-
bution of T-lymphocyte subpopulations in peripheral blood
were measured in CHI individuals with normal liver func-
tion tests. HBV markers were detected with ELISA. Serum
HBV DNA load was assessed with quantitative real-time
polymerase chain reaction. The results of peripheral T-cell
subsets were compared among groups based on HBV pre-
core region 1896 mutation status, HBeAg, age, sex and the
quantities of HBV DNA.
Results: CHI individuals with normal liver function tests
had signiﬁcantly decreased CD4+ cells and CD4+/CD8+ ratio,
and increased CD8+ cells compared with unifected controls,
all with P < 0.01. Comparing with HBV precore region non-
mutation group, the patients with precore mutation had
signiﬁcant decreased CD4+ cells and CD4+/CD8+ ratio and
increased CD8+ cells. Univariate analysis showed a simi-
lar pattern of these parameters was signiﬁcantly associated
with presence of serum HBeAg expression and high viral
load, all with P < 0.05 or 0.01. The presence of HBeAg
y
t
a
ats e237
xpression carried by the HBV precore region mutation
ositive group were not signiﬁcant different than those
bserved in HBV precore region mutation negative group.
here is a signiﬁcant difference in the quantities of HBV
NA between the HBV precore region mutation positive
roup and negative group. No obvious differences of T-
ell parameters and presence of precore mutation were
bserved among various age groups and sex groups, all with
> 0.05.
Conclusion: T-lymphocyte impaired balance was signiﬁ-
antly associated with HBV precore region mutation in CHI
ndividuals with normal liver function tests. Which with
BeAg expression and the HBV DNA replication affect each
ther and co-result in lower T-cell immune function and
hronic infection persistent status.
oi:10.1016/j.ijid.2010.02.2016
3.035
atterns of hepatitis A infection by Brazilian regions:
esults of the national household survey 2004—2009
. Ximenes1, C.T. Martelli 2,∗, E. Merchan-Hamman3, U.
ontarroyos4, C. Braga5, R. Moreira6, G.M. Figueiredo7,
.R. Cardoso8, M. Turchi9, G. Coral10, A. Stein10, M.L.
ima11, M. Costa12, L.C. Arraes-Alencar11, D. Crespo13, A.
antos dos Santos14, L. Pereira4
Universidade de Pernambuco, Pernambuco, Brazil
Centro de Pesquisas Aggeu Magalhaes - FIOCRUZ, Recife,
razil
Universidade de Brasilia, Brasilia, Brazil
Universidade Estadual de Pernambuco, Recife, Brazil
Centro de Pesquisas Aggeu Magalhaes - FIOCRUZ, Recife,
ernambuco, Brazil
INSTITUTO ADOLFO LUTZ, São Paulo, SP, Brazil
Secretaria de Estado da Saúde, São Paulo, Brazil
Universidade de São Paulo, São Paulo, Brazil
Federal University of Goias, Goiania, Brazil
0 Santa Casa de Porto Alegre, Porto Alegre, Brazil
1 Universidade Federal de Pernambuco, Recife, Brazil
2 Hospital da Base do DF, Brasilia, Brazil
3 Núcleo de Estudos e Pesquisas em Hepatologia da Amazô-
ia, Belem, Brazil
4 Instituto Bioestatístico de Ciência e Tecnologia., Belem,
razil
Background: Brazil has been classiﬁed as high endemic
ountry and HAV vaccine is not implemented in the routine
mmunization calendar. The objectives were to estimate the
revalence of hepatitis A among children and adolescents
y Brazilian regions and household/contextual risk factors
ssociation. This population-based survey was conducted
etween 2004 and 2009. It was a Ministry of Health and
AHO initiative with the Universities and Public laboratories
ocated in the State capitals.
Methods: A stratiﬁed multistage cluster sampling tech-
ique with probability proportional to size was used to
elect around 6400 individuals aged between 5 and 19
ears residents of the State capitals and the Federal Dis-
rict. The sample was stratiﬁed according to age (5—9
nd 10- to 19-years-old) within each region. Individual-
nd household-level data were collected by home inter-
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iew. Total antibodies to hepatitis A virus were detected
y EIA. Frequencies of HAV infection by region and the
ge distribution of the susceptible population were esti-
ated and odds ratio (95% CI) were calculated using
LLAMM.
Results: The prevalence of hepatitis A infection in the
—9 and 10—19 age-group by region: North (28.7% and
7.5%); Northeast (41.5% and 57.4%); Midwest (32.3 and
6.0%); Federal District (33.8% and 65.1%); Southeast (20.6%
nd 37.7%); South (18.9% and 34.5%). There was increasing
rend for the prevalence of HAV infection with age in all
ites. The curves of susceptible populations differed from
ne area to another. Multilevel modelling showed that depri-
ation/low socio-economic status was associated with HAV
nfection in all regions.
Conclusion: This is the ﬁrst national population-based
urvey to determine prevalence of hepatitis A (HBA) in
ll capital cities showing the shift pattern from high to
ntermediated/ low endemicity. Differences in age trends
f infection were detected among settings. This multilevel
odel allowed for quantiﬁcation of contextual predictors of
epatitis A infection in urban areas. Support: PAHO, Ministry
f Health, CNPq.
oi:10.1016/j.ijid.2010.02.2017
3.036
cute liver failure in the Colombian pediatric population:
etrospective and prospective studies
. Santamaria1,∗, M.M. contreras2, L.C. Rubiano3, R.
evivero4, F. Medina5, J. Mojica6
Hospital Universitario San Vicente de Paul, MEDELLIN,
olombia
Hospital General De Medellin, Medellin, Antioquia, Colom-
ia
3Health Public Department, Cali, Valle Del Cauca, Colom-
ia
Hospital Infantil Napoleon Franco Pareja, Cartagena,
olombia
Clinic san luis, bucaramanga, Colombia
Sanoﬁ Pasteur Colombia, Bogota, Colombia
Background: Describe the epidemiological and clinical
haracteristics in the pediatric patients with Acute Liver
ailure that were attended in the period between 1998 and
009 in the different health institutions in Colombia.
Methods: A transversal study based on the revision of
linical histories and questionnaires carried out in 10 health
nstitutions in 5 Colombian cities; including 2 Centers spe-
ialized in Transplants to evaluate the cases of Fulminant
epatic Failure in patients under the age of 18 years of age
resented between January 1998 and November 2009. FHF
as deﬁned as: 1). The elevation of AST and ALT aminotrans-
erases and/or the elevation of conjugated bilirubin. 2). The
bsence of known chronic hepatic disease. 3). INR > or equal
o 1.5 or PT > or equal to 15 seconds after the administration
f vitamin K, if the patient presents encephalopathy or 4).
n INR > or equal to 2.0 or TP > or equal to 20 seconds after
he administration of vitamin K if encephalopathy is not
resented. 5.) The degree of encephalopathy was stratiﬁed
ccording to age and according to its classiﬁcation.ternational Congress on Infectious Diseases (ICID) Abstracts
Results: 47 clinical histories were revised and 46 sub-
ects were included. The average age was 5.8 years of age
4 months of age — 16 years of age); of which 58.6% corre-
ponded to the female gender; 28.35% (13/46) coming from
ural areas. Jaundice was found in 100% of the subjects upon
ntry and encephalopathy in 76% (35/46). Liver failure was
ortal in 32.6% (15/46), with the average age being 6, 5
ears of age. Infection as a result of the Hepatitis A Virus
as one of the ﬁrst causes of FHF with 32.6% (15/46) as well
s Indeterminate Hepatitis (32.6%) and 15.2% caused by a
oxic reaction to the medications. The greatest proportion
f deaths is associated to Indeterminate Hepatitis due to
he forcefulness of the disease and the limited elements to
nderstand its etiology. 76.6% of the transplant candidates
btained a successful transplant (67%); retransplant was car-
ied out in 2 subjects, one died and the other managed to
urvive.
Conclusion: Acute Liver Failure is a frequent pathology
mong the pediatric ages in Colombia and is caused by the
epatitis A Virus in up to 32.6% of the cases. A high per-
entage of patients need liver transplantation and in some
ases have fatal consequences. Many of these cases are pre-
entable with vaccination.
oi:10.1016/j.ijid.2010.02.2018
3.037
epatitis B seroprevalence and associated factors in preg-
ant women and their couples in 6 Amazonian indigenous
opulations in Peru 2007—2008
. Ormaeche ∗, A. Whittembury, L. Suarez-Ognio, M. Pun
Ministry of Health from Peru, Lima, Peru
Background: Since 1995, there are reports documenting
igh magnitude of Hepatitis B transmission, but information
bout associated factors is scarce.
Methods: From June 2007 to december 2008 a sero-
revalence study was conducted in 6 Amazonian indigenous
opulations: Shispibo-Konibo, Ashaninka, Kandozi, Shapra,
hayahuita, Matsigenka. Objective: to determine the mag-
itude of Hepatitis B infection, and associated factors.
lood samples and written surveys were obtained. Informed
onsent was obtained from National, Regional and local
ommunity leaders and participants. For Hepatitis B testing,
BsAg and Anti-HBc elisa tests were performed.
Results: 1274 pregnant women and 721 male cou-
les were surveyed. Anti-HBc positive results: 522 women
42.06% [95%CI: 39.30% — 44.87%]) and 377 males
54.09% [IC95%CI: 50.31%—57.84%]). HBsAg were positive for
1/393 Anti-HBc positive women (2.80% [IC95%: 1.41% —
.95%]), and 15/312 Anti-HBc positive males (4.81% [IC95%:
.72%—7.81%]).
Anti-HBc positivity in women was associated to:
tracts e239
OR (95%CI) P value
7.15 (5.09—10.03) 0.000
0.75 (0.59—0.96) 0.013
5.49 (2.38—12.64) 0.000
0.54 (0.40—0.72) 0.000
1.32 (1.05—1.66) 0.008
1.94 (1.36—2.76) 0.000
1.65 (1.22—2.23) 0.000
1.90 (1.22—2.96) 0.002
OR (95%CI) P value
5.88 (2.26—15.28) 0.000
0.41 (0.18—0.88) 0.016
1.99 (1.38—2.89) 0.000
1.60 (1.09—2.36) 0.010
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diagnosis of and surveillance for hepatitis E would require
the use of anti-HEV IgM assays with the better performance
characteristics.
doi:10.1016/j.ijid.2010.02.202014th International Congress on Infectious Diseases (ICID) Abs
Associated factor
Male couple Anti-HBc positivity
Sex during menstruation
Male couple history of sex with other men
Being younger than 19 years
Sexual initiation before age 15 years
Male couple with more than 10 sex partners lifetime
Male couple with at least 1 more sex partner in last 12 months
Male couple with more than 20 sex partners lifetime
Anti-HBc positivity in men was associated to:
Associated factor
History of sex with other men lifetime
Being younger than 19 years
Sexual initiation before age 15 years
Having sex with women presenting vaginal secretion
Conclusion: Hepatitis B is hyperendemic in Amazonian
indigenous populations studied. These results suggest sex-
ual transmission as the main infection route of Hepatitis B in
indigenous population in reproductive age. A national plan of
Hepatitis B prevention and control in the Amazonian indige-
nous population in Peru is urgently needed to provide proper
education, vaccination and treatment.
doi:10.1016/j.ijid.2010.02.2019
53.038
Performance of serologic assays speciﬁc to IgM antibodies
against hepatitis E virus: pangenotypic evaluation
J. Drobeniuc1,∗, J. Meng1, G. Reuter2, N. Khudyakov1, N.-T.
Le1, T. Greene-Montfort1, Z. Dimitrova1, S. Kamili 1, C.-G.
Teo1
1 Centers for Disease Control and Prevention, Atlanta, GA,
USA
2 Regional Laboratory of Virology, ANTSZ Regional Institute
of State Public Health Service, Pecs, Hungary
Background: The routine use of a reliable assay to iden-
tify infection by hepatitis E virus (HEV) belonging to all
4 genotypes is desirable in clinical practice and disease
surveillance. We evaluated assays developed to detect anti-
HEV IgM by interrogating them with panels of specimens
derived from patients known to be infected with HEV belong-
ing to each speciﬁc genotype.
Methods: Two in-house assays (assigned I and II) and
4 commercial assays (III to VI) were evaluated. Assay I
used as antigen a 56-kD protein expressed from open
reading frame (ORF) 2 of the SAR55 HEV strain in a bac-
ulovirus system. Assay II used as antigens recombinant
proteins (each 166 amino acids in length) derived from
ORF2 of 4 HEV strains, each strain originating from apeciﬁc genotype. The commercial assays evaluated were
urchased from International Immuno-Diagnostics (USA),
P-Diagnostics (Singapore), Diagnostic Systems (Russia) and
ikrogen Diagnostik (Germany). All 6 assays were of indirect
sandwich) format. A total of 194 sera comprised the test
anels. The acute hepatitis E panel comprised 51 samples
15 from patients infected by HEV belonging to genotype
, 4 to genotype 2, 15 to genotype 3 and 17 to genotype
). The non-acute hepatitis E panel comprised 143 sam-
les originating from patients with acute hepatitis A, acute
epatitis B and acute hepatitis C, as well as those conva-
escing from acute hepatitis E. Sensitivity, speciﬁcity and
nter-assay agreement were determined.
Results: The sensitivity of the assays among patients
nfected with 4 HEV genotypes varied from 72% for Assay IV
o 98% for Assays I, II and V. The speciﬁcity ranged between
5% for Assay I and 92% for Assays V and VI. Kappa values for
nter-assay agreement ranged from 0.38 to 0.75.
Conclusion: The sensitivities and speciﬁcities of the 6
nti-HEV IgM assays varied substantially. Inter-assay agree-
ents were mostly poor. Precise and accurate laboratory
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4.001
C-chemokine Co-receptor R5 genotypes in Ghanaian
ouples discordant for human immunodeﬁciency type 1
nfection
. Affram
University of Ghana Medical School, Accra, NA, Ghana
Background: The prevalence of HIV among heterosex-
al couples is high. In spite of this, there are instances in
hich one partner is HIV sero-positive and the other HIV
ero-negative (described as discordant couple) despite being
t risk for HIV infection. A number of factors are respon-
ible among which is a deletion in the major coreceptor
chemokine receptor CCR5) for entry of HIV-1 into CD4+ T
ymphocyte cells. Individuals homozygote for a 32 base pair
eletion (CCR5 Delta 32) do not express the CCR5 receptor
t their cell-surface and have a natural resistance to HIV-1
nfection.
Methods: In order to determine the CCR5 genotypes of
hanaian serologically discordant couples and the possible
ole of CCR5 Delta32 mutant allele in the lack of HIV-1
ransmission, 32 couples (serologically discordant couples
DC and serologically concordant couples SCC) visiting the
evers Unit (FU) of the Korle-Bu Teaching Hospital (KBTH)
ere enrolled. Couples were made to ﬁll questionnaires on
heir behavioural characteristics and blood samples were
aken for HIV-1 antibody testing and conﬁrmation. HIV-1 neg-
tive serostatus of discordant partners was conﬁrmed by
olymerase chain reaction (PCR). The CCR5 genotypes were
etermined using DNA subjected to PCR ampliﬁcation.
Results: Couples response to questionnaires revealed
hat they indulged in high risk behavioural practises.HIV
ntibody testing with PCR conﬁrmation revealed 8 SDC and
4 SCC. One SDC seronegative individual (out of 8 SDC
eronegatives) was heterozygous for the CCR5 Delta32 geno-
ype. This was an important ﬁnding (although possession of
CR5 Delta32 heterozygous genotype may delay the acqui-
ition of HIV-1 infection but cannot be implicated in natural
esistance to HIV-1 infection) because most research scien-
ist augment that the gene mutation does not exist in people
f African decent. This was the ﬁrst time that the CCR5 geno-
ypes of Ghanaians were determined and also the ﬁrst time
hat a heterozygous was found. The rest of the couples had
ild type CCR5 genotype.
Conclusion: CCR5 Delta 32 mutant allele is unlikely to
xplain discordance in this cohort. There the need for a
opulation based study to help ascertain the prevalence of
CR5 genotypes in the Ghanaian population. Counselling and
ollow-up must also be intensiﬁed in the group at risk group.
oi:10.1016/j.ijid.2010.02.2021
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4.002
ndothelial Progenitors Cells and Microparticles in HIV-
nfected patients
.F.R. Silva1,∗, F.A.H. Fonseca2, C.N. Franca2, P.R. Abrao1,
.M.C. Monteiro2, L.M. Camargo2, R. Salomao1, S.B.
enore1, D.S. Lewi1
Federal University of São Paulo, São Paulo, São Paulo,
razil
Federal University of São Paulo, Sao Paulo, Brazil
Background: HIV infection is an inﬂammatory disease and
an cause endothelial disfunction and increases the car-
iovascular risk. It plays a critical role in coronary artery
isease, but the assessment of the endothelial disfunction
as been problematical. Exposure to cardiovascular risk fac-
ors alters the regulatory functions of the endothelium that
rogresses from a quiescent state to activation, apoptosis
nd death. Recently, it has been shown that endothelial cells
EC) release microparticles (MP) on activation or apoptosis
nd that evaluation of MP can provide useful information on
C status in patients with an increased cardiovascular risk.
dentiﬁcation of circulating endothelial cells and microparti-
les has raised considerable interest as non-invasive markers
f vascular disfunction.
Methods: We studied these new markers of cardiovascu-
ar risk, as endothelial progenitors cells and microparticles
n HIV-infected naive patients and compared with HIV neg-
tive controls matched for age and sex.Standard laboratory
tudy included: lipid proﬁle, glycaemia, C-reactive protein
nd apolipoprotein B. The endothelial progenitors (EPC)
ells and microparticles (MP) were measure by ﬂow cito-
etry. The EPC were identiﬁed using the following markers:
D34+ (surface protein), KDR (vascular endothelial growth
eceptor 2) for deﬁnition and CD133+ for immature lineage
ells. The MP were characterized with CD31+ (MP platelet
nd endothelial derived), CD42+ (MP platelet derived) and
D51+ (MP endothelial derived).
Results: Thirty patients were included, 15 in each group,
3,3% were male with mean age 30,9 years. The lipid pro-
le was signiﬁcant only in the HDL-c and LDL-c between
he groups. In the HIV-infected group we observed 0,01%
f CD34+/KDR+ and it was not isolated CD34+/CD133+ nei-
her CD133+/KDR+. In this group it was also observed more
elease of MP CD51+ and CD31+/CD42+ comparing to the
ontrol group, any MP CD31+/CD42- were found.
Conclusion: Our results suggest a possible imbalance
etween EPC and MP. This new ﬁnding in HIV-naive patienthe long term follow-up of these patients, and can be aggra-
ated after antiretroviral therapy.
oi:10.1016/j.ijid.2010.02.2022
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54.003
Analysis of longitudinal nef sequence variation through-
out HIV-2 infection
M. Remedios1,∗, E. Paixao1, H. Feliciano2, A. Silva-Graca2,
E. Pádua1
1 National Institute of Health, Lisbon, Portugal
2 Hospital Militar de Belém, Lisbon, Portugal
Background: Human Immunodeﬁciency Virus type 1 (HIV-
1) and type 2 (HIV-2) may case a severe immunodeﬁciency in
humans (AIDS). However HIV-2 is more frequently associated
with lower levels of transmission and disease progression,
compared with HIV-1 infections. The role of nef gene in vivo
during the development of AIDS has been clearly demon-
strated in simian immunodeﬁciency virus infected Rhesus
macaques model, but the determinants which play a role
in the pathogenesis of HIV are relatively poorly understood.
However, even less is known about the role of nef in HIV-2
infections.
Methods: In this study, it was analyzed the variation
of 48 nef gene sequences, obtained from samples taken
between 1994 and 2009, corresponding to 17 HIV-2-infected
individuals with different clinical stages of infection. The
sequences obtained by Nested PCR were classiﬁed by phylo-
genetic analysis and the functional protein motifs, described
as important in CD4 and MHC-I downregulation and in viral
infectivity were also analyzed.
Results: In all individuals were identiﬁed nef sequences
from group A of HIV-2, which encoded possible functional
and complete protein. There was a greater conserva-
tion of residues in the Nef sequences of individuals in
the symptomatic stage (63%), comparatively to individuals
in the asymptomatic stage (19%). While some functional
motifs (MGxxxS1, DDDD93, RR137 and DD205) and also
residues (G128, I141 and L142) remained conserved, others
(YSRF39, LRAR21, PxxP101, EE185) revealed changes dur-
ing the follow-up period. The PxxP motif exhibited wide
inter-individual variation in vivo from an HIV-1-like tetra-
proline motif (PxxP)3 to disruption of the minimal core
PxxPLR motif. The disruption was observed in 11 sequences
exclusively from asymptomatic individuals (p = 0.021). The
sequence motif variation towards tetra-proline conﬁgura-
tion was observed in 2 symptomatic individuals during time
of infection. The results also revealed the existence of a
negative selective pressure, as well as codons under positive
pressure in the sequences.
Conclusion: In this HIV-2-infected individuals studied, it
was observed a need for a greater degree of Nef protein con-
servation in a symptomatic phase. Sequences altered and
potentially critical for the Nef function in vivo, in earlier
stages of infection, may contribute at some level to a dif-
ferent pattern in viral pathogenesis and disease progression.
doi:10.1016/j.ijid.2010.02.2023
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4.004
rediction of R5, X4 HIV-1 coreceptor usage based on
hysicochemical properties of envelope V3- loop using
rtiﬁcial neural network
. Falahi1, M. Ravanshad2,∗, A. Kenarkoohi1
Department of Virology, Faculty of Medical Sciences, Tar-
iat Modares University, Tehran, Iran, (Islamic Republic of)
Department of Virology, Faculty of Medical Sciences,
4115-331, Iran, (Islamic Republic of)
Background: HIV-1 cell entry commonly uses, in addition
o CD4, one of the chemokine receptors CCR5 or CXCR4 as
oreceptor. Human immunodeﬁciency virus type 1 (HIV-1)
solates can be classiﬁed phenotypically according to the
rimary coreceptor used to enter the cells. Third variable
egion (V3- loop) of the gp120 subunit of the HIV-1 enve-
ope protein has been identiﬁed as a major determinant of
oreceptor usage. Knowledge of coreceptor usage is crit-
cal for monitoring disease progression and for supporting
herapy with the novel drug class of coreceptor antagonists.
redictive methods for inferring coreceptor usage based on
he third V3- loop region can provide us with these monitor-
ng facilities while avoiding expensive phenotypic assays. In
his study we applied an artiﬁcially neural network on phys-
ochemical data, derived from V3- loop sequence to predict
oreceptor usage of viral isolate.
Methods: At ﬁrst authors has collected two reliable set of
ata that deﬁne the biochemical and structural conditions
f co receptor usage of virus. In the next step we have devel-
ped an ANN models to predict virus coreceptor usage and
ompare the results of ANN models with MLR model. In the
NN model, two levels of 1 and 2 are used as output vector
r goal, respectively for R4 and R5 and the physiochemical
spects are input variables, also it was in MLR model.
Results: The process of training and testing of this new
odel is done using a set of collected data. ANN model with
2 = 0.99 and RMSE = 15.18 in training stage and R2 = 0.91 and
MSE = 187.8 in testing stage is superior in predicting the
oreceptor usage. Several statistical and graphical criterions
re used to check the accuracy of the model.
Conclusion: The coreceptor usage values predicted by
he ANN model satisfactorily compared with the measured
ata. The predicted values were also compared with those
redicted using linear regression model. The presented
ethodology in this modeling is a new approach in estimat-
ng coreceptor usage and can be combinedwith othermodels
nd empirical methods of coreceptor usage determination.
oi:10.1016/j.ijid.2010.02.2024
IV: Therpeutics
5.001
linical and immunologic response of HIV patients on dif-
erent ART regimens at Gondar University Hospital (GUH). Ergete
I-TECH ETHIOPIA, ADDIS ABABA, ET, Ethiopia
Background: As HIV treatment program expands in
esource poor countries, antiretroviral drug selection is
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ased on WHO / National guideline criteria’s. Like ﬁrst line
RT combinations for initiating treatment and second line
RT combinations for treating ﬁrst line treatment failure
onditions. There are many combinations of ﬁrst line drugs
nd it is important to deﬁne are all these ﬁrst line regimens
qually effective in real clinical set ups.
Methods: We conducted a retrospective chart review
f the outcome of different ART regimens among 300
IV- infected patients whose CD4 count was less than
00 cells/mm3 on initiation of ART and has regular fol-
ow up at Gondar University Hospital in Gondar, Ethiopia
etween September 2008 and March 2009, who received
tandard ﬁrst line combination ART regimens. Group 1
N = 100) include those treated with AZT, 3TC, EFV/NVP
ombinations, Group 2 (N = 100) include those treated with
4T, 3TC, EFV/NVP combinations and Group 3 (N = 100)
nclude those treated with TDF, 3TC, EFV/NVP combina-
ions.
Results: There were no difference between Group 1,
and 3 with regard to: IRIS [Ten (10%), Thirteen (13%)
nd Eleven (11%), P = ns] respectively; new opportunistic
nfections [Four (4%), Seven (7%), and Three (3%), P = ns]
espectively; average CD4 increment by 30% [Eighty (80%),
eventy six (76%), and Eighty three (83%), P = ns] respec-
ively and death [Six (6%), Five (5%), and Four (4%), P = ns]
espectively. However, adverse drug side effect occurs more
requently in Group 1 and 2 than in Group 3 [Eighteen (18%)
nd Twenty (20%) versus Three (3%), P = 0.03] respectively,
hich more frequently resulted poor adherence in Group
and 2 than Group 3 [Seventeen (17%) and Sixteen (16%)
ersus Three (3%), P = 0.05] respectively.
Conclusion: This manuscript shows that in a retrospective
eview of HIV patients who are in different Antiretroviral
rug combination regimens attending follow ups at GUH,
he clinical and immunological responses for the different
RT regimens are similar and comparable however it depicts
ifferences in areas of drug side effects and adherence prob-
ems. Therefore different ﬁrst line ART drug combinations
election in resource poor countries can be guided by drugs
ide effect and adherence issues.
oi:10.1016/j.ijid.2010.02.2025
5.002
omparison of efavirenz and nevirapine based HAART reg-
mens in 4187 patients with up to 6 years of follow up, a
rospective, open label observational study
. Cortes1,∗, C. Beltran2, M. Wolff 1
University of Chile School of Medicine, Chilean AIDS
ohort, Santiago, Chile
University of Santiago, Chilean AIDS Cohort, Santiago,
hile
Background: Non nucleoside reverse transcriptase
nhibitors (NNRTI) based regimens are widely recommended
s 1st line HAART and they are preferred in resource
onstrained settings due to high efﬁcacy and low cost. Few
tudies compare effectiveness of efavirenz (EFV) and nevi-
apine (NVP) in large, prospective cohorts with extended
ollow up (f/u). Objective: To determine the effectiveness,
ate of discontinuation or change, toxicity and mortality
o
d
i
bternational Congress on Infectious Diseases (ICID) Abstracts
f patients with EFV versus NVP based regimens as initial
AART in a nation wide cohort.
Methods: Prospective, open label, f/u of patients
nrolled in the Chilean AIDS Cohort (ChiAC) from October
001 to March 2008. All subjects receiving at least one dose
f EFV or NVP were included. Primary outcomes were sur-
ival, maintenance of initial HAART, reason for change of
NRTI, viral suppression and immune recovery.
Results: Of 5120 patients initiating ﬁrst HAART in ChiAC,
187 started a NNRTI based regimen (plus 2 NRTIs); 3107
74.2%) with EFV and 1080 (25.8%) with NVP. Median f/u
as 2.7 years. At baseline the NVP group had a signiﬁcantly
ess advanced stage (CDC classiﬁcation) and higher median
D4 count (151 vs 86 cell/mm3 in EFV, p < 0.001), but similar
iral load (VL) compared to the EFV group. Rate of change
r discontinuation was signiﬁcantly lower for EFV (12.8% vs
2.3%, p < 0.001), due to fewer adherence problems or toxi-
ity. Timing for change was similar in both arms (median 950
s 1008 days for EFV and NVP respectively). There were no
tatistical differences in viral suppression rate (<80 cps/mL)
t any time: 67.2, 74.9, 74.4, 65.1, 59.8% vs 63.6, 74.3,
2.7, 61.7, 59.4% at 6, 12, 24, 36 and 48 months for EFV
nd NVP respectively. At 12 months of f/u median CD4 cell
ount was similar for groups (242 for EFV and 250/mm3 for
VP). Mortality for the total period was 2.89 and 2.85 per
00pts-year for EFV and NVP respectively (p =NS).
Conclusion: Efavirenz based HAART regimens were asso-
iated with similar viral and immune outcomes as Nevirapine
ased regimens, despite more severe disease at baseline in
he EFV group. Discontinuation of NVP was more frequent,
ainly due to toxicity and lower adherence, but not to viral
ailure.
oi:10.1016/j.ijid.2010.02.2026
5.003
he economic impact of introducing HIV/AIDS guide-
ine into Colombian National Drug Formulary. Cost-
ffectiveness analysis
.V. Lemos Luengas ∗, B.C. Castan˜eda, E. Quevedo, C.
astillo, L.R. Lemos
Fundacion para el Desarrollo y Apoyo en Salud Internacional
FUDASAI), Bogota, Colombia
Background: Colombia has >165000 people infected
ith human immunodeﬁciency virus (HIV). In 2009, the
orld Health Organization (WHO) estimated only 40% had
ntiretroviral therapy coverage. Colombia’s AIDS treatments
uidelines became available in 2006 and are currently being
sed by physicians in their daily practice. However, these
uidelines have not yet been evaluated with respect to their
elative costs and effectiveness.
Methods: A Markov model was developed using TreeAge
Pro-2009 and clinical experts. Success probabilities were
erived from published randomized controlled trials. Drug
osts were obtained from the 2009 Drug Price Guideline from
ogotá and the ISS 2008 Manual. Hospitalization costs were
btained from theWest Kennedy Hospital, Bogotá 2008/2009
atabase, adjusted to 2008. One-way and two-way sensitiv-
ty analyses were performed to test the model’s robustness
y varying clinical success rates and costs of antiretrovirals.
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Probabilistic sensitivity analyses were also performed using
Monte Carlo simulations.
Results: Based on our Markov model, AZT-3TC-efavirenz
had the lowest cost of treatment (USD $12.09 per day)
and the highest rate of success (69%). It was the primary
cost-effective HAART for HIV/AIDS in Colombia. AZT-3TC-
efavirenz dominated all other HAART treatments. Results
were generally robust within ranges tested.
Conclusion: In Colombia, antiretroviral therapy will lead
to major survival beneﬁts and is cost-effective by World
Health Organization criteria. The availability of second-line
regimens will further increase survival, but their cost-
effectiveness depends on their relative cost compared with
ﬁrst-line regimens.
doi:10.1016/j.ijid.2010.02.2027
55.004
Prevalence of metabolic abnormalities and metabolic syn-
drome in a cohort of hispanic patients on HAART
E. Bissio1,∗, G. Lopardo2
1 FUNCEI, Buenos Aires, Argentina
2 Corunna, Argentina
Background: Metabolic abnormalities are a well known
side-effect of HAART. However, some studies show similar
prevalences of metabolic syndrome in patients on HAART
and the general population. According to different studies,
prevalence of metabolic syndrome in the general popula-
tion ranges from 23.7% to 24.6% using the ATP III deﬁnition.
The aim of this study was to determine the prevalence
of metabolic abnormalities and metabolic syndrome in a
cohort of hispanic patients on HAART attending an ID Clinic
in Buenos Aires, Argentina.
Methods: Retrospective cross-sectional study. The
records from the patients were reviewed to determine
prevalence of the metabolic syndrome (as deﬁned by the
NCEP ATP III Update), and the prevalence of metabolic
abnormalities.
Results: The cohort was composed of 78 hispanic
patients on stable HAART for at least 6 months (mean age:
40.89± 8.55 years [range: 22—64]; 9% were women). Mean
CD4: 583± 282 cells/mm3; median VL: 50 (IQR: 50—50).
The general prevalence of the metabolic syndrome was
24.7% (95% CI 15.6-36.8). The prevalence among patients on
a protease inhibitor(PI)-based regimen (n = 15) was 26.7%,
versus 24.2% among those without PI (p =NS). In this last
group, those on efavirenz (n = 43) had a prevalence of 26.2%
compared to 14.3% those on nevirapine (p < 0.05). The age-
speciﬁc prevalence in the 30-39 years group was 22.2%, and
32.1% in the 40-49 years group. The prevalence of hyper-
trigliceridemia was 47.4%, but differed according to therapy
group (PI, EFV or NVP; mean values (mg/dL): 240± 322.76;
165± 109 and 150± 80.4; respectively), and increased with
age group (20-29: 33%, 30-39: 45.7%, 40-49: 50%). General
prevalence of low HDLwas 37.3% (women: 42%, men: 38.2%);
there was no difference between patients with or without
PI; but in this last group, prevalence among those on EFV was
42.5% vs 21.41% in those on nevirapine (p < 0.05). Hyperten-
sion prevalence was 39.5%.
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Conclusion: In this cohort, prevalence of the metabolic
yndrome was similar to the prevalence in the gen-
ral population. However, patients on protease inhibitors
nd efavirenz had a higher prevalence than those on
evirapine (and the general population). Drug-induced
ypertrigliceridemia seems to be one of the major drivers
eading to the emergence of the metabolic syndrome among
hese patients.
oi:10.1016/j.ijid.2010.02.2028
5.005
edication errors in patients receiving antiretroviral
herapy at an urban hospital
. Zangeneh1,∗, G. Dickinson2
University of Miami, 33125, FL, USA
Miami VA Medical Center, Miami, ﬂ, USA
Background: Combination Antiretroviral therapy (ART)
as decreased morbidity and mortality for persons with
uman immunodeﬁciency virus (HIV) infection. These
omplex regimens involve three or more agents, and
here are many potential errors. The errors in prescrib-
ng ART may lead to adverse/toxic effects, treatment
ailure, and drug resistance. We evaluated medication
rrors occurring among patients receiving ART at the
iami VAMC to identify potential interventions to decrease
rrors.
Methods: This was a retrospective study utilizing a med-
cal chart review to evaluate medication prescribing errors
ccurring among patients who had received ART during Jan-
ary 1 through December 31, 2007 at the Miami VAMC.
sing the DHHS guidelines for HIV therapy as a source, we
creened for the following prescribing errors: inappropri-
te dosing, use of inappropriate regimens/combinations,
se of other medications and ART when contraindicated,
ailure to adjust for renal insufﬁciency, and insufﬁcient mon-
toring. In addition, we evaluated the frequency of errors
ccurring during admission in comparison to the out patient
linic.
Results: The medical charts of 833 patients of whom
14 (62%) were receiving ART were reviewed. A total of 24
igniﬁcant prescribing errors involving antiretrovirals were
etected. Themost common errors involved failure to adjust
or renal insufﬁciency (54%) followed by use of contraindi-
ated combinations with potential for drug interactions
46%). Overall, 17% of the errors occurred while the patient
as admitted to the hospital. Although 75% (3) of the errors
n the inpatient group were due to renal dosing as opposed to
5.5% (10) in the outpatient group; this was not statistically
igniﬁcant. Similarly, there was no statistical difference
egarding contraindicated combination medications among
oth groups.
Conclusion: In this Patient population, the most fre-
uent errors involved failure to adjust ART in the face
f renal insufﬁciency and the co-administration of con-
raindicated medications with ART. These errors can be
voided by automated alerts in the computerized medical
ecord used at this facility and emphasizing to physicians
he importance of adjusting dosage or changing the ART
o account for renal insufﬁciency. System-based interven-
e th In
t
o
d
5
C
n
b
i
K
R
1
I
2
o
w
i
c
o
m
p
e
N
s
(
i
A
i
r
l
p
t
u
m
o
d
o
p
w
t
p
s
p
f
p
i
(
f
w
t
l
t
d
5
N
c
v
G
M
1
B
2
B
3
B
4
B
5
i
a
M
l
t
m
s
s
v
H
o
p
o
t
(
v
7
K
m
w
a
a
t
3
o
t
r
d
5
I
a
N
K244 14
ions can be developed to prevent these errors before they
ccur.
oi:10.1016/j.ijid.2010.02.2029
5.006
omparison of the effectiveness of low dose Indi-
avir/ritonavir (IDV/r) versus Atazanavir/ritonavir (ATV/r)
ased antiretroviral therapy in NNRTI experienced HIV-1
nfected patients in India
. Patel1,∗, A.K. Patel1, J.K. Patel1, E. Naik2, J. Duan2, R.
anjan1, S. Hamisu2
Vedanta Institute of Medical Sciences, 380009, Gujarat,
ndia
University of South Florida, Tampa, FL, USA
Background: Currently, data on the effectiveness of sec-
nd line antiretroviral regimens using IDV/r and ATV/r along
ith two back bone nucleosides in resource poor settings
s limited. It is important to compare the potency and efﬁ-
acy of each regimen in order to establish utility on clinical
utcomes. We sought to evaluate viro-immunologic deter-
inants of response to IDV400/r BID and ATV300/r QD in
re-treated HIV-infected patients.
Methods: Prospective cohort study on 441 patients who
xperienced immunological or clinical failure to ﬁrst line
NRTI-based treatment and were enrolled in a 96-week
tudy follow-up. Based on the patients ability to pay, 321
72.8%) and 120 (27.2%) patients were prescribed reg-
mens containing low dose of IDV/r 400/100mg BID or
TV/r 300/100mg QD with 2NRTI, respectively. Successful
mmunologic response to treatment was deﬁned by annual
ise in absolute CD4 count of 100/cmm or more from base-
ine, while successful virologic response was deﬁned by
VL < 400 copies/ml at 12 or 24 weeks after initiation of
reatment. Multivariate Cox Proportional Hazards Model was
sed to assess comparative effectiveness of treatment regi-
ens with correction for intra-cluster correlation by means
f the Robust Sandwich Estimator.
Results: Both the groups had similar age, sex and weight
istribution. (p = 0.302, 0.232 & 0.459 respectively). A total
f 63 patients (14.8%) had failed second line treatments, 53
atients (17.2%) were using IDV/r while 10 patients (8.5%)
ere on ATV/r. Patients who took IDV/r were more than
wice as likely to experience treatment failure as com-
ared to those on ATV/r (HR 2.18; 95% CI 1.14, 4.15). A
igniﬁcant treatment-response interaction was observed for
atient weight and prior combination of NRTI use. Success-
ul response was not different between the two groups when
atients weighed < 55 kg at baseline (log rank p value = 1.00)
n contrast to the ﬁndings among individuals weighing ‘‘55 kg
p = <0.0001). Patients with one NRTI recycled, ATV/r was
ound to be superior to IDV/r (p = 0.01) while among those
ith both NRTI recycled, there was no difference in response
o either group (p = 0.61).
Conclusion: We found that Successful response to second
ine therapy was twice as likely in the ATV/r group; however,
his difference was eliminated in patients less than 55 kg.
oi:10.1016/j.ijid.2010.02.2030
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RTI resistance proﬁle of the subtype F HIV-1 strains from
hildren and adolescents treated with multiple antiretro-
iral drugs
. Jugulete1,∗, M.L. Luminos2, M. Mardarescu3, D. Otelea4,
. Merisescu5
Institute of Infectious Diseases ‘‘Prof. dr. Matei Bals’’,
ucharest, sector 2, Romania
Institute of Infectious Diseases ‘‘Prof. dr. Matei Bals’’,
ucharest, Romania
Institute of Infectious Diseases ‘‘Prof. dr. Matei Bals’’,
ucharest, Romania
Institute of Infectious Disease ‘‘Prof. dr. Matei Bals’’,
ucharest, Romania
Institute of Infectious Diseases, Bucharest, Romania
Background: The HIV epidemic in Romania is character-
zed by the existence of a large cohort of children and
dolescents that have been infected in the late eighties.
ost of these patients have been under treatment for the
ast ten years: all of them are currently on HAART but
heir majority has experienced a period (years) of either
onotherapy (AZT) or bitherapy (AZT with 3TC or ddC). This
tudy examines resistance proﬁles in the RT gene of HIV-1
trains obtained from these patients.
Methods: We have studied resistance tests on antiretro-
iral therapy of experienced children’s and adolescents with
IV infection and AIDS hospitalized in National Institute
f Infectious Diseases ‘‘Prof. dr. Matei Bal#’’. On these
atients we have evaluated: antiretroviral therapy, number
f antiretroviral schemes, the type of resistance muta-
ions selected on Nucleoside Reverstranscriptase Inhibitors
NRTI’s) and the implications on to established of antiretro-
iral therapy, also.
Results: The most frequent mutations were: M184V/I -
8.8%, T215F/Y — 74.4%, D67N — 68.2%, K219E/Q — 66.6%,
70R — 56.9%, M41L — 41.4%. The thymidine analogue
utations (TAMs) were common and frequently associated
ith M184V. Within the TAM group, T215F/Y was frequently
ssociated with D67N, K70R and/or K219E/Q. V75T/V was
ssociated with K219E but only seldom with K219Q. The mul-
iresistention on experimented HIV infected children was
.2% (Q151M, 69ins, K65R).
Conclusion: The mutation associations in the RT gene
f the subtype F HIV-1 strains are partly different from
hose communicated for the subtype B strains and therefore
equire further scrutiny.
oi:10.1016/j.ijid.2010.02.2031
5.008
mplementation of HLA-B*5701 genetic screening prior to
bacavir prescription in Georgia
. Dvali ∗, N. Chkhartishvili, L. Sharvadze, L. Dzigua, M.
archava, L. Gatserelia, T. TsertsvadzeInfectious Diseases, AIDS and Clinical Immunology Research
enter, Tbilisi, Georgia
Background: A hypersensitivity reaction to abacavir
evelops in approximately 2-8% of patients receiving this
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drug and is strongly associated with presence of the human
leukocyte antigen (HLA)-B*5701. Screening for HLA-B*5701
reduces the risk of developing an abacavir hypersensitivity
reaction. The carriage rate of HLA-B*5701 has not been stud-
ied in Georgia before 2009. Objective of the study was to
determine HLA-B*5701 prevalence in HIV-infected patients
in Georgia.
Methods: One hundred and sixty HIV-1 positive patients
attending Georgian Infectious Diseases, AIDS and Clinical
Immunology Research Center in 2009 within the national
treatment and care program were recruited for the study.
None of the patients had previously been treated with
abacavir. Blood samples were collected and screened for
HLA-B*5701 prior to abacavir prescription. Statistical anal-
yses were performed using SAS 9.1. Proportion with exact
95% conﬁdence interval (CI) and median with interquartile
range (IQR) are reported.
Results: Of 160 patients recruited 108 were male (67.5%)
and 42 (32.5%) - female. Median age of subjects was 32 years
(IQR 27—36). Nine patients tested HLA B*5701 positive —
5.6% (95% CI: 2.6—10.4%). Out of these nine patients 7 were
males (male prevalence: 6.5%, [95% CI: 2.6—12.9] %) and 2
females (female prevalence: 4.8% [95% CI: 0.6—16.2%]).
Conclusion: The ﬁrst prospective study of HLA-B*5701
prevalence in Georgia show similar results to the results
of other studies conducted in Caucasians. Abacavir still
remains one of the key drugs of antiretroviral regimens in
Georgia and other resource limited countries. Therefore,
prospective HLA-B*5701 screening should be implemented
in all settings where abacavir is widely used to guide selec-
tion of ART regimens and to reduce the risk of potentially
life threatening hypersensitivity reaction.
doi:10.1016/j.ijid.2010.02.2032
55.009
Efﬁcacy of multivitamins containing phosphatidyl choline
in the mananegment of hepatotoxicity from antiretroviral
and/or antituberculous drugs
N. Ladep1,∗, N. Shehu2, A. Muazu2, P. Ugoagwu2, F.
Kakjing2, B. Badung2, C. Daniyan2, J. Idoko3
1 St George’s University, St George’s, St George’s, Grenada
2 AIDS Prevention Initiative Nigeria, Jos, Plateau, Nigeria
3 National Agency for the Control of AIDS, Abuja, FCT, Nige-
ria
Background: When hepatotoxicity develops in the course
of treatment with anti-tuberculosis and anti-retroviral
drugs, early improvement is important in order to con-
tinue speciﬁc treatment as early as possible. We aimed
to determine the efﬁcacy, safety and effect on quality of
life of phosphatidyl choline-containing multivitamin in the
management of antiretroviral and anti-tuberculosis hepato-
toxicity.
Methods: This was a randomized, single blinded placebo-
controlled pilot study. Included in the study were subjects
that had been enrolled to access drugs in the ARV pro-
gramme of Jos University Teaching Hospital (JUTH), who
had signed consent to participate in the parent PEPFAR
protocol and have started ARVs or antituberculous drugs.
Subjects received phosphatidyl choline-containing multivi-
g
p
a
wts e245
amin (Livolin forte®) or placebo (Vitamin B +Vitamin E as
n Livolin forte). Patients had either been on antitubercu-
ous or antiretroviral medications. Subjects on each arm
ere reviewed fortnightly or earlier if they had worsening
f symptoms. The liver function tests including ALT, AST
mprovements and deteriorations were noted and appro-
riate clinical decisions were taken according to standard
uidelines during the four weeks of each recruitment. The
ata were analysed and displayed in proportions and appro-
riate representations.
Results: Sixteen subjects completed the study. Five and
leven subjects were on placebo and livolin respectively.
he placebo recruitment was stopped after the ﬁfth sub-
ect due to deteriorations in liver function with associated
ncreased mortality in that group. Nine subjects were co-
nfected with Hepatitis B or C infection and one had triple
nfection of all three viruses. The baseline means ALT
or the livolin group and placebo arms were 313.19mM/L
nd 239.76mM/L respectively. There was signiﬁcant decline
f the mean ALT in the livolin group to 49.21mM/L and
8.17mM/L compared to placebo group 227.74mM/L and
29.24mM/L at two and four weeks respectively. While
oint pains reduced from 73.3% through 6.7% to 0% at the
nd of the study period in the Livolin group; the placebo
rm showed a ﬂuctuating course of 33.3%, 83.3% and 16.7%
espectively.
Conclusion: Phosphatidyl choline-containing multivita-
in demonstrated moderate beneﬁts to HIV infected
atients who develop hepatotoxicity to anti-tuberculosis or
ntiretroviral drugs when introduced early in their manage-
ent.
oi:10.1016/j.ijid.2010.02.2033
5.010
revalence of minor populations of drug-resistant HIV-1
n newly-diagnosed treatment-naïve individuals in Singa-
ore
.-J. Sun1,∗, P. Kaur1, Y.S. Leo2
Tan Tock Seng Hospital, Singapore, Singapore
Communicable Disease Centre, Tan Tock Seng Hospital, Sin-
apore, Singapore
Background: Primary drug-resistance in HIV-1, whether in
ajor viral populations or minor populations, is a signiﬁcant
linical and public health concern. Previous studies based on
onventional direct sequencing of virus samples have shown
hat HIV-1 primary drugresistance was insigniﬁcant in Singa-
ore. But it is not clear whether this is also true to the minor
IV-1 populations of the samples because direct sequencing
sually cannot detect resistance mutations in these popula-
ions. We performed this study to determine the prevalence
f primary drug-resistance in minor HIV-1 populations.
Methods: Twenty-four PBMC-associated virus samples
rom 24 newly-diagnosed treatmentnaïve patients were ana-
yzed. PCR products of pol gene that encompass the entire
rotease gene and two-third of the reverse transcriptase
ene were ampliﬁed using an in-house method. The PCR
roducts were then column-puriﬁed for direct sequencing
nd gel-puriﬁed for clonal sequencing. The viral gene cloning
as performed using the TOPO TA cloning kit (Invitrogen).
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There’s need for collaboration between DHT and hospitals
in support supervision of lower health units. Home visits and
training of staff need to be reinforced.
doi:10.1016/j.ijid.2010.02.2036246 14
NA sequencing was performed on an Applied Biosystems
130xl Genetic Analyzer.
Results: All the sequences of the 24 samples produced
y direct sequencing were wild type, with no any known
rug-resistant mutation detected. A total of 70 viral gene
lones were obtained and sequenced for the 24 samples,
ith average 2.9 clones per sample. Clonal sequencing
etected 4 drug resistance-associated mutations (PI, V82A;
RTI, M184V, K70E; NNRTI, K101E) from the viral clones of
samples; therefore the prevalence rate of primary HIV-
drug-resistance in the minor HIV-1 populations was 16.7%
4/24).
Conclusion: Our data suggest that a considerable
roportion of treatment-naïve patients are infected by drug-
esistant HIV-1 virus in Singapore, but it was not detected by
onventional direct sequencing. This ﬁnding has important
mplications for the clinical management and public health
f HIV-1, and also suggests that more sensitive genotyping
ethod should be employed to determine the baseline of
IV-1 primary drug-resistance.
oi:10.1016/j.ijid.2010.02.2034
5.011
revalence of HIV-1 primary resistance among HIV chron-
cally infected patients in Brazil’s Southeast region
.M.P.M. Soares1, T.R.C. Vergara1, M.M. Caseiro2, R.
ôrtes1, B. Scarpellini 1,∗, M.C.A. Sucupira1, R.S. Diaz1
Escola Paulista de Medicina - Universidade Federal de São
aulo, Sao Paulo, SP, Brazil
Centro Universitário Lusíada, Santos, SP, Brazil
Background: The prevalence of HIV primary resistance
utations has increased overtime and transmitted muta-
ions can persist in HIV-1 chronically infected patients.
tudies have shown that it is cost-effective to perform pri-
ary resistance testing when one observes a prevalence of
IV-1 primary resistance above 5% in a certain geographical
ocation. Nevertheless, such studies were conducted among
cutely/recent HIV infected patients. Our study hypothe-
is was that HIV-1 primary resistance prevalence would be
reater than 5% among HIV-1 chronically infected patients
ith indication for antiretroviral therapy in Brazil’s South-
ast (SE) region.
Methods: We have included 75 patients from 2 major
ities: 47 from Rio de Janeiro and 28 from Santos. Our pop-
lation proﬁle was non-pregnant chronically HIV-1 infected
atients with indication for antiretroviral therapy based on
ational Guidelines. HIV DNA was extracted and ampliﬁed
rom dried blood spots samples. HIV’s pol gene protease and
everse transcriptase regions were sequenced. Antiretrovi-
al resistance mutations algorithm which excludes frequent
olymorphisms was utilized.
Results: Prevalence of HIV-1 primary resistance was
7,3%. 18 mutations were observed among 13 out of 75
ncluded patients. Of these 18 mutations, 10 were related
ith NRTI’s, 8 were related to NNRTI’s and none to PI’s. The
ost commonly detected mutations were: K103N (16.6%),
69D (11.1%), M41L (11.1%). Only 4% (3 individuals) had two
lass (NRTI and NNRTI) primary resistance mutations. Theternational Congress on Infectious Diseases (ICID) Abstracts
ost prevalent HIV subtype was B (77.3%), followed by BF
33.3%), F (6.66%) and C (1.3%).
Conclusion: High primary resistance levels were observed
ccording to WHO’s deﬁnition (5—15%), suggesting being
ost-effective to perform primary resistance testing in this
egion. The increased prevalence of NNRTI’s mutations and
he absence of M184V mutations are two ﬁndings observed
n this study, contrasting with previous studies from Brazil.
oi:10.1016/j.ijid.2010.02.2035
5.012
hallenges of antiretroviral therapy among children aged
to 15 years in Kabarole district (Western Uganda)
. Isabirye ∗, N. Kiwanuka, J. Kiguli
Makerere University School of Public Health, KAMPALA,
ganda
Background: HIV/AIDS is one of the leading causes of
ortality among children in Kabarole district. It is however
nknown how many children are on ART and there is very lit-
le documented evidence of the challenges faced by children
ged 6 to 15 years on ART.
Methods: A cross-sectional study was conducted to assess
he challenges associated with ART among children aged
to 15 years in Kabarole district. Quantitative data were
ollected using a semi structured interviewer administered
uestionnaire and qualitative using Key Informant inter-
iews. Adherence levels were assessed using self report
nformation from caretakers and children 10 years and
bove. Logistic regression models were used to estimate
dds ratios (OR’s) of adherence and their associated 95%
onﬁdence intervals.
Results: As at 30th April 2009, there were 478 children
n ARV’s in the district. Of the 332 children in the study, 51%
ere girls and 66.3% were aged 9-12 years. Using one month
ecall, 95.5% of the respondent’s adherence was 100%, 1.8%
ad 95-99% and 2.7% had adherence levels of less than 95%.
n 3-day recall, 98.5% had 100% adherence, 1.5% had less
han 95% adherence. Major challenges were a low propor-
ion of children on ART, 42.5% of respondents failed to get
ransport at least once, 51% were orphans, co-trimoxazole
tock outs at government facilities, lack of follow up and
nadequate support supervision.
Conclusion: Co-trimoxazole prophylaxis among children
ged 6 to 15 years was found to be a plausible predictor of
dherence. Challenges to ART are numerous and solutions
o them require a multi-faceted approach.
Recommendations: Co-trimoxazole prophylaxis should be
rioritised in all ART clinics for children aged 6 to 15 years.
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55.013
Survival, clinical, immunological and hematological out-
comes of antiretroviral therapy among HIV-infected
children attending a public clinic in Kinshasa, Democratic
Republic of Congo
M. Yotebieng1,∗, A. Van Rie1, J. Luisiama2, F. Kitetele3, A.
Edmonds1, F. Behets1, G. the SARA team2
1 Gillings School of Global Public Health, University of North
Carolina at Chapel Hill, Chapel Hill, NC, USA
2 Ecole de Santé Publique, University of Kinshasa, Demo-
cratic Republic of Congo, Kinshasa, Congo, Democratic
Republic of
3 Kalembe Lembe Pediatric Hospital, Kinshasa, Democratic
Republic of Congo, Kinshasa, Congo, Democratic Republic
of
Background: To assess the mortality, immunological,
hematological, and clinical outcomes of children initiating
antiretroviral therapy (ART) during the ﬁrst 5 years (Novem-
ber 2004 — October 2009) of a standardized HIV care and
treatment program at the Kalembe-Lembe pediatric hospital
in Kinshasa, DRC.
Methods: Retrospective analysis of routine clinical data
from a cohort of 603 HIV-infected children) 17 years of age
at ART initiation.
Results: Children initiated ART at a median age of 6.4
[interquartile range 3.2—10.5] years. At ART initiation,
27.1% were on treatment for tuberculosis, 54.6% were in
WHO stage III&IV, 52.8% had < 10 g/dL hemoglobin, 63.0%
had a CD4%) 15% (severe immunosuppression), 39.6% had
a weight-for-age Z score (WAZ)) -3 (severe underweight),
and 9.8% had previously received antiretrovirals. The ﬁrst
line regimens included stavudine or zidovudine, lamuvi-
dine, and nevirapine or efavirenz. During 1409.8 child-years
of follow-up (median follow-up, 28.7 months), 61 children
died: 38 during the ﬁrst 90 days of treatment (early mortal-
ity rate, 28.0/100 child-years; 95% Conﬁdence Interval (CI),
20.4—38.4) and 23 after 90 days (latemortality rate, 1.6/100
child-years; 95% CI, 1.9—2.5). The mean CD4% and WAZ rose
rapidly from 11.6% and -2.57 at baseline to 25.0% and -1.92
at 12 months before stabilizing above 28.0% and around -
1.80 between 18 and 48 months, respectively. The mean
height-for-age Z scores (HAZ) and hemoglobin increased
almost linearly from -2.23 and 9.8 g/dL at baseline to −1.78
and 10.8 g/dL at 12 months to -1.23 and 12.0 g/dL at 48
months, respectively. Children under two years of age at ART
initiation had greater and more sustained gains in weight,
height, CD4% and hemoglobin compared to children who
started ARTwhen at least two years of age (p < 0.01, p < 0.01,
p = 0.01, p < 0.01, respectively).
Conclusion: Despite late presentation in our clinic, good
clinical, immunological, and hematologic outcomes were
obtained within the ﬁrst 12 months and maintained through
48months of ART among children who survived the ﬁrst three
months. The high early mortality rate reﬂects obstacles to
health seeking behavior, early HIV diagnosis, and access to
timely ART initiation in Kinshasa.
doi:10.1016/j.ijid.2010.02.2037
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pparent virologic failures and blips in a suburban HIV
linic caused by laboratory errors in a commercial HIV-1
NA PCR assay
. Cariello ∗, T. Treadwell
MetroWest Medical Center, Framingham, MA, USA
Background: The use of commercial assays for quantiﬁca-
ion of viral RNA is a cornerstone in management of patients
ith HIV infection. We recently observed an increase in blips
nd apparent virologic failure not explained by poor adher-
nce or resistance and that resolved when our clinic changed
aboratories.
Methods: We retrospectively collected data on patients
ho were receiving highly active antiretroviral therapy
HAART) from October 2004 until June 2006 and who had
ne or more HIV-1 plasma viral load (VL) > 1,000 copies/mL.
e excluded patients who had interruptions in therapy
r had known poor adherence to clinic visits or medica-
ions.
Results: Our clinic changed our reference laboratory in
ecember 2005. In the previous 15 months, 38 patients on
AART had at least one VL > 1,000 copies/mL. Six patients
ad at least one VL > 10,000 copies/mL and 24 patients
ad more than 2 determinations > 1,000 copies/mL. In the
months following the lab change, 37/38 patients had
L < 400, 21/38 < 50, and only one patient had a VL >
00 copies/mL. One year later, 36/38 had no detectable
lasma viral RNA. All patients had stable CD4 lymphocyte
ounts (mean = 636 cells/mm3). Twenty-one patients had at
east one genotype during this period; no new mutations we
ound.
Conclusion: We believe that systematic errors in a com-
ercial laboratory contributed to apparent virologic failures
nd blips in this small group of patients.
oi:10.1016/j.ijid.2010.02.2038
5.015
ntiretroviral resistance-associated mutations and
enomic diversity in reverse transcriptase and protease
ene among drug-naïve patients
. Saini 1,∗, P. Bhalla1, U.K. Baveja2, S.T. Pasha2, R. Dewan3
Maulana Azad Medical College, New Delhi, India
National Institute of Communicable Diseases, Delhi, India
Maulana Azad Medical College, Delhi, India
Background: Antiretroviral drugs (ARV) are being pro-
ided by Govt. of India since 2004 under 3 by 5 initiative
ed by WHO-UNAIDS. Despite wide spread use of ARV, little
nformation is available on the prevalence of transmitted
esistance-associated mutations in HIV-1, particularly from
orth India. The present study was designed for molec-
lar characterization of HIV-1 and identiﬁcation of ARV
esistance- associated mutations and naturally occurring
enotypic variation in reverse transcriptase (RT) and pro-
ease region of pol gene of HIV-1.
Methods: Seventy ARV drug-naïve HIV-1 sero-reactive
atients, newly registered in ART clinic of Lok Nayak Hos-
ital, were enrolled in the study after obtaining written
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a pandemic situation, the rapid virucidal activity provides
a decided advantage in reducing Inﬂuenza transmission via
hand contact.248 14
nformed consent. Plasma HIV-1 RNA levels were estimated
y Amplicor HIV-1 Monitor test V 1.5 (Roche Diagnostics).
IV-1 pol gene, enconsisting protease region (codons;1-99)
nd RT region (codons;1-232 to 1-239) was reverse tran-
cribed, followed by nested PCR with self designed primers.
he PCR product was sequenced with an ABI PRISM 3100
enetic analyzer system.
Results: The median HIV-1 RNA levels were log10 4.6
opies/ml (IQR; 4.2-5.3). All patients were found to be
nfected with HIV-1 subtype C. Only one (1.4%) study
equence harbored resistance-associated mutations in RT
egion, showing NRTI resistance mutation (M184I). No muta-
ion at major resistance positions in protease region was
etected. High rate of polymorphisms were observed at
odons; 35, 39, 40, 48, 60, 121, 122, 123, 135, 166, 173,
74, 177, 185, 200, 204, 206, 207, 208, 211, 216, 217, 233
239 in RT gene and 12, 15, 18, 19, 36, 38, 41, 63, 69, 70,
9 & 93 in protease gene.
Conclusion: The overall prevalence of transmitted
esistance-associated mutations was found to be 1.4%, lower
han the alert cut off of 5% deﬁned by WHO. HIV-1 sub-
ype C exhibited enormous polymorphism in RT and protease
egions of pol gene as compared to subtype B.
oi:10.1016/j.ijid.2010.02.2039
nfection Control, Nosocomial Infections and Critical
are (Poster Presentation)
6.001
linical, radiological and microbiological corroboration to
ssess the role of endotracheal aspirate in diagnosing
entilator-associated pneumonia in an intensive care unit
f a tertiary care hospital, India
. Mukhopadhyay ∗, S. Krishna, A. Shenoy, K. Prakashini
Kasurba Medical College, Manipal, India
Background: Early and accurate diagnosis and follow up
f VAP varies considerably with the clinical, radiological and
icrobiological criteria employed.
Methods: This study was aimed to correlate clinico-
adiological ﬁndings with microscopy and quantitative
ulture of consecutive ETA from 50 mechanically ventilated
atients along with the antibiogram and risk factor assess-
ent.
Results: The prospective observational study in MICU
evealed the incidence of VAP to be 42% with a rate of
16/1000 ventilator days. 8 had early onset and 13 late
nset VAP, with no age or sex signiﬁcant preponderance. The
ttributable mortality rate was 61.9% which rose with dura-
ion of stay. The important independent risk factors were
ulti-organ failure, reintubation and pleural effusion. The
ost commonly isolated organisms were multidrug resistant
cinetobacter baumannii (76%) and Pseudomonas aerugi-
osa (42%). All enterobacterial isolates were ESBL producing
nd all S. aureus isolates were methicillin resistant. In 66%,
olonization on day 1 resulted in development of VAP on day
. Gram stain ﬁndings had a signiﬁcant correlation with the
uantitative culture of ETA, which by itself showed a signif-
cantly progressive increase in speciﬁcity in diagnosing VAP
n day 7. The strength of association between CPIS scoring,
dternational Congress on Infectious Diseases (ICID) Abstracts
he microbiological ﬁndings and the clinical diagnosis was
ound to be strong.
Conclusion: This study emphasizes that Gram stain and
uantitative culture of ETA can be considered useful for the
iagnosis of VAP and a combined clinical, radiological and
icrobiological approach can be successful in the manage-
ent and further follow up of VAP.
oi:10.1016/j.ijid.2010.02.2040
6.002
irucidal efﬁcacy of topical antiseptics versus a novel
train of Inﬂuenza H1N1
. Dzyakanava1,∗, K. Burningham2, J. Stahl3
BioScience Laboratories, Bozeman, MT, USA
Bioscience Laboratories, Bozeman, MT, USA
3M Company, Saint Paul, MN, USA
Background: On April 11, 2009 the WHO raised the epi-
emic alert to Phase 6 and declared a pandemic of novel
nﬂuenza H1N1. During the impending inﬂuenza season, the
umber of ‘‘swine’’ inﬂuenza cases is expected to increase,
mphasizing the importance to public health of contact and
espiratory hygiene. This study evaluated the susceptibility
f Inﬂuenza H1N1 A/California/04/2009 strain to three topi-
al sanitizing products, designed for application in a variety
f public and healthcare settings.
Methods: ASTM E 1052-96, Standard Test Method for Efﬁ-
acy of Antimicrobial Agents against Viruses in Suspension,
as used to evaluate a non-medicated soap and three topical
ntiseptics: AvagardTM Surgical and Healthcare Personnel
and Antiseptic (1% Chlorhexidine Gluconate, 61% Ethanol);
vagardÔ Foam Instant Hand Antiseptic (62% Ethanol); and
vagardÔ D Instant Hand Antiseptic (61% Ethanol). All
roducts were tested at a 90% (v/v) concentration versus
nﬂuenza H1N1 A/California/04/2009 strain with exposures
f 30 seconds, 1minute, and 2minutes. Viral titers were cal-
ulated using the Spearman- Kärber Method.
Results: All products signiﬁcantly reduced infectivity
f the epidemic strain of Inﬂuenza H1N1. AvagardTM (1%
hlorhexidine Gluconate, 61% Ethanol) and AvagardTM D
61% Ethanol) produced 5.25 log10 (>99.999%) reduction
fter 30 second exposure, as well as after 1 and 2minute
xposures. AvagardÔ Foam (62% Ethanol) reduced the viral
opulation by 4.25 log10 (>99.99%) after 30 second, 1, and
minute exposures. Testing performed on non-medicated
oap revealed low virucidal efﬁcacy after short-term expo-
ures: 2.50 log10 (99.68%) reduction after 30 second and
minute exposures.
Conclusion: Signiﬁcant reduction (>99.99%) in the pop-
lation of A/California/04/2009 strain was achieved after
0 second exposures of the virus to the hand sanitizers. Inoi:10.1016/j.ijid.2010.02.2041
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56.003
Risk factors and clinical outcomes of multidrug-resistant
Acinetobacter baumannii bacteremia in a University Hos-
pital, Thailand
S. Anunnatsiri ∗, P. Tonsawan
Khon Kaen University, Khon Kaen, Thailand
Background: Multidrug-resistant (MDR) Acinetobacter
baumannii has become a major threat of nosocomial infec-
tion worldwide. The study aimed to assess the incidence
of bacteremia due to MDR A. baumannii, factors associated
with the infection, and clinical outcomes.
Methods: A retrospective study was conducted for eval-
uating 49 episodes of A. baumannii bacteremia in adult
patients admitted to a university hospital in Northeast
Thailand between 2005 and 2007. Comparison of the data
between patients with susceptible A. baumannii bacteremia
and those with MDR A. baumannii bacteremia was per-
formed.
Results: The incidence of MDR A. baumannii bacteremia
was 3.6 episodes per 10 000 hospital admission. The mean
(SD) age of the patients was comparable between the 2
study groups [56.9 (17.3) years in susceptible group and
59.4 (16.8) years in drug-resistant group]. Most of the
patients had pre-existing diseases; cancer, chronic kidney
disease, and diabetes mellitus were the 3 most common.
The most common source of bacteremia was pneumonia.
The signiﬁcantly independent factors associated with MDR A.
baumannii bacteremia were prior ICU admission (odds ratio
(OR) 10.01, 95% conﬁdence interval (CI) 1.39-72.20), prior
beta-lactam/beta-lactamase inhibitor use (OR 8.06, 95%CI
1.39-46.64), and prior carbapenems use (OR 11.40, 95%CI
1.44-89.98). Overall mortality rate was signiﬁcantly higher
in MDR group (48% vs. 91.7% in susceptible and MDR group,
respectively, p = 0.001). The signiﬁcantly independent fac-
tors related to mortality were APACHE II score (OR 1.25,
95%CI 1.03-1.52) and secondary bacteremia (OR 14.86, 95%CI
1.37—161.90).
Conclusion: This study revealed that the signiﬁcantly
independent factors associated with MDR A. baumannii bac-
teremia were prior ICU admission and prior use of broad
spectrum antibiotics. This infection caused high mortality
rate. Emphasize on prevention, strict application of infec-
tion control and appropriate use of antibiotic could reduce
the risk and control this infection.
doi:10.1016/j.ijid.2010.02.2042
56.004
Assessment of health care workers occupational exposure
to HIV and post-exposure prophylaxis (PEP) in health cen-
ters and hospitals of Addis Ababa, Ethiopia
T. Alemayehu
Abt Associates Inc. USAID/Private sector Program for TB and
HIV in Ethiopia, Addis Ababa, Addis Ababa, EthiopiaBackground: Occupational exposure that places a worker
at risk of HIV infection is a percutaneous injury, con-
tact of mucous membrane or skin with blood or other
body ﬂuids. Exploring the extent of exposures, knowl-
p
i
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dge and practices of health care workers on occupational
IV risks is important. The study was done to assess
ccurrence of occupational exposures and knowledge and
ractice regarding HIV post-exposure prophylaxis among
ealth care workers in health centers and hospitals of Addis
baba.
Methods: A facility based cross-sectional study, involving
72 health care workers, was conducted in Addis Ababa from
arch to April 2008. A pre-tested, interviewer administered,
tructured questionnaire was applied for data collection.
dds ratio with 95% conﬁdence interval and logistic regres-
ion analysis were employed to measure the degree of
ssociation between factors and identify the predictors for
ccurrence of needle stick injuries.
Results: The study revealed that 38.2% of health
are workers experienced at least one needle stick
njury in their life time and 19% of respondents expe-
ienced injury within the last one year. Rate of needle
tick injury in the previous one year was estimated
t 1.34 injuries per person. Factors associated with
ccurrence of injuries were being a nurse (AOR = 15.39,
5%CI = 3.70—18.05), having work experience for more
han 10 years (AOR = 2.68, 95%CI = 1.30—5.54), working
ong hours (AOR = 1.90, 95%CI = 1.10—3.31), attending fewer
atients per day (AOR= 2.21, 95%CI = 1.32—3.58), self per-
eption of high risk HIV (AOR= 2.05, 95%CI = 1.10—3.82)
nd non-consistent use of personal protective equipments
AOR= 1.67, 95%CI = 1.01—2.76). Two hundred sixty four
71.0%) respondents had knowledge about HIV post-exposure
rophylaxis.
Conclusion: The ﬁndings of this study indicated that
ccupational exposures were common among health care
orkers. Health facilities should make available to their
ystem that includes a standardized written protocol and
eporting unit for management of occupational expo-
ures. Improvement of work environment and appropriate
anagement of exposed cases, including addressing the psy-
hosocial burden health workers face after exposure is also
mperative.
oi:10.1016/j.ijid.2010.02.2043
6.005
ealthcare workers compliance to infection control prac-
ices in the haemodialysis unit in Sungai Buloh Hospital
alaysia
. Chua1, A. Adnan2,∗, Z. Abdul Wahab1
Sungai Buloh Hospital, Sungai Buloh, Selangor, Malaysia
Faculty of Medicine Universiti Teknologi MARA, Shah Alam,
elangor, Malaysia
Background: The number of patients with end-stage renal
ailure treated with haemodialysis in Malaysia has been
ncreasing in recent years. Haemodialysis patients are at a
igher risk of developing infections either directly or indi-
ectly via contaminated devices, equipment, environmental
urfaces or hands of healthcare workers (HCWs). Thus com-
liance to infection control practices by HCWs is very crucial
n the prevention of the transmission of infections among
aemodialysis patients. The Haemodialysis Unit in our hos-
ital has been in existence only for the past two years and
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e would like to determine the compliance of the HCWs to
he infection control practices.
Methods: We carried out a survey on the compliance to
nfection control practices among HCWs in the haemodial-
sis unit of our hospital over a two-week period. Two
nfection control nurses were stationed at the unit and
standard checklist was prepared. The CDC recommen-
ations for preventing transmission of infections among
hronic haemodialysis patients were used as a guide (MMWR
001;50(No. RR-5).
Results: The unit has 25 dialysis machines with an average
umber of 46 patients per month. Four medical assistants,
nurses and 4 healthcare attendants were observed dur-
ng the study period. Hepatitis B seropositive patients were
anaged in a separate area with dedicated dialysis machine
om Hepatitis B seronegative patients. The HCWs were most
ompliance to wearing gloves, provided dedicated items,
edications or supplies for single patient use (100% compli-
nce). The HCWs were least compliance to hand washing and
emoval of gloves in between patients (9% compliance rate).
he staff failed to clean or disinfect the prime buckets (0%).
Conclusion: The results of the study provided a baseline
nformation on the compliance of the HCWs to infection
ontrol practices in the care of haemodialysis patients
n our hospital. Continuous education and training of the
CWs in infection control practices which are unique to the
aemodialysis centre are required in order to create the
wareness of the importance of adherence to these prac-
ices and thus will help reduce infections in the patients.
oi:10.1016/j.ijid.2010.02.2044
6.006
revalence of nosocomial sinusitis in ICUs admitted
atients in Rasool Hospital, Tehran, Iran
. Noorbakhsh1,∗, M. Barati 1, J. Mousavi 1, A. Tabatabaei2
Iran University of Medical Sciences, Tehran, Iran, (Islamic
epublic of)
2Research Center of Pediatric Infectious, tehran, Iran,
Islamic Republic of)
Background: We studied the incidence rate of sinusitis in
atients with fever of unknown origin (FUO) in ICUs.
Methods: A prospective, cross sectional study done in
ICU and ICUin Rasoul hospital; Tehran Iran (2007-2008).
aranasal sinus computed tomography was performed in all
adult)patients admitted in ICU within 48 h of admission and
epeat thereafter (4-7 days) in adult cases with fever of
nknown origin (FUO) after initial clinical and diagnostic
creening. Infectious sinusitis was diagnosed by microbio-
ogical analysis of sinus ﬂuid aspirates.
Results: 63 cases had full ciritera and followed for
osocomial sinusitis(age = 1—86 years;mean 17 + 25).Acute
acterial nosocomial sinusitis proved in 82% (51/ 63),
llergic sinusitis 18% (n = 12).Head truma was the most
ommon cause of admission in 45% (n = 22) of cases. Pos-
tive cultures seen in 82% (45/51) of cases included:
taphylococcus Aureus,Streptococus.spp in %22(n = 9), gram
egative organisms predominantly Klebsiella ,Pseudomonas
nd acinetobacter species detected in 41% (n = 19), mixed
erobic/anaerobic in 37%(n = 17) of cases. 7 patients had
n
(
i
tternational Congress on Infectious Diseases (ICID) Abstracts
egative culture but positive smear or rapid antigen
etection in sinus material included: S. Pneumonia in 5 chil-
ren,Hemophilus inﬂuenza detected in 2cases. Mean age
f cases for nosocomial infection included: Gram negative
rganisms 7years; Staph 14 year and mixed infection 27
ears.We did not observe correlation between type of organ-
sms and GCS; (P = 0.3).
Conclusion: Physicians treating critically ill patients
hould be aware of the high risk of nosocomial sinusitis
specially incases with head truma.Appropriate preventive
easures, including the removal of nasogastric tubes in
atients requiring long-termmechanical ventilation and rou-
ine investigation of FUO should include sinus CT scan should
e linked to naso tracheal intubation, but its occurrence
fter orotracheal intubation is less clear.
oi:10.1016/j.ijid.2010.02.2045
6.007
spects of needlestick injuries among medical students:
eported or not?
.J. Salzer1, H. Langmann2, F. Stigler3, M. Sprenger4, M.
oenigl 5,∗
Internal Medicine, Graz, Austria
Institute of Health Promotion and Prevention, Graz, Aus-
ria
International Federation of Medical Students’ Associa-
ions, Ferney-Voltaire, France
Medical University of Graz, Graz, Austria
Internal Medicine, Graz, Austria
Background: Medical students (MS) may be at high risk
or needlestick injuries (NSI) and hence of transmission of
lood borne pathogens including Hepatitis B (HBV), Hepatitis
(HCV) and HIV. Information is limited regarding the fre-
uency of NSIˇıs, the associated factors and the barriers to
eporting them.
Methods: A self-administered anonymous questionnaire
as distributed to 81 MS during an international students
eeting on public health (ISMOPH). The questionnaire
onsisted of 21 questions covering topics including the
requency and reporting of NSI’s as well as policy and
ost-exposure experiences. Completion of the survey was
onsidered implied consent for study participation. The
tudy served as a pre-test for an international cross-
ectional multicentre study on NSIˇıs among MS to evaluate
he validity and feasibility of the developed survey question-
aire.
Results: A total of 32 MS completed the questionnaire giv-
ng a response rate of 40%. 25% (8/32) reported that they had
t least one NSI during their studies and for 38% of respon-
ents, that injury had involved a high-risk patient (deﬁned as
istory of HBV, HCV and/ or HIV). 7 of the students reported
hat the injury was ‘‘self-induced’’ and described a feeling
f being in ‘‘hurry’’ as the underlying cause. 50% (4/8) did
ot report the most recent NSI. The main reasons for under-
eporting were due to an injury with a clean needle, little or
o perception of risk as well as shame of having a NSI. 69%
22/32) reported that their facility has a clear policy regard-
ng post-exposure follow-up of NSIˇıs, whereas more than a
hird were not familiar with this policy. When 81 MS were
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asked which blood-borne pathogen they feared most, 45%
identiﬁed HIV, 36% identiﬁed HCV, and 18% identiﬁed HBV.
Conclusion: The experience of NSI’s and underreporting
seems to be frequent among MS. Therefore improved edu-
cation and reporting strategies are needed to encourage the
awareness of MS for an effective prevention of NSI’s.
doi:10.1016/j.ijid.2010.02.2046
56.008
Factors associated with septic shock in patients with
hematological malignancies and Pseudomonas infections
R. Jeddi ∗, H. Ghédira, R. Ben Amor, A. Turki, L. Aissaoui,
K. Kacem, W. Bouteraa, Y. Ben Abdennebi, R. Ben Lakhal,
H. Ben Abid, Z. Bel Hadjali, B. Meddeb
Aziza Othmana University Hospital, Tunis, Tunisia
Background: Pseudomonas is a leading cause of nosoco-
mial infections usually associated with high mortality. The
aim of this study was to determine predictive factors of sep-
tic shock in patients with hematological malignancies and
Pseudomonas infections.
Methods: This study was conducted in a teaching hos-
pital (Aziza Othmana University hospital, Tunis, Tunisia) to
evaluate the clinical proﬁle of infection due to Pseudomonas
species and to determine risk factors for septic shock deﬁned
according to the criteria of the American College of Chest
Physicians/Society of Critical Care Medicine Consensus Con-
ference. Statistical analysis was performed with Pearson
test.Level of signiﬁcance was at p = 0.05.
Results: Between 2001 and 2009 a total of 80 Pseu-
domonas isolates (77 P.aeruginosa) was collected in 66
patients: 52 with acute leukemia (79%),7 with lymphoma
(10.5%), and 7 with other hematological disorders (10.5%).
The median age was 30 years (range, 2—64years). Most
common sites of the isolates were from bloodstroom
(45%), and skin lesions (31.5%). Median time for micro-
biological documentation was 8 days (range, 0-35days)
from onset of neutropenia. At least 12 patients (18.1%)
had recurrent (≥2) infections due to Pseudomonas. The
most common clinical signs observed were: skin lesions
(34%), diarrhea (20%), isolated fever (18%), and respiratory
symptoms (14%). Susceptibility to major anti-Pseudomonas
antibiotics revealed that isolates tested were resistant to:
piperacillin/tazobactam (43%), ceftazidim (31%), imipenem-
cilastatin (26%), ciproﬂoxacin (25%), and amikacin (26%).
Septic shock occured in 16.2% of episodes (13/80). Crude
mortality was (19.6%,13 of the 66 patients) all caused by
septic shock. For the remaining 53 patients (79.4%) median
time for response to antibiotherapy was 2.5 days. In uni-
variate analysis, factors associated with septic shock were:
fever lasting for more than 3 days in patients on antibio-
therapy (p = 0.019), Creactive protein > 150mg/l (p = 0.065),
serum lactate > 5mmol (p = 0.05), hemoglobin level < 50 g/l
(p = 0.042), hypoproteinemia < 50 g/l (p = 0.01), and procal-
citonin >10ng/ml (p = 0.031).ts e251
Conclusion: This study revealed that several factors
uch as high procalcitonin level, low hemoglobin level,
evere hypoproteinemia,high lactate level,and antibio-
herapy >72 h before microbiological documentation are
igniﬁcant factors associated with septic shock and
ncreased mortality in patients with hematological malig-
ancies and Pseudomonas infections.
oi:10.1016/j.ijid.2010.02.2047
6.009
nitiatives to decrease the incidence and transmission of
lostridium difﬁcile (C. difﬁcile)
. Murillo1, V. Heitzer2,∗, M. Ruiz3, F. Ordieres2
Miami, USA
South Miami hospital, 33143, Fl, USA
South Miami Hospital, Miami, Fl, USA
Background: Due to the increased incidence and trans-
ission of Clostridium difﬁcile (C. diff) in healthcare
acilities in our community, surveillance and a retrospective
tudy for 2005 was conducted. We noted in our 2006 ongoing
urveillance a gradual increase in the incidence of C. diff.
n our facility.
Methods: We convened a multidisciplinary Task Force to
ddress the increased incidence of C diff in 2006. The Task
orce recommended the following actions: Contact isola-
ion/precautions for all individuals with diarrhea, physician
esigned signage implemented to encourage hand antisep-
is with soap and water followed by alcohol hand rinse
or all patients with diarrhea, Fluoroquinolone evaluation
as conducted and judicious prescribing practices for Flu-
roquinolones was disseminated, yogurt twice a day was
ncorporated into patient’s dietary regimen for those receiv-
ng antibiotic(s) or physicians whose patients disliked or
ere intolerant of yogurt were contacted by a dietitian to
rescribe a prophylactic probiotic.
Results: Our data has demonstrated a sustained decrease
n the incidence of C.diff. This was accomphished through
ightened awareness of judicious prescribing of ﬂuoro-
uinolones, institution of proper isolation/precautions of
atients, by the addition of yogurt to patient dietary
egimen or probiotic therapy, and staff acceptance and uti-
ization of new hand hygiene products.
e th International Congress on Infectious Diseases (ICID) Abstracts
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tees need to continue to investigate new products that will
increase hand hygiene in healthcare workers, patients, and
visitors.
doi:10.1016/j.ijid.2010.02.2049252 14
Effective initiatives in decreasing the incidence of
.diff
Conclusion: A sustained decrease in the incidence of
.diff over the last 3 years is attributed to the implementa-
ion of all the Task Force recommendations.
oi:10.1016/j.ijid.2010.02.2048
6.010
nitiatives to decrease the incidence of methicillin resis-
ant Staphylococcus aureus (MRSA)
. Murillo1,∗, V. Heitzer2, M. Ruiz3, F. Ordieres2
Miami, USA
South Miami Hospital, 33143, Fl, USA
South Miami Hospital, Miami, Fl, USA
Background: Nationally MRSA has been identiﬁed as
oth a hospital and community concern. The CDC and
ome national healthcare organization have implemented
n admission screening cultures and contact isolation in an
ffort to prevent transmission of MRSA in the healthcare
nvironment. The system infection preventionists addressed
his issue of universal screening cultures in 2006. Retrospec-
ive surveillance of our facility demonstrated we that we
xceeded our 7.1 mean per 10,000 patient days. The Infec-
ion Control committee after reviewing our data determined
hat screening cultures and contact isolation on admission
as not warranted. We acknowledge the seriousness of this
apidly escalating healthcare infection in our community
nd elected to implement a conservative approach based
n clinical symptomatology, in conjunction with laboratory
ndings.
Methods: The Infection preventionist(s) review the daily
icrobiology ﬁndings, and note MRSA identiﬁcation. The
hysical condition of the affected patient(s) is assessed for
emperature, erythema, cellulitis, and drainage. Positivendings requires that the patient be placed in a private
oom and contact isolation precautions be instituted. Based
n the recommendation of the Infection Control Commit-
ee, the practice of hand antisepsis among the medical staff
as increased due to the installation of hand washing sinks
n close proximity to the physicians charting area on each
edical surgical unit. Hand hygiene compliance data was
ollected, reviewed and communicated to staff. Education
as provided through general orientation, annual manda-
ory education, and the infection control newsletter ‘‘Bug
f the Month’’. The Hand washing Team and Infection Con-
rol Week activities promoted a heightened awareness of the
eed for continued hand hygiene compliance. Implementing
hanges in hand antisepsis (new dispenser for alcohol hand
inse and foam hand soap) for increased acceptance and
sage of Hand hygiene products by all healthcare workers.
Results: Through heightened awareness, proper isolation
recaution implementation and increase in hand hygiene
ompliance we have decreased the incidence of MRSA.
Conclusion: Increased hand antisepsis compliance had a
igniﬁcant effect on the decreasing rate of MRSA infection
n our facility. Infection control and New Product commit-
trac
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56.011
Failure of dry mist of hydrogen peroxide 5% to kill
Mycobacterium tuberculosis
B.M. Andersen1,∗, G. Syversen1, H. Thoresen1, M. Rasch1,
K. Hochlin1, B. Seljordslia1, I. Snevold1, J. Berg2
1 Ulleval University Hospital, Oslo, Norway
2 Bakteriefritt, Oslo, Norway
Background: Multi-drug-resistant (MDR), or extensive
drug-resistant (XDR) strains of M tuberculosis are increas-
ing, resulting in spread of infections, extremely difﬁcult to
treat. M tuberculosis may survive in the environment for up
to a year if not exposed to sunshine (or ultraviolet light).
Enhanced environmental cleaning and disinfection is there-
fore important in the hospital environment to control the
spread of infection. Disinfectants like chlorine and 5% chlo-
ramine, have been used for surface disinfection purposes
after discharge of patients with contagious tuberculosis. The
last few years, a dry mist of hydrogen peroxide disinfectant
(DMHP) has also been used for decontamination of rooms,
medical equipment and ambulances. DMHP has also been
tried against M tuberculosis as a routine decontamination.
The effect of DMHP on M tuberculosis is studied at Oslo
University Hospital - Ullevål, Norway.
Methods: Mycobacterium tuberculosis strain CCUG 37357
was subcultured in Løwenstein Jensen (LJ) medium. A ﬁnal
dilution of 3 x 105 CFU/ml was added to each of 20 plas-
tic agglutination wells and and dried at room temperature
for 2 h. 10 samples were placed in room temperature in
laboratory A and the other 10 were placed in a sepa-
rate decontamination room B and treated with 3—6 cycles
with dry mist hydrogen peroxide (H2O2 5%,Sterinis, Gloster
Sante) during the night. Ppm of H2O2 and spore tests
were monitored during the experimental period. Controls
and treated samples were eluated and grown for 4 weeks
in parallel LJ and Bactec media. Four separate, repeated
experiments were performed during a period of 60 days,
using three decontamination cycles in two experiments and
six cycles in two. The results were only read as growth or no
growth.
Results: Growth of M tuberculosis was observed in all
broth media (Bactec) and was present on Løwenstein Jensen
media, both in controls and in treated samples. All spore
control tests were negative. The ppm level reached during
each cycle was high. No signiﬁcant decontamination effect
could be observed on bacteria grown on LJ media, neither
after 3 nor 6 decontamination cycles with DMHP (5%).Conclusion: A dry mist of hydrogen peroxide; DMHP
(Sterinis) had no signiﬁcant decontamination effect on air-
dried samples of Mycobacterium tuberculosis.
doi:10.1016/j.ijid.2010.02.2050
w
m
p
s
a
l
i
dts e253
6.012
utbreak of methicillin-sensitive Staphylococcus aureus
oint infections associated with magnetic resonance
rthrograms performed at a single outpatient radiology
enter-Los Angeles County, California, USA, 2009
. Kim, C. Tyson, L. Mascola ∗
County of Los Angeles, Los Angeles, CA, USA
Background: Septic arthritis after arthrography is rare.
n May 2009, the Los Angeles County Department of Pub-
ic Health investigated an outbreak of joint infections after
atients received magnetic resonance arthrograms (MRAs)
rom one outpatient radiology center, Facility A, during a
-day period.
Methods: Prospective and retrospective outbreak inves-
igations were done, including interviewing radiology staff,
bserving procedures, and reviewing medical records from
7 April through 1 May 2009. We deﬁned conﬁrmed cases as
atients from Facility A who had MRAs and septic arthritis
ith positive synovial ﬂuid cultures and possible cases as
atients from Facility A with acute onset of new joint pain
fter MRA requiring further medical evaluation.
Results: Seven case-patients were identiﬁed (5 con-
rmed, 2 possible) out of 15 who received MRAs (attack
ate = 47%). Average onset time of new acute joint pain
ymptoms following the MRA was 1.1 days (range 1—2
ays). Five knees and two shoulder joints were affected.
oth possible case-patients required emergency department
ED) evaluation. Synovial ﬂuid cultures on conﬁrmed case-
atients grew methicillin-sensitive Staphylococcus aureus
MSSA), requiring hospitalization and surgical arthroscopic
ncision and drainage, peripherally inserted catheter place-
ent, and 6 weeks of intravenous antibiotics. Average length
nd cost of hospitalization was 10.8 days (range 5-16 days)
nd $140.000. Two radiologic technologists routinely pre-
ared contrast media for intra-articular injection. Contrast
edia and MSSA synovial ﬂuid isolates were not available
or further testing. We observed multiple breaches in asep-
ic technique during preparation of contrast media and
mproper multidose use of single-dose contrast media vials
n multiple patients for cost-savings purposes.
Conclusion: One third of patients developed septic
rthritis during a 5-day period following MRAs at a single
utpatient radiology center and 47% required hospitaliza-
ion or ED evaluation. This outbreak was likely caused by
apses in infection control, providing opportunity for extrin-
ic contamination of a single-dose contrast media vial which
as misused as a multidose vial and resulted in signiﬁcant
orbidity and costs. The case-patients were clustered tem-
orally with MSSA joint infection, making a localized point
ource most likely. No new case-patients were identiﬁed
fter corrective actions were instituted. This outbreak high-
ights the need for infection control monitoring particularly
n outpatient settings which lack formal oversight.
oi:10.1016/j.ijid.2010.02.2051
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6.013
redictors of mortality in neutropenic patients with septic
hock
. Jeddi, H. Ghédira, R. Ben Amor ∗, L. Aissaoui, W.
outeraa, Y. Ben Abdennebi, K. Kacem, R. Ben Lakhal, A.
urki, H. Ben Abid, Z. belhadjali, B. Meddeb
Aziza Othmana University Hospital, Tunis, Tunisia
Background: Chemotherapy-induced neutropenia is a risk
or serious infection.Septic shock still causes high mortality
mong cancer patients. We aimed at identifying predictive
actors of mortality in neutropenic patients (ANC < 0.5 x
09/l) who developed septic shock.
Methods: All cases of septic shock deﬁned according to
he ACCP/SCCM criteria observed in our department (Hema-
ology, Aziza Othmana University Hospital) between 2005
nd 2009 were included in this study. All clinical, biolog-
cal and microbiological data were collected at the onset
f septic shock and during outcome. Initial score on the
equential Organ Failure Assessment (SOFA score) was per-
ormed for each patient. Statistical analysis was performed
sing Pearson test.
Results: Thirty three septic shock were observed in
atients with hematological malignancies:Acute leukemia
31),lymphoma (2).Median age was 27 years (range,
—67).58% of septic shock were observed during chemother-
py induction phase .Median time for occurrence of septic
hock was 15 days from onset of neutropenia (range,
—32). Microbiological documentation was obtained in
3 cases (69.6%).The bacteria involved were:Klebsiella
9),Pseudomonas (7), Stenotrophomonas (4), E.coli (1),
cthrobacter anthropi (1) and Acinetobacter (1). 9 (39.1%)
solates were resistant to broad spectrum antibiotics. 20
atients (60.6%) developed ARDS during the evolution. Ini-
ial SOFA score was >11 (i.e. a risk of mortality of 95%)
n only 6 patients (18.1%).Only 8 patients (24.2%) were
dmitted in ICU with a median time of 1.8 day (range,
—3 days).Day 30 mortality was 85%.By univariate analy-
is predictors of mortality were: Disease status (p = 0.009),
eutropenia lasting more than 15 days (p = 0.012),fever for
ore than 3 days in patient on antibiotherapy (p = 0.009),
emoglobin level <50 g/l (p = 0.038), isolate resistant to
iperacillin/tazobactam (p = 0.025), presence of clinical
ymptoms from more than 1 site (p = 0.008), patients not
n imipenem antibiotherapy at the onset of septic shock
p = 0.019), occurrence of ARDS during evolution of septic
hock (p = 0.003) and non—admission in ICU (p = 0.043). No
ndependent predictor found in multivariate analysis.
Conclusion: This study revealed that several factors play
signiﬁcant role in mortality during septic shock. Despite
ow proportion of patients with baseline high SOFA score,
he mortality rate in our study was very high highlighting
he need for appropriate management and early admission
n ICU to improve outcome.
oi:10.1016/j.ijid.2010.02.2052
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ncidence of nosocomial respiratory tract infection in
ediatric intensive care unit of University Hospital Center
UHC) of Tirana
. Kasmi ∗, G. Kasmi, S. sallabanda, E. Kola, F. Zavalani, R.
lukaj, I. Bakalli, A. Koja, E. Celaj, K. Marku
University Hospital Centre ‘‘Mother Theresa’’, Tirana, AL,
lbania
Background: Nosocomial Respiratory Tract Infection
NRTI), have high morbidity, random mortality, increase hos-
ital stay and the patient cost.
Methods: This is a prospective study, including all
atients during the period February 2007- January 2008.
RTI was deﬁned according to CDC criteria: - new produc-
ion of sputum - new pulmonary inﬁltrates appearing in the
hest x-rays associated with respiratory failure. - lab evi-
ence of infection Correlation between extrinsic factors and
he appearance of NRTI identiﬁed by Kendall‘tau b test for
wo nonparametric variables turned out to be signiﬁcant.
Results: The number of NRTI was 15 from 484 patients
reated in PICU. 213 patients were exposed to nasogastric
ubes, 97 to endotracheal tubes, 39 to antiacids usage. Out
f 15 patients with NRTI in 13 were used ET, in 6 antiacids,
n 13 were used nasogastric tubes. Average NRTI appear-
nce day was 5.38. Average stay in hospital for patients
ithout NRTI was 3.6 days. Average stay for patients with
RTI was 18.5 days. Comparison of above mentioned aver-
ges revealed to be signiﬁcant (p < 0.01). Etiological pattern
f NRTI was as follow: Pseudomonas aeruginosa 40%, Kleb-
iella sp 13.3%, Acinetobacter sp 13.3%, others gramnegative
9.9%, gram-positive 13.3%. The antibiograme indicates
resence of Pseudomonas aeruginosa resistant to quinolone
nd aminoglucoside (gentamycine) — in 30%.
Conclusion: Incidence of NRTI was 3%. Multiresistant
trains pose major difﬁculties in managing NI. This study
how the correlation between the extrinsic factors and the
ppearance of NRTI. This research highlights the need to
ssess the preventive measures and the identiﬁcation of
onitoring actions.
oi:10.1016/j.ijid.2010.02.2053
6.015
linical chracteristics and prognostic factors in patients
ith Stenotrophomonas maltophilia bacteremia
. Nukui ∗, S. Hatakeyama, Y. Shintani, H. Yotsuyanagi, K.
oriya, K. Koike
University of Tokyo Hospital, Tokyo, Japan
Background: Stenotrophomonas maltophilia is a multi-
esistant, non-fermentative gramnegative bacillus, which
s increasingly being recognized as an important nosoco-
ial pathogen affecting debilitated patients. S. maltophilia
nfections are associated with high morbidity and mortal-
ty. This study aimed to clarify the clinical characteristics,
ntibiotic susceptibility, antibiotic treatment, outcome, and
rognostic factors in patients with S. maltophilia bac-
eremia.
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Methods: A retrospective cohort study was conducted at
the University of Tokyo Hospital, comprising 1,150 beds, with
specialty services including intensive care and transplanta-
tion in Japan, from January 2003 to September 2009.
Results: During this study period, 7,216 positive blood
cultures were identiﬁed. Of these, 87 (1.2%) blood cul-
tures from 54 patients showed S. maltophilia growth. The
mean age of the patients was 53.3± 3.0 years. In 52
patients (96%), S. maltophilia bacteremia was hospitalac-
quired, in particular, in 49 patients (91%) it developed after
prolonged hospitalization of >2 weeks. Forty-one patients
(76%) had an indwelling central venous catheter (CVC),
50 (93%) had received antibiotic therapy, 48 (89%) had
underlying malignancy, 11 (20%) had diabetes mellitus, and
11 (20%) were receiving corticosteroid therapy. In 19% of
all the cases of bacteremia, polymicrobial isolates were
conﬁrmed. The overall and bacteremia-related mortality
rates were 39% and 26%, respectively. The most common
sources of bacteremia were CVC (33%) and pneumonia (15%);
the source was unknown in 20% cases. Tests for antibi-
otic susceptibility revealed that the isolates were most
sensitive to trimethoprimsulfamethoxazole (79%). Only 47%
and 43% of the isolates were susceptible for ceftazidime
and ciproﬂoxacin, respectively. Univariate analysis revealed
that bacteremia originating from the pneumonia, patients
treated with inappropriate antibiotics, and patients with a
persistent indwelling CVC had a signiﬁcant higher mortality
rate (P < 0.0001, P < 0.0001, P = 0.0027, respectively).
Conclusion: S. maltophilia is an important pathogen, par-
ticularly, in immunocompromised hosts. Isolation of this
organism from a blood culture should prompt a careful
review of the patient, with particular emphasis on removal
of an indwelling CVC and commencement of appropriate
antibiotic therapy. In this study, we noticed an increas-
ing trend of resistance to ceftazidime, cefepime, and
ciproﬂoxacin. Therefore, we believe that proper usage of
antibiotics is important for infection control.
doi:10.1016/j.ijid.2010.02.2054
56.016
Prevalence of mecA, aap genes and slime layer formation
and its association with antibiotic resistance in isolated
Staphylococcus epidermidis of TUMS hospitals health care
staffs
M.R. Pourmand ∗, Z. Abdossamadi, M.H. Salari
Tehran University of Medical Sciences, Tehran, Iran, (Islamic
Republic of)
Background: Staphylococcus epidermidis strains are fre-
quently associated with catheterrelated infection, acute
bacteremia and hospital-acquired infection. Some of the
isolates have extracellular matrix called slime. The recent
studies show that slime-forming bacteria are more resistant
to antibiotics than planktonic bacteria. In S.epidermidis, the
accumulation associated protein (aap) is essential to bioﬁlm
development and is involved in the accumulation phase of
bioﬁlm formation. methicillin resistance is mediated by the
mecA gene. However in contrast to MRSA,very little atten-
tion is paid to MRSE. The aim of this study was to determine
the prevalence of mecA, aap gene and slime production in
1
1
1
1ts e255
.epidermidis isolates and antibiotic resistance in nasophar-
nx isolates of health care personnel.
Methods: A descriptive cross sectional study was per-
ormed on 163 isolates. These were collected from July to
ecember 2008. S. epidermidis isolates tested for slime pro-
uction onto CRA and antibiotic resistance. The extracted
NA of S. epidermidis isolates were examined by PCR involv-
ng speciﬁc primers for mecA and aap genes.
Results: Among 163 collected nasal swabs 99 (60.7) were
. epidermidis. Of these 35.3 isolates produced slime. Sig-
iﬁcant relation between slime production and resistance
o Penicillin, oxacillin (p < 0.0001), tetracycline (P = 0.0005),
rythromycin (P = 0.001) and clindamycin (0.003) was found.
5.8% and 94.8% isolates were PCR-positive for mecA and
ap, respectively.
Conclusion: Surveillance of nasal colonization with slime-
orming MRSE in health care workers might provide useful
nformation for the establishment of infection control pro-
edures toward these bacteria.
oi:10.1016/j.ijid.2010.02.2055
6.017
entral line associated bloodstream infection rates in 166
ntensive care units of 54 cities in 23 developing coun-
ries: ﬁndings of the International Nosocomial Infection
ontrol Consortium (INICC)
. Rosenthal1,∗, C. Álvarez Moreno2, A. Mehta3, H.
eblebicioglu4, E.A. Medeiros5, L. Raka6, B. Hu7, S.
amulitrat8, I.A. Khader9, M.G. Miranda Novales10,
. Hussain11, R. Fernández Hidalgo12, S.S. Kanj13, Á.
illacres14, J.A. Navoa-Ng15, T. Mapp16, H. Guanche
arcell 17, A. Barkat18, V. Suljagic19, Z. Mitrev20, L.
uen˜as21, L. Cuellar22, A. Hamdi23
International Nosocomial Infection Control Consortium
INICC), Buenos Aires, Argentina
San Ignacio University Hospital, Pontiﬁcia Javeriana Uni-
ersity, Bogota, Colombia
PD Hinduja National Hospital & Medical Research Centre,
umbai, India
Ondokuz Mayis University Medical School, Samsun, Turkey
Sao Paulo Hospital, São Paulo, Brazil
National Institute for Public Health of Kosova and Medical
chool, Prishtina University, Prishtina, Kosovo, Republic of
under UNSCR 1244/1999)
Zhongshan Hospital, Shanghai, China
Songklanagarind Hospital, Songkla, Thailand
Jordan University Hospital, Amman, Jordan
0 CMN Siglo XXI, IMSS, Pediatric Hospital, Mexico, Mexico
1 Shaukat Khanum Cancer Hospital and Research Centre,
ahore, Pakistan
2 Clínica Bíblica Hospital, San Jose, Costa Rica
3 American University of Beirut Medical Center, Beirut,
ebanon
4 Sociedad de Lucha contra el Cáncer, Quito, Ecuador
5 St. Luke’s Medical Center, Quezon City, Philippines
6 Clínica Hospital San Fernando, Panama, Panama
7 Hosp Joaquín Albarrán, La Habana, Cuba
8 Children Hôspital of Rabat, Rabat, Morocco
9 Military Medical Academy, Belgrade, Serbia
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0 Filip II Special Cardiosurgery Hospital, Skopje, Macedonia
1 Hospital Nacional de Nin˜os Benjamin Bloom, San Salvador,
l Salvador
2 Instituto Nacional de Enfermedades Neoplásicas (INEN),
ima, Peru
3 Hôpital d’Enfants, Tunis, Tunisia
Background: To determine rate, microorganism proﬁle,
acterial resistance, extra length of stay (LOS) and extra
ortality of Central Line associated Bloodstream Infection
CLAB) in intensive care units (ICUs) of 23 countries in
NICC hospitals in Argentina, Brazil, China, Colombia, Costa
ica, Cuba, Ecuador, El Salvador, India, Jordan, Kosovo,
ebanon, Macedonia, Mexico, Morocco„ Pakistan, Panama,
eru, Philippines, Serbia, Thailand, Tunisia, and Turkey.
Methods: An open label, prospective cohort, active
evice-associated infection (DAI) surveillance study was
onducted on adult, pediatric and neonatal patients admit-
ed to tertiary-care ICUs. DAI rates were collected from
66 ICUs, and were recorded by using CDC-NNIS deﬁni-
ions. Microorganism proﬁle, bacterial resistance, LOS and
ortality data were collected in 128 out of the 166 ICUs.
ata were collected from patients with and without DAI
sing the INICC protocol, forms and methods, which pro-
ided researchers with a general view of patients’ outcomes,
llowing researchers to suspect DAI and avoid possible DAI
missions if no cultures were done. Patients with and with-
ut DAI can be matched to calculate LOS, costs, and extra
ortality. Data were uploaded and analyzed at INICC ofﬁce.
tatistical analysis was performed using Chi-square test.
< 0.05 was considered signiﬁcant.
Results: We collected data from 01/02 to 11/08, repre-
enting 563,322 CL days. The pooled CLAB rate was 8.06 per
000 CL days; data stratiﬁed by ICU type are shown in Table.
verall 17.1% of all CLAB were caused by Staphylococcus
ureus (83.1% were MRSA); 17.1% by Coagulase-negative-
taphylococci (80.1% were methicilin resistant); 13.9%
y Acinetobacter sp (83.3% were Piperaciline-Tazobactam
esistant); and 11.8% by Pseudomonas sp (42.2% were
mipenem resistant). The LOS of patients without DAI was
.3 days; and of patients with CLAB, 16.7 days (RR, 3.14),
epresenting 11.4 extra days. 7,464 out of 52,549 (14.2%)
atients without any DAI died; 397 out of 1,305 patients
30.4%) with CLAB died, the extra mortality being 16.2% (RR,
.14, 95% CI, 1.94—2.37, P, 0.0001).
Conclusion: Pooled CLAB rate of 8.02 per 1000 CL days
as higher than the 2.0 rate (medical surgical ICUs) per
000 CL days published by CDC-NNIS. Patients with CLAB had
signiﬁcantly higher LOS, with 11.4 extra days, and extra
ortality of 16.2%.
oi:10.1016/j.ijid.2010.02.2056
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entral line associated bloodstream infection rates, extra
ength of stay, extra mortality and microbiological proﬁle
n a German tertiary intensive care unit: ﬁndings of the
nternational Nosocomial Infection Control Consortium
.W. Friedrich1,∗, R. Köck2, C. Goeters3, K. Becker4, K.
ohl5, V. Rosenthal6
University Hospital Munster, Institute of Hygiene, Munster,
ermany
University Hospital Munster, Institute of Medical Microbi-
logy, Institute of Hygiene, Munster, Germany
University Hospital Munster, Department of Anaesthesiol-
gy and Intensive Care, Munster, Germany
University Hospital Munster, Institute of Medical Microbi-
logy, Munster, Germany
University Hospital Munster, Department of Anaesthesi-
logy and Intensive Care, Institute of Hygiene, Munster,
ermany
International Nosocomial Infection Control Consortium
INICC), Buenos Aires, Argentina
Background: To determine rate and consequences of
entral line associated bloodstream infection (CLAB) in 1
erman surgical intensive care unit (ICU) cooperating with
he International Nosocomial Infection Control Consortium
INICC).
Methods: We performed an open label, prospective
ohort, active surveillance study in adult ICU patients of a
erman tertiary-care hospital. At the ICU, for all patients
emi-rigid and/or glass infusion containers and stopcocks
ere used. INICC (www.inicc.org) protocols, forms and
ethods were used. According to these methods, data is
ollected from patients with and without healthcare associ-
ted infections (HAIs) enabling the match for variables such
s age, gender, underlying diseases, diagnosis, severity-of-
llness, invasive device use in order to calculate risk factors
nd outcome parameters. In this study, length of stay (LOS)
nd extra mortality are presented. Statistical analysis was
erformed using Chi-square test. P < 0.05 was considered
igniﬁcant.
Results: 447 patients were enrolled from 02/08 to 10/08,
epresenting 2,844 bed days. The overall CLAB rate was 7.86
er 1000 central line (CL) days. Overall, 33.3% of CLABs were
aused by Staphylococcus aureus (n = 4), 0% were methicillin
esistant; 33.3% by coagulasenegative staphylococci (n = 4),
00% were methicillin resistant; and 33.3% by Enterococcus
pp. (n = 4), 0% were vancomycin resistant. LOS of patients
ithout HAI was 4.5 days; LOS of patients with CLAB was 18.9
ays (RR, 4.19; 95% CI, 3.68 - 4.77; P < 0.001), representing
4.4 extra days. 20 of 406 (5%) patients without HAI died,
hereas the course of 2 of 14 patients (14%) with CLAB was
atal. Extra mortality was 9% (RR, 2.90; 95% CI, 0.68 - 12.41,
= 0.13).
Conclusion: In this study, the CLAB rate of 7.86 per 1000
L days is lower than the published rate of 9.2 per 1000 CL
ays observed in other hospitals cooperating in INICC. INICC
ethods allow for the comparison between patients with
nd without HAIs; LOS in patients with CLAB was signiﬁcantly
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higher, mortality rate was not signiﬁcantly affected and no
MRSA bacteraemia was observed.
doi:10.1016/j.ijid.2010.02.2057
56.019
Impact of outcome surveillance on ventilator associated
pneumonia rates in 3 intensive care units from 2 Mexican
cities: ﬁndings of the International Nosocomial Infection
Control Consortium (INICC)
M. Sobreyra Oropeza1, V. Rosenthal2,∗, H. Torres
Hernández3, A. Chávez Gómez3, J. Rivera Morales3,
J.E. Valero Rodríguez3
1 Hospital de la Mujer, Mexico, Mexico
2 International Nosocomial Infection Control Consortium
(INICC), Buenos Aires, Argentina
3 Irapuato General Hospital, Irapuato, Mexico
Background: To determine the effect of outcome and
process surveillance (intervention) on the rate of Ventila-
tor Associated Pneumonia (VAP) infection in three intensive
care units (ICU) from 2 cities of Mexico.
Methods: An open label, prospective cohort, active VAP
surveillance, sequential study was conducted on adult and
neonatal patients admitted to tertiary-care ICUs. Rates of
VAP were recorded by applying the deﬁnitions provided
by CDC-NNIS. The protocol, forms, and outcome and pro-
cess surveillance methodology used were developed by the
INICC. Data were collected from patients with and without
device associated infection (DAI). Forms were designed to
continuously prompt surveillance ofﬁcer to suspect DAI by
providing a panoramic view of outcomes for each patient
(eg, vital signs, invasive device use, cultures, antibiotic use,
etc); this is useful when no cultures have been done and
thus DAI could be wrongly omitted. Data were collected in
ICU. Data uploading and analysis were done at INICC ofﬁce
analyzing DAI rates, microbiological proﬁle of isolates, bac-
terial resistance, LOS, extra mortality. The VAP rates during
baseline were compared to the rates during an intervention
period. Statistical analysis was performed using Chi-square
test. P < 0.05 was considered signiﬁcant.
Results: The baseline period included the ﬁrst eight
months of the medical centers’ participation, and the inter-
vention period lasted a mean of 8 months (range 7-9
months). During the baseline period, 584 ICU patients were
enrolled, and 454 patients were enrolled during the inter-
vention period. Patients’ characteristics were similar over
the two periods (Patient gender, P: 0.3394; Diabetes, P:
0.1715; Renal Failure, P: 0.3951; Stroke, P: 0.2929). The
rate of VAP per 1,000 ventilator days during the interven-
tion period was signiﬁcantly lower than during the baseline
period, 17.6 (19/1,078) vs 8.3 (15/1,797) VAP per 1000 ven-
tilator days (RR, 0.47; 95% CI, 0.24-0.93; P 0.0267).
Conclusion: Outcome and process surveillance resulted
in a signiﬁcant reduction in the VAP rate.
doi:10.1016/j.ijid.2010.02.2058
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6.020
xpectations and perceptions of Nigerian patients regard-
ng infectious diseases in dentistry
. Azodo1, A. Umoh2, H. Oboro1,∗
University of Benin Teaching Hospital, Benin City, Edo
tate, Nigeria
University of Benin, Benin City, Edo State, Nigeria
Background: Dental treatment procedures frequently
nvolve blood and saliva that may be contaminated with
nfectious diseases. There has been no recent assessment of
igerian patients’ concern on the risk of infectious diseases
ransmission during dental care.
Objective: To assess the expectations and perception of
igerian patients regarding infectious diseases in dentistry.
Methods: A questionnaire based cross-sectional survey
f patients attending dental centre of University of Benin
eaching Hospitals, Nigeria was conducted in 2009.
Results: Themajority of patients (76.5%) expressed worry
bout contracting infection during the dental treatment and
7.4% of them identiﬁed HIV as a risk. One hundred and three
25.4%) would avoid dental treatment because of fear of
ontracting HIV. Ninety-two (22.7%) would switch from HIV
nfected dentists and 37.8% would not allow HIV-infected
entist to treat them. Only 10.4% of the respondents would
xpect the dentist to refuse treat to HIVinfected patients.
Conclusion: This survey revealed that a high proportion
f Nigerian patients are worried of infectious diseases dur-
ng dental treatment which also inﬂuenced their dental care
eeking behaviour. Improved public education and risk com-
unication on dental care associated infectious diseases is
eeded to allay the fear of Nigerian patients.
oi:10.1016/j.ijid.2010.02.2059
6.021
osocomial infections in a pediatric hospital in Santo
omingo, Dominican Republic
.S. Mota
Hospital Dr. Robert Reid Cabral, Santo Domingo, Dominican
epublic
Background: Nosocomial infection or ‘‘healthcare associ-
ted infection’’ lead to signiﬁcant morbidity, mortality and
conomy burden beyond those expected for patients’ under-
ying diseases alone, patients with nosocomial stay extra
0-14 days. In the developing world the nosocomial infection
ate can be 25%.
Methods: This is a descriptive, observational, cross sec-
ional study to determine the characteristics of nosocomial
nfection in Hospital Infantil Dr. Robert Reid Cabral, in the
eriod of January-June 2009; we looked through the reports
rom the hospital’s Nosocomial Infections Surveillance Com-
ittee.
Results: The period between January and June 2009,
200 patients were admitted to the hospital, from those
27 (3.96%) developed a nosocomial infection. 74.8% (N95)
ere admitted in areas considered high risk areas - Neonatal
ntensive Care Unit (NICU) 16.5% [21/127]; Pediatric Inten-
ive Care Unit (PICU) 9.4% [12/127]; Newborn unit 13.4%
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17/127]; Burns Unit 8.6[11/127]; Oncology 6.2% [8/127];
urgery 14.4% [18/127]; Nephrology 6.2% [8/127]. The noso-
omial infection was determinate as the direct cause of
he dead in 49 (38.5%) patients. The highest mortality rate
elonged to the PICU with 83.3% (10/12), follow by the
ICU 71.4% (15/21); the mortality rate in the Newborn Unit
as 70.5% (12/17); in contrast in the Surgery department
he mortality rate was 0. In 65 of the cases at least one
icroorganism was isolated, being K. pneumonia Extended
pectrum Beta Lactamases (ESBLs), the most frequently iso-
ated, 21.5% (14/65), it was also responsible of mostly of the
ortal cases, and by area the most isolated from the NICU.
o MRSA was isolated in this revision.
Conclusion: Although the creation of the Nosocomial
nfections Surveillances Committee, the nosocomial infec-
ions, its burden in costs, morbidity and mortality continuing
eing a big concern, especially in the NICU and Newborn
nit. Moreover, the high costs of the treatment for those
inds of infections sometimes are not affordable for patients
n a weak healthcare system.
oi:10.1016/j.ijid.2010.02.2060
6.022
redominance of diarrhoeagenic E.coli in hospital
cquired diarrhoea in a case-controlled study in a tertiary
are hospital in North India
. Taneja1,∗, B.K. Chandra1, G. Singh1, S. Pahil 1, M.
harma1, S. Singhi2
Post Graduate Institute of Medical Education and
esearch, Chandigarh, India
Postgraduate Institute of Medical Education and Research,
handigarh, India
Background: In developing countries nosocomial diarrhea
s an important cause of mortality and morbidity in paedi-
tric patients. Many bacterial agents such as Salmonella,
higella, different pathotypes of Diarrhoeagenic E.coli,
lostridium difﬁcile etc. have been reported to cause
utbreaks. We wanted to establish an etiological and epi-
emiological proﬁle of nosocomial diarrhoea among children
dmitted to the APC at PGIMER, India so that appropriate
reventive measures can be formulated.
Methods: From January 2008 to June 2009, we sys-
ematically enrolled 100 children between the age of 2
onths and 14 years as having nosocomial diarrhoea and
0 patients as control subjects. Stool samples were pro-
essed for bacterial agents by culture. Diarrhoeagenic E.coli
ere screened by using a multiplex PCR for elt-322 bp, est-
47 bp, bfpa-367 bp, aatA-630 bp and eae-881 bp. Rotavirus
ntigen and C.difﬁcile toxin A&B detection were performed
y ELISA. Parasitic agents were studied by doing a direct
tool examination. Patient’s clinical presentation, severity
core, outcome, type and courses of antibiotics received
ere analysed between cases and controls.
Results: In this study Diarrhoeagenic E. Coli such as
.T.E.C., E.A.E.C. and E.P.E.C. were isolated in 25%, 17%
nd 7% respectively. The diarrhoeagenic E.coli showed high
evels of multidrug resistance. Maximum resistance was seen
gainst naidixic acid(97.5%). C.difﬁcile toxin was seen in 9%
f cases, while Rotavirus was found in 8% of the cases. Mean
S
l
h
tternational Congress on Infectious Diseases (ICID) Abstracts
uration of diarrhoea and hospitalisation were 3.28 days and
7.45 days respectively.
Conclusion: Rotavirus and C.difﬁcile are the major
ausative agents of hospital acquired diarrhoea in the devel-
ped world but in our country Diarrhoeagenic E.coli are
esponsible for majority of cases of hospital acquired diar-
hoea. Exact reasons for this ﬁnding are not known but
t could be related to lack of stringent quality control
hile preparing and storing formula milk preparation. The
tatistically signiﬁcant factors for the development of noso-
omial diarrhoea were hospital stay, usage of antibiotics
vancomycin, imipenem and metronidazole) and nasogas-
ric feeding. Nosocomial diarrhoea is also most common in
hildren less than 5 years.
oi:10.1016/j.ijid.2010.02.2061
6.023
osocomial infections — 5 years of prevalence studies in
he Czech Republic
. Cecetkova1,∗, M. Girod Schreinerova2, M. Kolarova3,
. Kancelova4, R. Chlibek5, J. Jirous6, J. Kapek7, J.
ohoutova8, J. Kratochvilova9, V. Kurkova10, E. Mickova11,
. Podzimkova12, V. Ryantova13, I. Sipova14, P. Totusek15
Faculty Hospital of Thomayer, Prague, Prague, Czech
epublic
Public Health Institute, Carlsbad, Czech Republic
University Hospital, Brno, Czech Republic
University of Thomayer, Prague, Czech Republic
University of Defence, Hradec Kralove, Czech Republic
Faculty Hospital, Plzen, Czech Republic
General University Hospital, Prague, Czech Republic
Faculty Hospital, Olomouc, Czech Republic
Saint Anne University Hospital, Brno, Czech Republic
0 Hospital Pisek, Pisek, Czech Republic
1 Faculty Hospital, Hradec Kralove, Czech Republic
2 Faculty Hospital Bulovka, Prague, Czech Republic
3 Faculty Hospital Kralovske Vinohrady, Prague, Czech
epublic
4 Hospital Ceske Budejovice, Ceske Budejovice, Czech
epublic
5 Institute of Clinical and Experimental Medicine, Prague,
zech Republic
Background: As an important part of the nosocomial
nfections (NI) surveillance, hospital epidemiologists from
he faculty type hospitals in the Czech Republic perform
he one-day prevalence studies in 10 University Hospi-
als since the year 2005. Up to now, the point-prevalence
tudies included surgery, urology, neurology, cardiology,
eurosurgery, otorhinolaryngology, traumatology, gynecol-
gy and intensive care units departments. The aim is to
btain the descriptive and clear data in the time line, using
he simple questionnaire method, easy to perform, easy to
epeat and cheap.
Methods: The methodic approach is close to the HELICs
Hospital in Europe Link for Infection Control through
urveillance) protocol, as the current consensus for preva-
ence studies in european countries. In each of the involved
ospital, the medical ﬁles of all patients hospitalised in
he given department at the date of prevalence study are
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checked. From each medical ﬁle, the speciﬁc information
for the unigue questionnaire are obtained:
I. Descriptive data (patients’ identiﬁcation, diagnosis)
II. Information related to the NI and risk factors (diagnosis
of NI respects CDC criteria)
II. Laboratory and microbiology ﬁndings
IV. Informations about ATB treatment and/or prophylaxis
Data from the questionnaires are statistically analysed
using MS Excel and Epi Info.
Results: Up to now, 2225 hospitalised patients were
checked and 112 NI was found, what represents prevalence
4,7 NI on 100 hospitalised patients. Based on the studies
performed during this 5 years in the faculty hospitals, the
Czech Republic decided to perform the national pilot preva-
lence study on the intensive care units in autum 2009. All
hospitals in the Czech Republic with the given departments
were invited to the study on voluntary basis. 93% of hospitals
(109 units) conﬁrmed their involvement, what represents
1947 beds. The epidemiologists from the national public
health institutes network are involved in the organization
and data recovery. (ongoing at the time of abstract submis-
sion, results expected in January 2010).
Conclusion: We can recommend the similar approach to
the countries looking for the optimal tool to determine the
NI and deﬁne NI control priorities, when resources are lim-
ited.
doi:10.1016/j.ijid.2010.02.2062
56.024
Predicting health care associated infections (HAI) in a high
incidence low cost intensive care unit
G. George ∗, S. Kumar, K. Sivagnanam, P. Srikanth
Sri Ramachandra University, Chennai, India
Background: All across the world it has been documented
that Health care associated infections increase the costs of
medical care, morbidity and mortality and are a challenge
in health care delivery. Our objective was to to predict the
possibility, properties and antibiotic susceptibility of HAI in
patients in an ICU.
Methods: All patients admitted to an adult multi disci-
plinary ICU between July 1-August 15 2009 were monitored
prospectively in our pilot study. Information on clinical
parameters, risk factors, co-morbid conditions, culture
source, organisms isolated and antibiotic susceptibility was
documented and analysed using appropriate statistical soft-
ware. The probability of a HAI in the presence of risk
factor(s) was calculated. The probability of involvement of
speciﬁc systems or organisms, given a HAI was calculated.
Results: In all 108 patients were studied. 104 cultures
were performed on 51 of the 108 patients. The only sig-
niﬁcant risk factors (p < 0.01) for HAI were found to be
duration of stay (eg. independent probabilities of 0.25 and
1 at 5 and 20 days respectively), duration of IV lines and uri-
nary catheterization (irrespective of duration). Probability
of pulmonary and urinary infections respectively increased
independently with duration of hospital stay and catheter-
ization (eg. probability of a pulmonary infection at 20
(
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ays-0.55). Most of the isolates were gram negative. The
robability of a urine culture growing Klebsiella or E.coli
as 0.5. The probability of de novo sepsis was 0.13 while the
robability of sepsis occurring in the presence of a preceding
ulmonary or urinary infection was 0.3 irrespective of dura-
ion of stay. The independent probability of being infected
ith an MDR organism within 20 days of stay was 0.11. The
robability of E.Coli, Klebsiella, Acinetobacter and Pseu-
omonas being MDR were 0.78, 0.36, 1 and 1 respectively.
ost of the Acinetobacterwere found to be sensitive to Imip-
nem(75%), Ecoli to Imipinem(85.7%) and Amikacin(71.4%),
nterococci to Linezolid(100%) and Vancomycin(100%). Sen-
itivity of Pseudomonas was high to Amikacin(75%) and
iproﬂoxacin(71.4%) but low to Imipinem(25%).
Conclusion: Dynamic monitoring of HAI can help predict
heir occurrence andmost likely susceptibility pattern of the
ost likely organism(s) for a given set of risk factors prior
o culture. This can help choose better empirical antibiotics
nd decrease morbidity associated with HAI.
oi:10.1016/j.ijid.2010.02.2063
6.025
ram negative bacillary catheter related blood stream
nfection in the era of increased resistance
. Kapoor ∗, C. Engell, E. Bishburg
Newark Beth Israel Medical Center, Newark, NJ, USA
Background: Gram negative bacilli (GN) are recognized as
n important cause of catheter related blood stream infec-
ions (CRBSI). CRBSI caused by resistant GN (RGN) is less
ell described. Our objective was to 1) evaluate whether
ases with discharge diagnosis of GNCRBSI were diagnosed
ppropriately based on predetermined criteria, and whether
orrect diagnosis had an effect on outcome 2) describe the
pidemiology of GN-CRBSI and its impact on patient out-
omes.
Methods: A retrospective chart review in a 670 bed ter-
iary care hospital from 1/2002- 11/2008. Patients with
ischarge diagnosis of CRBSI and GN bacteremia were
ncluded. Deﬁnite GN-CRBSI was deﬁned as positive cul-
ures (PC) from peripheral blood and either positive central
enous catheter (CVC) or CVC tip cultures without another
ource of GN bacteremia. Probable GN-CRBSI was deﬁned as
ositive CVC blood cultures or CVC tip cultures and no other
ource of infection. Data was collected for demographics,
iagnoses, type and site of CVC, bacterial isolates, length
f stay, and outcomes.
Results: Ninety two patients were included: 25 met cri-
eria for deﬁnite GN-CRBSI and 24 met criteria for probable
N-CRBSI. 43(47%) patients did not meet our criteria for
RBSI: 23 had another source of bacteremia, 19 had PC
rom peripheral blood only. Comparison between patients
ith deﬁnite and probable GN CRBSI and patients without
hese diagnoses did not show a difference in mortality (12%
s 7%, p = 0.39) or median time to discharge (13 days vs
0days: p = 0.92). Of all the GN isolated, Klebsiella spp.
59%) and Enterobacter spp. (25%) predominated. Twenty
ercent (10/49) of all GN isolates from deﬁnite and probable
RBSI were RGN including extended spectrum $ lactamase
roducing isolates and multidrug resistant isolates. Twenty-
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our percent (12/49) of patients received inappropriate
nitial antibiotics and 83% (10/12) of these were patients
ho had RGN. Mortality trended higher in patients with RGN
nfection compared to other GN bacilli (3/10, 30% vs. 3/39,
.7%; p = 0.06).
Conclusion: Most patients diagnosed with GN-CRBSI did
ot meet our strict criteria for diagnosis, a fact that suggests
hat GN-CRBSI is misdiagnosed. However, the true diagnosis
f GN-CRBSI does not clearly impact mortality or median
ength of stay. There was a nonsigniﬁcant trend towards
ncreased mortality in patients with RGN infection. Antibi-
tics active against RGN should be considered as part of
nitial empiric coverage.
oi:10.1016/j.ijid.2010.02.2064
6.026
evice-associated infection rates, extra length of stay,
xtra mortality, microorganism proﬁle, and bacterial
esistance in two ICUs from Cuba: Findings of the inter-
ational nosocomial infection control consortium (INICC)
. Rosenthal1,∗, H. Guanche Garcell 2, O. Requejo Pino3,
. Morales Pérez4, O. Delgado González3, D. Fernández
onzález3
International Nosocomial Infection Control Consortium
INICC), Buenos Aires, Argentina
Hosp Joaquín Albarrán, La Habana, Cuba
Hospital Universitario Gral. Calixto García, Havana, Cuba
Hospital Docente Clínico Quirúrgico ‘‘Joaquín Albarrán
omínguez’’, Havana, Cuba
Background: To determine the rates and consequences
f device-associated infections (DAI) in two intensive care
nits (ICU) of two INICC members hospitals in Cuba.
Methods: An open label, prospective cohort, active DAI
urveillance study was conducted on adults admitted to
wo tertiary-care ICUs of Cuba. The protocol and methodol-
gy implemented were developed by INICC. Data collection
as performed in the participating ICUs. Data uploading
nd analyses were conducted at INICC headquarters on
roprietary software. DAI Rates were recorded by apply-
ng the deﬁnitions of the CDC NNIS. We analyzed the
AI, mechanical ventilator-associated pneumonia (VAP),
entral line-associated bloodstream infection (CLAB), and
atheter-associated urinary tract infection (CAUTI) rates,
icroorganism proﬁle, bacterial resistance, extra length of
tay (ELOS) and extra mortality.
Results: From 5/06 to 9/09, we enrolled 1,914 patients,
epresenting 14,157 bed days. The overall DAI rate was 22.6%
95% CI, 20.7 — 24.5) and 30.6 per 1000 bed days (95% CI,
7.8 — 33.5). The VAP rate was 43.67 per 1000 device days
95% CI, 39.17 — 48.5), CLAB rate was 1.25 per 1000 CL days
95% CI, 0.72 — 2.00), and CAUTI rate was 6.37 (95% CI, 5.09
7.86). Overall 28.0% of all DAI were caused by E.Coli—–
00% were resistant to Ceftazidime and 100% Ceftriaxone—–;
0% by Klebsiella sp.—–100.0% of which were resistant to
eftazidime, 100% to ceftriaxone and 100% to imipenem—
; 20% by Coagulasa Negative Staphylococci; and 16.0% by
seudomonas sp—–100.0% were resistant to ceftazidime, and
00% were resistant to ceftriaxone. The LOS of patients
ithout DAI was 5.0 days; the LOS of patients with CLAB
t
i
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as 10.0 days (RR, 2.00; 95% CI, 1.29-3.10; P, 0.0016), rep-
esenting 5.0 extra days; the LOS of patients with VAP was
7.0 days (RR, 3.41; 95% CI, 3.08-3.77; P, 0.0001), represent-
ng 12.0 extra days; and the LOS of patients with CAUTI was
5.1 (RR, 3.03; 95% CI, 2.50 — 3.67, P 0.0001), representing
0.1 extra days. A total of 245 out of 721 (34.0%) patients
ithout DAI died; 1 out of 2 patients with CLAB died (50.7%),
he extra mortality being 16% (RR, 1.47, 95% CI 0.21 — 10.49,
, 0.6981); 20 out of 24 patients with VAP died (83.3%), the
xtra mortality being 49% (RR, 2.45, 95% CI 1.55 — 3.87, P,
.0001); 4 out of 7 patients with CAUTI died (57%), the extra
ortality being 23% (RR 1.68, 95% CI 0.63 — 4.52, P 0.2970).
Conclusion: The VAP rate is higher than NHSN’s rates and
ower than INICC’s rates, CLAB rates are lower than INICC’s
nd NHSN’s rates, and CAUTI rates are similar to NHSN’s rates
nd lower than INICC’s rates. VAP increased signiﬁcantly the
OS and mortality rate.
oi:10.1016/j.ijid.2010.02.2065
6.027
haracterization of hospital-acquired infections in a Uni-
ersity Hospital in Colombia: January 2005 - July 2009
.G. Jiménez, J.K. Balparda ∗, D.M. Castrillón, S.Y. Díaz,
.A. Echeverri, C. Estrada, C. Lopera, M.M. Raigosa, L.V.
ásquez
Universidad Pontiﬁcia Bolivariana, Medellín, Colombia
Background: Hospital-Acquired Infections represent a
rowing concern in Colombia’s healthcare system, due to
ts relationship with an extended length of hospital stay, a
igher morbidity and mortality and an increase in overall
osts. The purpose of the following study was to perform
n epidemiological characterization of Hospital-Acquired
nfections reported during a four and a half years period
n a University Hospital in Colombia.
Methods: Information regarding the occurrence of
ospital-Acquired Infections was initially obtained from the
ospital’s Epidemiologic Surveillance Committee Databases
omprising the sought period. In cases in which all the infor-
ation was not readily available, additional details of every
atient were obtained from their respective clinical records.
ll data was condensed into a single database developed for
he present study, and analyzed using statistical software.
Results: A total of 1136 Hospital-Acquired Infections
ccurring in 953 patients were included, for an overall
isk of 2,2 infections per 100 hospital discharges. Most
f the (63,7%) were female, with an average age of
9,6± 25,8 years and a mean length of stay of 17,7 days.
he most common infections, along with their relative fre-
uencies, were: surgical site infections (25,9%), urinary
ract infections (16,3%) and pneumonia (12,4%). The most
ommonly isolated microorganisms were: Escherichia coli
27,9%), Staphylococcus aureus (17,9%), Klebsiella pneu-
onia (11,1%) and Pseudomona aeruginosa (10,2%). After
he start of intensive educational programs regarding tech-
iques for the reduction of Hospital-Acquired Infections,
hese have dropped signiﬁcantly, specially surgical site
nfections (p = 0,0213) and nosocomial sepsis (p = 0,0078);
evertheless, urinary tract infections have risen 104,8% dur-
ng the study years.
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Conclusion: Hospital-Acquired Infections are relatively
low in the studied hospital, when compared to similar
Colombian and international institutions. The most frequent
nosocomial infection was that of the surgical site, with the
most common microorganism being E. coli, which showed a
medium-to-low antibiotic resistance to ﬁrst- and second-line
antibiotics. In the studied hospital, intensive educational
programs have showed a marked success in diminishing
Hospital-Acquired Infection rates.
doi:10.1016/j.ijid.2010.02.2066
56.028
‘‘Non Traditional’’ Extended Spectrum Beta-lactamase-
producing Isolates at a Community Hospital
R. Nog ∗, K. Singaravelu, P. Dhaubhadel, A. Guddati, S.
Upadhyay, S. Mannheimer, C. Badshah, V. Sivapalan
Columbia University College Of Physicians and Surgeons
afﬁliation at Harlem Hospital Center, New York, NY, USA
Background: Extended spectrum $-lactamase (ESBL)-
producing gram-negative bacteria (GNB) represent the most
common multidrug-resistant organism infections worldwide,
with limited treatment options and frequent adverse out-
comes. Two decades since their initial recognition, ESBL
producing organisms continue to pose a challenge to infec-
tious disease and infection control practitioners. ESBL
activity is most frequently described in Klebsiella spp. and
Escherichia coli. The prevalence and mortality associated
with other gram-negative bacteria with ESBL activity has
not been documented as well.
Objective: To describe trends of ESBL activity in culture
isolates obtained at a community hospital in New York.
Trend: Traditional vs Non-Traditional ESBLs
Methods: A retrospective chart- review of inpatients
over a three-year period (1/1/06 to 12/31/08) was
conducted to identify cultures positive for GNB. ESBL
activity was deﬁned based on antibiogram resistance
to cephalosporins, monobactams and penicillin. Data on
demographics, imipenem/cilastatin (IMP) resistance and dis-
charge status was collected. E. coli and Klebsiella were
deﬁned as Traditional ESBL’s (T-ESBL) and other GNB (Pseu-
domanas, Serratia, Citrobacter, Proteus etc.) were grouped
as Non-Traditional ESBL (NT-ESBL). The mortality rate was
calculated by discharge status.s
o
t
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ESBLs Rate of Imipenem resistance and All Cause Mor-
ality
Results: Among a total of 3032 isolates evaluated dur-
ng study period, 19.1% (n = 579) were deﬁned as ESBL. Of
hese 579 isolates, 23.3% (n = 135) were T-ESBL and 76.7%
n = 444) were NT-ESBL. The proportion of NT-ESBL remained
onsistently high during this period (68 to 83%). Among ESBL
solates, 211 (36.44%) exhibited IMP resistance of which
0 (33.18%) were T-ESBL and 141 (66.82%) were NT-ESBL.
his greater proportion of IMP resistant NT-ESBL organisms
as consistently represented (rates of 72.58%, 52.86% and
4.68% in 2006, 07 and 08 respectively). Of the 269 unique
atients with ESBL infection identiﬁed during the study
5.65% (n = 69) expired. Two thirds of these patients (78.03%,
= 54) had NT-ESBL organisms.
Conclusion: The majority of the ESBL-producing iso-
ates examined over a three year period at our institution,
ere non-traditional (other than E.coli and Klebsiella spp)
SBL-producing organisms. These were more likely to be
mipenem-resistant and associated with fatal outcomes.
herefore, monitoring ESBL activity in Klebsiella spp. and
scherichia coli isolates alone may underestimate the real
xtent of problem, precluding timely initiation of appropri-
te antibiotics and infection control practices.
oi:10.1016/j.ijid.2010.02.2067
6.029
entilator-associated pneumonia in HIV-infected ICU
atients
. Gino ∗, H. Bagnulo
Hospital Maciel, Montevideo, Uruguay
Background: Ventilator-associated pneumonia (VAP) is
he main complication of mechanical ventilation (MV), it
ccurs in 27% of the mechanical ventilated (MV) patients in
ur Unit. VAP in HIV infected patients has the same incidente
nd etiology than in HIV-non infected The objective of the
tudy is to determine the incidence, etiology and outcome
f VAP in HIV infected patients admitted in an ICU.
Methods: We performed a retrospective analisis of all
he HIV infected patients admitted to ICU of Hospital Maciel
rom June 1990 to December 2008 who were on MV. Cate-
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orical variables were expressed in median and interquartile
ange. Chi square was used when applied. P value <0.05 was
onsidered signiﬁcative.
Results: 351 HIV patients were assisted during the period.
edian age was 32 YO (27—39). 73.5% male and 26.5%
emale. Median SAPS II 35 (29—43). 186 (54%) were on MV.
ength of stay was 6 days (3—11). 162 patients (46.2%)
ied. Considering patients on MV, SAPS II was 41 (34—51),
ength of stay in ICU was 6 days (2—10) and 143 died
76.9%) VAP ocurred as a complication in 43 (23%) patients
n MV, median SAPS II was 36 (31—42), length of stay 12
ays (9—17), 39/43 died (90.7%) 35 (89.7%) of whom died
n septic shock Etiology: Acinetobacter 17, Pseudomona
eruginosa 14, Methicillin-sensitve Staphylococcus aureus 4,
ethicillin-resistant Staphylococcus aureus 4 and Klebsiella
p 4. 143 patients (77%) on MV did not develop VAP, SAPS
I was 43 (36—54), length of stay in ICU 4 days (2—8), 104
72.7%) died. Patients on MV who developed VAP were less
ll at admission (SAPS II 36 vs 43 p < 0.001) length of stay was
onger (12 vs 4 p < 0.001 and mortality was higher (39/43 vs
04/143 OR 3.66 [CI 1.15—12.9]).
Conclusion: Although HIV-infected patients VAP incidence
nd etiology is similar to that of the HIV-non infected
atients, its overwhelming evolution to multiorgan failure
ndmuch highermortality almost always represents the ﬁnal
vent in the clinical evolution of this group of ICU patients.
oi:10.1016/j.ijid.2010.02.2068
6.030
mplementation of a central line bundle to reduce central
ine associated bacteremia at the intensive care unit
. Alvarez1, J. Pisapia1, C. Rosello1, M. Lira1, M. Curone1,
. Vidiella2,∗
Maternidad Suizo Argentina, Buenos Aires, Argentina
Maternidad Suizo Argentina y Sanatorio Agote, Buenos
ires, Argentina
Background: Central line associated bacteremia (CLAB) is
ssociated with an increased length of stay of up to 6 days
t the intensive care unit (ICU), with an attributable mor-
ality of 35% approximately. The reduction in the incidence
f Methicillin-resistant staphylococcus aureus (MRSA) cen-
ral line associated bloodstream Infections continues being
challenge according to the last tendencies published by the
DC in the (ICU) of the United States. S. aureus is the most
recuent pathogen causing blood stream infections in Latin
merica (SENTRY 1996-2006). The prevalence of nosocomial
. aureus oxacillin resistant is 46% in Argentina. The purpose
f this study was to decrease CLAB at the ICU, particulary
RSA (most prevalent pathogen of CLAB in our institution).
Methods: Data was collected from September 1, 2007 to
uly 1, 2009, on all ICU patients who had central venous
atheter placed at the Clínica y Maternidad Suizo Argentina.
fter one year of baseline data collection the infection con-
rol team implemented a set of measures for the insertion
f CVC (bundle): antiseptic handwashing, maximal barrier
recaution, skin preparation with chlorhexidine 2% instead
f iodopovidone solution, use of gown mask and cap for
he assistant and avoidance of femoral lines. The staff
f physician and nurses was educated on bloodstream-
i
s
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nfection-control practices before the new elements were
dded to the protocol. A check list form was ﬁlled out by
n ICU nurse manager after each central line placement.
he NHSN criteria for CLAB were met. The data were col-
ected by an infection control nurse. The rates of CLAB were
alculated with Excel and Epi 5 Control Argentina program.
Results: During the pre-intervention period the rate of
LAB was 9,47 ‰ (1900 CVC lineday) and decreased to 3,62
post-intervention (1934 CVC line-day). The rate of gram
ositive CLAB also decreased from 6,84 ‰ (IC. 0.31%-0.15%)
o 1,55 ‰ (IC. 0,02%—0,33%). P: < 0,022.This decreasing ten-
ency was also observed in relation to the MRSA(5 ‰ versus
,09 ‰).
Conclusion: The use of central line bundle and to mon-
tor its adherence with a central line insertion check list,
igniﬁcantly reduced the rate of CLAB.
oi:10.1016/j.ijid.2010.02.2069
6.031
henotipic and molecular characteristics of Clostridium
ifﬁcile infections in a tertiary-care center
. Mendoza1,∗, A. Camacho2, J.O. Herrera2, J.E. Diaz2,
.D.M. Aldrete2, A.L. Martinez2, A. Hernandez2, M.
obadilla2, A. Ponce de Leon2, J. Sifuentes2
Instituto Nacional de Ciencias Médicas y Nutrición Salvador
ubirán, Mexico City, Mexico, Mexico
Instituto Nacional de Ciencias Méidcas y Nutrición Salvador
ubirán, Mexico City, Mexico, Mexico
Background: An increased number of cases of C. difﬁcile
ssociated disease (CDAD) has been observed, associated
ith the emergence of a particular strain, NAP1/BI/027. The
bjective of this prospective study was to characterise C.
ifﬁcile isolates in a referral hospital.
Methods: From 6/1/2008 to 9/30/2009 all stool samples
ent to the clinical microbiology laboratory for C. difﬁcile
oxin A/B detection were processed by a commercial EIA and
ulture. A further RT-PCR for detection of TcdC was done
n all positive samples for either toxin or culture; in each
solate multiplex-PCR was performed to detect TcdA/TcdB
nd CdtA/CdtB genes, and all isolates were ribotyped. Clin-
cal data was recorded from patients with a positive result.
DAD was diagnosed when the microbiology data supported
he clinical ﬁndings.
Results: A total of 1093 samples were screened for toxin
/B and culture; 6.2% were positive by toxin A/B detec-
ion (68/1093), 8.32% (91/1093) by culture, and 10.52%
115/1093) by any of them. Out of the 115 cases, 13 were
xcluded. From the 102 remaining patients, only 85 (83%)
ad CDAD; 25 (29.5%) had severe CDAD; 55 received oral
etronidazole: 89% cured, 7.3% relapsed, and 11% failed.
rom 64 isolates from CDAD patients: 45.3% had a negative
oxin A/B, 89% a positive TcdA/TcdB, and 87.5% had a posi-
ive TcdC; 35.7% revealed the characteristic 18 pb deletion
n TcdC, and 10 patients had severe disease (40% vs 16%,
< 0.02). From 55 ribotyped isolates, 49 (89%) were groupedn 11 clusters, none similar to the 027 ribotype. From 20
evere CDAD isolates analysed, 3 showed the 18 bp deletion,
ositive CdtA/CdtB genes and quinolone resistance.
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Conclusion: Our data shows the presence of a diversity
of C. difﬁcile strains, however 89% of the isolates were
clustered, and among them some hypervirulent strains have
emerged.
doi:10.1016/j.ijid.2010.02.2070
56.032
Epidemiology of diarrhea due to Clostridium difﬁcile in
a tertiary general hospital in San José, Costa Rica, from
January to October, 2009
E. San-Gil 1,∗, E. Avendano2, N. Mora2
1 Hospital San Juan de Dios, San José, Costa Rica
2 Hospital San Juan de Dios, San Jose, Costa Rica
Background: Description of the epidemiological behavior
of diarrhoea associated to Clostridium difﬁcile in patients
admitted to Hospital San Juan de Dios (San José, Costa Rica)
from January 1st to October 31st. This is the largest hospital
of Costa Rica, a tertiary level general medical center, man-
aged by the Costa Rican Bureau of Social Security. It has 730
beds and had a mean of 30,467 discharges per year in the
2004-2008 period.
Methods: Collection of all positive immunoassays for C.
difﬁcile, reported by the Clinical Laboratory of the Hospital,
from stool samples of hospitalized patients who were diag-
nosed with diarrhoea during the 10 month period previously
described.
Results: A total of 442 positive results of C. difﬁcile from
427 hospitalized patients with diarrhoea were obtained. Out
of these patients 413 had one diarrheal episode and 14
two or more. During this period of time there were 27040
recorded discharges from the Hospital, which makes for
a rate of 16,42 cases/1000 discharges. The 442 episodes
include 11 recurrences and 3 reinfections. There were 44
deaths recorded in this group, for a mortality rate of 10,30%.
Conclusion: There are no hospital incidence reports of
diarrhoea due to Clostridium difﬁcile in Costa Rica. Epidemi-
ological reports of nosocomial diarrhoea from this agent are
scarce in the literature, thus making it difﬁcult to establish
endemic channels for this disease. Diarrhea from Clostrid-
ium difﬁcile is endemic at Hospital San Juan de Dios and
due to its frequency, pathogenicity, virulence and commu-
nicability it is important to improve and maintain an active
epidemiological surveillance system. This work provides the
ﬁrst epidemiological description of diarrhoea from C. difﬁ-
cile at a general hospital in Costa Rica.
doi:10.1016/j.ijid.2010.02.2071
56.033
Impact of pretransplant nutritional status and supplement
on postoperative sepsis in living donor liver transplanta-
tion
T. Kaido ∗, F. Oike, Y. Ogura, A. Mori, S. UemotoKyoto University School of Medicine, Kyoto, Japan
Background: Protein-energy malnutrition is common in
patients with end-stage liver disease requiring liver trans-
plantation (LT) and is a risk factor for posttransplant
m
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orbidity including sepsis. Especially, infectious compli-
ations including sepsis often occur after LT and are the
ost frequent causes of in-hospital death despite recent
dvances in surgical procedures and perioperative manage-
ent. Therefore, it is important to accurately estimate
reoperative nutritional status and provide adequate peri-
perative nutritional support in order to improve the results
f LT. We examined the efﬁcacy of preoperative nutritional
ssessment by bioelectric impedance analysis and prognos-
ic factors of posttransplant sepsis in patients undergoing
iving donor LT (LDLT). Moreover, we investigated the effects
f individually tailored preoperative aggressive nutritional
herapy.
Methods: 1) We prospectively measured body cell mass
BCM) using a body composition analyzer and various nutri-
ional parameters including prealbumin, branched-chain
mino acids (BCAA)/tyrosine ratio, and zinc as well as com-
on nutritional parameters such as albumin, cholinesterase,
nd total lymphocyte count in 50 consecutive recipients
ndergoing LDLT between February 2008 and February
009. Multivariate analysis was performed to determine
he prognostic factors of posttransplant sepsis, focusing on
utritional parameters. 2) We developed an individually tai-
ored preoperative aggressive nutritional treatment based
n the nutritional status of each patient especially in poorly
ourished recipients in April 2009; the treatment consists of
CAA-enriched nutrient mixture followed by immunonutri-
ion for 7 days prior to surgery and synbiotics. The usefulness
f the new nutritional treatment was examined.
Results: The incidence of severe perioperative infec-
ion and in-hospital death was signiﬁcantly higher in
atients with low BCM than in patients with normal or
igh BCM. Multivariate analysis showed that preoperative
ow BCM, absence of preoperative supplementation with
CAA-enriched nutrient mixture, and a Model for End-stage
iver Disease (MELD) score of 20 or above, but not com-
on nutritional parameters, were of prognostic signiﬁcance.
retransplant aggressive nutritional treatment reduced the
ncidence of postoperative sepsis.
Conclusion: Pretransplant nutritional assessment with a
ody composition analyzer could predict the postoperative
linical course. Malnutrition before LT was closely related
o the incidence of posttransplant sepsis and pretransplant
ggressive nutritional therapy was useful in preventing post-
perative sepsis.
oi:10.1016/j.ijid.2010.02.2072
6.034
ultidrug-resistant Acinetobacter spp. bloodstream
nfections in a University Hospital of Buenos Aires,
rgentina: frequency and antimicrobial susceptibility
. Zárate1,∗, L. Contardi1, D. Cecchini 2, J. Smayevsky1
CEMIC, Buenos Aires, Argentina
Helios salud, Buenos Aires, Argentina
Background: Bloodstream infections caused by
ultidrug-resistant Acinetobacter spp. (MRA) have
ncreased worldwide, particularly in Latin America.
he limited therapeutic options against this nosocomial
icroorganism constitute a major problem for establishing
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infection sources and underlying condition. But community-
acquired infections were more common in non-SIRS group
(p = 0.01). 30-days of overall and infection-related mortal-264 14
n adequate antimicrobial treatment. Therefore, early
dentiﬁcation of this microorganism and surveillance of its
esistance patterns are important tools to reduce morbidity
nd mortality. Our objective was to determine the: 1)
requency of bloodstream infection by MR-A; 2) time to
lood culture positivization; 3) primary sources of blood-
tream infection; 4) overall mortality rate; 4) antimicrobial
usceptibility proﬁle.
Methods: Retrospective analysis of episodes of MR-A
loodstream infections in a tertiary university hospital in
uenos Aires, Argentina (period: January 2006 - October
009). Blood samples were routinely cultured in Bact /
lert bottles (Biomerieux) and incubated for 5 days. Bio-
hemical identiﬁcation was performed according to Murray
t al. (2008) and automated VITEK. Antimicrobial suscepti-
ility was determined by disk diffusion method according
o CLSI, 2008 and automated VITEK (Biomerieux). The
inimum Inhibitory Concentration (MIC) to colistin was
etermined by E-test methodology according to manufac-
urer’s recommendations (AB biodisk). Multidrug resistance
as deﬁned as resistance to two or more antimicrobial drug
amilies.
Results: One hundred and three episodes of MR-A blood-
tream infection occurred in 3346 inpatients (3.0%). Median
ime to blood culture positivization was 10 hours (range: 2.5-
4.1). Median age of patients was 61 years (range: 21-91).
he documented clinical sources were catheter: 39%; noso-
omial pneumonia: 29%; skin and soft tissue infection: 5%;
bdominal: 4%; and urinary tract: 1%. In 22% of the cases, no
rimary source could be documented (primary bacteremia).
verall mortality was 22%. Antimicrobial susceptibility was:
mpicillinsulbactam: 7%, ceftazidime:1%, cefepime:2%,
iperacillin-tazobactam:1%, imipenem:5%, meropenem:4%,
mikacin:3%, gentamicin:26%, ciproﬂoxacin:1%, minocy-
line:100%, colistin:100% and tigecycline:100%.
Conclusion: The frequency of MR-A bloodstream infec-
ions in our institution is higher than the reported in
nternational literature. Overall mortality is comparable to
revious reports. In this scenery, early identiﬁcation of this
icroorganism and periodic surveillance of its antimicrobial
esistance are of utmost importance to guide the physician
n the selection of an adequate initial empirical therapy in
rder to reduce morbidity and mortality by this pathogen.
oi:10.1016/j.ijid.2010.02.2073
6.035
ecovery rate of NTM from AFB smear-positive sputum
pecimens during the pseudooutbreak of mycobacterium
pecies at a long-term care facility
.-W. Lee1, K.A. Jun2, S.Y. Shin3,∗
Jeju Medical Center, Jeju, Korea, Republic of
Jeju National University, Jeju, Korea, Republic of
Jeju National University/Jeju National University Hospi-
al, Jeju, Korea, Republic of
Background: Sputum smears for acid-fast bacilli(AFB)
xamined microscopically is the most important diagnostic
est for pulmonary tuberculosis. However, the AFB observed
n the smear may represent either M. tuberculosis or non-
uberculous mycobacteria(NTM). This study examined the
i
pternational Congress on Infectious Diseases (ICID) Abstracts
ecovery rate of NTM from the AFB smear-positive sputum
pecimens during the pseudo-outbreak of mycobacterium
pecies at a 300 bed long-term care facility.
Methods: We detected a signiﬁcant increase the posi-
ive results of AFB smear during January 2009 that led us
o suspect of an outbreak. we performed an epidemiolog-
cal investigation of the outbreak including acid-fast stain
nd culture for Mycobacterium tuberculosis between Jan-
ary 2008 and July 2008.
Results: A total of 49 patients were enrolled in the study.
2 sputum specimens collected from 28 patients were posi-
ive AFB smear or culture. NTM were recovered from 52.4%
22/42) of the sputum specimens, and from 50.0% (14/28)
f the patients. NTM were recovered from 13.0% (3/23)
f the smear-positive sputum specimens, and from 18.75%
3/16) of patients with smear-positive sputum. We think the
eservoir for this pseudooutbreak could be associated with
contaminated suction lines and bottles.
Conclusion: These results suggest that a substantial
roportion of patients with AFB smearpositive sputum
pecimens may have NTM during the pseudo-outbreak of
ycobacterium species.
oi:10.1016/j.ijid.2010.02.2074
6.036
linical impact of Systemic Inﬂammatory Response Syn-
rome (SIRS) in patients with bloodstream infection
.A. Jun1, S.Y. Shin2,∗
Jeju National University, Jeju, Korea, Republic of
Jeju National University/Jeju National University Hospi-
al, Jeju, Korea, Republic of
Background: To evaluate the clinical impact of systemic
nﬂammatory response syndrome (SIRS) in patients with
loodstream infection
Methods: We prospectively collected medical records of
dult patients with bloodstream infection who visited to all
epartments of Jeju National University Hospital for 2 years
from March 2007 through March 2009), including clinical
ata to meet the criteria of SIRS when blood culture was
one.
Results: A total of 309 patients with bloodstream infec-
ion were enrolled in this study. We compared 191 (61.8%)
atients who met criteria for SIRS at the time of blood
ollection (SIRS group) with 118 patients (38.2%) who did
ot meet criteria for SIRS (non-SIRS group). Underlying dis-
ases of bloodstream infection were malignancy (21.7%),
iabetes mellitus (14.9%) and liver disease (13.3%). The
robable sources of bloodstream infections were urinary
ract infection (30.1%) intraabdominal infection (28.5%),
espiratory tract infection (12.6%) and catheter-related
nfection (4.5%). There were no signiﬁcantly statistic differ-
nces between SIRS group and non-SIRS group on probablety were signiﬁcantly higher in SIRS group (p = 0.001 and
= 0.004, respectively).
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Conclusion: The presence of SIRS when blood culture was
done could be a prognostic marker in patients with blood-
stream infection.
doi:10.1016/j.ijid.2010.02.2075
56.037
Risk factors for central venous catheter-related infections
in cardiac unit of tertiary care hospital in northern India
R. Kumar ∗, B. Kajla, D. Kaur, G.S. Wander
Dayanand Medical College & Hospital, 141001, Punjab, India
Background: The need for therapy and nutrition of
severely ill patients has led to ever increasing use of
indwelling central intravascular catheters. Intravascular
catheters are indispensable in modern-day medical prac-
tice, particularly in intensive care units (ICUs). This study
estimated the incidence and risk factors of central venous
catheter related infections.
Methods: During a 18-month period, a total of 150
patients who underwent central venous catheterization
were enrolled. Catheters (n = 150) were cultured semiquan-
titatively and blood cultures done simultaneously. Isolates
obtained were identiﬁed and the risk factors were analyzed
statistically.
Results: The rate of catheter related bloodstream infec-
tion was 3/1000 catheter days. On multivariate analysis,
fever was found to be independent predictor of CRBSI.
The rate of CVC colonization was 54.01/1000 catheter
days. On univariate analysis, statistically signiﬁcant corre-
lation was found with duration of catheterization, raised
total leukocyte count and fever on day of removal of
catheter. On multivariate analysis co-morbid state such
as Diabetes mellitus and Hypertension, raised TLC and
fever on the day of removal of catheter were found to be
independent predictors of CVC colonization. The organ-
isms isolated were Staphylococcus aureus, Pseudomonas
aeruginosa, Klebsiella pneumoniae, Non Haemolytic
Streptococci, E.coli, Acinetobacter baumannii, Candida
spp., Staphylococcus epidermidis and Stenotrophomonas
maltophila.
Conclusion: Despite their potential preventability,
catheter-related infections still impose a substantial bur-
den on critically ill patients. Recent studies have brought
better understanding of the risk factors for intravascular
catheter infections and have clariﬁed preventive infection
control strategies.
doi:10.1016/j.ijid.2010.02.2076
56.038
Success in stopping transmission of enterococci in a Brazil-
ian public teaching hospital
F. Rossini ∗, R. Fagnani, M. Leichsenring, L. Cardoso, M.L.
Moretti, P. TrabassoUNICAMP, Campinas, Brazil
Background: Vancomycin-resistant enterococci (VRE) are
a major problem in many hospitals mainly because of their
capability to colonize or cause disease among high risk
b
E
s
ﬁts e265
atients in addition to their ability to contaminate the envi-
onment.
Objective: To describe an outbreak of VRE in a Brazilian
eaching hospital and evaluate the impact of educational
nd engineering measures in its control.
Methods: We conducted a retrospective study from
ebruary 2008 to January 2009. Medical reports were
eviewed in respect of demographic data, underlying dis-
ases, comorbidities, risk factors, wards, and length of stay.
rimary outcomes were if the patient was colonized or
nfected and death. Differences between the variables were
onsidered signiﬁcant when p < 0.05.
Results: There were 150 patients with isolation of VRE,
39 (93%) of them in rectal swab. The 11 (7%) left patients
ere infected in blood (n = 4), ascitic liquid (n = 2), cen-
ral venous catheter (n = 2), and in pleural effusion, urine
nd wound infection (n = 1 each). There were 94 (63%) men
nd the median age was 50 yrs-old. The main wards were
edical, Onco-Hematology, Trauma, Clinical Emergency
nd Gastroenterology, corresponding of 73% of patients.
here were no differences between patients in respect of
eing colonized or infected according sex, age, underly-
ng disease and comorbidities. Patients with infection were
bserved more frequently among those in mechanical venti-
ation (p = 0,013), with central venous catheter (p = 0.043),
ndwelling urinary catheter (p = 0.049) or surgical drains
p = 0.049). Death was more frequent among infected (73%)
han in colonized (17%) patients (p < 0.001). An informa-
ive campaign was carried out, comprising of lectures for
he healthcare professionals and distribution of leaﬂets for
atients. Environmental cleaning was reinforced, and gel
lcohol dispensers were widely distributed in all hospital
reas. Isolation precautions for VRE and restriction to visits
ere implemented. The ongoing monitoring of the outbreak
hows a signiﬁcant decrease in the number of cases, with 25
ew cases in 8 months.
Conclusion: Educational measures and reinforcement of
nvironmental cleaning were effective for deterring the dis-
emination of VRE.
oi:10.1016/j.ijid.2010.02.2077
6.039
seudooutbreak of Cedecea lapagei bacteremia in emer-
ency room
.S. Choi ∗, Y.K. Youn, Y.M. Jo, J.Y. Kim, M.J. Kim, W.J. Kim,
.J. Cheong, J.-W. Sohn, J.Y. Song, D.W. Park
Korea University College of Medicine, Seoul, Korea, Repub-
ic of
Background: Cedecea lapagei is a very rare pathogen for
uman infection. There was only one report of prior isolation
f C. lapagei from blood. We experienced a pesudoout-
reak of C. lapagei bacteremia in emergency room (ER). We
escribed the outbreak and outbreak investigation, along
ith performing genetic analysis of the isolated bacteria.
Methods: From September 28 to November 5, 2009, 19lood samples, which were collected from 11 patients in
R, were positive for C. lapagei. The 19 isolates showed
imilar antibiogram. The isolates were genotyped by pulsed-
eld gel electrophoresis (PFGE). We performed case-control
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tudy to identify risk factors of the outbreak. Environmental
urveillance culture was performed to determine the source
f the outbreak.
Results: The case patients had been diagnosed with
arious different types of diseases at the time of the admis-
ion to ER. There was no inﬂuence in the clinical course
f the patients even though proper antibiotics were not
dministered for C. lapagei. The PFGE results showed an
ndistinguishable pattern. In the results of case-control
tudy, the case patients were older than the control patients
51.27± 23.31 years vs. 27.22± 28.54 years, P = o.oo7). The
ase patients had more drugs injected intravenously dur-
ng staying in the ER than control patients (1.64± 1.57
s. 0.38± 0.81, p < 0.001). The blood sampling of the case
atients were performed by seven different interns. There
ere no signiﬁcant differences in sex, chronic underlying
iseases, use of a nebulizer, O2 supply, wound dressing, total
arenteral nutrition, urinary catheter, central catheter,
asogastric tube, length of stay in ER before performing
lood culture, and the area of the patients’ staying in the
R. Among 73 environmental samples, there was no sam-
le positive for C. lapagei. After the outbreak, the infection
ontrol unit instituted infection control measures including
septic techniques, and no more outbreak of C. lapagei has
een documented for one month in the ER.
Conclusion: We suggested that multiple manipulations
uch as intravenous injection might be a risk factor of a pseu-
ooutbreak and aseptic technique should be emphasized for
reventing contamination.
oi:10.1016/j.ijid.2010.02.2078
6.040
t
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Table 1 Development of bloodstream infections subsequent to is
cancer patients with indwelling Hickman Catheters.
Microorganisms Subsequent BSI/ isolated positive
HC-drawn blood culture (%)
Gram-positive organisms 2/58 (3)
CNS 0/29 (0)
Enterococcus 1/10 (10)
Corynebacterium 0/5 (0)
Bacillus 0/4 (0)
Viridans strep 0/3 (0)
S aureus 1/2 (50)
Leuconostoc 0/2 (0)
Other g(+) cocci 0/3 (0)
Gram-negative organisms 4/42 (10)
E coli 0/10 (0)
Klebsiella spp 0/8 (0)
P aeruginosa 0/6 (0)
Acinetobacter 2/5 (40)
Enterobacter 1/5 (20)
S maltophilia 1/4 (25)
B cepacia 0/2 (0)
Other g(−) rods 0/2 (0)
Candida 2/4 (50)
Polymicrobial 1/8 (13)
Total 9/112 (8)ternational Congress on Infectious Diseases (ICID) Abstracts
evelopment of subsequent bloodstream infections in
atients with positive catheter-drawn blood culture
esults and negative peripheral blood culture results
.-H. Park, S.-H. Kim, O.-H. Cho, Y.P. Chong, S.-O. Lee, S.-
. Choi, Y.S. Kim, J.H. Woo ∗
Asan Medical Center, University of Ulsan College of
edicine, Seoul, Korea, Republic of
Background: There are limited data on incidence of
evelopment of subsequent bloodstream infection (BSI) and
ffect of systemic antibiotic therapy in patients who positive
atheter-drawn blood culture results and negative periph-
ral blood culture results.
Methods: We retrospectively evaluated all paired blood
ultures from adult patients with indwelling Hickman
atheters (HC) on the hematology-oncology ward of a
ertiary care hospital over a 12-year period. A positive HC-
rawn blood culture as a case in which a paired blood culture
as done and HC-drawn blood culture revealed any organ-
sm and all peripheral blood culture revealed no organism.
ubsequent BSI was deﬁned as a case with development of
acteremia or fungemia caused by same organism between
and 28 days after initial positive blood culture.
Results: One hundred and twelve episodes from 103
atients with HC met the criteria of isolated positive HC-
rawn blood culture. Nine (8.0%, 95% CI 3.0% to 13.1%) of
he 112 episodes developed subsequent BSI within 28 days.
he detailed data are shown in Table 1. There was more
requent occurrence of subsequent candidemia (50%, 2 of 4)
han that of subsequent bacteremia (6%, 7 of 108) (P = .03).
olated positive catheter-drawn blood cultures in Hematologic
Subsequent BSI/Isolated positive
HC-drawn blood culture (%)
P
Appropriate empiric
therapy
Inappropriate
empiric therapy
1/39 (3) 1/19 (0) 1.00
0/18 (0) 0/11 (0) . . .
0/5 (0) 1/5 (25) . . .
0/4 (0) 0/1 (0) . . .
0/3 (0) 0/1 (0) . . .
0/2 (0) 0/1 (0) . . .
1/2 (50) 0/0 . . .
0/2 (0) 0/0 . . .
0/3 (0) 0/0 . . .
1/33 (3) 3/9 (33) 0.03
0/10 (0) 0/0 . . .
0/8 (0) 0/0 . . .
0/5 (0) 0/1 (0) . . .
1/4 (25) 1/1 (100) . . .
0/4 (0) 1/1 (100) . . .
0/1 (0) 1/3 (33) . . .
0/0 0/2 (0) . . .
0/1 (0) 0/1 (0) . . .
0/3 (0) 2/2 (100) 0.33
0/6 (0) 1/2 (50) 1.00
3/82 (4) 6/30 (21) 0.01
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ing cross-transmission intra and inter-hospitals. Genotyping
surveillance is an important tool for understanding transmis-
sion patterns and for guiding infection control interventions.
doi:10.1016/j.ijid.2010.02.208114th International Congress on Infectious Diseases (ICID) Abs
Subsequent BSI developed in 6 (20%) of 30 episodes in which
empiric antibiotic treatment were inappropriate while but
in 3 (4%) of 82 episodes in which empiric antibiotic treatment
were appropriate (P = .01).
Conclusion: In patients with isolated positive HC-drawn
blood cultures, the overall incidence of subsequent BSI was
8.0%. Isolation of Candida species and inappropriate empiric
treatment were associated with development of subsequent
BSI.
doi:10.1016/j.ijid.2010.02.2079
56.041
Prevalence and factors associated with hospital acquired
infections in Kayunga district hospital, central Uganda
R. Ankunda1,∗, D. Musisi 2, R. Tweheyo1, O. Namusisi 3
1 Makerere University School of Public Health, Kampala,
Kampala, Uganda
2 Department of Health, Kayunga district, Kayunga, Uganda
3 African Field Epidemiology Network, kampala, Uganda
Background: Globally about 2 million people annually
suffer Hospital Acquired Infections (HAIs), mainly patients
hospitalized for other conditions leading to prolonged stay,
increased morbidity and mortality. The magnitude of HAIs in
Kayunga district hospital (KDH) was unknown in 2009; how-
ever, it is acknowledged that the lack of basic equipment
and infrastructure compromises infection control practice
making transmission of HAIs favorable. This study set out to
estimate the prevalence and assess factors associated with
HAIs in Kayunga district hospital (KDH) to enable the hospital
management design interventions to address HAIs.
Methods: We conducted a cross sectional survey in the
ﬁrst week of July 2009 in Kayunga district hospital; - with
100 bed capacity. One hundred in-patients who had spent
at least 72 hours were recruited consecutively into the
study. Face-to-face interviews with study participants were
conducted using a structured questionnaire and an obser-
vational check list ﬁlled on each ward. Ministry of Health,
Epidemiological and Surveillance case deﬁnitions were used
to identify new infections categorized as HAIs based on the
disease-speciﬁc incubation period. Data was analyzed using
SPSS version 12.0; the primary outcome was having a HAI.
Results: The prevalence of HAIs was 34.0% (34/100).
Majority cases of HAIs had multiple infections (26.5%),
followed by single infections; Respiratory tract infections
(23.5%), Diarrhoea (17.6%), Urinary tract infections (14.7%)
and others. Infection control practice on the wards was
compromised by lack of hand washing facilities, lack of an
isolation ward and lack of supplies for disinfection. HAIs in
KDH were associated with having a surgical procedure at the
current admission (OR 2.68, 95% CI: 1.10—6.53).
Conclusion: The prevalence of HAIs in KDH is high neces-
sitating enforcement and monitoring of infection control
practices in the hospital. Creation of an isolation unit
for highly communicable diseases in the KDH should be
offered priority. The District Health Team should lobby to
ensure that ﬂowing piped water is available in KDH. Active
surveillance of HAIs among Post operative patients should
be instituted. There is need for a study to investigate
the relationship between having surgery and developingts e267
HAI.
oi:10.1016/j.ijid.2010.02.2080
6.042
ancomycin-resistant enterococci cross-transmission
mong patients admitted to public and private hospitals
n central Brazil
.A. Souza1, A.O. Guilarde1, M. Turchi1, M.C.D.P.B.
ndré1, J.L. Cardoso1, S.A.S. Paiva2, C.A. Kobayashi3,
.X. Carvalho1, G.S. Leal1, A. Kipnis1, J.D.G. Vieira1,
.J.A. Batista1, A.L. Andrade1,∗
Federal University of Goias, Goiania, Brazil
INGOH, Goiania, Brazil
Goias Health State Secretariat, Goiania, Brazil
Background: Enterococci harbouring a vancomycin
esistance gene have emerged as an important nosoco-
ial pathogen associated with high mortality. In Brazil,
ancomycin-resistant enterococci (VRE) infection was ﬁrst
eported in the late 90 s, in the South region. In August 2007
he ﬁrst case of VRE was identiﬁed in the city of Goiania (∼1
illion inhabitants), Central Brazil. We herein present the
olecular characteristics of VRE isolated two years apart
rom its ﬁrst isolation in our municipality.
Methods: Screening for VRE was performed in the two
ajor public hospitals and one private hospital. Microbiolog-
cal samples (rectal swabs, blood, urine, surgical specimens)
ere collected from adult patients admitted to clinical and
urgical wards and Intensive Care Units (ICU). Suspected
RE colonies were submitted to identiﬁcation using con-
entional biochemical tests and antimicrobial susceptibility
CLSI, 2008). Detection of vancomycinresistance genes was
erformed by PCR. The genetic relatedness of bacterial
trains was evaluated by PFGE and the results were analyzed
sing Tenover criteria and BioNumerics (v. 5.0.)
Results: A total of 58 VRE (41 E. faecium and 17 E. fae-
alis) were isolated from 58 patients. Patients’ age ranged
rom 13 to 84 years (median of 54 years). 76.5% of E. faecalis
epresented colonization (rectal swab) in contrast, almost
alf of E. faecium were associated with infection (blood,
rine or surgical wound secretion). All VRE strains carried
he vanA gene. 27 out of 41 (65.8%) strains of E. faecium
elonged to the same cluster (genetic similarity ≥80%) and
o 5 lineages highly related. Strains from private hospital
ere identical and not correlated to the ones from public
ospitals. E. faecalis strains were classiﬁed in 5 clusters.
0.3% of the samples were susceptible to ampicillin and
6.2% to linezolid.
Conclusion: The study discloses the presence of VRE
enetically related strains in distinct hospitals, suggest-
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6.043
eterminants of good adherence to hand hygiene among
urgical health care workers
. Masuet Aumatell ∗, M. Banque Navarro, I. Roman Romera,
. López Gallego, A.J. Sanabria Uribe, A. Fité Gallego, J.M.
amon Torrell
Hospital Universitari de Bellvitge, L’Hospitalet de Llobre-
at, Spain
Background: Hand hygiene is the main pillar on standard
recautions (hospital infection prevention), and of increas-
ng concern. Nevertheless few is known about cognitive,
ttitude, perception and motivational determinants of hand
ygiene’s health care workers in a surgical arena where they
ave never been exposed to amultimodal hand hygiene cam-
aign.
Methods: Cross-sectional study in a 900-bed univer-
ity teaching hospital in Barcelona (Spain). A conﬁdential
elf-administered and validated questionnaire survey was
onducted in a sample of 176 surgical units’ healthcare
orkers (medical and nursing) before a multimodal Hand
ygiene (HH) campaign started.
Results: A total of 172 questionnaires were returned
response rate 97.7%), 54 (30.7%) were physicians, 75
42.6%) were nurses and 47 (26.7%) nursing assistants. The
edian years of institution experience was 13.00 years
IQR 20.0), 68.8% were women, 21% were from the General
urgery ward, 21.6% were from the Urology, 39.8% from the
rthopedics and 17.6% from the Vascular Surgery ward. The
elf HH compliance estimated was 77.47(DE17.74), being in
07 participants (63.7%) higher than 80%. Knowledge deter-
inants were poorly ranked as determinants of hand hygiene
OR 1.08, CI95% 1,02—1.15), while motivation to improve
he hand hygiene compliance (OR 0.59, CI95% 0,39—0.88)
nd medical staff (OR 0.11, CI95% 0.02—0.55) or nurses (OR
.15, CI95% 0.04—0.66) versus nursing assitants were higly
anked as determinants, independently of positive percep-
ion about hand hygiene, gender, attitude toward HH and
ears of institutional experience.
Conclusion: In a setting of absent exposure to hand
ygiene campaign, knowledge about hand hygiene, moti-
ation and profesional status are strongly in favor of hand
ygiene, rather than behavioral beliefs, independently of
ender, more than 10 years of institution experience, and
rofessional category. These results are quite different from
hat observed in an extensive exposure to hand hygiene cam-
aigns where behavioral beliefs and the perception of high
elf-efﬁcacy are related to hand hygiene compliance rather
han reasoning. This additional insight should be considered
n settings that have never been exposed to promotion activ-
ties about standard precautions.
oi:10.1016/j.ijid.2010.02.2082
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6.044
ffectiveness of copper contact surfaces in reducing the
icrobial burden (MB) in the intensive care unit (ICU) of
ospital del Cobre, Calama, Chile
. Prado1,∗, C. Durán1, M. Crestto2, A. Gutierrez2, P.
apiain2, G. Flores2, H. Fabres2, M. Schmidt3
Faculty of Medicine, University of Chile, Santiago, Chile
Hospital del Cobre de Calama, Calama, Chile
Medical University of South Carolina, Charlestone, SC, USA
Background: The environment plays a role as reservoir
nd transmission of microbes in hospital settings. In vitro
tudies have demonstrated the microbicidal activity of cop-
er (Cu). We studied the ability of Cu to reduce the MB
ssociated with commonly contact surfaces within an ICU
f Hospital del Cobre de Calama, located in a semi-desert
rea in the north of Chile.
Methods: Copperized (Cu) surfaces (bed rails, bed lever,
ray tables, chair arms, touch screen monitor stylus, and
V poles) were placed into 3 randomly selected ICU rooms.
hree paired rooms were compared by measuring the MB
uring 18 weeks. The mean(m) MB for each Cu object,
etermined as colony forming units (cfu)/100cm2 was com-
ared to noncopper rooms. Antimicrobial efﬁcacy of Cu
as calculated as the difference in mMB between the Cu
nd non-Cu objects. The environmental cleaning procedures
ere equivalent for Cu and non-Cu rooms. The Kruskal-
allist test for two groups was used.
Results: The mMB associated with 594 Cu surfaces from
4 rooms containing Cu was compared against the mMB of
quivalent surfaces from 54 non-Cu rooms from an ICU with
umidity between 7.2 to 19.7%. Cu was effective in reducing
MB on all 6 surfaces tested (bed rails by 86%, bed lever by
4%, tray tables by 93%, chair arms by 88%, monitor pen by
9%, and IV poles by 89%). Total mMB count in rooms with
u (2,142 cfu/100cm2) was signiﬁcantly lower than in rooms
ithout Cu (13,215 cfu/100cm2) p < 0.00001 Staphylococci
ere the most predominant microorganism isolated. Cu was
quivalently effective and signiﬁcant in reducing the staphy-
ococcal burden associated with the objects, p < 0.00001.
RSA and VRE were never isolated, regardless of the pres-
nce of Cu. Gram negatives were infrequently isolated from
ome surfaces, and Cu reduced the Gram negative burden
y 74%—88%.
Conclusion: The antimicrobial effect of Cu was evident
nd signiﬁcant in this arid region of Chile; reduced the
otal mMB, mMB of staphylococcal and Gram negative incal impact of reducing the mMB by Cu objects within the
nvironment of hospitals is warranted.
oi:10.1016/j.ijid.2010.02.2083
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Cytomegaloviris antibodies amongst immunocompro-
mised (HIV) patients at Lagos University Teaching Hospital
(LUTH) Idi-Araba, Lagos
A. Akinbami
LASUCOM, LAGOS, LAGOS, Nigeria
Background: CMV infection constitutes a real risk
of pathogenecity in immunocompromised patient. HIV-
infected patients who require transfusion are at high risk of
developing symptomatic CMV infection when they are trans-
fused with CMV-infected donor blood. This study intends
to determine the risk that blood transfusion poses in CMV
infection in a population of HIV- infected patients.
Methods: A study was carried out amongst clients attend-
ing HIV clinic at Lagos University Teaching Hospital (LUTH),
they were recruited consecutively. Replacement blood
donors of the hospitals were recruited as controls A total of
10mls of blood sample was collected per consenting partic-
ipant. The serum obtained from 5ml of blood was assayed
for CMV IgG/IgM using an enzyme- linked immunosorbent
assay (ELISA) based Kit whilst full blood count and CD4 cell
counts were also performed on the remaining 5mls. The
descriptive data was given as mean± standard deviation
(SD). Chi-squared test was used for the analytic assessment.
The differences were considered to be statistically signiﬁ-
cant when the p value obtained was less than 0.05.
Results: A total of 129 HIV-infected were studied. All
(100%) were IgG anti-CMV positive. 8 (6.6%) were IgM anti-
CMV positive. This difference was found to be statistically
signiﬁcant P = 0.004, (P < 0.05). Of 122 replacement blood
donor controls, 118 (96%) of them were IgG anti-CMV pos-
itive whilst 26 (19.5%) of 121 were IgM anti-CMV positive.
The mean CD4+ cell count of HIV-infected patients was
(234± 173.181). Previous history of blood transfusion did not
affect CMV antibody positivity directly.
Conclusion: The seroprevalence of CMV is very high in
HIV-infected patients, which is comparable to the sero-
prevalence amongst the general population The use of
leukoreduced blood units for anaemic HIV infected patients,
is recommended.
doi:10.1016/j.ijid.2010.02.2084
57.002
Evaluation of Tanzania National Measles Surveillance Sys-
tem with laboratory component, for 2006 and 2007
D.M. Kadigi
Ministry of Health, Tanzania, Dar Es Salaam, Tanzania,
United Republic of
Background: Measles is among the seven vaccine pre-
ventable diseases of priority under the Expanded Program
on Immunization in Tanzania. The objectives of the measles
surveillance system which was established in 1975 are to
establish disease early detection, prevention, control of its
outbreak, monitor disease pattern and integrate enhanced
M
s
b
Vts e269
urveillance for polio and measles cases. The objective of
his evaluation was to determine whether the surveillance
ystem is achieving its objectives, purposes and to asses its
ttributes.
Methods: Used the Centres for Disease Control and
revention (CDC) guideline document, discussions and
nterviews with different stakeholders, reviewing National
easles data for 2006 and 2007 with reference to WHO indi-
ators of quality measles surveillance system.
Results: There was a total of 7656 suspected measles
ases with 2871 (37.5%) of cases conﬁrmed by IgM labora-
ory testing which is above WHO target of 10%. The system
s highly sensitive with low Predictive Value Positive, ﬂex-
ble and acceptable. Not simple as it requires laboratory
onﬁrmation. Quality of data in terms of completeness and
imeliness is good with description of age and vaccination
tatus. There is poor data feedback communication with low
evels and between Expanded Programme in Immunization
eadquarters and Epidemiology Section.
Conclusion: The System mainly achieves its objectives
nd purposes, but should strengthen the timely distribution
f feedback to lower levels, and strengthens data commu-
ication with Epidemiology section, for better preparedness
n case of any outbreak.
oi:10.1016/j.ijid.2010.02.2085
7.003
he ﬁrst needle and syringe exchange program in Iranian
risons
. Shahbazi1,∗, M. Farnia2, M. Keramati 2
GFATM (www.theglobalfund.org) - Iran prisons organiza-
ion, Tehran, Iran, Islamic Republic of
Tehran, Iran, Islamic Republic of
Background: Needle and syringe exchange programs
ithin prisons have been reported in international literature
o be associated with reduced blood-borne pathogens among
ntravenous (IV) drug users. Due to lack of previous evalu-
tions for its effect on prevalence of IV drug using among
ranian prisoners, herein we decided to perform the ﬁrst
valuation of this program in the Iranian prisons.
Methods: In a period of nine months, from July 2008 to
arch 2009, 347 volunteer prisoners enrolled and followed
p. All the volunteers were IV drug abusers. The program
ad been performed in three major prison centers in Iran,
ncluding Tehran, Isfahan and Hamadan. The prisoners were
iven sterile needles and syringes weekly, and the used
nes were also collected regularly. Data including number
f syringes and shared ones used by each person was col-
ected at the beginning of program; and this data was also
ocumented on a weekly basis as the program proceeded.
nformation regarding blood-borne diseases was also given
o the enrolled prisoners continuously.
Results: Among 347 volunteer prisoners enrolled in this
rogram, an average of 17 syringes were reported to be used
eekly for IV drug injection before starting the program.
oreover, the volunteers reported to use an average of 3.7
hared syringes during a week. Documented infection with
lood-borne diseases (including Human Immunodefﬁciency
irus, Hepatitis B or C) was also found in 44 prisoners. At
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he end of the program, prevalence of using shared syringes
mong volunteers was decline to zero.
Conclusion: Execution of needle and syringe exchange
rograms within prisons can play an important role in
ecreasing the number of prisoners using shared syringes
nd also number of shared syringes used by each prisoner.
herefore, it can greatly help medical staff with controlling
lood-borne diseases.
oi:10.1016/j.ijid.2010.02.2086
7.004
revalence of urinary schistosomiasis in Ofﬁnso-South
unicipality in Ashanti Region-Ghana
. Adu-Gyasi 1, K. Kye-Amoah2, E. Sorvor2,∗
Kintampo Health Research Centre, Kintampo, BA, Ghana
St. Patrick’s Hospital, Maase-Ofﬁnso, Ashanti Region,
hana
Background: Of the 200 million people infected world-
ide, 85% of the burden is concentrated in Africa. Ghana, a
ub-Sahara Africa nation has records of Schistosomiasis and
ther Soil Transmitted Helminthes infection. The pathology
f SH infection has known public health effects on reproduc-
ion and productivity in affected persons.
Methods: The exploratory survey was undertaken in the
fﬁnso South Municipality, in the Ashanti Region of Ghana
est Africa for the period of January 2007 to August 2009
nvolving 10759 subjects within the ages of 9 to 25 years.
he selection of the site was inﬂuenced by the presence of
iver Oﬁn which has adjoining tributaries that pass through
he main town. The observation which was hospital-based
ooked at results of all diagnostic laboratory requests for
amples of out-patients for the stated period. Urine of at
east 10ml was routinely collected. Urine chemistry was
easured for all samples using urine test strip and analyzer
y RocheTM following all standard procedures. Schistosoma
aematobium (SH) ova identiﬁcation and quantiﬁcation was
one at low power magniﬁcation (x10 objective). Quantiﬁ-
ation of SH ova was done using the routine diagnostic plus
+) system.
Results: 1.69% of the samples were positive for SH ova.
he intensity of ova seen on each positive slide corresponded
o the level of hematuria reported per urine appearance
nd proteinuria. The concentrations of leucocytes recorded
ere normal and did not suggest any parasitic infection.
Conclusion: A prevalence of 1.69% is low when compared
ith values from other studies. Hunter et al, 2003, saw
revalence from 17% to 51% in a farming community that
ived by a Dam in Upper East Region of Ghana. The ade-
uate treatment schedule realized from the hospital could
lso contribute to the probable reduce transmission rate of
H infection. It also shows probable reduced risk associated
ith water-contact pattern in its infection. Even though uri-
ary schistosomiasis infection is not a public health concern
t this moment in the municipality, proper surveillance and
ffective intervention should be in place to eradicate the
nfection in the municipality and other parts of the country.
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his could also help to reduce co-morbidity that results from
H infections.
oi:10.1016/j.ijid.2010.02.2087
7.005
nﬂuenza-like illness among US pilgrims returning from
he Hajj in the Kingdom of Saudi Arabia compared to other
S-bound Travelers: Data from the CDC quarantine activ-
ty reporting system (QARS), 2006-2008
. Yanni1,∗, A. Berro2, P. Han3, C. Lawson1, N. Gallagher1,
. Liske1, P. Houck1, H. Lipman3, G. Brunette2, N.
arano1, C. Brown3
Centers for disease Control and Prevention, Atlanta, GA,
SA
CDC, Atlanta, GA, USA
Centers for Disease Control and Prevention, Atlanta, GA,
SA
Background: Every year,approximately two million Mus-
im pilgrims(Hajjis) from almost 140 countries gather in the
ingdom of Saudi Arabia(KSA) for 2-3 weeks to perform Hajj
eligious rites in a limited geographic area. Crowded condi-
ions have historically played a role in the transmission of
nfectious diseases among Hajjis. Inﬂuenza-like illness(ILI)
as deﬁned as fever ≥100 ◦F with cough and/or sore throat,
n the absence of a known cause other than inﬂuenza. The
bjective of this study was to describe the occurrence of ILI
mong Hajjis returning to the United states from KSA.
Methods: Data for all ill Hajjis traveling from KSA to the
nited States reported into QARS during three consecutive
nnual Hajj seasons were analyzed to identify the relative
isk(RR) of reported ILI among Hajjis versus other US-bound
ravelers during January 2006,2007 and 2008. US Bureau of
ransportation Statistics data were used to identify the num-
er of direct US-bound travelers from KSA and countries with
LI cases reported in the QARS during each year. The numbers
f US-bound travelers from both the Middle East countries
nd other countries reporting ILI cases in QARS were used as
enominators to calculate the incidence of ILI among return-
ng US Hajjis versus its incidence among US-bound travelers
eturning from other countries. The RR was then calculated.
Results: The RR of having ILI was signiﬁcantly higher
mong US-bound Hajjis than other US-bound travelers in
anuary 2006(RR = 9.73, P = 0.006) but was insigniﬁcantly
igher in January 2008(RR = 2.62, P = 0.2). No ILI case was
eported among hajjis in January 2007 compared to 11 cases
eported among travelers from other countries.
Conclusion: A potential reporting bias of ILI among hajjis
ersus other travelers may represent a limitation to the
tudy results. However, travelers to mass gatherings such as
he Hajj may be at signiﬁcant risk of acquiring ILI. QARS data
ould permit early detection of infectious diseases among
S-bound travelers. QARS data can also be a useful adjunct
o other surveillance systems to determine the need for
nhanced health surveillance at the US ports of entry for
ravelers returning from mass gatherings.
oi:10.1016/j.ijid.2010.02.2088
14th International Congress on Infectious Diseases (ICID) Abstrac
57.006
Assessing burden and depth of hepatitis B infection within
Asian Paciﬁc islander families in San Francisco
T. Vijayan ∗, P. Zheng, C. Nguyen, M. Peters
University of California at San Francisco, San Francisco, CA,
USA
Background: Community-based data suggest that the
prevalence of chronic Hepatitis B (HBV) infection among
Asian and Paciﬁc Islanders (API) is 6-14%. At least 25% of
persons of API descent with chronic HBV will develop compli-
cations from liver disease and/or hepatocellular carcinoma
during their lifetime. Many family members of patients with
known HBV have not been screened. For each HBV-infected
person of API descent, we estimated the number of family
contacts that had not been screened for HBV.
Methods: From May-September 2009, 31 HBV-infected
persons of API descent from a UCSF Liver Clinic who agreed
to participate in the study completed a detailed question-
naire about their family history and knowledge of their
disease. Each index case subsequently was given coupons
to give to family members whose kinship was deﬁned by
descent and marriage and whose HBV status remained
unknown. These coupons contained information to attend a
free screening clinic as well as an identiﬁcation number link-
ing our index cases to each potential family member. A chart
review for each index case was also performed; laboratory
values recorded were taken at the time of visit.
Results: Study participants had a median age of 48 and
were predominantly men born outside the US (Table 1). For
every one index case, 7.5 family members who were at risk
were identiﬁed; in total, we identiﬁed 233 family mem-
bers whose HBV status was unknown including 26 parents,
20 siblings and 10 children. Fifty-three percent of index
cases stated that they had acquired HBV from their par-
ents, while 33% stated that they did not know how they
had acquired it. Alternative transmission modes included
from dirty water, ‘‘homegrown’’ anti-malarial medication,
dentists, and street vendors. Ninety-three percent of index
cases stated that they had informed their family members
of their status; reasons for not informing include stigma,
shame and unclear understanding of transmission methods.
Conclusion: Though nationwide vaccination campaigns
are beginning to target this underrepresented immigrant
Table 1 Index Case Characteristics (n = 31)
Mean Age 48 (22—87)
Male 63%
Ethnicity 39% Chinese
13% Vietnamese
13% Filipino
7% Korean
9% South/Southeast Asian
Born outside of US 83%
Mean Albumin 4.0 (2.7—4.7)
Mean ALT 41 (11—182)
Detectable HBV viral load 82%
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opulation, screening Asian and Paciﬁc Islander families for
BV remains a challenge.
oi:10.1016/j.ijid.2010.02.2089
7.007
erological typing improves the epidemiological surveil-
ance of gonorrhoea among men who has sex with men
. Sylvan1,∗, J. Hedlund2
Uppsala University Hospital, Uppsala, Sweden
Uppsal University Hospital, Uppsala, Sweden
Background: Gonorrhoea remains a major sexually trans-
itted infection (STI) worldwide. Neisseria gonorrhoaea has
owadays a high prevalence of resistance to several antibi-
tics traditionally used for treatment. During April 2004 to
ebruary 2007, we characterized all isolates from cases of
onorrhoea reported to the County Medical Ofﬁcer of Upp-
ala county serologically with monoclonal antibodies and for
ntibiotic susceptibility.
Methods: Isolates were characterized by using two panels
f different monoclonal antibodies commercially available
Gentec Systems and Pharmacia). Susceptibility testing was
erformed according to standardized methodology using
test for determination of MIC for ampicillin, ceﬁxime, cef-
riaxone, azithromycin, ciproﬂoxacin and spectinomycin.
roduction of beta-lactamase was examined by using nitro-
eﬁn disks.
Results: Of 57 isolates studied, 7 strains were produc-
rs of beta-lactamase (13%). Decreased susceptibility to
mpicillin and ciproﬂoxacin was observed in 81 and 56%,
espectively. Eight isolates (14%) exhibited reduced suscep-
ibility to azithromycin. All isolates were susceptible to
eﬁxim, ceftriaxon and spectinomycin. The majority of the
solates belonged to serogroup WII/III (98%). Bropyst (49%)
nd Brpyust (11%) was the most common Ph serovar. The
pidemiological study demonstrated that most ciproﬂoxacin
esistant isolates were isolated from men who had sex with
en and that the majority of these isolates belonged to the
ame serovar. A difference in gender was obvious (4 women,
%). The mean age was for women 36 years and for men 24
ears.
Conclusion: A clonal outbreak of gonorrhoea among men
ho has sex with men was observed during 2005 to 2006 in
ppsala county. This clone is resistant to ciproﬂoxacin and
as reduced susceptibility to ampicillin. Preventive mea-
ures and intensive epidemiological control of gonorrhoea
mong men who has sex with men is warranted.
oi:10.1016/j.ijid.2010.02.2090
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7.008
urveillance of human infections with Avian inﬂuenza in
uangzhou during 1997—2006
.Z. Qin1,∗, W. Ming2, Y. Liu1
Guangzhou Centers for Disease Control and Prevention,
uangZhou, Guangdong, China
Guangzhou Centre for Disease Control and Prevention,
uangzhou, China
Background: The special geographic location of
uangzhou, as well as certain practices of poultry
reeding and marketing, and the habits of food handling in
uangdong, have made this region a hot spot of inﬂuenza
nfection. Therefore, since 1997, disease surveillance has
een conducted in Guangzhou.
Methods: Surveillance was conducted in Guangzhou from
997 among a group of workers involved in the breeding,
elling and slaughtering of poultry and other animals which
ay potentially carry avian inﬂuenza viruses. Serum sam-
les were collected from this high risk population to detect
peciﬁc antibodies via the microhemagglutination inhibition
est. An epidemiological survey was conducted on people
nfected with H9N2 or H5N1.
Results: Among the total of 2546 samples collected within
he period 1997—2005, the positive rate for H9 was 4.56%,
hile the testing for anti-H5 antibody resulted in no posi-
ive response. Among serum samples collected in 2006 from
26 workers in the live poultry food markets, where the
rst H5N1 case was found, one person working in poultry
laughtering was positive for anti-H5 antibody, while another
ositive was found among the 432 samples from persons
ithout contact with poultry. The H9 infection rate among
he occupational group that handled poultry in Guangzhou
as 4.56% (0.51%—10.00%), There was no signiﬁcant dif-
erence among different age groups and different gender,
ut the rate is higher than that in the urban group that
racticed scattered home-breeding of poultry. One charac-
erized human case of avian inﬂuenza A (H5N1) in Guangzhou
n 2006 was reported to have visited many live poultry food
arkets before the onset of the disease. A poultry slaugh-
erer working in one of these live poultry food markets had
positive anti-H5N1 antibody response, while a person with
nti-H5N1 antibody and a patient with anti-H9N2 antibody
ad no history of direct contact with poultry.
Conclusion: H5N1 and H9N2 may cause an asymptomatic
r low symptomatic infection in humans. In addition to
eople working in poultry farms, those involved in avian
reeding, selling and slaughtering of poultry are also at high
isk for avian inﬂuenza viral infection.
oi:10.1016/j.ijid.2010.02.2091
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apid analysis of known and unknown pathogens using a
an-microbial detection microarray
. Thissen ∗, S. Gardner, K. McLoughlin, T. Slezak, C. Jaing
Lawrence Livermore National Laboratory, Livermore, CA,
SA
Background: Rapid analysis of known, emerging and
nknown viral and bacterial infections is critical for pub-
ic health. Assays that can only identify a small handful of
athogens are not sufﬁcient to deal with complex microbial
nfections. In this study, we report our development of a
igh-throughput microarray designed to detect known and
iscover unknown pathogens.
Methods: We designed a pan-Microbial Detection Array
MDA) to detect all viruses, bacteria, and plasmids with
195 viral species and 924 bacterial species represented.
e took an approach balancing the goals of conservation
nd uniqueness for probe design, aiming for uniqueness rel-
tive to other families and kingdoms, and for conservation,
o the extent possible, within a family. Long probes were
elected to tolerate some sequence variation to enable
etection of novel, divergent species with homology to
equenced organisms. We have used our arrays to iden-
ify pathogen infections from various clinical samples. We
eveloped a novel statistical analysis method, maximum
ikelihood analysis method that enabled quantiﬁable pre-
ictions of likelihood for the presence of multiple organisms
n a complex sample.
Results: The MDA correctly identiﬁed multiple viral
nd bacterial infections in unknown fecal, sputum and
asopharyngeal samples that were later conﬁrmed through
ndependent highthroughput sequencing or PCR assays. Up
o strain level identiﬁcation can be achieved for fully
equenced pathogens in as little as a few hours. Family level
dentiﬁcation was achieved for highly divergent viruses. The
rray is highly sensitive and able to achieve low-copy viral
enome detection of spiked samples when coupled with
hole genome random ampliﬁcation.
Conclusion: Our Microbial Detection Array is a fast, efﬁ-
ient and cost-effective tool to rapidly characterize known,
merging and unknown pathogens from clinical and envi-
onmental samples. The MDA has higher probe density and
arger phylogenetic representation of viral and bacterial
equenced genomes than other available array designs. It
an be applied to problems in viral and bacterial detection
rom pure or complex environmental or clinical samples. It
ill enable informed responses to novel biological threats
nd infectious agents and provide a complement to high-
hroughput sequencing data.
oi:10.1016/j.ijid.2010.02.2092
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sentation to sick call was 1.6± 0.8 days. The most frequent
symptoms, other than fever, included cough and headache
(both 75%), malaise (74%), nasal congestion (73%), and sore
throat (55%). A majority (99%) of the cases had been vac-14th International Congress on Infectious Diseases (ICID) Abs
57.010
Indexing infectious disease information into a relational
database for useful queries on the World Wide Web
J. Brown
National Library of Medicine, Tacoma, WA, USA
Background: In the twenty-ﬁrst century, we now have
new tools for indexing infectious disease information (the
relational database) and for disseminating that information
worldwide (the Internet). A book such as the ‘‘Control of
Communicable Diseases Manual’’ has a helpful index, but
it does not have an electronic index that can provide the
powerful queries of a relational database, and it cannot
be accessed by the millions of computer-users around the
world.
Methods: All pertinent infectious disease information was
envisioned as a knowledge domain that could be mapped
into a relational database using indexes that are structured
and unambiguous. The database would be designed to pro-
vide queries that return useful differential diagnoses, e.g.,
all diseases matching the syndrome ‘‘Rash and Fever.’’ The
database would contain a table of Diseases and related
tables of Findings (signs and symptoms), Jobs, Risk Factors,
and Syndromes.
Results: The author has designed three different
databases that use queries to ﬁnd all infectious diseases that
match one or more search criteria. One of the databases
covers 275 communicable diseases and contains 119 signs
& symptoms, 39 epidemiological factors, and 16 regions of
the world. An example of a query is to search for all dis-
eases that match the job ‘‘Veterinarian’’ and the syndrome
‘‘Acute Neurological and Fever.’’ The search criteria are
the indexes that were built into the tables at the begin-
ning of the project, not the ambiguous and unsystematized
indexes that are added at the end of a book. Each disease
proﬁle shows initial symptoms, incubation period, common
ﬁndings, endemic areas, laboratory diagnostics, and epi-
demiological factors. Epidemiological factors include entry
(e.g., ingestion), source (e.g., soil), vector (e.g., ticks), and
reservoir (e.g., cats). These factors are displayed for each
disease, and they are also used as search criteria. Haz-Map is
the earliest demonstration of this tool, and it is available for
free searching on the National Library of Medicine website.
Conclusion: All useful infectious disease information
can be collected and indexed into a web-based relational
database to help practitioners quickly build accurate, up-to-
date differential diagnoses and ﬁnd detailed information.doi:10.1016/j.ijid.2010.02.2093ts e273
7.011
espiratory disease surveillance aboard Peruvian Navy
hips: Detection of a pandemic inﬂuenza A (pH1N1) out-
reak
. Vera1,∗, R.A. Hora1, V. Gonzaga1, J. Quispe1, J.M.
eyra1, M. Ramos1, C. Loret de Mola1, P. Mote2, M.
ernández3, J. Montgomery1
US Naval Medical Research Center Detachment, Lima -
eru, Lima, Peru
University of Georgia, Athens, GA, USA
Peruvian Navy Directorate of Health (DISAMAR), Lima,
eru
Background: Living conditions aboard navy ships provide
n ideal environment for respiratory disease transmission
nd place military personnel in these settings at higher
isk for outbreaks of viral respiratory diseases. We sought
o determine the incidence rates and etiologies of Febrile
cute Respiratory Infections (FARI) on deployed Peruvian
avy ships by implementing an onboard respiratory disease
urveillance system. Notably, the system allowed for detec-
ion of an outbreak of pH1N1 in the ﬁrst study ship.
Methods: The onboard surveillance system was designed
o include all Peruvian navy ships deployed on sea mis-
ions from May 2009-2011. Prior to deployment, onboard
ealth personnel were trained to maintain daily counts of
rewmembers who presented to sick call with FARI symptoms
fever > 100.5 ◦F and either cough or sore throat). Trained
ersonnel completed a case report form for each person
eeting the case deﬁnition and obtained respiratory sam-
les for both rapid Quick Vue® Inﬂuenza and real-time
everse transcriptase polymerase chain reaction (rRT-PCR)
esting.
Results: From June 25 to July 17, 2009, 85 of 355
rewmembers from the ﬁrst Peruvian navy study ship pre-
ented to sick call with FARI symptoms. Of those, 52 tested
ositive for inﬂuenza A with the rapid test (attack rate
4.6%), and 78 tested positive for pH1N1 with rRTPCR
attack rate 21.7%) [See Figure]. Descriptive analysis of
ases showed that 9% were female; mean age was 25.5± 8.4
ears; mean temperature was 38.6± 0.5 ◦C; and that the
ean number of days between onset of symptoms and pre-
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inated against seasonal Inﬂuenza (Agrippal® S-1) before
eployment. Approximately 8% were asthmatic and 43.6%
ad past history of tobacco use. No complications or fatal
utcomes were observed among conﬁrmed cases. Presenta-
ion of FARI cases to sick call aboard a Peruvian Navy Ship,
une — July, 2009.
Conclusion: Our ﬁndings highlight the importance of the
mplementation of robust respiratory surveillance systems
board military ships for timely detection and control of res-
iratory disease outbreaks, ultimately preventing potential
issemination back to their country of origin.
oi:10.1016/j.ijid.2010.02.2094
7.012
opulation-based seroprevalence of hepatitis C virus
nfection in the South and Southeast regions of Brazil
. Moreira1,∗, G.M. Figueiredo2, R. Ximenez3, U.
ontarroyos3, C. Braga3, M.R. Cardoso4, G. Coral5, F.
arrilho4, A. Stein5, Z. Marion6, A. Spina7, A. Cardoso8,
. Moriya9, A. Alves5, E.B.D. Correa10, M. Theme-Filha11,
. Muzzillo12, A.C. Vidor13, C.V. Nogueira14, M.E. Pinto15,
.A. Barone4, L. Ferreira16, L. Pereira3
Instituto Adolfo Lutz, São Paulo, SP, Brazil
Secretaria de Estado da Saúde, São Paulo, Brazil
Universidade Estadual de Pernambuco, Recife, Brazil
Universidade de São Paulo, São Paulo, Brazil
Santa Casa de Misericórdia de Porto Alegre, Porto Alegre,
razil
LACEN- Porto Alegre, Porto Alegre, Brazil
Instituto Adolfo Lutz, São Paulo, Brazil
LACEN - Santa Catarina, Florianópolis, Brazil
LACEN- Paraná, Curitiba, Brazil
0 Universidade Federal de Florianópolis, Florianópolis,
razil
1 Escola Nacional de Saúde Pública, Rio de Janeiro, Brazil
2 Universidade Federal do Paraná, Curitiba, Brazil
3 Secretaria Muncipal de Saude de Florianópolis, Flori-
nópolis, Brazil
4 Universidade Federal do Rio de Janeiro, Rio de Janeiro,
razil
5 Universidade Federal de Ciencias Médicas, Porto Alegre,
razil
6 Secretaria Municipal de Saúde de Curitiba, Curitiba,
razil
Background: In Brazil, few studies describe HCV preva-
ence in general population and it is estimated from 0.4 to
e
i
uternational Congress on Infectious Diseases (ICID) Abstracts
.0% in distinct regions of the country. The objective of this
tudy was to estimate the seroprevalence of hepatitis C in
he South and Southeast regions of Brazil.
Methods: A population-based survey was carried out in
he South and Southeast regions of Brazil (2007/2008), as
art of a national survey conducted in all ﬁve regions of
razil. The sample was representative of the 7 state cap-
tals in these regions and people from 10 to 69 years old
ere considered. In each capital census tracts and, then,
locks were drawn with probability proportional to size; sub-
equently a systematic sample of households was drawn and
heir residents selected. The study was approved by regional
nd national ethical committees and signed informed con-
ent was obtained. Hepatitis C antibodies (anti-HCV) was
creened by automated ELISA (AxsymTM — ABBOTT Labora-
ories) and conﬁrmed by manual test (DiaSorinTM). It was
onsidered as positive serum samples with reagent results
y both tests.
Results: A total of 7,835 individuals were investigated
rom both regions. Anti-HCV prevalence was 0.056% (95%-CI:
.000-0.167) in the age group 10-19 and 1.1% (95%- CI:0.581-
.633) in the age group 20 to 69 from South region. From
outheast region Anti- HCV prevalence was 0.112% (95%-
I:0.000-0.268) in the age group 10-19 and 0.76% (95%-
I:0.389-1.130) in the group 20-69.
Conclusion: Our data show low HCV prevalence in these
razilian regions. The occurrence of HCV in children, despite
he fact of low proportion, means that HCV prevention
easures must be improved. Sponsors: Brazilian Ministry of
ealth, Pan-American Health Organization.
oi:10.1016/j.ijid.2010.02.2095
7.013
he European Centre for Disease Prevention and Control
trengthening MedISys as a tool to accelerate detection of
hreats to human health from communicable diseases in
he EU
. Mantero1,∗, A. Cox1, J. Linge2, E. van der Goot2, D.
oulombier1
European Center for Disease Prevention and Control
ECDC), Stockholm, Sweden
Joint Research Centre of the European Commission, Ispra
Varese), Italy
Background: MedISys is an automated, web-based news
ggregator developed at the European Commission Joint
esearch Center (EC-JRC) that uses weighted keywords and
eywords combinations to collect articles of public health
nterest in 42 languages. The European Center for Dis-
ase Prevention and Control (ECDC) is mandated to detect
nd assess health threats from communicable diseases and
o strengthen Epidemic Intelligence (EI) within the EU. In
008, an internal analysis indicated that although MedISys
as rarely used to detect threats, it issued alerts faster
han human-mediated sources. Considering that real-time
creening is crucial for early threat detection, ECDC is
xploiting Medisys potential as eearly detection tool.
Methods: ECDC performed a descriptive study of MedISys,
dentifying search strategies, sources, web interface and
ser capacity as targets for improvement. To reduce the
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detection of irrelevant articles, alternative English search
strategies for 15 diseases were tested against existing
alerts. Precision was measured using Positive Predictive
Value (PPV), deﬁned as the probability of detected article to
have public health relevance, where relevance was deter-
mined by EI experts (human ﬁlter) who evaluated 13,679
English articles scanned within 24 hours. EU national public
health experts supported sources and interface revision.
Results: Alternative search strategies successfully
reduced false positives without reducing sensitivity (PPV
from 15% to 30%). Best reﬁnement of search strategies
requires using fewer keywords (diseases basic deﬁnitions),
adjusting their weights with an extensive use of negative
values and using epidemiological terms in the keywords
combinations. New alerts have been set up for English
and translation to other EU languages is ongoing with the
support of public health experts. Expansion of the sources
and restructuring of the interface are underway based on
EU Member States feedback.
Conclusion: Results indicate that optimization of search
strategies and revision of sources with the support of
national public health experts can help MedISys reaching its
potential. Plans for 2010 include extension of the analysis to
all diseases and languages and capacity building within the
EU to encourage knowledge and use of the revised system.
ECDC plans to create customized versions for EU Member
States (country editions) and, on request, special versions
for mass gathering surveillance.
doi:10.1016/j.ijid.2010.02.2096
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Changing trend of measles and rubella in Nepal: Is it time
to introduce rubella immunization?
S.P. Dumre1,∗, S. Malla2, G. Shakya2, K. Kc2, P. Ghimire3
1 Thammasat University, Faculty of Allied Health Sciences,
Pathumthani, 12121, Thailand
2 National Public Health Laboratory, Kathmandu, Nepal
3 Tribhuwan University, Kathmandu, Nepal
Background: Measles and rubella are serious public
health problems in many developing countries, though the
incidence is signiﬁcantly reduced in developed countries.
Measles is under national immunization activity in Nepal
while there is no such program for rubella. The lack of infor-
mation on the burden of rubella is one of the obstacles for
such initiatives.
Methods: The present study was conducted from January
2003 through December 2007 under national measles surveil-
lance program. Blood specimens from measles like cases
(based on case deﬁnition) during any outbreak throughout
the country were collected, serum separated, transported
to National Measles Referral Laboratory and tested for
detection of anti-measles IgM by ELISA technique. Measles
negative specimens were further tested for anti- rubella IgM
to analyze the trend.
Results: Of the total cases, 43.65%(805/1844) and
42.95%(424/987) were found to be positive for measles
and rubella respectively. Distribution of measles cases was
observed as 82.7%(158/191), 72.6%(600/827), 6.4%(19/295),
2.8%(6/214) and 6.9%(22/317) in the year 2003, 2004,
n
s
a
sts e275
005, 2006 and 2007 respectively. In contrast, rubella cases
ere reported as 0%(0/33), 28.5%(57/200), 67.1%(169/252),
0.75%(105/207) and 31.5%(93/295) in the year 2003, 2004,
005, 2006 and 2007 respectively. We found that the num-
er of measles cases signiﬁcantly decreased (P < 0.001) with
he increasing rubella cases (P < 0.0001) till 2005 and rubella
emained at high burden level in the following years as well.
n the recent years, most of the clinical measles cases were
urned out to be rubella by results of laboratory investiga-
ion.
Conclusion: The incidence of measles has been rapidly
educed to a minimal after the measles immunization cam-
aign (started at late 2004) and the routine immunization
ctivity; however the emerging and increasing trend of
ubella infection is a serious concern in Nepal. Continu-
tion of measles immunization with the introduction of
ubella immunization (both routine and supplementary)
nto national immunization strategy is the key measure to
ddress this emerging problem.
oi:10.1016/j.ijid.2010.02.2097
7.015
nﬂuenza A activities in Shanghai, China during 2004 to
009
. Jiang1,∗, L.-W. Ju1, X. Lv1, J. Yang1, Q. Shi1, Y. Tan2, H.
hen2, Q.-W. Jiang1
School of Public Health, Fudan University, Shanghai, China
The Minghang District Center of Diseases Preventive and
ontrol, Shanghai, Shanghai, China
Background: Inﬂuenza has been a considerable public
ealth problem in China as well as the global for it remains
nadequatedly controlled. The knowledge about the epi-
emiological features is valuable for surveillance strategy,
nd molecular characteristics of viruses are useful for selec-
ion of variant strains.
Methods: The seasonal inﬂuenza was intensively moni-
ored for the entire year in Shanghai area during 2004 to
009. The clinical activities of the Outpatient Department
f Minhang Centre Hospital were documented. The respi-
atory specimens from patients with inﬂuenzalike illness
ere collected and then identiﬁed by viral isolation and RT-
CR. The molecular characteristics of A/H1 and A/H3 viruses
ere also analyzed by sequencing and comparing the genetic
iversity of HA segment respectively.
Results: Two separated high peaks of inﬂuenza appeared
etween February to March and between July to August,
hich were consistently correlated with the waves of ILI
onsultant proportion. Obviously succession of predominant
nﬂuenza A viruses was observed while inﬂuenza B virus kept
n a mild level: A/H3 predominated in 2004 and 2005, and
hen was subrogated by A/H1 in 2006. A/H3 increased again
n 2007 till the winter of 2008, but A/H1 became dominated
n the summer of 2008, and maintained dominating in 2009.
ll the isolates from both subtypes were similar to the strains
f the same period in other countries and regions. Phyloge-
etic analysis of HA1 subunit revealed a linear trunk with
uccession of A/H3 isolates in different inﬂuenza seasons,
nd a multi-directional tree with cluster of A/H1 isolates in
ame inﬂuenza season.
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province. The greater convenience and efﬁcacy of the ICT
test compared with night blood ﬁlm examination confers a
signiﬁcant prospect of further LF surveys in Lao.
doi:10.1016/j.ijid.2010.02.2100276 14
Conclusion: The inﬂuenza activities in Shanghai revealed
ypical winter and summer seasonal feature. The predom-
nant inﬂuenza A virus changed almost every season. The
ver-changing spectrum of circulating inﬂuenza strains and
heir molecular characteristics support the need for sea-
onal surveillance of inﬂuenza viruses in Shanghai, for more
recise information about the circulating strains may have
mplications for predicting the following season strains and
electing vaccine composition.
oi:10.1016/j.ijid.2010.02.2098
7.016
erological survey on inﬂuenza A (H1, H3, H5 and H9) anti-
odies in human populations in Shanghai, China in 2008
nd 2009
.-W. Ju1, L. Jiang1,∗, Q. Shi1, X. Lv1, J. Yang1, H. Shen2,
. Zhou3, W. Zhu4, Q.-W. Jiang1
School of Public Health, Fudan University, Shanghai, China
The Minghang District Center of Diseases Preventive and
ontrol, Shanghai, Shanghai, China
The Putuo District Center of Diseases Preventive and Con-
rol, Shanghai, Shanghai, China
The Pudong District Center of Diseases Preventive and Con-
rol, Shanghai, Shanghai, China
Background: Inﬂuenza A is a common respiratory disease
n human, and A/H1 and A/H3 are currently co-circulating
n the world. Meanwhile, inﬂuenza A/H5N1 virus has been
preading throughout South-East Asia and extended to Rus-
ia, Europe, Africa, the Indian subcontinent and the Middle
ast with associated human infections as well as inﬂuenza
/H9N2 virus has also caused repeated human infections in
sia since 1998. The periodic serological survey is useful to
now the current seroprevalence of human A/H1and A/H3
nﬂuenza antibodies in human population and to provide
eroepidemiological information of avian H5, H9 inﬂuenza
virus infections in humans in Shanghai.
Methods: Yearly serological surveys were carried out
n the occupational exposure personnel (OEP) and general
opulation (GP) in Shanghai from 2008 to 2009. Human
/H1, A/H3 and avian A/H5, A/H9 inﬂuenza antibodies were
etected using hemagglutination inhibition (HI) assays.
Results: The prevalences of human A/H1 inﬂuenza anti-
odies were 45.3% in 2008 and 64% in 2009 respectively while
he prevalences of A/H3 inﬂuenza antibodies were 37.4% in
008 and 40.7% in 2009 respectively. Obviously increasing
f anti-H9 antibodies prevalence were observed: 36.3% in
009, signiﬁcant higher than 17.7% in 2008 in OEP; 3.3% in
009, slightly higher than 2.6% in 2008 in GP. However, anti-
5 antibodies prevalence kept relatively stable: 4.0% in 2008
nd 3.8% in 2009 in OEP as weii as 0.3% in 2008 and 0.3 in
009 in GP.Conclusion: The seroprevalences of human H1 and H3
nﬂuenza antibodies were consistent with the activities of
nﬂuenza virus in Shanghai recent years. There were poten-
ial human infections with inﬂuenza A/H5 and A/H9 in
hanghai, especially in the occupational exposure person-ternational Congress on Infectious Diseases (ICID) Abstracts
el, and meanwhile the risk of human inﬂuenza A/H9 virus
nfection was increased.
oi:10.1016/j.ijid.2010.02.2099
7.017
survey of lymphatic ﬁlariasis using ICT test in Attapeu
rovince, Lao PDR
. Knight1,∗, C. Chanthavisouk2, V. Nakhonesid-Fish2, K.
hindavongsa3, E. Michael1, P. Aratchige2
Imperial College London, W2 1PG, United Kingdom
World Health Organisation, Vientiane, Lao, People’s
emocratic Republic of
Centre of Malariology, Parasitology and Entomology, Vien-
iane, Lao, People’s Democratic Republic of
Background: Baseline observations suggest lymphatic
lariasis (LF) is likely to be endemic in parts of Lao PDR. To
ate in Lao diagnosis has relied on the use of night blood ﬁlm
xamination, which through its inconvenient testing time
as limited the ability to conduct a regional LF prevalence
urvey. In Lao’s southernmost province of Attapeu, two of
he province’s ﬁve districts have been identiﬁed as endemic
>1% prevalence) using night blood ﬁlm examination. In this
tudy we have conducted a regional survey of the remaining
hree districts in Attapeu province using immunochromato-
raphic (ICT) ﬁlarial test kits. All work was performed in
ollaboration with the Centre for Malariology, Parasitology
nd Entomology, Ministry of Health, Lao PDR.
Methods: In August 2009 ICT ﬁlariasis tests were per-
ormed on 320 adults across the districts of Sanamxai,
amakkhixai and Sanxai in Attapeu province. Sample vil-
ages were evenly distributed across each district to ensure
eographical spread. Minimum village sample size was 50
ersons.
Results: Twenty-two ICT positive cases were identiﬁed; 3
n Sanxai (n = 157 tested), 5 in Samakkhixai (n = 112 tested)
nd 14 in Sanamxai (n = 51 tested). The prevalence per
istrict sample was 1.9% in Sanxai, 4.5% in Samakkhixai
nd 27.5% in Sanamxai. Night blood ﬁlm examination was
erformed on 20 ICT positive cases; of these 2 showedmicro-
lariae on thick blood ﬁlm. There were no observed cases
f elephantiasis or hydrocoele. Cases without contraindica-
ions were treated with DEC and/or Albdenazole.
Conclusion: This is the ﬁrst ICT ﬁlariasis test survey
erformed in Lao PDR. Given that each district showed
1% prevalence, this study’s ﬁndings support a mass drug
dministration programme to eliminate ﬁlariasis in Attapeu
14th International Congress on Infectious Diseases (ICID) Abstrac
Table 1 Indicators selected to evaluate the results of
BMSSP, introduced in São Paulo state in 2007 — comparing
the frequency of indicators between 2006 and 2008.
Indicators Year Test
2006 (%) 2008 (%) Chi-square
test
p
Bacterial
meningitis lab +
*
40.7 60.7 53.7 <0.01
Non-speciﬁed
bacterial
meningitis
39.1 19.5 57.5 <0,01
Culture + ** 31.1 36.3 4.15 0.04
Culture positive
for N.
meningitidis
33.3 50.0 36.1 <0.01
Identiﬁcation of
serogroup (N.
meningitidis)
48.0 64.1 15.7 <0.01
N. meningitidis serogroup
B 24.2 14.3
C 68.5 75.0
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A/H5N1 cases were still found in Indonesia and the spread of
novel virus inﬂuenza A/H1N1 in 2009 have raised our concern
about the importance of SARI surveillance.
doi:10.1016/j.ijid.2010.02.2102W135 5.0 8.5
Y 0.4 1.2
Others 1.9 1.0
57.018
Evaluation of bacterial meningitis Sentinel Surveillance
Program (BMSSP) introduce in 2007 in Sao Paulo state,
Brazil
T.R.M.P. Carvalhanas ∗, B.L. Liphaus, A.C.G. Pellini, A.L.F.
Yu, G.D. Freitas, A.F. Ribeiro
State Secretary of Health of Sao Paulo, Sao Paulo, SP, Brazil
Background: Lab conﬁrmation of bacterial meningitis
(BM) is cumbersome, because of the low sensitivity of lab
tests and problems associated with storage of samples and
laboratorial practices. The proportion of BM of unknown eti-
ology is high, especially after use of antibiotics.
Methods: We describe implementation and results of a
PAHO program (BMSSP) to get better surveillance of BM,
based Sentinel Hospitals, that add multiplex PCR to tradi-
tional tests (culture and antigen detection). Since 2007, 13
sentinel hospitals (10 in São Paulo and 3 in Campinas city)
have been selected to monitoring BM in São Paulo state.
To evaluate the results of this program, we compared 5
selected criteria (Table 1) in 2006 and 2008, pre and pos
implementation of BMSSP. Multiplex PCR is able to identify
Neisseria meningitidis, Haemophilus inﬂuenzae and Strep-
tococcus pneumoniae in both serum and CSF.
Results: The results, summarized in table 1, showed that
BMSSP improve signiﬁcantly the quality of diagnosis of BM,
especially when caused by N. meningitidis, and showed that
the serogroups prevalence is changing.
Conclusion: The PAHO BMSSP is an excellent tool to
monitoring MB. The detection of N. meningitidis with iden-ts e277
iﬁcation of serogroups will give support for public healthy
ecisions involving future strategies of immunization.
oi:10.1016/j.ijid.2010.02.2101
7.019
he proportion of inﬂuenza infections from severe acute
espiratory infection (SARI) cases in Indonesia 2008-2009
. Ramadhany1,∗, V. Setiawaty1, H.A. Wibowo1, D. Lokida2
National Institute of Health Research and Development,
akarta, Indonesia
Tangerang Hospital, Tangerang, Banten, Indonesia
Background: Severe acute respiratory infections (SARI) is
n acute infections occur in respiratory systems especially
n alveoli or interstitial tissue in human lung. The symptoms
hich lead to SARI are fever, cough, sore throat, difﬁculty
f breathing and requiring hospitalization. Bacterial and
iruses can be responsible for acute respiratory infections in
uman. Since Indonesia is a country with the highest number
f fatal cases caused by Avian Inﬂuenza from July 2005 until
ecently, therefore Inﬂuenza was one of major concern in
olving health problems in Indonesia.
Methods: National Institute of Health Research and
evelopment, MOH of Indonesia has been conducting SARI
urveillance and collected 549 samples of nasal and throat
wabs from SARI patients during April 2008 until March 2009
rom eight hospitals in eight provinces in Indonesia. The sam-
les were analyzed for Inﬂuenza by using real-time RT-PCR.
he RTPCR test used several primers. These primers were
peciﬁc for inﬂuenza A (A/H1N1, A/H3N2 and A/H5N1) and
nﬂuenza B. The sequence of these primers was provided by
DC, Atlanta.
Results: About 516 (94%) of the specimens testing results
ere not inﬂuenza A or B viruses. We found 33 (6%) of SARI
ases caused by Inﬂuenza A and B viruses, which are 21 (4%)
ases caused by inﬂuenza A and 12 (2%) caused by inﬂuenza
. From the inﬂuenza A cases we found one case of SARI was
aused by A/H1N1, two cases were A/H5N1, 17 cases were
/H3N2 and one case was unidentiﬁed Inﬂuenza A.
Conclusion: The majority of SARI cases were not caused
y inﬂuenza viruses. From this surveillance the most com-
on inﬂuenza A related to severe acute respiratory infection
n Indonesia is A/H3N2. Since the avian inﬂuenza virus
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cases of infection with the novel H1N1v. It would be inter-
esting to assess the contribution of sustained transmission
of the virus in this tropical region of Mexico.278 14
7.020
anking the burden of infectious diseases in Ontario,
anada
. Ratnasingham1,∗, J. Kwong1, N. Daneman2, M.
ampitelli 1, N. Crowcroft3
Institute for Clinical Evaluative Sciences, Toronto, ON,
anada
Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Ontario Agency for Health Protection and Promotion,
oronto, ON, Canada
Background: Evidence-based priority-setting requires
nowledge about the relative contributions of diseases to
he loss of healthy life. The Global Burden of Disease method
ses the Disability-Adjusted Life Year (DALY), a measure that
ncorporates the population burden of mortality and mor-
idity, to compare the relative contributions of diseases.
e calculated DALYs for infectious pathogens in Ontario
o inform the policies of the province’s new public health
gency.
Methods: The DALY is a health gap measure compris-
ng two components: 1) years of life lost due to premature
ortality (YLL); and 2) years of ‘‘healthy’’ life lost due to
isability (YLD). Health gap measures quantify the amount
f ‘‘healthy’’ life lost by estimating the difference between
ctual population health and a speciﬁed ideal. We used an
ncidence-based approach and incorporated modeling tech-
iques where possible to estimate the disease burden of
arious infectious disease agents. Data sources included
ensus estimates, vital statistics, public health reportable
isease data, health care utilization data, cancer registries,
nd epidemiological studies.
Results: For most infectious diseases, mortality (YLLs)
ontributed more to DALYs than morbidity (YLDs). Overall,
he infectious agents accounting for the greatest bur-
en were: inﬂuenza, Streptococcus pneumoniae, hepatitis
virus (HCV), Escherichia coli, Gram negative bacteria
xcluding E. coli, HIV/AIDS, Staphylococcus aureus, human
apilloma virus (HPV), hepatitis B virus (HBV), and other
ram positive bacteria. The DALYs for HPV and urinary
ract infections were greater in females while the DALYs for
IV/AIDS, HCV, and HBV were greater in males.
Conclusion: Strategic priorities for speciﬁc infectious dis-
ases in Ontario should focus on those identiﬁed here to
ave the greatest burden. Further work is also required
o improve the timeliness of data access and the qual-
ty of information available. While the prevention of some
nfectious diseases will require the development of novel
nterventions, much of Ontario’s infectious disease burden
ould be reduced through better implementation of existing
nterventions.
oi:10.1016/j.ijid.2010.02.2103
dternational Congress on Infectious Diseases (ICID) Abstracts
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urden of new swine-origin H1N1 inﬂuenza virus in a sub-
ropical region of Mexico
. Ayora-Talavera1,∗, M. Betancourt-Cravioto2, A. Quijano-
ivas2, M.R. Gonzalez-Losa1
Centro de Investigaciones Regionales, Universidad
utonoma de Yucatan, Merida, Yucatan, Mexico
Servicios de Salud de Yucatan, Merida, Yu, Mexico
Background: The current inﬂuenza pandemic caused by
he novel H1N1 virus was ﬁrst reported in Mexico City on
pril 18, by the end of May the number of conﬁrmed H1N1
ases was of 5, 563 nationwide. Through strict self protec-
ion measures and the closure of all school and non essential
ctivities, the epidemic was controlled and the number of
nfected people at least in central and North Mexico dimin-
shed down to undetectable cases in some Federal Entities.
urprisingly, the epidemic of inﬂuenza virus H1N1 had a geo-
raphical shift and by mid June the number of suspected
nd conﬁrmed H1N1 cases exponentially increase in those
ederal entities of the South, mainly Yucatan and Chiapas.
he burden and impact of inﬂuenza virus in tropical and sub-
ropical regions has been poorly analyzed and recent reports
ave underline the importance of inﬂuenza virus circulation
n tropical regions associated to persistence of the virus in
emperate countries or reintroduction of inﬂuenza from the
ropics every year.
Methods: Using retrospective inﬂuenza surveillance
ata from Yucatan and the epidemiology of the actual
nﬂuenza H1N1 and concurrent meteorological information
e described in here the burden of the novel swine H1N1
uman inﬂuenza virus in a subtropical region of Mexico.
Results: Restrospective analysis of inﬂuenza surveil-
ance in Yucatan, Mexico has showed us a seasonal trend
n inﬂuenza circulation typical of tropical countries. In
eneral, it occurs twice a year, with the more intense
ctivity during the rainy season. The novel H1N1 virus was
rst detected in Yucatan on April 21st, however despite
he national contingence, the actual outbreak in Yucatan
ccurred until the end of May when the numbers of infected
eople increase to such level that Chiapas and Yucatan were
ostly the only two Mexican states reporting cases of infec-
ion with the novel H1N1v.
Conclusion: Now, at 6 months after the ﬁrst cases were
eported, Yucatan still is the third Mexican state reportingoi:10.1016/j.ijid.2010.02.2104
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Measles, neonatal tetanus (NNT), pertussis, cerebrio-
spinal meningitis (CSM) and polio trends in Nigeria, 1994
to 2007
M.O. Akhimien
Nigerian Field Epidemiology and Laboratory Training Pro-
gram, Abuja, Ab, Nigeria
Background: There has been concerted effort by the
Nigerian public health system both at the National and
State levels to tackle the problem of childhood vaccine-
preventable diseases. This study was done to monitor the
trend of these vaccine-preventable diseases and to assess
the effects of the various interventions on these disease
burden.
Methods: Data on some childhood vaccine-preventable
diseases from 1994 to 2007 were obtained from the Fed-
eral Ministry of Health, Nigeria. Theses data were reviewed,
summarized and graphically analyzed.
Results: Measles cases were highest (217,151) in 1999 and
dropped steadily to 12,925 in 2007. CSM cases recorded their
highest number (17,028) in 2003 and their lowest (3,547) in
2007. Pertussis cases dropped steadily from 50,175 in1999 to
17,141 in 2006. NNT and polio cases maintained low values
with peak values of 2,175 NNT cases in 2005 and 2,860 Polio
cases in 2002. The case fatality rate (CFR) for NNT increased
steadily from 3.5% in 1999 to 19.1% in 2007; CSM dropped
from 18.8% in 1995 to 2.5% in 1997 and spiked again to 13.3%
in 2003. Measles CFR dropped from 15.5% in 1997 to 1.8% in
2007. Pertussis had an annual steady CFR of 0.7% while Polio
had a steady drop from 0.7% in 2001 to 0% in 2007.
Conclusion: The steady increase in the CFR of NNT, though
it has low annual cases, calls for public health attention.
Efforts should be intensiﬁed towards CSM control. The public
health interventions for measles, polio and pertussis seem
to be effective.
doi:10.1016/j.ijid.2010.02.2105
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two year surveillance for inﬂuenza and RSV using Real-
ime PCR among childrenwith acute respiratory infections
n Kolkata reveals distinct seasonality of infection
.S. Agrawal, S. Chakrabarti, M. Chawla-Sarkar ∗
National Institute of Cholera and Enteric Diseases, Kolkata,
ndia
Background: Respiratory tract infections are one of the
ost common cause of morbidity andmortality in young chil-
ren all over the world. Inﬂuenza and Respiratory Syncytial
iruses (RSV) are the predominant etiology during seasonal
pidemics and thus rapid and sensitive molecular tests for
creening & timely identiﬁcation of epidemics are required.
n this study, we report comparison of real time PCR (Q-
CR) with conventional RT-PCR for parallel identiﬁcation of
nﬂuenza A or -B and RSV.
Methods: Nasal and throat swabs were collected from
091 children <5 years of age with fever and 2 or more
ymptoms of ARTI (cold/cough, sore throat, myalagia, body-
che) from the B. C. Roy Memorial Hospital for children,
olkata, India for 2 years (Jan 2007-Dec 2008). RNA was
xtracted from the clinical samples using RNeasy Mini Kit
Qiagen). Two one step multiplex Q- PCR assays were stan-
ardized. First assay was for matrix (M) genes of Inf- A and
nf-B {S. Lindstrom, CDC, USA}. Second assay was speciﬁc
o the polymerase gene of RSV and the RNase P.
Results: Of 1091 samples, 275 (25.21%) were positive for
ither Inﬂuenza or RSV by Q-PCR compared to 262 (24%) pos-
tives by RT-PCR. Overall Inf-A, -B and RSV were detected in
total of 121 (11.075%), 59 (5.38%) and 95 (8.68%) samples
espectively. Age distribution of virus infection in infants
< 1year), toddlers (1—2 years) or pre-school going chil-
ren (2—5 years), the positive samples was analyzed. We
bserved increased prevalence of RSV in 0—1.0 (13.9%) and
.0—2.0 years (12.1%) age group compared to only 3.8% pos-
tivity among 2—5 year old children. Inﬂuenza (A + B) was
redominant in 1.0—2.0 and 2.0—5.0 yearr (19.6% and 17.2%)
ge group in Kolkata. In spite of overlapping clinical symp-
oms, RSV and Inﬂuenza showed distinct seasonal peaks.
nf-A positively and RSV, negatively correlated with rain-
all and temperature (Fig. 1). No distinct seasonality was
bserved in Inf-B infections.Correlation of meteorological variations with preva-
ence of Inﬂuenza-A, -B and RSV during 2007-08 in
olkata.
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streamlined the management of cases and outbreaks,
facilitated realtime crossborder surveillance and improved
communication and cooperation.280 14
Conclusion: This is the ﬁrst report of a systemic surveil-
ance of respiratory viruses with seasonal correlation and
revalence rate from Eastern India. The two year study con-
rmed feasibility of using Q-PCR in developing countries,
hich will not only improve scope for prevention of epi-
emics but also provide crucial epidemiological data from
he tropical regions.
oi:10.1016/j.ijid.2010.02.2106
7.024
ampling considerations for Flavivirus arthropod vectors
n Western Canada — Making sense at a data collection
evel
. Waeckerlin ∗, S. Cork
University of Calgary, Calgary, AB, Canada
Background: West Nile virus has displayed a remark-
ble geographical expansion in North America during the
ast ten years, with peaking numbers of diagnosed cases in
003 and 2007, entailing numerous arthropod and vertebrate
ost monitoring programs throughout Canada. Culex tarsalis
as been identiﬁed as the main vector for West Nile Virus
ransmission in Western Canada, however, other arthropod
pecies are also discussed as potential vectors.
Methods: The presented work outlines factors that inﬂu-
nce the spread of West Nile virus and epidemiological and
cological considerations to be taken into account to ensure
ppropriate data collection for the assessment of West Nile
rthropod vector dynamics in the province of Alberta. The
ain factors that result in a change in vector composition
nd abundance are likely to be climate and habitat changes.
he dynamics of successful viral transmission are subject
o the suitable arthropod vector and vertebrate host com-
unities, introduction of previously non-indigenous insect
pecies, changes in mosquito habitats, genetic adaptations
f the virus, and changes in insect biting behavior.
Results: Considering previously collected data in Canada,
e propose weekly CO2 trap sampling for a minimum period
rom June to August in ﬁve of the six distinct geographic
egions of Alberta (Boreal Forest, Canadian Shield, Foothills,
arkland and Grassland). The boundaries between Grassland
nd Parkland as well as Parkland and Boreal Forest are to
e especially emphasized in the sampling. Vector speciation
n conjunction with assessment of biting behavior of indi-
idual arthropod species on a molecular level is necessary
or examination of variations in vector and vertebrate host
nteraction between these regions. Screening, characteri-
ation and phylogenetic analysis of variable regions (NS5
rotein gene) of mosquito borne Flaviviruses from insects
ollected allows implementation of molecular epidemiologic
elationships with preexisting data and assessment of pos-
ible routes of virus spread in relation to vector and host
cology and distribution.
Conclusion: Taking into account the complex ecology of
est Nile virus spread, the importance of appropriate sam-
ling is evident. The outlined experimental design covers
irological, epidemiological ecological and entomological
spects in the context of the unique landscape of Alberta.
oi:10.1016/j.ijid.2010.02.2107
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7.025
rossborder infectious disease surveillance in the Nether-
ands, Germany and Belgium
. Kara-Zaïtri 1,∗, H. ter Waarbeek2
inFact UK, Bradford, United Kingdom
GGD Zuid Limburg, Heerlen, Netherlands
Background: The Euregion Meuse-Rhine (EMR) covers an
rea of 10,478 square kilometres with 3.9 million people
nd includes the Provinces of Limburg-South (Netherlands),
imburg (Belgium) and Liege (Belgium), Region Aachen (Ger-
any) and the German-speaking community in Belgium. The
eavy daily trafﬁc of goods, services and people across the
orders poses a serious threat in respect of infectious dis-
ase control. The recent pandemic inﬂuenza experience
as re-emphasised the urgent need for improved collabo-
ation and integration of surveillance and response systems
specially in crossborder countries where political systems,
edical infrastructures, economies, and cultures are varied.
hallenges include the handling of differences in legisla-
ion for sharing data and resources, surveillance algorithms,
ommunication with the public and response protocols.
Methods: This paper discusses an EU funded project
y the Euregion Meuse-Rhine (EMR) to enhance crossbor-
er cooperation on infectious diseases surveillance and
esponse. The project included the customization and sub-
equent implementation of two secure web-based decision
upport applications for the management of pandemic ﬂu
FluZone) and general infectious disease control (HPZone).
luZone and HPZone were developed and successfully
eployed nationally in England.
Results: The implementation of FluZone and HPZone in
he EMR has yielded the following outcomes:
Formalised approach to synthesising and exchanging
experiences on pandemic ﬂu preparedness and securing
a consolidated plan allowing local nuances and including:
- Preparing for an emergency
- Surveillance, case investigation and treatment
- Preventing spread of disease
Real-time surveillance dashboard on sources, cases, con-
tacts, enquiries and outbreaks
Consolidation of continuously changing case deﬁnitions,
protocols and triage methods.
Rapid exchange of epidemiology and laboratory data
Geographical mapping of cases, contacts, and contextual
locations such as schools and care homes.
Secure communications between health protection pro-
fessionals and the crossborder community.
Conclusion: Cross-border collaboration on infectious dis-
ase surveillance is complex but essential. Using a common,
ealtime and secure web-based system has signiﬁcantlyoi:10.1016/j.ijid.2010.02.2108
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transmission, while those undetected cases due to latent or
asymptomatic infection would be the source of new dengue
outbreaks each year.
doi:10.1016/j.ijid.2010.02.211014th International Congress on Infectious Diseases (ICID) Abs
57.026
Realtime intelligence for infectious disease prevention
and control
C. Kara-Zaïtri ∗, R. Hamilton
inFact UK, Bradford, United Kingdom
Background: Infectious disease surveillance is complex,
multi-disciplinary and high proﬁle. The emergence of new
diseases and their speed of onset, coupled with current bio-
terrorism threats have re-emphasised the urgent need for
novel methods for harvesting and acting upon appropriate
and timely surveillance data using intelligent information
systems based on enhanced communication technologies.
Methods: The methodology developed is based on
two secure web-based applications - HPZone and HP-
Intelligence. HPZone is a decision support tool for infectious
disease control at the local Health protection Unit level or
Zone and has been deployed nationally in England and six
regions in the Netherlands. HPZone captures a rich data set
to support all the key business processes from the handling
of routine Enquiries, through Case management and Contact
tracing, right up to the management of Outbreaks and Inci-
dents. HP-Intelligence is a data mining application which
harvests surveillance data from each of the HP-Zones and
persistently analyses all entries to provide alerts given a
protocol of rules. Data mining functions include the detec-
tion of coincidences of events (time, place and scenario),
associations (infection versus seasonal parameters), sequen-
tial patterns (behavioural trends), and ad-hoc queries. Rules
can be entered on an individual zone, region, national or
even international levels with individual users being able to
subscribe to speciﬁc alerts.
Results: HP-Intelligence yielded positive results includ-
ing the discovery of relationships, which were not obvious.
Immediate outcomes include:
- Coincidence, incidence and threshold alerts at National,
Regional and Locals levels.
- Rich data sets for scientiﬁc evaluation to forecast projec-
tions and prioritise options for control strategies.
- Timely assessment of the descriptive epidemiology of a
major public health incident including progress and out-
come.
- Capture of key contextual data including environmental
information such as contact with animals, travel history
and possible transmission mode.
- National Incident Board for viewing aggregate summary
Situation, Case, Contact and laboratory data nationally
using various means including GIS.
Conclusion: Immediate gains from HPZone and HP-
Intelligence include an efﬁcient early warning function for
problems that are ‘‘bubbling away’’, and the capture of indi-
vidual, regional and national wisdom using easily sharable
rules and protocols for enhanced intelligence in health pro-
tection.
doi:10.1016/j.ijid.2010.02.2109ts e281
7.027
he implement of airport fever screening for dengue sen-
inel in Taiwan, 2003-2008
.-M. Kuan
Centers for Disease Control, Taipei, Taiwan, R.O.C
Background: This study aimed to examine the epidemi-
logical trends of dengue as well as the impacts of the
mported cases and airport fever screening on community
ransmission in Taiwan, a dengue non-endemic island.
Methods: All the data of dengue cases obtained from
he surveillance system in Taiwan CDC were analyzed to
resent the relationship among cases or population factors
y Pearson correlations, linear regression and/or GIS-based
apping. The comparison of the impact on whether imple-
enting airport fever screening or not was evaluated the
tudent’s and the twoway ANOVA.
Results: Being a dengue non-endemic region, 44.6%
244/542; 99% CI: 33.1-57.8%) imported dengue cases
ith fever symptomatic was at airport rapid screened by
on-contact infrared thermometer and subsequently con-
rmed by laboratory. A positive association of the imported
engue cases screened by airport fever screening with
he total imported dengue cases was found i.e. num-
er of total imported cases = 3.459 + 0.418 x number of
mported cases detected by fever screening (n = 5, R = 0.890,
2 = 0.792) during 2003-2007. Moreover, by viewing of geo-
raphic heterogeneity, the southern Taiwan, supposed to
e as the competent region for dengue endemics with
ropic climate and existence of Aedes aegypti, where
he imported dengue cases was positively associated with
ndigenous cases in 2003—2007 with the implementing air-
ort fever screening i.e. the number of indigenous dengue
ases = 53.398× the number of imported dengue cases-
69.283 (n = 25, R = 0.778, R2 = 0.605) whereas it was lesser
ssociation (n = 25, R = 0.312, R2 = 0.017) during 1998-2002
ithout this intervention in Southern Taiwan. On the other
and, in Northern (Subtropical) Taiwan, less association
etween the number of imported cases and the number of
ndiginous cases was shown.
Conclusion: It implicates ﬁrst time that upon conducting
f this border screening by airport fever screening followed
y labotory’s conﬁrmation, the numbers of imported dengue
ases could provide for early alert and sentinel of dengue
o predict the the numbers of indiginous dengue cases in
on-endemic but dengue competent (risk) region and there-
ore may help in targeting the controlling of local dengue
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7.028
omparison of three time series models for predicting
ampylobacteriosis risk in Georgia, Minnesota and Oregon
. Weisent
University of Tennessee, Knoxville, TN, USA
Background: Three time series models (regression,
ecomposition, and Box-Jenkins Autoregressive Integrated
oving Averages) were applied to national surveillance data
or campylobacteriosis with the goal of disease forecasting
n three U.S. states.
Methods: Data sets spanned 1998 to 2007 for Minnesota
nd Oregon, 1999 to 2007 for Georgia. Year 2008 was used to
alidate model results. Mean absolute percent error, mean
quare error and coefﬁcient of determination (R2) were the
valuation ﬁt statistics.
Results: Results showed that decomposition best cap-
ured the temporal patterns in disease risk. Training dataset
2 values were 72.2, 76.3 and 89.9% and validation year R2
alues were 66.2, 52.6 and 79.9% respectively for Georgia,
regon and Minnesota. All three techniques could be uti-
ized to predict monthly risk of infection for Campylobacter
p. However, the decomposition model provided the fastest,
ost accurate, user-friendly method.
Conclusion: Use of this model can assist public health
ersonnel in predicting epidemics and developing disease
ntervention strategies.
oi:10.1016/j.ijid.2010.02.2111
7.029
nticipating the species jump: Surveillance for emerging
iral threats
. Flanagan
Penn State University, State College, PA, USA
Emerging infectious diseases (EID) may pose new inter-
ational security threats because of their potential to inﬂict
arm upon humans, crops, livestock, health infrastruc-
ure, and economies. Some viruses pose unique challenges
ecause of their high mutation rates, which enable them
o evade host immunity, persist in the environment, and
nfect new host species. For example, inﬂuenza and human
mmunodeﬁciency viruses originally infected animals, but
ubsequent mutations enabled these viruses to ‘‘jump’’ to
ew human hosts. Current disease surveillance efforts rely
pon data from clinical specimens — that is, from individuals
ho are already sick. As a result, little is known about the
bundance of viruses that exist in nature but do not (yet)
ause human disease. Human populations could be preemp-
ively protected if researchers can learn what events lead to
iral species jumping. If researchers can discover common
enetic and ecological determinants that precede species
umping, then these determinants may be used to detect
iruses teetering on the threshold of human pathogenicity.
nowledge of such determinants may ultimately prove use-
ul to threat analysts and others charged with anticipating
he genetically engineered viruses of the future, be they
atural or man-made. This paper will report the ﬁndings of
thought leaders workshop convened to debate the fea-ternational Congress on Infectious Diseases (ICID) Abstracts
ibility of identifying determinants and hypothesize what
nformation and technologies might be needed to make such
urveillance possible.
oi:10.1016/j.ijid.2010.02.2112
7.030
he making of a world atlas of infectious diseases
.F. Wertheim1, P. Horby1, T.L. Viet1, T.N.T. Tanh1, J.
oodall 2,∗
Oxford University, Hanoi, Viet Nam
ProMED-mail, Brookline, MA, USA
Background: Many infectious diseases are restricted in
heir geographical range due to climatic conditions, pres-
nce of vectors or speciﬁc reservoir hosts, local food
ustoms, hygiene, antibiotic use, among others. Currently
here is no comprehensive illustrated overview of the
eographic spread of infectious diseases and their determi-
ants. Such a compendium of world infectious disease maps
s crucial for teaching, research and creating awareness of
isk.
Methods: With the collaboration of experts from around
he globe we are collecting and making updated maps of
ore than 100 infectious diseases and their preferred con-
itions. We do extensive data searches to arrive at the best
eospatial data available. Each map will be accompanied by
n explanatory text. All our maps are sent out for indepen-
ent peer review to ensure their quality and accuracy.
Results: The atlas will be published by Wiley-Blackwell,
nd at a later stage the maps will be updated and made
vailable online under open access.
Streptococcus suis, Human Cases and Pig Density
Conclusion: The printed atlas will be followed up with
web-portal for global infectious disease mapping activi-
ies, where all the data will be bundled, visualised and made
vailable to anyone interested, and updated regularly.
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Henipaviruses and distribution of ﬂying fox bat (Ptero-
pus)
doi:10.1016/j.ijid.2010.02.2113
57.031
Pertussis in Latin America: Developing the tools to face
the challenge ahead
F. Coronado1,∗, M. Grifﬁth1, M.L. Tondella1, M. Bonkosky1,
M. Landaverde2, T. Clark1
1 Centers for Disease Control and Prevention (CDC), Atlanta,
GA, USA
2 Pan American Health Organization, Washington, DC, USA
Background: Pertussis surveillance worldwide is lim-
ited by reduced clinical recognition of disease, suboptimal
conﬁrmatory testing, and poor reporting, yet adequate
understanding of pertussis in necessary for implementa-
tion and evaluation of prevention and control measures.
We describe the current status of pertussis and vaccina-
tion coverage in Latin America (LA) and a process to achieve
enhanced pertussis surveillance.
Methods: We reviewed publicly available pertussis
surveillance and vaccination coverage data for LA and
calculated incidence rates by region and country. Field
evaluations of surveillance capacity are being conducted
in selected LA countries, followed by development and
implementation of locally-responsive capacity building at
selected sentinel sites to strengthen recognition, conﬁrma-
tion and reporting of pertussis.
Results: From 1990 to 2008, >160,000 cases of pertussis
were reported in LA. Cases decreased from 25,409 in 1990 to
7,827 in 2007, with the lowest number (3,595) in 2002. The
rate also decreased from 1990 (5.8 cases/100,000 pop.) to
2002 (0.68 cases/100,000 pop.), but then increased to 1.4
cases/100,000 pop. in 2007. Reported three-dose childhood
diphtheria-pertussis-tetanus vaccine coverage has steadily
increased from 39% in 1980 to 91% in 2008. Collabora-
tive efforts among LA Ministries of Health and international
stakeholders are now focusing on evaluating current surveil-
lance systems for pertussis, with implementation of capacity
building and enhanced surveillance activities begining 3rd
quarter 2010.
c
n
its e283
Conclusion: Although vaccination efforts in LA have
educed pertussis morbidity, trends indicate that incidence
ay be increasing again. Efforts to prevent pertussis have
ocused on childhood vaccination; however, burden of dis-
ase does not strictly correlate with vaccine coverage.
dditionally, limitations of reported data imply that the true
urden of pertussis remains uncertain. Enhanced sentinel
ite pertussis surveillance, endorsed by the WHO’s Strate-
ic Advisory Group of Experts on immunization, may prove
n efﬁcient method to improve pertussis surveillance and
upport evolving vaccination policy.
oi:10.1016/j.ijid.2010.02.2114
7.032
stablishing the tuberculosis monitoring system at
razil’s, Paraguay’s and Argentina’s frontier
. Lise1,∗, J.R.P.D. Santos1, R.G. Abreu1, P. Colombana2,
. Martinez3, D. Barreira1
Brazilian Ministry of Health, Brasilia, Brazil
Ministry of Health, Misiones, Argentina
Ministry of Health and Welfare. Paraguay, Asunción,
araguay
Background: Brazil shares frontiers with 10 South Ameri-
an countries. From 2001 to 2009, in Brazil, it was registered
nd treated 225 TB cases among non residents. There is
o surveillance system among South American countries to
etect TB cases and its contacts. Our objective was describe
he proposals and activities (2008-2009) whose main goal
as establishing a ‘‘Surveillance System of TB Cases at the
rontier among Brazil, Paraguay and Argentina’’.
Methods: There were organized eighteen meetings with
he presence of TB sector decision makers from the three
ountries. There was a meeting with the coordinators of
he National TB Programs and the Brazilian Representa-
ion of the Pan-American Health Organization. There were
wo technical training courses: one about the DOT Strategy
nd another one about the epidemiology at the Bi-national
ydroelectric in Foz do Iguac¸u (Brazil).
Results: At the end, a total of 139 professionals were
nvolved in the creation of the Surveillance System, and
7 technicians from different management levels of the
hree countries were trained. The coordinators meeting
stablished responsibilities and identiﬁed the necessity of
reating a bilingual TB notiﬁcation report, a bi-national
nformation, standards for laboratorial diagnosis, forms of
dentifying circulating strains, standards for the treatment
t the country of origin. During the DOT Strategy course,
t was introduced a methodology, activities and a proposal
o standardize country actions. At the applied epidemi-
logy course, it was discussed fundamental concepts of
pidemiology surveillance and integration among countries.
he municipal technicians involved have informed and have
eferred patients in treatment at the frontiers municipali-
ies. It is in course the creation of a bi-national card for the
dentiﬁcation of Tb cases and the establishing of primary
are common protocols.
Conclusion: The Surveillance System will allow the diag-
ostic of the TB magnitude in the regions of frontiers,
dentifying the non residents’ cases, widening the treatment
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ffer at the diagnostic places and at the countries of ori-
in, widening the contact investigation, raising the directly
bserved treatment rate and decreasing the TB default.
hose actions will strengthen the TB surveillance system in
trategic areas contributing to the better understanding of
he migration ﬂows for TB treatment in neighbor countries.
oi:10.1016/j.ijid.2010.02.2115
7.033
rends in pediatric bacterial meningitis in Sudan 2005-
006
.H. Mahmoud1,∗, M.E.M. Alkarsani2
Alzaem Alazhari University, faculty of medical laboratory
ciences, khartoum north, Sudan
National Reference laboratory, Stack, khartoum, Sudan
Background: Asurvellance of epidemiological pediatric
acterial meningitis was carried out between January 2005
nd january 2006 in sudan, in National Reference Laboratory.
Methods: 932 CSF samples were collected from children
uspected having bacterial meningitis, gram stain, culture,
iochemical tests and serotybing was done,
Results: with the following results: Bacterial meningi-
is cases numbered (46 boys, 32 girls), from atotal of 932
hilds suspected having bacteral meningitis. The age dis-
ribution for the infections was the highest under 2 year of
ge, decreasing with increasing age. N. meningitides was the
ost common pathogen, followed by Haemophilus inﬂuen-
ae, Streptococcus pneumoniae, Staphellococus aureus(one
solate). The relationship between causactive pathogens
nd age distribution was as follows: staph aureus was iso-
ated from child of 6 months of age and H. inﬂuenzae and
. pneumoniae were major pathogens less than 5 years
f age.where meningococci were from mor than 5 years
f age.Susceptibility tests demonstrated that. 60% of H.
nﬂuenzae isolates and. 58% of S. pneumoniae isolates were
rug-resistant.
Conclusion: Ceftriaxone an affective againest meningo-
occi,where chloramphenicol antibiotics are currently less
ffective a combination of ampicillin and cephem antibi-
tics is used ﬁrst line at many facilities for patients below 4
onths of age. A combination of carbapenem which showed
ffective against PRSP and cephem which showed effective
gainst H. inﬂuenzae is the ﬁrst choice in childhood bacterial
eningitis for patients above 4 months of age.
oi:10.1016/j.ijid.2010.02.2116
‘
e
s
e
s
e
o
c
n
a
r
t
t
s
e
dternational Congress on Infectious Diseases (ICID) Abstracts
7.034
limination of neglected diseases in Latin America and the
aribbean: A mapping of selected diseases
.C. Schneider1, X.P. Aguilera1, J. Barbosa da Silva Jr.1,∗,
.K. Ault1, P. Najera1, J. Martinez1, R. Requejo1, R.S.
icholls 1, Z. Yadon1, J.C. Silva2, L.F. Leanes3, M. Roses
eriago1
Pan American Health Organization, Washington DC, DC,
SA
Organización Panamericana de la Salud, Bogota DC, Colom-
ia
Centro Panamericano de Fiebre Aftosa PANAFTOSA, Rio de
aneiro, Brazil
Background: In Latin America and the Caribbean, around
95 million people live in poverty, a situation that increases
he burden of some infectious diseases. Neglected diseases,
n particular, are often restricted to poor, marginalized
ections of the population. Most cause chronic conditions,
hich in turn reduce learning capabilities, productivity and
ncome earning capacity. Cost-effective tools exist to com-
at these diseases, making it imperative to work towards
heir elimination. In 2009, the Pan American Health Organi-
ation received a mandate to support the countries in the
egion in eliminating neglected diseases and other pover-
yrelated infections.
Methods: This study analyzed and determined which
ountries in the Region exhibit evidence of selected poverty-
elated diseases, determine areas where particular diseases
oexist, and detect ‘‘hotspots’’ where countries can imple-
ent interprogrammatic and intersectoral approaches. Five
iseases with available information were analyzed using
eoprocessing techniques at the ﬁrst subnational level
states), identifying the presence and overlap of these dis-
ases.
Results: In the Region, there are approximately 570
tates. Lymphatic ﬁlariasis is present in four countries (29
tates), onchocerciasis in six countries (25 states), schisto-
omiasis in four countries (39 states), trachoma in three
ountries (29 states), and human rabies transmitted by
ogs in ten countries (20 states). The information indi-
ates that 102 of the 570 states have one or more of the
elected neglected diseases, thus they may be considered
‘hotspots’’ in the Region. 33 states present two of the dis-
ases, 2 states present three of the diseases, and only one
tate has evidence of four of the selected neglected dis-
ases, classifying these areas as the major ‘‘hotspots.’’
Conclusion: The analysis suggests a majority of the
elected diseases are not widespread and can be consid-
red part of an unﬁnished agenda with the elimination
f neglected diseases as its goal. Integrated plans and a
omprehensive approach, ensuring access to existing diag-
ostic and treatment tools, and establishing a multi-sectoral
genda that addresses social determinants of disease, are
equired. More speciﬁc baselines are needed for most of
he diseases included in the study and criteria to measure
he presence of some diseases need to be reviewed. Future
tudies can include additional diseases, socioeconomic and
nvironmental variables.
oi:10.1016/j.ijid.2010.02.2117
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57.035
Warning System in Gaza Strip, post conﬂict 2009
F. Riccardo1,∗, A. El Jaish2, Y. Shahin1, M. Maqadma2, M.R.
Malik3, A. Pinto4, G. Sabatinelli 1
1 United Nations Relief and Works Agency for Palestine
Refugees in the Near East, Amman, Jordan
2 United Nations Relief and Works Agency for Palestine
Refugees in the Near East, Gaza City, Palestina
3 World Health Organization Regional Ofﬁce for Eastern
Mediterranean, Cairo, Egypt
4 World Health Organization SEARO DSE subunit, Bangkok,
Thailand
Background: After the Gaza war ceaseﬁre, WHO indicated
outbreaks as one of the highest public health risks in the
post-conﬂict phase. UNRWA, the United Nations Relief and
Works Agency for Palestine Refugees in collaboration with
WHO set up an early warning (EWAR) system for epidemic
prone infectious diseases.
Methods: After four and half months of activity, the sys-
temwas evaluated.The EWAR relies on weekly notiﬁcation of
9 syndromes from 17 PHC facilities, data is analysed in Gaza
City, used to trigger outbreak investigations and transmitted
as a bulletin to health stakeholders.
Results: Between 01 January to 16 April 2009, a total of
11 alerts were ﬂagged, two cases of meningococcal menin-
gitis identiﬁed and alarm thresholds breached for hepatitis
and watery diarrhoea. No outbreaks were conﬁrmed. The
UNRWA EWAR is a simple system built on the Agency’s
existing surveillance network, did not require additional
investment or massive training for implementation. The
ﬁrst output from the system was available less than one
month after cessation of hostilities. The system includes
all routine surveillance data, but due to the lack of out-
breaks, it was not possible to measure the sensitivity (SE).
The positivepredictive-value for outbreaks of seasonal dis-
eases was low. Over the past years, UNRWA recorded a
reporting incidence increase of seasonal diseases due to
over-reporting. Thresholds using historical data were set
with alarm thresholds at 3 standard deviations but they
still proved to be too sensitive. Acceptability and time-
liness were very high, 100% of reporting units submitted
every week. It was not possible to evaluate ﬂexibility in
adapting to changes in epidemiology, however adaptation of
thresholds to data quality showed ﬂexibility in methodology.
Representativeness was over 80% for the refugee community
who account for over 70% of the entire Gaza Strip popula-
tion.
O
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Conclusion: The UNRWA EWAR system is still the only
ource of epidemiological information in Gaza Strip and was
sed regularly by WHO to monitor outbreaks in the area. It
as a very useful instrument in the wake of a humanitarian
risis for monitoring the health of the affected population
nd proved feasible to implement even during a complex
mergency.
oi:10.1016/j.ijid.2010.02.2118
7.036
revalescent infections post hurricanes Hanna & Ike
. Font
Hospital Mariano y Luciano De La Vega, Moreno, Buenos
ires, Argentina
Background: Commune of Gonaives, Haiti 2008
Methods: Surveillance of infectious pathologies at the
rrival of the Voluntary physicians response team.
esults: Age: Days 1st to 22nd
ll ages
ex:
oth
athologies Cases %
cute respiratory infection 2087 15,6%
ase of Paludism 661 4,9%
ase of Typhoid 342 2,6%
ase of Dengue 0 0,0%
cute hemorrhagic fever syndrome 10 0,1%
cute infectious icteric syndrome 4 0,0%
ever of undetermined origin 314 2,3%
ase of German measles (Rubella) 35 0,3%
nfectious watery acute diarrhea 1338 10,0%
aginal infections 1791 13,4%
rinary tract infections 1156 8,6%
nfectious bloody acute diarrhea 0 0,0%
cute malnutrition 9 0,1%
etanus 2 0,0%
rauma - infected grazes 1453 10,9%
nfected burns 7 0,1%
nfectious cutaneous dermatitis 1120 8,4%
rterial hypertension 438 3,3%
ntestinal parasites 432 3,2%
thers 0 0,0%
ther unspeciﬁed infections 2192 16,4%
OTAL 13391 100,0%
Conclusion: See image
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oi:10.1016/j.ijid.2010.02.2119
7.037
entinel surveillance of pandemic inﬂuenza A H1N1 in
enya in the period August — November 2009
. Achilla ∗, J. Majanja, M. Wadegu, W. Bulimo, D. Schnabel
USAMRU-K, Nairobi, Kenya
Background: In April 2009 a new variant of Inﬂuenza virus
hat was later declared a pandemic strain by the World
ealth Organization appeared on the American continent.
he ﬁrst case of the pandemic Inﬂuenza A H1N1 (pH1N1) in
enya was detected on 29th June 2009. The ﬁrst sentinel
urveillance case appeared in August 2009 and since then
ncreasing numbers of pH1N1 have been detected within the
egular sentinel surveillance network.
Methods: Eight public hospitals distributed across and
epresenting the entire country comprise our sentinel
urveillance sites. Nasopharyngeal swab specimens are col-
ected within 72 hours of symptom onset from consenting
atients presenting with inﬂuenza like illness. Specimens
re transported in liquid nitrogen to the National Inﬂuenza
enter. For all patient specimens, RNA is extracted followed
y reverse transcription and real time PCR assays. The spe-
iﬁc assays include screening for seasonal inﬂuenza A and B.
ll samples positive for Inﬂuenza A are further subtyped for
easonal H1, Seasonal H3 and pandemic H1.Results: In the four months from August to November,
total of 1329 samples were screened from the sentinel
urveillance network. Out of these 160 samples represent-
ng 12% were positive for pH1N1. Of these, 83(51.8%) were
t
c
r
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rom males and 120 (75%) of the patients were aged 5 years
nd below. The ages of the positive cases ranged from 9
onths to 53 years. No deaths were recorded in the coun-
ry during that period. 55% of the cases were found in the
estern region, 18% in the central region and 27% in the
astern/Coastal region. The epicenter of the outbreak was
n the Western region and this is reﬂected in the higher
ercentages of cases from that region. The Eastern/Coastal
egion receives many tourists from outside Africa and this
lso is reﬂected in the high percentages of cases reported
ere.
Conclusion: These results indicate that within a few
onths of introduction into Kenya, the pH1N1 quickly spread
hroughout the country. Most of the cases were seen among
hildren less than ﬁve years of age. The results show that
ender was not a risk factor in contracting the virus in Kenya.
oi:10.1016/j.ijid.2010.02.2120
7.038
holerae in the Americas region: An eradicated problem?
. Ramon-Pardo1,∗, G. de Cosio1, M. Tato2, J. Mckenney1
Pan American Health Organization, Washington, DC, USA
Hospital Ramón y Cajal, Madrid, Spain
Background: The Pan American Health Organization
PAHO) proposed, in 1996, monitoring of resistance to
ntibiotics in the Americas Region. Thus organizing the
urveillance and Monitoring Network of Antimicrobial Resis-
ances countries committed to compiling information on
he identiﬁcation of isolated species and their sensitivity
o antibiotics. The protocols of surveillance used within the
etwork are consistent with the recommendations of WHO
or diarrheal diseases and respiratory tract infections. As
athogen responsible for severe disease and serious impact
n public health, Vibrio cholerae from human isolates has
een included among the surveyed pathogens. This study
ims at describing the capacity of the Network for detect-
ng V. cholerae outbreaks, by geographic distribution and
he trends of resistance to antibiotics.
Methods: Information about the serogroups and antimi-
robial susceptibility patterns of V. cholerae isolates were
nnually sent to the Network by the countries. Period of
tudy: 2000-2007. V. cholerae were identiﬁed by standard
aboratory methods. Serotype characterization was per-
ormed by serologic test (slide agglutination technique with
olyvalent antisera). Susceptibility to antimicrobial agents
as determined by the Kirby-Bauer disk diffusion method
nd interpreted ace recommended by the Clinical Labora-
ory Standards Institute.
Results: The total number of V. cholerae human isolates
otiﬁed during the study period was 2095. V. cholerae iso-
ates were only reported from Brazil, Cuba, El Salvador,
exico and Peru. V. cholerae serogroups O1 and non-O1
onstituted 179 (8.5%) and 1561 (74.5%) isolates, respec-
ively. During 2000, 2001 and 2002, 355 (17%) isolates were
otiﬁed without serotype characterization. Since 2003 all
he isolates were reported with the corresponding serotype
haracterization. For V. cholerae serogroup non-O1, the
esistance to ciproﬂoxacin and clorafenicol has remained
ow throughout these years. Nevertheless, the resistance
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to tetracycline, co-trimoxazole and erythromycin were vari-
able during the study period.
Conclusion: The number of isolates reported through the
Network was different from those published by the annual
summaries of cholera cases in WHO Weekly Epidemiologi-
cal Record. These discrepancies reﬂect the limitations in
surveillance and reporting systems. Data demonstrate that
choleare is present in the Americas Region with potential
for oubreaks. Laboratory surveillance should be integrated
in the national surveillance systems for accurate information
on outbreaks and burden of disease.
doi:10.1016/j.ijid.2010.02.2121
57.039
Evidence for inﬂuenza A virus infection among patients
with respiratory tract infections in Nigeria
D. Ehichioya1,∗, R. Orenolu2, N. Gerloff3, S. De
Landtsheer4, A. Nasidi 5, T. Harry5, C. Muller3, S. Omilabu6
1 University of Lagos, Lagos, Nigeria
2 College of Medicine, University of Lagos, Idi-araba, P.M.B.
12003, Lagos, Lagos, Nigeria
3 Institute of Immunology, Department of the National
Health Laboratory, Luxembourg, Luxembourg
4 Institute of Immunology, Department of the National
Health Laboratory, Luxempourg, Luxembourg
5 Department of Public Health, Federal Ministry of Health„
Abuja, Nigeria
6 College of Medicine, University of Lagos, Idiaraba, P.M.B.
12003, Lagos, lagos, Nigeria
Background: Inﬂuenza viruses cause a highly contagious
acute respiratory disease that has resulted in epidemic and
pandemic in human populations over the years. In February
2006, poultry outbreaks of highly pathogenic avian inﬂuenza
A (H5N1) virus were conﬁrmed in Nigeria. A survey was
therefore set up to assess the role of inﬂuenza A virus in
several respiratory tract infections seen in some hospitals in
some hospitals in Lagos, Nigeria.
Methods: From April, 2008 to November 2009, sterile
swabs were used to swab the throat of 182 patients present-
ing with ﬂu-like symptoms. These patients had no knowledge
of exposure to any strain of inﬂuenza virus. Viral RNA were
eluted in transport media, extracted, transcribed and sub-
sequently, the polymerase chain reaction (PCR) was used to
amplify the complementary DNA.
Results: Seventy-eight (42.9%) tested positive for
inﬂuenza A virus: 53.8% and 46.2% were males and females
respectively. Overall, sampling was done in exactly the same
way for the wet (rainy) and dry seasons but 41 (52.6%) of the
positive patients were seen during the wet season while 37
(47.4%) were seen in the dry season. There was no statisti-
cally signiﬁcant difference between these values (p < 0.05).
Conclusion: The results shows inﬂuenza A virus plays
a signiﬁcant role in respiratory tract infections seen all
through the year. As diagnosis is hardly considered in the
management of these infections, it is advised that there
should be continued surveillance for inﬂuenza A infections
in humans. Seroprevalence investigations are also needed to
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ssess the risk associated with strains of inﬂuenza A virus,
iven that these viruses continue to circulate and evolve.
oi:10.1016/j.ijid.2010.02.2122
7.040
elevance of infectious diseases in nephrology patients: A
etrospective single center Review of twenty renal biop-
ies
. Nguyen
Medical College of Georgia, Augusta, GA, USA
Background: Previous studies have examined the speciﬁc
ntities of renal pathology with bacterial/viral diseases.
ew have broadly studied infectious disease relevance
n patients affected by current immunosuppressive and
ytotoxic regimens. This retrospective was performed on
atients who had renal biopsy to assess renal dysfunctions.
Methods: Twenty transplant/non-transplant renal biop-
ies performed between January 1, 2009 and November 30,
009 were randomly reviewed. Concurrent infectious dis-
ases were identiﬁed.
Results: The biopsies belonged to 13 males & 6 females
7 cases: native biopsies & 13 cases: transplant biopsies). Of
he transplant cases, 4 cases showed concurrent infectious
iseases (23%). These cases included 2 cases (15%) from 1
atient with recurrent polyoma nephropathy, 2 cases (15%)
ith chronic allograft nephropathy (including 1 case with
yelonephritis/reﬂux nephropathy & 1 case with HIV having
cute tubular injury). The others, with no infectious compli-
ations, included 5 cases (38%) with delayed graft functions,
case (8%) with severe transplant glomerulopathy, and 1
ase (8%) with chronic allograft nephropathy/recurrence of
ocal proliferative lupus nephropathy. Of the native renal
ases, 2 cases (29%) were identiﬁed with infectious com-
lication. The cases include 1 case (14%) with HIV/HCV
& hypertension/chronic kidney disease/recurrent bacte-
ial pneumonia) and 1 case with urethral stenosis and
hronic pyelonephritis. The remaining cases without infec-
ions include recurrent focal segmental glomerulosclerosis
FSGS), 1 case (14%) with membranous lupus nephropathy,
case (14%) with focal proliferative nephritis & Henoch-
chonlein Purpura (HSP), 1 case with minimal change (14%)
n complete remission, and 1 hypertensive nephropathy
ase with thrombotic microangiopathy (TMA). With current
mmunosuppressive/cytotoxic drug regimen and careful fol-
ow up, few patients demonstrate concurrent infectious
isease. The few affected patients have history of urinary
ract infections associated urinary tract reﬂux/obstruction.
ecurrent polyoma viral nephropathy, seen in 2 cases of
pediatric patient, needed decreased immunosuppressive
egimen, altered cytotoxic therapy, and antiviral medica-
ion. One native kidney case of a patient with HIV/Hepatitis
infection showed recurrent pneumonia.
Conclusion: In this small review, most native & all
ecently transplanted specimens (within several months)
id not show systemic infections despite heavy initial dose
f cytotoxic/immunosuppressive regimen. Few affected
ases showed underlying chronic conditions such as HIV or
bstructive/reﬂux uropathy. Current regimens and clinical
anagement of medical renal diseases/renal transplants
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ppear adequate & effective without risking the patient to
nnecessary infections.
oi:10.1016/j.ijid.2010.02.2123
7.041
he impact of socioeconomic factors on risk and fre-
uency of hospitalization for infectious diseases among
eenagers in sub-sahara Africa
. Udorji 1,∗, C. Ude2
Association for Integrity in Healthcare Research, Enugu,
igeria
University of Nigeria Enugu Campus, Enugu, Nigeria
Background: The association between socioeconomic sta-
us and illness in adults and childhood has been studied
xtensively but the relationship between socioeconomic sta-
us and the risk and frequency of hospitalization has not
een well studied among teenagers. The purpose of this
tudy was to shed light on the individual socioeconomic
tatus on the risk and frequency of hospitalization in a sur-
ey among Teenagers in sub-sahara Africa. This study was
o evaluate the inﬂuence of socioeconomic factors on the
ospitalization of Teenagers with infectious diseases
Methods: A survey of 1250 teenagers were conducted
o ascertain the impact of socioeconomic factors on the
isk and frequency of hospitalization of infectious diseases.
he main exposure variables adjusted for confounding fac-
ors were parents education, parents income and residence
ocation and type of apartment. Hence multiple linear
egressional analysis was applied for the analysis.
Results: 1250 respondents with age 15.61 + 3.71 yrs, male
2.5%, female 47.5%. Teenagers with low income parents
howed the greatest rate of hospitalization than for the
verage and high income parents. In respect of the risk of
ickness, teens with high income parents showed the highest
evel compared to the average and low income counterparts.
he risk of hospitalization was increased in teenagers of
arents with a low level of education compared with voca-
ional education. Malaria was the leading infectious disease
n respective of the level of income, education, residence
ype and location. Malaria is a major health problem and
mong the top leading causes of morbidity in Africa. Low
ocioeconomic status showed a signiﬁcant association with
he rate of being sick of infectious diseases. There was no
igniﬁcant relationship that exist for the risk and frequency
f hospitalization with the location and type of apartment.
Conclusion: The results of this study provides evidence
hat socioeconomic factors can be incriminated as a pre-
isposing factor for increased rate of hospitalization but
ould not be established for the risk of infectious diseases.
ence, support for undertaking larger epidemiological stud-
es to ascertain objectively the impact of socioeconomic
tatus on the risk and frequency of hospitalization in sub-
ahara Africa, so that future preventive efforts can be better
nderstood.
oi:10.1016/j.ijid.2010.02.2124
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8.001
eroprevalence of Toxoplasma gondii antibodies amongst
regnant women at Lagos State University Teaching Hos-
ital
. Akinbami
LASUCOM, LAGOS, LAGOS, Nigeria
Background: Toxoplasma gondii (T.gondii), an obligate
ntracellular parasite found in many species throughout the
orld, causes a variety of clinical syndromes in humans and
nimals. It is also associated with morbidity and mortality
n pregnancy. Hence the need to determine the seropreva-
ence of antibody to toxoplasmosis gondii amongst pregnant
omen.
Methods: A cross-sectional study was carried out using
atients attending the ante-natal clinic of Lagos State
niversity Teaching Hospital Ikeja. All consenting newly reg-
stered antenatal patients were recruited consecutively into
he study within a time frame of six weeks during which a
otal of 179 pregnant participants were obtained. Partici-
ants ﬁlled self administered questionnaires. Five milliliters
f blood was collected from each participant after obtaining
atient’s consent. Sera were assayed for antitoxoplasmo-
is IgG antibody by enzyme linked immunosorbent assay.
ELISA.)
Results: A total of 179 pregnant women were studied.
n assessment of patients’ status to anti-toxoplasmosis IgG
howed 40.8% were positive while 59.2% were negative.
Conclusion: It appears that seroprevalence of toxoplas-
osis IgG antibody amongst the pregnant women in this
tudy population is high. Therefore, it is valuable to fol-
ow up the IgM—antibody status of their off springs which
ndicates recent exposure.
oi:10.1016/j.ijid.2010.02.2125
8.002
typical neuroimaging of neurocystercercosis
.D. Wilke ∗, J. Farrell
OSF St. Francis, Peoria, IL, USA
Background: A 29 year-old Haitian-born woman, who
oved to Chicago at the age of ﬁve, was brought to the
mergency department (ED) by the local police, where she
ad a witnessed seizure. She was afebrile and physical exam
as only remarkable for several tongue lacerations consis-
ent with bite marks. MRI revealed three ring enhancing
upratentorial cystic lesions. The largest was a 4.1× 2.7 cm
ell circumscribed cyst centered within the subcortical
hite matter of the right posterior parietal lobe contain-
ng a ﬂuid/ﬂuid level with a small rim of circumferential
dema.
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Right posterior parietal lobe NCC cyst on MRI.
Methods: CT scan of the head demonstrated multiple,
bilateral supratentorial calciﬁc nodules highly suggestive of
Neurocystercercosis (NCC). Abdominal ultrasound was neg-
ative for focal hepatic lesions. Anticonvulsant and steroid
treatment were begun.
Results: Serum was sent to the parasitology lab at the
CDC for NCC serology, and it was positive. The patient com-
pleted an 8-day course of albendazole as an outpatient
without incident, but presented one month later with recur-
rent seizures refractory to IV anticonvulsant therapy.
Conclusion: NCC is a parasitic infection of the brain
caused by the tapeworm Taenia solium, and is the most
common cause of late-onset seizures in countries where
the infection is endemic, such as Haiti (1, 2). Diagnosis can
be made clinically or by serology, but neuroimaging using
MRI and CT have improved diagnostic accuracy (1). Vesicu-
lar (living) cysticerci appear as isodense cystic lesions with
thin walls without perilesional edema. The scolex is usu-
ally visualized as a ‘‘hole-with-dot’’ lesion (3). Colloidal
cysts (degenerating parasites) are ill-deﬁned ring-enhancing
lesions surrounded by edema. Granular cysticerci (continued
degeneration) appear as nodular hyperdense lesions sur-
rounded by edema or a rim of gliosis. Calciﬁed cysticerci
appear on contrast enhanced images as small hyperdense
nodules without perilesional edema or abnormal enhance-
ment after parasite death. The large ﬂuid/ﬂuid containing
cyst noted in our patient presented a diagnostic challenge.
Published reports of large central nervous system cysts with
intracystic ﬂuid/ﬂuid levels are lacking in the NCC litera-
ture. But the CT ﬁndings, positive serology for NCC and the
low likelihood of two parasitic diseases of the brain con-
vinced us of the diagnosis of NCC.
doi:10.1016/j.ijid.2010.02.2126
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8.003
etection of Toxoplasma gondii antibody for diagnosis of
cular toxoplasmosis
. Maleki 1,∗, S. Sarafpoor2
Iran University of Medical Sciences, Tehran, Iran, Islamic
epublic of
Iran university of medical sciences, Tehran, Iran, Islamic
epublic of
Background: Forty patients with cataracts, as well as 40
atients with proven ocular toxoplasmosis were enrolled in
his prospective clinical study.
Methods: Serum IgG and aqueous IgG in both group were
easured by enzyme linked immunosorbent assay (ELISA)
nd the corresponding ratios were calculated.
Results: Serum IgG/ Aqueous humor IgG ratio was less
hen 100 in the patient group and more then 100 in the con-
rol group. On the other hand in the chorioretinitis subgroup
he ratio was less 13, while in the group with uveitis, the
atio was more then 13 (P < 0.05).
Conclusion: The results revealed that calculating the
atio = SerumIgG (antitoxo)/AqueousIgG (antitoxo) may be
elpful as an adjunet to diagnosis in cases with clinically
typical ocular toxoplasmosis.
oi:10.1016/j.ijid.2010.02.2127
8.004
wo-dimensional gel electrophoresis analysis of T. solium
ysticerci lower molecular mass (10—30kDa) antigens for
he serodiagnosis of neurocysticercosis in children
.S.R. Atluri ∗, P.D. Singhi, N. Khandelwal, N. Malla
Postgraduate Institute of Medical Education and Research,
60012, Chandigarh, India
Background: Neurocysticercosis (NCC) caused by T.
olium cysticerci is an increasingly important health issue in
ndian children. The sensitivity and speciﬁcity of available
erological techniques were low in case of single cysticercus
ranuloma cases which is a more common feature in Indian
atients.
Methods: Serum samples were collected from 13 clin-
cally and radiologically suggestive NCC children and
eropositive by ELISA, 25 clinically and radiologically sug-
estive NCC children and seronegative by ELISA and 25
ontrol subjects. The 10—30 kDa antigens of T. solium cys-
icerci were subjected to 2- dimensional gel electrophoresis
2D-PAGE) followed by Enzyme-linked immunoelectrotrans-
er blot (EITB) assay to detect antibody in serum samples.
DQuest software (Bio-RAD) was used to analyze the
soelectric Point of the protein spots obtained in the
D-PAGE.
Results: Analysis of 10—30 kDa antigenic fraction 2D-PAGE
ap showed 31 proteins between 10- ≤28 kDa and innumer-
ble proteins between >28—30 kDa with the Isoelectric point
f 3—10. All the 13 (100%) NCC seropositive and 15 (60%) out
f 25 NCC seronegative samples were reactive with 2D frac-
ion antigens. In the control group, none of the serum was
eactive except 2 hydatid samples (92% speciﬁcity). Anti-
enic fractions present in between 28—30 kDa with 3—10 pI
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Conclusion: Thus, the present work proved that the stud-
ied ﬁsh harboured infective parasites in their ﬂesh and
intestine that can have great impact on the human health.290 14
ere immunoreactive with signiﬁcantly higher number of
amples.
Conclusion: The sensitivity and speciﬁcity of 2D-PAGE
ITB assay were higher than that reported earlier with the
se of lentil lectin puriﬁed glycoprotein antigenic fractions
ITB assay, which is considered the gold standard serodiag-
ostic method for neurocysticercosis.
oi:10.1016/j.ijid.2010.02.2128
8.005
revalence of intestinal parasitic infections in theMinistry
f Health Hospitals in Sharjah, UAE: 2-year retrospective
tudy
. Dash1,∗, H. Al-Jesmi2, M. AL-Zarouni3, D. Panigrahi1
University of Sharjah, Sharjah, United Arab Emirates
Higher College of Technology, Sharjah, United Arab Emi-
ates
Al-Qassimi Hospital, Sharjah, Sharjah, United Arab Emi-
ates
Background: In United Arab Emirates (UAE) having four
nd a half million population, Sharjah boasts the third
ost populated emirate having 600,000 people [1]. Approx-
mately 80% of the population is expatriates coming from
ountries where parasitic infections are endemic. Many of
hem ﬁnd suitable jobs in various food manufacturing indus-
ries, hotels, restaurants and fast food outlets. They also
ork as food handlers, housemaids and baby sitters. Thus,
ossible transmission can occur between the immigrants
orkforce and native emarati population in the commu-
ity. The present study investigates the prevalence of the
ntestinal parasitic infections in Ministry of Health hospitals
n Sharjah emirate of United Arab Emirates.
Methods: Retrospective laboratory data analysis of ten
housand ﬁve hundred fourteen fecal specimens in ﬁve
ifferent Ministry of Health hospitals within the emirate
f Sharjah, was carried out between January 2007 and
ecember 2008. The stool specimens were examined using
ifferent microbiological analysis including direct and stool
oncentration techniques.
Results: During the study period, eight hundred fourteen
tool specimens were found to be positive for intestinal par-
sites. Of this 814 positive specimens, ﬁve hundred ninety
hree (73%) were from local emarati people and rest 27%
elongs to the expatriates. There was a higher rate of
rotozoal infections (92.2%) than the helminths infection
7.8%). Entamoeba histolytica (71.8%) and Giardia lamblia
17.5%) were the commonest intestinal parasites identiﬁed.
mong the helminths, Ancylostoma dudenale and Ascaris
umbricoides were the common ones. The rate of protozoa
nfection in native emarati population was 71% (577). On the
ther hand, the helminth’s infestations were more common
mong the expatriates (6%).
Conclusion: Possibly the most surprising and unantici-
ated ﬁnding was the far greater prevalence of intestinal
arasitic infections among the native emarati population
73%) compared with the expatriates (27%), and this may
e attributable to better health seeking attitude and more
ccessibility of native emarati people to government hospi-
als then the expatriates. The high prevalence rate among
dternational Congress on Infectious Diseases (ICID) Abstracts
he local people indicates that there is a high transmission
ate in the community. The existing screening methods espe-
ially for food handlers and housemaids need to be improved
nd strengthened.
eference
1]. UAE Population. (2009, April 28). Retrieved April 28, 2009,
from http://www.asiarooms.com/7travel-guide/7united-arab-
emirates/7uae-overview/7uaepopulation.html.
oi:10.1016/j.ijid.2010.02.2129
8.006
study of medically important ﬁsh - transmitted parasites
n Alexandria
.M.G. Diab, M.M. ElTemsahy ∗, E.D. ElKerdany, M. Gaafar,
.A. Nasr
Faculty of Medicine - Alexandria University, Alexandria,
lexandria, Egypt
Background: Seafood has traditionally been a popular
art of the diet in many parts of the world. However, salt and
reshwater ﬁsh can serve as sources of parasitic infections
o man. This study aimed to identify parasites of medical
mportance in the commonly consumed ﬁsh in Alexandria
amely, Tilapia zilli, Mugil cephalus, Clarias gariepinus,
rycinus nurse and Atherina boyeri, and to study their infec-
ivity to laboratory mice.
Methods: The study was applied on 300 ﬁsh during both
old and hot months throughout a year starting from Novem-
er 2006 to October 2007. They were examined for the
resence of parasites in their intestines and ﬂesh, using
odiﬁed Ziehl-Neelsen, safranin and modiﬁed trichrome
tains. Furthermore, ﬁsh ﬂesh was screened for metacer-
ariae of Heterophyidae, which were then isolated by in
itro pepsin-hydrochloric acid digestion. Infection of labo-
atory mice with the detected parasitic protozoa and the
ncysted metacercariae was done to study their infectivity
nd their pathological outcome. The obtained heterophyids
ere examined after clearance in lactophenol and staining
ith carmine stain.
Results: Results showed that the following parasites were
etected; Microsporidia, Cryptosporidia and Cyclospora in
sh intestine, and metacercaria of Pygidiopsis genata in
sh ﬂesh. Tilapia zilli was the most infected ﬁsh, followed
y Clarias gariepinus, then, Atherina boyeri and Brycinus
urse. The least infected ﬁsh was Mugil cephalus. All the
etected parasites were found to be infective to exper-
mental mice as proved by observation of the previously
entioned protozoa and heterophyid eggs in their stool
amples, and also by the histopathological changes in their
ntestinal sections.oi:10.1016/j.ijid.2010.02.2130
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58.007
Study of the clinical efﬁciency of covariumtm10 on
patients suffering from intestinal amoebiasis
M.N. Emmanuel
University of Yaoundé I, Yaoundé, Centre, Cameroon
Background: Amoebiasis is caused by a protozoan par-
asite, Entamoeba histolytica with or without clinical
symptoms and is the third leading cause of death from par-
asitic diseases. This study evaluated the efﬁciency of the
improved traditional medicine (CovariumTM10) in the treat-
ment of intestinal amoebiasis.
Methods: Thirty patients suffering from intestinal amoe-
biasis and aged from 3-77 years were selected and grouped
according to the stage of infection. These patients were
sequentially treated with 2 zip-locked bags of Covari-
umTM10 for two days, by administration of one bag once
per day. Six days after, stool was collected for parasitological
examination. Concomitantly, blood samples were collected
from all patients for the quantiﬁcation of transaminases
(AST, ALT) and creatinin. An additional bag of CavariumTM10
was prescribed to patients who still presented some Enta-
moeba histolytica cysts in their stool and 4 days after
the administration, another parasitological examination was
carried out.
Results: The research of amoebae in stool on day 6 of
treatment showed that 25 of the 30 patients (83.33%) were
cured with 2 zip-locked bags of CovariumTM10 and the rest
(5 of the 30: 16.67%) were cured after taking the third bag
of the drug. It was observed that, only adult patients (20%
of them) needed an additional bag of the drug for com-
plete treatment while all the children were cured with 2
zip-locked bags of CovariumTM10. Blood chemistry showed
no abnormal changes in creatinin and transaminases levels.
All of these parameters were maintained at their normal
level 6 days after completion of the therapy.
Conclusion: CovariumTM10 is efﬁcient in treating
patients suffering from intestinal amoebiasis and a posol-
ogy of two bags of CovariumTM10 for children and three
for adults, taking one bag once per day, may efﬁciently cure
patients suffering from this infection. This medicine can now
be considered as an alternative drug in the treatment of
patients suffering from intestinal amoebiasis.
doi:10.1016/j.ijid.2010.02.2131
58.008
Anisakis simplex from the Adriatic sea
I. Zurak
Hospital/University, Zagreb, Croatia
Background: The presence of parasites in ﬁsh is very
common, between more species of helminth parasites from
ﬁsh are known to cause diseases in man, more important is
Anisakis simplex. Anisakis simplex is ubiquitary parasite in
world sea, distributed and in the Adriatic sea. During clean-
ing of ﬁsh, many fail to notice the presence of the lively larva
of the Anisakis simplex, parasite in the abdominal cavity.
Methods: The examine randomly collected ﬁsh, avail-
able a few ﬁsh market at the Zagreb. During cleaning of
s
d
sts e291
sh to ﬁeld the pesence very mobile of the lively Anisakis
implex. The parasites can be found in the viscera, in
he musculature, collected from different organs in the
bdominal cavity, the prime site of infection was the liver.
nisakis simplex is ﬁnd in: Scomber scrombrus, Spanish
ackerel, Scomber japonicus colias, Trachurus trachurus
nd mediterrabeus, Sarda sarda and Merlucius merlucius
aught. During cleaning of ﬁsh to ﬁeld the pesence very
obile of the lively Anisakis simplex. The parasites can be
ound in the viscera, in the musculature, collected from
ifferent organs in the abdominal cavity, the prime site of
nfection was the liver. Anisakis simplex is ﬁnd in: Scomber
crombrus, Spanish mackerel, Scomber japonicus colias,
rachurus trachurus and mediterrabeus, Sarda sarda and
erlucius merlucius caught.
Results: The most intensive infection was noticed in
orse mackerel, Spanish mackerel and then Atlantic mack-
rel. Do not discover in pilchard. Activity was in muscles
ept at 4oC. Immersed in a saline solution in a Petri dish,
wam undulating the body. In these conditions, they could
urvive several days at room temperature. Low (-20oC) or
igh temperatures (55oC during 1minute) and high salt
oncentrations (NaCl) may be used to kill or inactivate
ematodes in ﬁsh.
Conclusion: Anisakis simplex is of much medical impor-
ance because of the severe allergic reactions and
astrointestinal symptoms it causes in humans after eating
r handling infected ﬁsh or crustaceans. Bad, inaccessible
aboratory diagnostics conditions miss in the rareripe discov-
ring of falling ill. Infection is high in the ﬁsh species from
driatic area and it is expected to be reﬂected on human
ealth.
oi:10.1016/j.ijid.2010.02.2132
8.009
valuation of OSOM Trichomonas rapid test for diagnosis
f Trichomonas vaginalis infection in females
. Shujatullah1,∗, H.M. Khan1, R. Khatoon1, T. Rabbani1, M.
hahid2, A. Raza1
J.N. Medical College, 202001, India
J.N. Medical College & Hospital, 202002, India
Background: Trichonomas vaginalis is a parasitic proto-
oan, sexually transmitted world wide. WHO estimates show
hat this infection accounts for almost half of all curable
exually transmitted infections. Diagnosis is usually done
y observing motile parasite from vaginal or cervical swab
pecimens by direct wet mount examination. Other diagnos-
ic test includes geimsa staining, ﬂuorescent staining and
ulture.. OSOM rapid test (Genzyme Diagnostics Cambridge
assachusettes) based on immunochromatographic capillary
ow dipstick is newer method available for diagnosis of sex-
ally transmitted disease.
Objectives: To compare wet mount examination, giemsa
taining and acridine orange staining, culture as diagnos-
ic test for Trichomonas Vaginalis To compare sensitivity,
peciﬁcity of OSOM trichomonas rapid test with culture and
ifferent staining techniques vailable for diagnosis of this
exually transmitted disease.
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Methods: The study was carried out on 405 aged 15-45
ears patients attending gynecological out patient depart-
ent with complaint of vaginal discharge. Four high vaginal
wabs from posterior fornix of vagina were taken from each
atient. One swab used for preparation of wet mount, one
or making smearsof giemsa and acridine orange staining and
ther for OSOM trichomonas rapid test and culture done on
upferberg culture medium.
Results: Out of 405 patient of vaginal discharge included
n the study, Wet mount and giemsa staining showed
.vaginalis in 7 (1.7%) cases each. Acridine orange stain-
ng was positive in 12 cases (3.0%), while OSOM rapid test
etected vaginalis infection in 15 cases. Culture on kupfer-
erg medium was positive in 18 (4.4%) patient, sensitivity;
peciﬁcity of wet mount examination was found to be 38.9%,
00%, positive and negative predictive values, 100% and
7.2%. Giemsa and acridine orange staining showed sensi-
ivity of 38.9% and 66.67% and speciﬁcity 100% each. OSOM
apid test was found to be most sensitive when compared to
et mount examination and staini8ng techniques taking cul-
ure on kupferberg medium as gold standard, while staining
ethods and OSOM test were found to be equally speciﬁc.
Conclusion: OSOM rapid test can be used as adjunct to
icroscopy and culture. Its high sensitivity and speciﬁcity
dvocates its use in settings were culture is not possible as
irect microscopic examination and different staining tech-
iques fails to detect infection in large number of cases.
oi:10.1016/j.ijid.2010.02.2133
8.010
iardia intestinalis: DNA extraction approaches to
mprove PCR results
. Babaei1,∗, E. Razmjou2, H. Oormazdi3, S. Rezaie4, M.
ezaeian1
Tehran, Iran, Islamic Republic of
Iran University of medical siences, Tehran, Iran, Islamic
epublic of
Iran university of medical sciences, Tehran, Iran, Islamic
epublic of
Tehran university of medical sciences, Tehran, Iran, Islamic
epublic of
Background: Difﬁculty in disrupting cysts of Giardia
ntestinalis, a cosmopolitan protozoan parasite, decreases
he yield of DNA extracted and reduces the effectiveness of
he polymerase chain reaction (PCR). To improve the detec-
ion of the Giardia Glutamate Dehydrogenase (gdh) gene,
e re-evaluated the effects of deoxyribonucleic acid (DNA)
xtraction methods.
Methods: The Giardia cysts were concentrated from 33
ositive fecal samples in a sucrose gradient with a spe-
iﬁc gravity of 0.85M and then washed with distilled water.
NA extraction was carried out by one of two methods,
he QIAamp Stool Mini Kit (QIAgene, Germany) or the con-
entional phenol/chloroform/isoamyl alcohol (PCI) method.
or pretreatment, the Giardia cyst walls were disrupted by
lass beads, freeze-thaw cycles, or combinations of these
ethods, and DNA extraction was performed by one of two
ethods. Ampliﬁcation of the gdh gene was performed as a
ingle PCR.
3
r
c
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Results: Without pretreatment of cysts, the gdh gene was
ot ampliﬁed from any DNA sample whether using the con-
entional PCI extraction method or the QIAamp DNA Stool
ini Kit. After pretreatment of the cysts with glass beads
nd freeze/thaw cycles, the target gene was ampliﬁed in
ll 33 extracted DNA samples. The 458 bp fragment of gdh
ene was ampliﬁed in nine samples using PCI (31.0%), and in
he 24 remaining extracted DNA samples with the QIAamp
NA Stool Mini Kit.
Conclusion: Consequently, the pretreatment of cysts with
lass beads and freeze/thaw cycles followed by extraction
f DNA with the QIAamp Stool Mini kit was the more effective
rotocol.
oi:10.1016/j.ijid.2010.02.2134
8.011
an cystic Echinococcosis trigger autoimmunity?
. Aslan1, Y.A. Oner2, S. Saribas1,∗, E. Polat1, H. Cakan3,
. Yuksel1, K. Zengin1, S. Arikan4, M.M. Torun1, B.
ocazeybek1
Istanbul University Cerrahpasa Faculty of Medicine,
urkey, Turkey
Istanbul University, Istanbul Medical Faculty, Istanbul,
urkey
Istanbul University, Forensic Medicine Institue, Istanbul,
urkey
T.C Health Minister Istanbul Education and Training Hospi-
al, Istanbul, Turkey
Background: Cystic echinococcosis(CE) is a zoonosis and
isseminated disease in worldwide. Little is known about
arasitic molecules that behave like immunomodularoty
ntigens and the mechanisms that they use to evade
he host’s immune response. Some authors suggested that
mmunomodulatory antigens of Echinococcus granulosus can
irectly inhibit the basic immune cell functions and stim-
late the immune molecules for the development of CE.
e aimed to evaluate the role of parasitic molecules
f E. granulosus and also evaluate the link between
mmunomodulatory effects of these molecules and autoim-
unity etiopathogenesis of the host by serology.
Methods: Twenty-eight non-operated patients with
ydatid cysts (NOP) and 88 operated patients with hydatid
ysts (OP) were included as study group and 54 healthy indi-
iduals with no known chronic diseases were included as
ontrol group. The presence of ANA (Anti nükleer antibody),
SMA (Anti Smooth Muscle Antibody) and AMA/LKM (Anti
itokondrial Antibody /Liver Kidney Microsomal Antibody)
ntibodies which were known as autoimmune parameters
ere investigated for all groups by using Euroimmune indi-
ect ﬂuorescent antibody (IFA) kits (Euroimmune Labor
iagnostica, Germany). The ages of patients were between
6- 83 years and patient and control groups were matched
or age and gender. Patients with positivity in at least one out
f three tests were considered positive for autoimmunity.
Results: The antibodies were detected in 16(57,1%),
2(36,3%) and 12(23%) of NOP, OP and control groups,
espectively It was detected a statistically higher signiﬁ-
ant difference between NOP and healty controls (p < 0.01).
o difference was detected between OP and healty con-
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trols (p > 0.05). No statistically signiﬁcant difference were
detected between OP and control groups, but we detected a
moderately higher positivity in results of OP. It was detected
a signiﬁcant difference between all patient groups (patients
with NOP and OP) and control group (p < 0.05).
Conclusion: As a result, detection of high autoantibod-
ies in NOP regarding to our results suggested us, these
chronic long-lasting disease process together with their
immunoregulatory molecules may activate unknown autoim-
mune mechanisms of the host and lead to formation of
autoimmunity. We also suggest that the decrease of autoan-
tibodides in OP may be caused by the absence of antigenic
stimulus originated from hydatid cysts.
doi:10.1016/j.ijid.2010.02.2135
58.012
Prevalence of intestinal parasitoses and factors related
in the population infant of the community Santa Bárbara,
Municipality Valley Guanape, State Anzoategui, Bolivarian
Republic of Venezuela
R. Martínez
Instituto de Medicina Tropical ¨Pedro Kourí¨, Ciudad
Habana, Cuba
Background: Intestinal parasitism affects mainly the
infant population, on a worldwide scale; it is assessed that
contributes the greatest number of infected among more
than 1000000 of people who every year is declared. The
objective was to determine the prevalence of intestinal par-
asitism in the infant population of the community Santa
Barbara and to identify some risk factors.
Methods: A prevalence study was conducted. Universe:
infant population from 0 to 14 years, including a total of 172.
The collection of the primary datum was carried out under
the total consent of the parents, who were interviewed, and
some general data and of epidemiological interest was also
gathered. Two stool samples were in addition collected by
spontaneous defecation to each child. This study was con-
ducted during the months from February to August 2008.
For the analysis of association among the variables there
were used the tests of comparison of proportions, and of
X2, being considered a level of statistical signiﬁcance when
p value was equal or less than 0.05. In order to establish the
strength of association among some variables, the Reason of
Prevalence was used, there was taken into account the 95%
conﬁdence interval (CI).
Results: A total of 89 children were parasitized, for a
prevalence of 51.7%, being the ages of 5-9 most affected
(52.8%), as well as the male sex (56.1%). The risk factors
associated with the intestinal parasite infection were water
consumption without boiling, PR = 2.91 [1,8—4.4], not hav-
ing in-house WC, (PR = 3.8 [1.61—6.31], the utilization of
the collective well as source of water supply (RP = 1.80 [1.1-
3.1] and the use of feeding-bottle, (PR = 3.85 [1.8—8.1]. The
symptom that most frequently we found was the abdominal
pain (43.8%), the parasite that predominated was Giardia
lamblia followed by Entamoeba histolytica.
Conclusion: The prevalence of intestinal parasitism in the
infant population of the community studied was high, being
corroborated a narrow relationship between the presence
a
o
lts e293
f parasites and some risk factors that predisposed to the
ntestinal parasitism.
oi:10.1016/j.ijid.2010.02.2136
8.013
fﬁcacy and safety of ivermectin versus high dose
lbendazole for chronic strongyloidiasis in immunocom-
romised patients
. Suputtamongkol1,∗, K. Bhumimuang1, D. Waywa1,
. Nilganuwong1, N. Premasathian1, A. Karuphong1, T.
nekthananon2, D. Wanachiwanawin3, S. Silpasakorn1
Department of Medicine, 10700, Thailand
Department of Preventive Medicine, 10700, Thailand
Department of Parasitology, 10700, Thailand
Background: Ivermectin and albendazole are effective
gainst strongyloidiasis. However the efﬁcacy and the most
ffective dosing regimen in immunocompromised patients
re to be determined.
Methods: A prospective randomized open study com-
ared a 7-day course of oral albendazole 800mg daily with
single dose (200mg/kg), or two single doses given 2 weeks
part of ivermectin in Thai patients with chronic strongy-
oidiasis. The primary end points were relief of symptoms (if
resent) and clearance of Strongyloides larvae from faeces
fter treatment and at one year follow up.
Results: 90 patients were included in the analysis (30,
1, and 29 patients in albendazole, single dose, and two-
ingle doses ivermectin group respectively). Only 3 patients
n this study did not have any underlying diseases. Diabetes
ellitus, SLE, nephrotic syndrome, hematologic malignancy,
olid tumor, and HIV infection were common underlying dis-
ases these patients. The median (range) duration of follow
p were 15 (2—62) weeks in albendazole group, 30 (2—59)
eeks in single dose ivermectin group, and 24 (2—61) weeks
n two single doses ivermectin group. Cure rates were 76.7%,
6.8% and 100% in albendazole, single dose oral ivermectin,
nd two single dose oral ivermectin respectively (P = 0.003)
n perprotocol analysis. No serious adverse event associated
ith treatment was found in all groups.
Conclusion: This study conﬁrms the superiority of iver-
ectin compared to high dose of albendazole for the
reatment of chronic strongyloidiasis in immunocompro-
ised patients. A single oral dose was as effective as two
ingle oral doses of ivermectin.
oi:10.1016/j.ijid.2010.02.2137
8.014
iochemical and immunological characterization of the
hCBP30 protein from Entamoeba histolytica
. González ∗, A. Carabarin, L. Baylon-Pacheco, J.L.
osales-Encina
CINVESTAV-IPN, México, MexicoBackground: Entamoeba histolytica, is the causative
gent of the amoebiasis. The infection is asymptomatic, but
nly a few people develop complications such as amebic
iver abscess. During this event, E. histolytica trophozoites
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urvived in liver in anaerobic conditions, and they can sur-
ive high concentration of reactive oxygen species (ROS),
his capacity for surviving to ROS is mediated by detoxifying
nzymes like peroxiredoxins.
Methods: The EhCBP30 gene, with homology to peroxire-
oxins, was ampliﬁed by PCR. The ampliﬁed DNA was cloned
n the plasmid pRSET, and the His-tagged EhCBP30 recombi-
ant protein was puriﬁed. The antioxidant capacity of the
rotein His::EhCBP30 was studied in MCO assays, and the
eroxidase activity (PO) of this protein was also assayed.
ice were immunized (ip) with the protein His::EhCBP, and
erum samples were obtained one week after the last immu-
ization. Anti-EhCBP30 antibodies (isotype) was assayed by
LISA, and induced cytokines were evaluated by ﬂow cytom-
try.
Results: In MCO assays, there is a iron-salt-dependent
ecomposition of hydrogen peroxide, generating the highly
eactive hydroxyl radical that promote oxidative DNA dam-
ge (nicks). However, a protein with PO activity will protect
NA against the damaging effect of hydroxyl radicals.
hen the His::EhCBP30 protein was included in the MCO
ssays, protection of DNA nicking was clearly detected,
uggesting a PO activity of the His::EhCBP30 protein.
n the PO activity assays the protein His::EhCBP30 was
ble to eliminate hydrogen peroxide in a dose depen-
ant reaction. Finally, to investigate whether the EhCBP
s immunogenic, mice were immunized (ip) with the pro-
ein, and 15 days after the last immunization serum samples
ere obtained. Results showed that the EhCBP30 protein
nduces an immunoglobulin immune response with the Igs
sotypes IgG2b > IgG1 > IgG2a > IgG3, suggesting a non polar-
zed Th1/Th2 immune response. However, when serum
ytokines were examined, only IL-2, IL-6, IL-10 and IL-17
ere detected, thus indicating that a Th1 immune response
as polarized.
Conclusion: The ﬁndings of this study indicated that the
hCBP30 protein has antioxidant activity (peroxiredoxin),
nd is able to induce a Th1 immune response. Therefore,
he EhCBP30 may be a good candidate for further immuno-
roﬁlaxis studies.
oi:10.1016/j.ijid.2010.02.2138
8.015
oil-transmitted helminthiasis in rural South West China:
revalence, intensity and risk factor analysis
. Moﬁd ∗, Q. Bickle
London School of Hygiene and Tropical Medicine, London,
nited Kingdom
Background: Soil-transmitted helminth infections (STHs)
re common across China and carry a signiﬁcant disease
urden, especially in children. Few studies have investi-
ated the local epidemiology of soil-transmitted helminth
nfections (STHs) in rural China or the risk factors for trans-
ission. The present study compared STH prevalences in
imao and Mengla counties, Yunnan province, China, in col-
aboration with the Yunnan Institute of Parasitic Diseases.
Methods: Faecal samples were collected from 317 school-
ged children and from 94 inhabitants of a single village
o determine age-prevalence. The Kato-Katz thick smear
i
t
e
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ethod was used to determine prevalence and intensities
f the different STHs found. Data on socio-demographic and
ehavioural risk factors for the schoolchildren were col-
ected using questionnaires.
Results: In Simao County the overall STH prevalence
as 40.2% (2.7%, 5.4% and 35.7% for ascariasis, trichuriasis
nd hookworm infection, respectively). STHs were signiﬁ-
antly higher in Mengla County, with an overall prevalence
f 68.3% (19.0%, 34.6% and 47.3% for ascariasis, trichuri-
sis and hookworm infection, respectively). According to
orld Health Organization (WHO) STH intensity guidelines,
he majority of infections were ‘‘light,’’ but, 6.6% of hook-
orm infections were ‘‘heavy’’. Multiple logistic regression
ound that females were less likely to be infected with
richuris trichiura (OR: 0.29, 95% CI: 0.15—0.56) and with
ookworms (OR: 0.55, 95% CI: 0.33—0.93) than males. Chil-
ren 12 years of age or older had increased risk of hookworm
nfection (OR: 2.9, 95% CI: 1.2—7.1). Children with mothers
ith educational attainment of secondary school or higher
ad a protective effect against T. trichiura (OR: 0.18, 95%
I: 0.06—0.54) and hookworm (OR: 0.21, 95% CI: 0.09—0.51)
nfections. The Jinuo ethnicity was most prevalent in Mengla
ounty and had the highest risk of infection with T. trichiura
OR: 10.71, 95% CI: 2.78—41.28) and hookworm (OR: 4.64,
5% CI: 1.50—14.30). In the village survey for age preva-
ence, hookworm was again the most prevalent species
62.8%) with a high prevalence persisting in those 50 years
f age and older.
Conclusion: The observed higher prevalences of STHs in
engla County could be due to differences in cultural and
ygiene practices among native ethnic groups. Based on
ecommended intervention strategies by the WHO, Simao
ounty should opt for schoolbased deworming annually,
hile Mengla County should implement a similar strategy
iannually. In addition, targeted strategies in Mengla County
hould include the elderly population.
oi:10.1016/j.ijid.2010.02.2139
8.016
ymenolepiasis in institutionalized Romanian children
.R. Olariu1,∗, G. Darabus2, I. Marincu1, C. Balutescu3, V.
umitrascu3, C. Petrescu3, A. Koreck3
Victor Babes University of Medicine and Pharmacy,
imisoara, Romania
Faculty of Veterinary Medicine, Timisoara, Romania
Victor Babes University of Medicine and Pharmacy,
imisoara, Romania
Background: Parasitic diseases represent an important
ublic health problem. Digestive parasitosis are char-
cterized by high prevalence and a variety of clinical
anifestations, being especially frequent in institutional-
zed children.The aim of the present study was to investigate
he prevalence of intestinal parasitic infections in a Roma-
ian Children Care Unit.
Methods: Stool examinations were performed using the
odine staining for the identiﬁcation of protozoan cysts and
he Willis-Hung method for the identiﬁcation of helminth
ggs. Eosinophil values were determined by differential
hite blood cell count with May Grunwald Giemsa staining.
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Results: We investigated 64 institutionalized children
aged 2 to 12 years. Parasitic infections were identiﬁed in 44
cases (68.7%). Hymenolepis nana (31.2%), Giardia lamblia
(28.1%), Blastocytis hominis (7.8%), Entamoeba coli (4.7%),
Ascaris lumbricoides (4.7%), and Trichuris trichiura (3.1%)
were diagnosed. We have determined associations of two
(45.4%) and more than two parasites (18.2%) among the
infected children; of the 20 with hymenolepiasis, 11 (55%)
had multiple parasitic infections. Clinical and laboratory
examinations were conducted to investigate the presence of
symptoms and eosinophilia in patients with parasitic infec-
tions. Diarrhoea (38.6%), weight loss (47.7%), abdominal
pain (25%), nervous disorders (34.1%), cutaneous manifesta-
tions (22.7%), fever (9.1%) and respiratory infections (59.1%)
were reported in the infected children. Eosinophilia was
noted in 27 (61%) of the 44 patients with parasitosis. High
eosinophil values were mostly observed among those diag-
nosed with helminth infections.
Conclusion: Hymenolepis nana infection was reported
with an increased frequency among Romanian institu-
tionalized children. The majority of the patients with
hymenolepiasis were diagnosed with multiple parasitic
infections.
doi:10.1016/j.ijid.2010.02.2140
58.017
Computational characterization of molecular mechanism
of surface receptor binding with alpha-enolase of Tri-
chomonas vaginalis
S. Dwivedi1,∗, S. Mishra2, N. Husain3, N. Malla4
1 CSM Medical University, Lucknow, India
2 College of Engineering & Technlology, Moradabad, UP, India
3 CSM Medical University, Lucknow, UP, India
4 Postgraduate Institute of Medical Education and Research,
160012, Chandigarh, India
Background: Trichomonas vaginalis is a parasitic proto-
zoan causing the most common human sexually transmitted
disease (STD), trichomoniasis. The exact mechanism of its
pathogenesis is still obscure. Alpha-enolase plays a piv-
otal role in the host-pathogen interaction, and as a surface
receptor of several protists mediating plasminogen binding.
In view of identifying plasminogen binding sites of T. vagi-
nalis alpha-enolase, homology modeling and docking studies
were conducted to obtain modeled structures of the T. vagi-
nalis alpha-enolase-plasminogen complex.
Methods: The protein sequence of T. vaginalis alpha-
enolase used in this study was kindly provided by Dr.
John F. Alderete (University of Texas, USA). Modeling tem-
plates were searched by using BLAST, followed by multiple
sequence alignment. The atomic coordinates of Escherichia
coli enolase was retrieved from Protein Data Bank. Molecu-
lar structures of T. vaginalis alpha-enolase were modeled
by using restraint-based modeling, followed by energy
minimization using MODELLER program. The quality and
stereochemistry of the models were evaluated by program
PROCHECK. After addition of Mg2+, the selected model
further reﬁned by energy minimization employing NAMD pro-
gram. The VMD program was used to superimpose structure
of T. Vaginalis alpha-enolase model with crystal structures
a
c
s
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f enolases from E. coli and S. pneumoniae. T. vaginalis
lpha-enolase model was docked to human plasminogen for
rotein-protein interaction using Hex 5.1. Mark Gerstein’s
alc-surface program was used to calculate the solvent
ccessibility at the interface of T. vaginalis alphaenolase
nd human plasminogen before and after docking.
Results: Molecular docking revealed hydrogen bond-
ng of eLys70-pgTyr50, eAsn165- pgThr66, eAla168-pgGlu21,
Asp17-pgLys70, and eAsn213-pgPro68/pgAsn69. Substantial
ecreases in accessible surface area (ASA) were observed
nd in concurrence with hydrogen bond pattern.
Conclusion: These ﬁndings provide new insights for inter-
ction at the protein-protein interface. Our theoretical
rediction is consistent with preexisting biochemical data.
he predicted interaction complex can be of great assis-
ance in understanding structural insights, probably being
ecessary to an interaction between pathogen and host-
omponent. The ability of T. vaginalis alpha-enolase to bind
lasminogen may be indicative of being a key player in
nvasion of this pathogen to host. Conclusively, this work
heoretically establishes the T. vaginalis alpha-enolase as a
ovel surface-linked virulence factor.
oi:10.1016/j.ijid.2010.02.2141
8.018
revalence of Dientamoeba fragilis among asymptomatic
ndividuals from North Central Venezuela
. Jimenez1, J. Cortez1, M. Diaz1, C. Duran2, G. Hidalgo3,
. Aguilera4, S. Nakal4, C. Albano5, R.N. Incani1, A.
odriguez-Morales6,∗
Department of Parasitology, Faculty of Health Sciences,
niversidad de Carabobo, Valencia, Venezuela
Coordination of Coproparasitology, Direction of Biolog-
cal Sciences, Foundation Center for Studies on Growth
nd Development of the Venezuelan Population (FUNDA-
REDESA), Ministerio del Poder Popular para las Comunas
Protección Social, Caracas, Venezuela
Direction of Biological Sciences, Foundation Center for
tudies on Growth and Development of the Venezuelan Pop-
lation (FUNDACREDESA), Ministerio del Poder Popular para
as Comunas y Protección Social, Caracas, Venezuela
Coordination of Statistics, Direction of Population Studies,
oundation Center for Studies on Growth and Development
f the Venezuelan Population (FUNDACREDESA), Ministerio
el Poder Popular para las Comunas y Protección Social,
aracas, Venezuela
General Direction of Research, Foundation Center for
tudies on Growth and Development of the Venezuelan Pop-
lation (FUNDACREDESA), Ministerio del Poder Popular para
as Comunas y Protección Social, Caracas, Venezuela
Direction of Population Studies, Foundation Center for
tudies on Growth and Development of the Venezuelan Pop-
lation (FUNDACREDESA), Ministerio del Poder Popular para
as Comunas y Protección Social, Caracas, Venezuela
Background: Dientamoeba fragilis is a protozoan par-
site, with the presence of only trophozoites in its life
ycle, with worldwide distribution, and that may be con-
idered responsible for enteric disease in humans. Although
escribed in 1918 by Dobell, many clinical and pathological
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spects of D. fragilis, including its epidemiology, still need
ore study in order to improve the understanding of this
merging parasite.
Methods: In the context of a Venezuelan Study on Human
rowth and Development (SENACREDH), a cross-sectional
tudy of 3388 asymptomatic individuals (1656 male, 1732
emale; mean age 13.05± 0.22year-old) from 40 municipal-
ties of North Central Venezuelan states (Aragua, Carabobo,
iranda, Vargas and Capital District) was carried out. Dien-
amoeba fragilis was diagnosed in stool samples after being
reserved in MIF media.
Results: We found a prevalence of 1.8%
95%CI1.39—2.32%). From the total of individuals with
. fragilis infection (61), 52.5% were females and 47.5%
ales. Mean age was 14.37years-old(±12.59). Preva-
ence according to sex was not different (p = 0.935),
either to age (p = 0.144). From those infected, 10.9% pre-
ented anemia (6.54% microcytic hypocromic), 43.5%
resented relative eosinophilia. Mean haemoglobin
as 13.07 g/dL(10.8—14.9 g/dL), mean %eosinophils
.17%(0—23%), and mean eosinophils count 396.93
ells/mm3(0—1760 cells/mm3). Co-infections with other
arasites were identiﬁed: 80.3% Blastocystis hominis,
7.9% Endolimax nana, 26.2% Iodamoeba butschlii, 13.1%
ntamoeba coli, 9.8% Giardia lamblia, 8.2% Ascaris lum-
ricoides, 1.6% Trichuris trichiura, 1.6% Hymenolepis nana
nd 1.6% Entamoeba histolytica/dispar.
Conclusion: Eosinophilia has been occasionally described
n cases of D. fragilis infection. However, herein a signiﬁcant
roportion of patients presented it suggesting a pathologi-
al role of this protozoan. As has been previously reported
signiﬁcant proportion of helminth and other protozoan
oinfections was found in this study, suggesting a shared
ransmission mode with these enteric parasites. There are
reat gaps in our present state of knowledge concerning
he virulence, pathogenicity, and mode of transmission of D.
ragilis. However, the neglect of D. fragilis as an emergent
arasite should not longer be justiﬁed as there are a grow-
ng number of reports incriminating it in different enteric
iseases.
oi:10.1016/j.ijid.2010.02.2142
8.019
isk factors in patients with trichinellosis from Western
omania
. Marincu ∗, L. Negrutiu, A.M. Neghina, I. Iacobiciu, R.
eghina
Victor Babes University of Medicine and Pharmacy
imisoara, Romania, Timisoara, Romania
Background: Trichinellosis continues to be an important
ublic health issue in Romania due to the consumption of
nveriﬁed pork from unauthorized sources. Authors of the
resent paper established the risk factors in a study group
f patients diagnosed with trichinellosis.
Methods: We have retrospectively analyzed the medi-
al charts of 121 patients, inhabitants of four trichinellosis
ndemic areas in Timis County, Romania who were admitted
o Hospital of Infectious Diseases Timisoara during 2002-
009. The diagnosis was based upon epidemiologic features
c
r
e
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the onset of infection following consumption of infected
ork with Trichinella spiralis), clinical features (fever,
eadache, chills, nausea, diarrhea, facial edema, myalgia,
rticaria etc.) and laboratory tests (erythrocyte sedimenta-
ion rate, ﬁbrinogen, antibodies against Trichinella spiralis,
eukocyte counts, eosinophil counts etc). The results of
he monitoring of the clinical, laboratory and therapeutic
arameters were registered in the individual ﬁles of the
atients. Epi Info soft was used for the statistical processing
f data.
Results: There have been recorded two trichinellosis foci
oth in rural (Iecea — 26 cases and Padureni — 5 cases) and
rban regions (Kuncz — 57 cases and Ronat — 33 cases).
ccording to the ethnic origin of the patients, 95.86% of
hem belonged to the gipsy minority, characterized by a low
evel of education (without respect to the basic individual or
ollective hygienic alimentary rules), and speciﬁc unhealthy
nd unsafe food habits. Although they were in the evidences
f general practitioners, only 9 of them (7.75%) used to ben-
ﬁt of the regular medical visits. Nevertheless they didn’t
uy the prescribed drugs and didn’t follow the indicated
herapy. All of the patients had consumed unveriﬁed pork
nfected with Trichinella spiralis that was illegally traded.
n Iecea focus the consumed meat was taken by the gypsies
rom a septic tank where it was deposited for destruction.
hirty-eight patients (30.17%) had consumed undercooked
ork and additional pork products (smoked sausages). During
he hospitalization, 86.20% of the gypsy patients presented
n inadequate and recalcitrant behavior.
Conclusion: The study of the risk factors for trichinellosis
llows the implementation of programs for prophylaxis and
ecrease of the incidence of disease in regions where this
evere zoonosis is widespread.
oi:10.1016/j.ijid.2010.02.2143
8.020
he prevalence of giardiasis in patients with acute ente-
ocolitis from Timis County, Romania
. Marincu ∗, L. Negrutiu, I. Iacobiciu, A.M. Neghina, R.
eghina
Victor Babes University of Medicine and Pharmacy
imisoara, Romania, Timisoara, Romania
Background: According to its increased incidence and
evere complications, acute enterocolitis continues to rep-
esent a global major public health concern. The present
tudy aimed to determine the prevalence of giardiasis in a
roup of patients diagnosed with acute enterocolitis in Timis
ounty, Romania.
Methods: We have retrospectively analyzed the medical
harts of 84 adult patients diagnosed with acute enterocol-
tis who were admitted at the Hospital of Infectious Disease
n Timisoara. The diagnosis was established upon clinical
eatures (fever, abdominal colic, repeated watery diar-
heic stools, dehydration, asthenia, unspeciﬁc cutaneous
ruption, muscular cramps etc.), laboratory tests (leuko-
yte counts, leukocytic formula, erythrocyte sedimentation
ate, ﬁbrinogen, C-reactive protein, stool culture, stool
xamination, natremia, kalemia, calcaemia etc.) and other
xplorations (abdominal echography, electrocardiography).
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ity test, conventional ELISA had just 32.9% of speciﬁty
(95%CI28.2—38.0).
Conclusion: These results, as other previous, suggest that14th International Congress on Infectious Diseases (ICID) Abs
Stool examinations, repeated after 1 to 2 days, were per-
formed in all patients to detect Giardia lamblia cysts.
Results: Of the 84 patients included in the study group,
in 8 cases (9.52%) were detected Giardia lamblia cysts. The
epidemiologic investigation revealed that 5 patients were
married, 2 were living in a student hostel, and one was liv-
ing alone. All patients were professionally active and part
of collective with over 10 individuals. Five patients pre-
sented a maculopapular urticarial eruption disseminated
on thorax, abdomen and limbs, and accompanied by a
moderately pruritus. All patients followed a diet and a
treatment with albendazole (2× 200mg daily, 5 days), anti-
spasmodics, antipyretics, calcium. Six of them required
a hydroelectrolytic replacement with different infusions
(Ringer, glucose, physiological serum). Three out of the 8
patients were ambulatory treated with antibiotics prior to
hospitalization. Nevertheless the symptoms didn’t remit and
consequently they necessitated hospitalization. The stool
exams of the family members (in 5 patients with fami-
lies) showed the relevance of setting of the ambulatory
antiparasitic therapy for the whole family. The outcome
was favorable in all cases. Adverse reactions were minor
and transitional: nausea in 3 cases, bitter taste 2 cases, and
pyrosis 2 cases.
Conclusion: The early detection of giardiasis in patients
with acute enterocolitis avoids unnecessary administration
of antibiotics and allows the administration of the antipara-
sitic therapy with optimal clinical results and decrease the
spread of this affection.
doi:10.1016/j.ijid.2010.02.2144
58.021
Immunological changes in children with giardiasis
T.R. Olariu1,∗, V. Dumitrascu2, I. Marincu3, C. Petrescu2, A.
Koreck2
1 Victor Babes University of Medicine and Pharmacy
Timisoara, Timisoara, Romania
2 Victor Babes University of Medicine and Pharmacy,
Timisoara, Romania
3 Victor Babes University of Medicine and Pharmacy
Timisoara, Romania, Timisoara, Romania
Background: Giardia lamblia is an intestinal parasite
which has been diagnosed with an increase frequency among
Romanian institutionalized children. The aim of the present
study was to assess peripheral blood lymphocytes popula-
tions and serum cytokine levels for IL-4 and IFN-/ in children
infected with Giardia lamblia.
Methods: Lymphocyte subpopulations were determined
using ﬂowcytometry and cytokines were quantiﬁed by sand-
wich ELISA.
Results: Total T cells, CD4+ helper T cells, activated
T cells (HLA-DR+ or CD25+) and NK cells did not differ
signiﬁcantly between children with Giardia lamblia infec-
tion and agedmatched healthy controls. In contrast, CD8+
T cell were elevated in Giardia lamblia (34.42± 6.08%)
infected children compared to controls (27.66± 2.15%). B
cells were signiﬁcantly reduced in the peripheral blood of
children with giardiasis (16.89± 2.44%) compared to healthy
controls (26.41± 4.12%). IL-4 was detected in higher con-
m
ots e297
entration in the serum of children infected with Giardia
amblia (4.19± 1.67 pg/ml) and was not detected in the
erum of healthy children. IFN−/ levels were elevated in
hildren with giardiasis (5.7± 5.04 pg/ml) compared to con-
rols (0.79± 0.47 pg/ml).
Conclusion: Our data suggest that Giardia lamblia
nfections in children may be accompanied by systemic
mmunological changes.
oi:10.1016/j.ijid.2010.02.2145
8.022
gG antibodies relative avidity as a phase-speciﬁc diagno-
is for toxocariasis in populations of Venezuela
. Delgado, J. Ortegoza, V. Coraspe, M.A. Rivas, S. Silvia,
. Duran, Y. Pascual, A. Rodriguez-Morales ∗
Immunoparasitology Section, Tropical Medicine Institute,
niversidad Central de Venezuela, Caracas, Venezuela
Background: IgG-Avidity ELISA has been recently devel-
ped in toxocariasis as a useful technique for ruling out
ecently acquired infections. Avidity of antibodies increases
ith time after antigen challenge and the measurement of
he avidity has been used to diagnose various infections
specially when differentiation of recent and distant infec-
ions is crucial.
Methods: In this study we focused on a method for dis-
inguishing acute and chronic Toxocara infection in children
nd adults, the basis of which was the assessment of spe-
iﬁc IgG antibodies avidity. We studied 400 serum samples
ollected from populations in Venezuela (aged 1—65y, 52%
ale).
Results: From this population screening with a validated
LISA (with locally prepared T.canis excretion-secretion
ntigens) we serologically diagnosed 71.25% of them (62%
:128dils). From these serologically positive patients we
valuated the Toxocara-speciﬁc IgG avidity, which was mea-
ured employing the dissociative method using urea as a
enaturing agent and the calculation of a relative avid-
ty index. The relative avidity index was calculated as the
atio of IgG values in sera treated with urea and the value
f IgG in nontreated sera (x100). Values on this index)50
ere considered as low avidity (indicating recently acquired
nfection) and those >50 were considered as indicative of
igh avidity (chronic infection). In the sera from these
atients low index of IgG antibodies avidity was shown in
1.25%; 50% of these patients presented avidity values)33.
hese values were independent of the ELISA titers of these
atients (t = 0.207; p = 0.837), age (F = 0.234, p = 0.631), sex
t = 0.624; p = 0.536) and epidemiological risk factor such
s dog ownership (t = 0.955; p = 0.348). In the group of
atients with titers of 1:32dils mean avidity was 32.7(low
ndex of IgG), in those with 1:128dils mean avidity was
1.9(low index of IgG) (p > 0.05). Compared with IgG avid-easurement of speciﬁc IgG avidity (which is independent
f the ELISA titers) may assist in the discrimination between
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ecent and distant toxocariasis, and particularly to ruling
ut (by high avidity) a recently acquired infection.
oi:10.1016/j.ijid.2010.02.2146
8.023
haracterization of proteins of excretion/secretion (ES)
f nematode parasite Mammomonogamus laryngeus
.I. Giraldo ∗, J.C. Castan˜o
University of Quindio, Armenia, Quindio, Colombia
Background: Mammomonogamus laryngeus is a
ematophage nematode parasite that affects the res-
iratory tract of domestic mammals. The female and male
re united in permanent copulation producing a distinctive
‘Y’’ form. So far, over 100 cases of human infection had
een reported in the scientiﬁc literature. In Colombia in
006 we reported the ﬁrst case of human infection in the
uindio region, and the second report in bovine livestock
ith a high prevalence of 14.5% (Fig. 1).
Methods: The protein proﬁle of excretion/secretion (ES)
fM. laryngeuswas determined by SDS-PAGE electrophoresis
nd the characterization of the enzyme activity was evalu-
ted with a zymogram using casein and gelatin dissolved in
0mM sodium phosphate buffer at pH 7.4 and copolymer-
zation with polyacrylamide 10% and to 0.8% bisacrylamide,
.5M Tris- HCl, pH 8.8. The protein concentration was deter-
ined by bicinchoninic acid assay (BCA). To evaluate the
ype of protease on the ES proteins, a zymogram assay
as performed with and without speciﬁc protease inhibitors
leupeptin triﬂuoro acetate, EDTA, pepstatin A, 4-2 amino
thyl benzene sulfonyl ﬂuoride Hydrochloric (AEBSF) and N-
osyl-L-phenylalanine chloromethyl ketone (TPCK)) in 10%
olyacrylamide gel and gelatin as substrate. To evaluate the
ffect of pH on the protein activity, the zymogram conditions
ere performed on pH from 4 to 11.
Results: The products of ES from adult M. laryngeus have
rotease activity showing four bands with molecular masses
f 94.4 kDa the most dominant and a diffuse series of bands
f 122 kDa, 108 kDa and 72 kDa. The M. laryngeus ES shows
protease activity. For the speciﬁc family of proteases,
metallopretease activity was found corresponding to the
nhibition of protease activity by EDTA but no under other
nhibitor. The pH did not change the protease activity over
he range tested.i
e
s
mternational Congress on Infectious Diseases (ICID) Abstracts
In the micrograph are observed Mammomonogamus
aryngeus specimens in copula permanent.
Conclusion: Our ﬁndings, suggest that maybe this ES
roteins are involved in skin penetration process and migra-
ion through connective tissues in the host, therefore, it is
andatory to obtain more data about this parasite for the
nderstanding of its infective process, and also look for ES
omologies within the same family of nematodes for the
earching of vaccine candidates and treatment strategies.
oi:10.1016/j.ijid.2010.02.2147
8.024
ibronectin increases the adherence of Taenia solium
ncosphere in CHO —K1 cells in vitro
. Palma1,∗, N. Chile1, J. Evangelista1, Y. Arana1, M.
erastegui1, R.H. Gilman2
Universidad Peruana Cayetano Heredia, Lima, Peru
The Johns Hopkins Bloomberg School of Public Health, Bal-
imore, MD, USA
Background: Neurocysticercosis is the infection caused
y the larval stage of Taenia solium and is also the most
ommon parasite of the nervous system in humans and is a
ublic health problem in poor areas of Latina America, Asia
nd Africa and it is spreading worldwide due to increased
igration of NC cases and tapeworm carriers. T. solium
ggs contain an oncosphere that is released and penetrates
n the host small intestine. This mechanism is not known.
herefore, the elucidation of the molecules involved in the
arasite-host cell recognition process is of extreme impor-
ance and that constitute a focal point of research. Previous
orks supported the idea that parasites can interact with
xtracellular matrix and basement membrane proteins, such
s ﬁbronectin (FN), laminin, collagen and vitronectin lead-
ng to enhanced adherence. The purpose of this study was
valuated the role of FN in the adherence mechanism of T.
olium oncosphere using in vitro assay in CHO-K1 cell.
Methods: The T. solium oncospheres and CHO-K1 cell
onolayer were incubated with different concentrations of
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FN (70, 80, 90 and 100 ug/ml) and the adherence was visual-
ized by immunoﬂuorescence using hyperimmune rabbit sera
against T. solium activated oncospheres. In the other hand,
only the CHO —K1 cells were preincubated with 80 ug/ml
of FN for 20 h and then the T. solium oncospheres with and
without FN were added on monolayer cell. FN ﬁbrils and
oncospheres were visualized by immunoﬂuorescence using
polyclonal anti-FN antibody produced in rabbit by UV light
microscopy.
Results: The adherence of T. solium oncospheres was
increased from 70 ug/ml FN versus control. The ﬁbrillar FN
matrix on CHO—K1 cells were visualized over monolayer cell.
Also, the adherence T. solium oncosphere with FN preincu-
bate reacted with anti-FN antibody but with minor intensity
versus control.
Conclusion: These results suggest that Fn increases the
adherence of oncosphere of T. solium serving as a bridge
between the T. solium oncosphere and cell. Additonal char-
acterization of T. solium oncosphere ﬁbronectin binding
protein that interact with host components, will further our
understanding of the adherence and could be markers as
candidate a vaccines.
doi:10.1016/j.ijid.2010.02.2148
58.025
Ectopic knee tungiasis and historical aspects in Peru
V. Maco1,∗, V. Maco C.2, E. Gotuzzo3
1 Instituto de Medicina Tropical Alexander von Humboldt,
Universidad Peruana Cayetano Heredia, Lima, Lima, Peru
2 Hospitales de la Solidaridad, Lima, Lima, Peru
3 Instituto de Medicina Tropical Alexander von Humboldt,
Universidad Peruana Cayetano Heredia, Lima, Peru
Background: Tungiasis is an zoonotic ectoparasitism
caused by the penetration of the female sand ﬂea Tunga
spp. into the skin. It can be caused by two species: Tunga
penetrans or T. trimamillata, and affects commonly distal
lower extremities of individuals living in poverty-stricken vil-
lages or suburban areas. Although it has been a well known
entity to Peruvian physicians and other care providers alike
for centuries, little is known about its current epidemiology.
Methods: We present a rare case of knee tungiasis which
was diagnosed by excisional biopsy. Brieﬂy, the patient was
a 7 years old mestizo female with no signiﬁcant PMH, who
lived in Villa El Salvador, Lima, a district with high poverty
index. She complained of a painful nodule in her right knee
that was noticed 3 weeks prior. Her dwelling was made of
straw mats and lacked electricity and water supply.
Results: On physical examination, a 0.5 cm tender nodule
with a central black dot was noticed in the extensor aspect
of her right knee, surrounded by a whitish halo and mild
redness around it. On microscopic examination, the epider-
mis showed hyperplasia, hyperkeratosis, parakeratosis, and
a hemorrhagic area in the dermis. Multiple structures com-
patible with eggs in different stages of development (arrow
heads) (Figure) were compatible with Tunga spp.B
g
t
sts e299
Conclusion: To our knowledge, our case is the ﬁrst human
ungiasis located in the knee. Evidence of tungaisis in Peru
ates back before the Inca civilization and the Conquest of
he Americas. Pre-Columbian, autochthonous inhabitants of
he coast depicted tungiasis on mud pottery called huacos,
s can be appreciated in anthropomorphic ornaments. More-
ver, the ﬁrst references in the local literature weremade by
he Peruvian Indian Guaman Poma de Ayala (∼1535/∼1619).
pidemiological data are scanty: a search on PubMed, Scielo,
ILACS and MedLine produced no articles on epidemiology of
ungiasis in Peru, except from a letter concerning the new
pecies, and an isolated case report. With the description of
new species of Tunga and several Brazilian epidemiologic
tudies, tungiasis has regained the interest of the scientiﬁc
ommunity. Epidemiological studies with identiﬁcation cam-
aigns to understand the status of this ancient parasitisim
n Peru is our next step.
oi:10.1016/j.ijid.2010.02.2149
8.026
lastocystis hominis infection among patients with and
ithout gastrointestinal disorders
. Rostami Nejad1,∗, E. Nazemalhosseini Mojarad2, H.
abiri 3, M.R. Zali 4
Centers for Gastroenterology and Liver Diseases, Shahid
eheshti University, M.C., Tehran, Iran, Islamic Republic of
The Research center of Gastroenterology and Liver dis-
ases, Shaheed Beheshti University, M.C, Tehran, Iran,
slamic Republic of
Shahid Beheshti University, M.C., Tehran, Iran, Islamic
epublic of
Tehran, Iran, Islamic Republic of
Background: Blastocystis hominis is a common micro-
copic parasite found in human fecal samples both from
ymptomatic patients and from healthy people. The aim of
his study was conducted to investigate the epidemiology
nd clinical features of Blastocystis hominis among Iranian
atients with and without GI symptoms.
Methods: Six hundred and seventy patients without GI
nd 670 patients withGI symptoms recruited during 2006-07.
tandard microscopic examinations following in vitro cul-
ure were used to examine the stool samples for presence
f trophozoites and cysts of B. hominis.
Results: Infection with B. hominis occurred most com-
only in those with GI symptoms (5.67%) compared with
hose patients without GI symptoms (3.43%). The most com-
on symptom in case group was abdominal pain (86.84%).
. hominis was mostly found with Giardia lamblia in case
roup and with Entamoeba coli in control group. In addition,
here was no signiﬁcant relation between the presence of GI
ymptoms and the incidence of B. hominis.
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Serology can be used as screening test for the diagnosis of
cysticercosis. And all the patient should be treated for the
intestinal carrier of the parasite as well.300 14
Conclusion: In the current study, with respect to no stat-
cally signiﬁcant difference between case and control group
n term of B.hominis prevalence (P > 0.05), we can express
his hypothesis that support the idea which B. hominis is
ot a GI symptom ethological agent in contrast to other
tudies Iran. Thus, to conﬁrm the complication is needed
o additional study especially on molecular pathogenesis of
his organism.
oi:10.1016/j.ijid.2010.02.2150
8.027
Portuguese couple with eosinophilia: From the diagnosis
o the treatment
. Abreu ∗, S. Xerinda, A. Sarmento
Hospital S. João, Porto, Portugal
Background: Zoonotic diseases are hard to control and
liminating as they require coordination among veterinary,
ivestock and human health departments and frequently are
eglected diseases.
Methods: We describe the work up of a young couple
resenting with vague abdominal complains and marked
osinophilia.
Results: A 35 years-old man, and his wife, 25 years-old,
oth previously healthy, without international travel, liv-
ng in a small town in the north of Portugal, presented to
heir medical doctor in October 08 complaining from right
pper quadrant pain, asthenia, nausea, cutaneous pruritus
nd urticaria; they had lost 4 pounds of weigh in 3 months.
ne month before becoming ill they ingested uncooked
atercress from local production; vomiting and diarrhoea
ccurred for a few days after the ingestion. Physical exam-
nation was unremarkable. Liver and renal function tests
ere normal except for GGT that was two times elevated;
osinophilia was revealed. In both 3 stool samples were
egative for parasites; abdominal ultrasonography and pul-
onary XR were normal. Serology titer for Fasciola hepatica
hemaglutination test) was high positive. Praziquantel was
rescribed (while waiting for triclabendazol (TCB) impor-
ation) with a short course of steroids. Two months after
o clinical or analytical improvement occurred. Praziquan-
el was repeated without sucesss; in both stool samples
emains negative and abdominal ultrasonography normal.
agnetic resonance imaging (MRI) revealed multiple ill-
eﬁned subcapsular clustered areas of low attenuation,
ore sharply delineated after contrast administration (later
mages), more pronounced in female patient. Two months
fter triclabendazol prescription (no elicited side effects)
hey gain weight and feel well; eosinophilia was absent and
erology titer dropped in the male patient but not in the
emale. They are still on observation.
WBC cmm / Eosinophilis (%) Fasciola Serology
(Cut-off: 1/320)
ate Male Female Male Female Treatment
ebruary 16640 / 43 17220 / 58 1/640 1/5000 PZQ (March)
ay 15000 / 32 12240 / 44 1/2560 1/5120 PZQ (May)
uly 13280 / 32 10820 / 42 1/1280 1/1280 TCB (July)
ctober 10580 / 9 6860 / 10 1/520 1/2560 —
Conclusion: The diagnosis of acute/prolonged acute fas-
ioliasis is high probable in both patients. The value of MRI
n the diagnosis/evolution is still questionable. The access
dternational Congress on Infectious Diseases (ICID) Abstracts
o triclabendazol is not so easy, although the WHO donation
rogram can be applied for endemic countries. Treatment
efore the chronic stage is needed. The control of livestock
isease is urgent.
oi:10.1016/j.ijid.2010.02.2151
8.028
ole of serology, neuroimaging and stool examination in
iagnosis of neurocysticercosis
. Sapkota1,∗, K. Sapkota2, S.P. Dumre3, K. Malla4, S.
ingh4
District Hospital, Myagdi, Nepal
New Mexico State University, Las Cruces, NM, USA
Thammasat University, Faculty of Allied Health Sciences,
athumthani, 12121, Thailand
Manipal Teaching Hospital, Pokhara, Nepal
Background: Neurocysticercosis(NCC) is a worldwide
roblem. It is the most common parasitic neurologic dis-
ase and the singlemost common cause of acquired epileptic
eizures in the developing world. Many cases remain undi-
gnosed due to lack and expertise and lab facilities. and
t remains a public health burden because of inability to
dentify and treat the intestinal carrier of the parasite. Cur-
ently it is diagnosed by detection of speciﬁc antibodies
r by imaging techniques. The study is done to evaluate
iagnostic signiﬁcance of serology (ELISA) and neuroimag-
ng technique in NCC and to determine the intestinal carrier
f the parasite.
Methods: The tests (Neuroimaging, ELISA and stool rou-
ine and microscopy) was applied to neurocysticercosis
atients, as well as to healthy controls and individuals with
ther parasitic infections. A total of 100 serum samples were
btained from patients meeting clinical, imaging and epi-
emiological criteria for neurocysticercosis. Samples were
rocessed by enzyme-linked immune-sorbent assay. Con-
rols included 50 serum samples from matched hospitalized
ontrols with a diagnosis unrelated to Neurocysticercosis.
imilarly, 50 serum samples from patients with parasitic
nfections different from cysticercosis.
Results: A total of 200 samples were analyzed. In samples
rom neurocysticercosis patients and healthy control individ-
als, the ELISA test showed an overall sensitivity of 80.7% (CI
5%) and a speciﬁcity of 85.4% (CI 95%). Out of 50 samples
rom patients with parasitic infections different from tae-
iasis, 8% were positive in ELISA. Abnormal neuroimaging is
een in 100% of the cases whereas conﬁrmation of diagno-
is by neuroimaging alone could be made only in 40% of the
ases based on diagnostic criteria. Stool microscopic exam-
nation showing eggs of Taenia solium is seen in 18% of the
ases.
Conclusion: The study indicated that Combined serology
nd neuroimaging should be done to conﬁrm the diagnosis.oi:10.1016/j.ijid.2010.02.2152
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Ixodes persulcatus tick salivary gland extract (SGE)
inhibits IL-4 and IFN−/ secretion and CD69 expression by
mitogen-stimulated murine splenocytes
V. Firstova1,∗, S. Biketov1, E. Zyrina1, A. Shtannikov1, I.
Vasiljeva2
1 State Research Center of Applied Microbiology and
Biotechnology, Obolensk, Russian Federation
2 The E.I. Marcinovsky Research Institute of Medical Para-
sitology and Tropical Medicine, Moscow, Russian Federation
Background: The tick Ixodes persulcatus are the main
vector of Lyme disease and viral encephalitis in Europe
and Asia. Immunosuppressive agents in tick saliva aid suc-
cessful blood meal acquisition and appear critical to the
transmission and establishment of pathogens, both viral and
bacterial. Our present work was undertaken to investigate
modulation of IL-4, IFN−/ production and CD69 expression
of murine splenocytes byI. persulcatus SGE, derived from
unfed and partially fed (3 days) I. persulcatus.
Methods: Splenocytes were isolated from naive BALb/c
mice. Cells (2 — 5 x 106 /mL) were cultured in RPMI sup-
plemented with 10% foetal bovine serum, 2mM glutamine,
1mM sodium pyruvate, 100U/mL penicillin and strepto-
mycin. Splenocytes were stimulated in triplicate by addition
of ConA, LPS (Sigma) and LAC GP (Leukocyte activation Golgi
Plug, BD) at a ﬁnal concentration of 5g/mL, 1g/mL and
1g/mL, respectively. Concentration of SGE in cell culture
were 5, 25 or 50 mkg/ml. Splenocytes were harvested after
24-h stimulation and stained for surface markers CD3, CD4,
CD19, CD69 and intracellular cytokines IL-4 and IFN−/. Cells
were analysed by ﬂow cytometry.
Results: We found that SGE, derived from both unfed
and partially fed I.persulcatus, reduced the early activation
marker CD69 expression on ConA- or LPS-activated T- and
B-cells in dose dependent manner. SGE reduced IL-4 and IFN-
/ production by LAC GP stimulated CD4+splenocytes. SGE,
derived from unfed I.persulcatus, markedly suppressed IL-4
and IFN-/ production by LPS-stimulated splenocytes by 35%
and 55%, respectively, compared to the control condition
without saliva. No signiﬁcant modiﬁcation of IL-4 and IFN-/
production was observed when SGE, derived from partially
fed ticks, was added.
Conclusion: Only SGE, derived from unfed I.persulcatus,
inhibits IL-4 and IFN-/ production by CD4+ T cells in naive
murine splenocytes. The inhibition of IL-4 and IFN-/ produc-
tion by SGE appears to be due to a reduced level of activation
in T and B cells: SGE treatment reduced the activation-
induced CD69 expression on splenocytes. Transmission of
pathogens into a site with lymphocyte unresponsiveness
would have great advantages for the establishment and dis-
semination of the pathogen in the host.
doi:10.1016/j.ijid.2010.02.2153 i
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eroprevalence of toxocariasis in hypereosinophilic indi-
iduals in Ahwaz city
. Maraghi
Jondi- Shapour University of Medical Sciences, Ahwaz, Iran,
slamic Republic of
Background: Human toxocariasis is a helminthozoono-
is due to the migration of Toxocara larvae in to human
rgans. Toxocariasis is one of the cause eosinophilia in
eripheral blood, and provokes eosinophilic inﬁltration in
nternal organs. The aim of this study was to evaluate the
revalence of toxocariasis in hypereosinophilic individuals in
hwaz city by Enzyme linked immunosorbent assay (ELISA)
nd Western blot techniques, using excretory-secretory Tox-
caracanis antigen.
Methods: Serum samples from 100 persons presenting
ith peripheral blood eosinophilia (>500 eosinophils/!l or
ore, equal or >10% of total white blood cells), and from
00 blank persons (without eosinophilia) were examined
sing ELISA technique (IBL Hambur). Sera with Toxocara anti-
odies underwent further conformative evaluations through
estern immuno-blotting. Results then, were analyzed using
tatistical descriptive and Chi-Square test.
Results: Seroprevalence antibodies against Toxocara in
ypereosinophilic individuals, with ELISA test were obtained
n 19% (19 persons) of wich, 12 persons (63.15%) were female
nd 7 persons (36.85%) were male. Positive sera were sub-
equently conﬁrmed by Western blot. All of the observed
ands ranged from 24 to 100 KDa. Antibodies against Toxo-
ara among blank persons was 1% which did not conﬁrmed
y Western blot. There were signiﬁcant differences between
he frequency of infection with age and gender (P > 0.05).
he highest prevalence of infection was seen in adult men
nd women. Also, in this study signiﬁcant differences was
bserved between the hypereosinophilic and healthy indi-
iduals, in term of Toxocara infection frequency (P > 0.05).
Conclusion: The present study conﬁrms the signiﬁcant
revalence of toxocariasis, as a hygiene problem, among
ypereosinophilic individuals in this area, and it is necessary
o examine the hypereosinophilic individuals for toxocaria-
is.
oi:10.1016/j.ijid.2010.02.2154
8.031
mmunogenicity of the recombinant ASP1r protein of A.
aninum in a murine model
.I. Giraldo ∗, J.C. Castan˜o Osorio
University of Quindio, Armenia, Quindio, Colombia
Background: Ancylostomiasis is a disease produced by the
ntestinal hematofhagous nematode Ancylostoma caninum.
his parasite has as major excretion/secretion protein ASP1,
hich has a molecular weight of 42KDa and is encoded by a
ene of 1016 pb.Methods: RNA of adults of Ancylostoma caninum was
mpliﬁed by reverse transcription polymerase chain reac-
ion. The ASP1 protein gene was inserted into the pcDNA3
ector. Plasmid was digested with Bamh1 and EcoR1 and
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loning was performed directionally. Later on, a transfor-
ation and selection of E. coli DH5a cell competent with
he product for the ligation was made. Then, a screening
y PCR was made to conﬁrm the presence of ASP1 gene.
cDNA3-ASP1 was inoculated by intraglandular parotide and
ntramuscular route in Balb/c mice. Determination of anti-
odies in these animals was measured in serum and saliva
y ELISA and immunochemistry.
Results: PcDNA3-ASP1 was incorporated and expressed in
. coli DH5a cell. This recombinant plásmid induced produc-
ion of antibodies anti-ASP1 speciﬁc in Balb/c mice.
Conclusion: It was possible to demonstrate that using of
cDNA3-ASP1 did not display reactogenicity and it did not
roduce unfavorable reactions, plus it induced a humoral
esponse against the excreción/secretion protein of Ancy-
ostoma caninum in mice.
oi:10.1016/j.ijid.2010.02.2155
8.032
revalence of intestinal parasites in urban, rural and com-
ercial farming communities in Zimbabwe
. Mtapuri-Zinyowera
Harare Central Hospital, Harare, Zimbabwe
Background: An estimated 3.5 billion people worldwide
re infected with intestinal parasites mainly in the devel-
ping countries where poor water and sanitation facilities
lay a pivotal role in transmission of diseases. Previous stud-
es on human protozoan parasites carried out in Zimbabwe
y Mason and Patterson (1987) and Simango and Dindiwe,
lso in 1987 concentrated mainly on Giardia duodenalis.
his study was done 21 years later, has provided the cur-
ent status of intestinal parasitic infections in Zimbabwe,
s societies change as a result of migration and constant
hange in socio-economic status.
Methods: Prevalence of parasitic infections in 1260 school
upils living in an urban, rural tribal trust land and commer-
ial farming area of Zimbabwe was done. Stool specimens
ere collected on 3 alternative days and processed for para-
ites according to the standard operating procedures (SOPs)
nd a questionnaire was administered. The assays carried
ut were; wet preparations then the specimen was pooled
n to sodium acetate formaldehyde preservative and the for-
al ether concentration method was done on the pooled
pecimen. The staining methods were the cold Ziehl Neelson
tain and Gomori/trichrome staining.
Results: Giardia duodenalis and Cyclospora cayetanen-
is were prevalent in the rural area, the risk factor of
eing infected with G. duodenalis being, not washing fruits
efore eating and drinking water from deep protected wells.
arasites most prevalent in the farming area were Enta-
oeba histolytica/dispar, Cryptosporidium parvum and the
elminthes. The risk factor of being infected with E. his-
olytica/dispar was not taking measures to make water safe
or drinking. Rare protozoan parasites such as Entamoeba
olecki and Enteromonas hominis were also identiﬁed in the
ural and farming areas respectively. Blastocytis hominiswas
revalent in the urban area.
t
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Conclusion: Measures such as health education and provi-
ion of safe water can now be undertaken by policy makers
o prevent infections by intestinal parasites.
oi:10.1016/j.ijid.2010.02.2156
uberculosis: Diagnosis, Treatment & Drug Resis-
ance (Poster Presentation)
9.001
eijing genotype and other predominant Mycobacterium
uberculosis spoligotypes observed in Mashhad city, Iran
. Rohani1,∗, P. farnia2, M. Torfeh1
Microbiology and Immunology, Kashan, Iran, Islamic
epublic of
Tehran, Iran, Islamic Republic of
Background: The molecular epidemiology of tuberculosis
n Khorasan province of Iran was studied by Spoligotyping
13 Mycobacterium tuberculosis isolates. The Spoligotyp-
ng results were in comparison to the word Spoligotyping
atabase of Institute Pasteur de Guadeloupe (SpolDB4).
poligotyping data from Iran have rarely been described up
o the present moment, and there is limited information on
he major circulating clades of M. tuberculosis in Iran was
resent.
Methods: Spoligotyping was performed on 113M. tuber-
ulosis isolates from Mashhad patients from November 2004
o September 2005.
Results: Fifty-seven Spoligopatterns were seen in this
tudy and 17 different clusters and 32 true orphan genotype
as seen. The biggest cluster has 13 isolates and had not
een previously reported. The Beijing genotype was seen in
(7.1%) isolates.
Conclusion: The genotyping and Spoligotyping provides a
nifying framework for both epidemiology and evolutionary
nalysis of M. tuberculosis populations.
oi:10.1016/j.ijid.2010.02.2157
9.002
ntegrating TB screening tool improved TB screening in
IV Patients in TASO
. Okoboi
The Aids Support Organization, Tororo, tororoi, Uganda
Background: Globally 9.2 million new TB cases and 1.6
illion deaths occur annually, 16% of new TB patients are
IV positive (WHO, 2007), Uganda estimated 70% of TB cases
re HIV positive (NTLP, 2007). In 2008 out of 82114 (94%) of
ASO registered clients screened for TB, 1960 (2.4%) were
iagnosed with TB and treated (TASO MIS). Globally case tar-
et detection target is 70% of infectious TB and successfully
reat 85%. Uganda detection rate is 60.1%, cure rate 62.2%
HSSP II), integrating TB screening tool reminded clinicians
o screen for active TB in TASO.Methods: This involves completing clinical record forms
y assessing if the patient enrolled for TASO care is symp-
omatic for TB using a screening tool. Patients who screened
ositive for one or more signs/symptoms were further inves-
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23 were efﬁcient on detecting early active lung TB cases
Accordingly with the results the occupational group at higher
risk are nursing techniques (ODSS ratio 2.72), followed by14th International Congress on Infectious Diseases (ICID) Abs
tigated to conﬁrm active TB by sputum analysis, chest X-ray,
lymph node aspirates and pleural tap for analysis. Cases with
conﬁrmed TB received respective treatment as they con-
tinue to attend the usual medical review on appointment.
Results: Overall percentage of patients screened for TB
improved from 78% to 98% between fourth quarter, 2008
and ﬁrst quarter, 2009. Of those screened the percentage of
patients with at least one or more positive signs/symptoms
increased from 23.3% to 42.5% within the same period TASO
Tororo MIS, out of those with a positive screen who took a
test, the percentage of patients diagnosed with TB increased
from (26/126)15.9% to (38/141) 27% within the same period.
Conclusion: Integrating screening tool in clinical record
will; prompt clinicians to screen for active TB at each
clinic visit, allow continuity and quality of TB care, prevent
unmasking of TB through immune reconstitution syndrome
in patients with lower CD4 cell count initiating ART and
monitors TB investigation results, treatment, progress and
outcomes.
doi:10.1016/j.ijid.2010.02.2158
59.003
A case report: Cutaneous tuberculosis presenting as
chronic thoracic chest wall ﬁstula
H. Afsali ∗, M. Momen Heravi
Kashan University of Medical Sciences, Kashan, Isfahan,
Iran, (Islamic Republic of)
Background: Cutaneous tuberculosis is now uncommon
despite the rising incidence of extrapulmonary tuberculosis
in areas with high prevalence of HIV infection. Nevertheless
it is still important to know the multiple clinical manifes-
tations of cutaneous tuberculosis .We report a rare form of
cutaneous tuberculosis presenting as cutaneous ﬁstula over
the anterior thoracic chest wall.
Methods: Patient presentation:
A 5o- year- old man from Afghanistan who presented
with complaint cutaneous lesions over the anterior chest
wall. There were two ﬁstula with purulent discharge which
started 3 month ago as a small papule without pain and
pruritus the size of papules increased and there was no
response to outpatient antimicrobial treatment There was
history of diabetes mellitus type 1 8 ischemic heart dis-
ease and hyperlipidemia .he migrated from Afghanistan to
Iran 16 year ago and he had no travel to there during past
years. There was no history of TB in patient and his fam-
ily. The PPD test was negative. In laboratory examination
there was signiﬁcant increased of ESR (125mm/hr)and ane-
mia (HB:11.1 g/dl). Cutaneous TB was suspected regarding
to lack of response to antibacterial treatment and persis-
tence of disease .Skin biopsy showed multiple granulomas
consisting langhans giant calls compatible with tuberculosis
and Ziehl-Neelsen staining of secretions revealed numerous
acid fast bacilli. Anti tuberculosis treatment with Isoni-
asid,Rifampin, Ethambutol, Pirazinamid was administered.
Culture of secretion was positive for mycobacterium tuber-
culosis after 4 week As a result of these medication the
skin lesions started to heal and after 6 month healing was
complete and there was no ﬁstula.
Results: this is a csae report and it has no results
R
rts e303
Conclusion: cutaneous tuberculosis can occur in an
nusual form in an immunocompetent patient such as ﬁstula
ormation .Regarding to high prevalence of TB among Afgha-
ian people, TB must be suspected in any chronic cutaneous
esion and the disease deserves special attention because its
revalence can be expected to increase due to high rate of
igration from Afghanistan to Iran.
oi:10.1016/j.ijid.2010.02.2159
9.004
se of Imunotest (tuberculin skin test) for early detec-
ion of pulmonary tuberculosis among health workers in
private hospital, 2008, Lima, Peru
. Manga
Chemonics, Lima, Lima, Peru
Background: To determine the occupational risk of tuber-
ulosis infection among health care workers. Examine the
fﬁcacy of intradermal tuberculin test in a population with
igh vaccination coverage rates with antibodies to Bacille
almette Guerin.
Methods: After obtaining informed consent, to ﬁll a
uestionnaire,TST test was performed Mantoux technique
sing 0.1ml of pure protein intradermal tuberculin then
e mesured intradermal reaction between 304 workers
nclude doctors, resident nurses, technical and nursing assis-
ants, pharmacist, exclution criteria pregnant or postpartum
omen Positives cases were include into a diagnosis conﬁr-
ation protocol Radiological and Chest CT, serologic test of
denosine deaminase,erythrocyte sedimentation rate, Spu-
umm Culture by staining Nielseen Zielh Nielsen method was
sed.
Results: 272 dose of 0.1ml. pure protein derivative of
uberculin RT 23 were applied. Reading was 72 hours after.
ere found 52 (19.11%) of positives cases when the cutoff
as 10mm and 50 (18.38%) when the cutoff was 15mm.
fter a positive test greater than or equal to 15mm, the
orker was admitted into a deep diagnostic protocol by
he pulmonologist, which consists on: radiological exami-
ation CT; erythrocyte sedimentation rate, serologic test of
denosine deaminase; test for AFB staining Nielseen Zielh or
putum culture and sensitivity or bronchoscopy in 03 work-
rs 10.66% were positive to the test TB, and three cases of
ctive lung tuberculosis (36× 100.000) was founded those
tarted DOTS 23 workers were test positive they are receiv-
ng Isoniazid.
Conclusion: On despite of high vaccination coverage rates
ith antibodies to Bacille Calmette Guerin (BCG) in a health
are workers in Lima Peru; the intradermal reaction of a
PD showed high efﬁcacy in early detection of occupational
elated lung TB cases, which is an important founding in
country living an multiresistant TB outbreak. The intra-
ermal test using pure protein derivative of tuberculin RTesident Nurse (ODSS ratio 2.02); Medical doctors (ODSS
atio 1.99) Medical Technologists (ODSS ratio 1.25). We
e th In
s
t
d
5
P
p
M
K
1
R
2
3
I
4
5
t
r
c
t
r
t
c
t
t
i
t
t
p
p
o
m
(
i
P
s
8
f
s
c
o
s
t
d
5
C
t
C
R
p
g
o
s
a
c
c
t
t
r
t
m
o
s
r
p
u
a
s
s
s
p
i
p
s
s
a
s
t
o
t
s
a
s
t
o
t304 14
trongly recommended using this simple, cheap easy to use,
est at least every 9 months in all health care workers.
oi:10.1016/j.ijid.2010.02.2160
9.005
redictive value and cut off point of PPD in probable
atients with pulmonary tuberculosis
. Soﬁan1,∗, L. Moini 1, S. Farahani2, A. rostampour3, H.
halili 2, A. Aghakhani4, M. Banifazl 4, A. Ramezani5
Arak University of Medical Sciences, Arak, Iran, Islamic
epublic of
ARAK HEALTH CENTER, ARAK, Iran, Islamic Republic of
ISLAMIC AZAD UNIVERSITY OF ARAK BRANCH, ARAK, Iran,
slamic Republic of
Tehran, Iran, Islamic Republic of
Pasteur Institute of Iran, Tehran, Iran, Islamic Republic of
Background: Tuberculin skin testing (TST) is used for iden-
iﬁcation of tuberculosis infection. Interpretation of test is
elated to many factors such as prevalence of disease in
ommunity, use of vaccine, age of patients and exposure
o non-tuberculous mycobacteria. Cut off point of TST is
eported between 2 to 16mm in different communities. In
his study we aimed to determine the predictive value and
ut off point of TST in probable patients with pulmonary
uberculosis (TB).
Methods: A total of 714 probable patients with pulmonary
uberculosis with mean age 57± 20.11 years were included
n this study. 52.9% of them were male. All subjects were
ested using 5 tuberculin units of puriﬁed protein deriva-
ive (PPD). Gold standard for diagnosis of TB was considered
ositive smear or culture. Speciﬁcity, sensitivity, positive
redictive value (PPV) and negative predictive value (NPV)
f TST were determined. Cut off point of PPD was deter-
ined using Roc curve.
Results: 113 patients from 714 suspicious subjects
15.82%) had pulmonary tuberculosis. 80% of them had pos-
tive sputum smear. Sensitivity, speciﬁcity, PPV and NPV for
PD > = 5mm were 80%, 61%, 28% and 94% respectively. Sen-
itivity, speciﬁcity, PPV and NPV for PPD > = 10mm were 53%,
2%, 35% and 90% respectively. The calculated cut off point
or PPD was > = 4mm.t
dternational Congress on Infectious Diseases (ICID) Abstracts
Conclusion: Our results showed that a TST reaction
maller than 5mm was seen in patients with bacteriological
onﬁrmed pulmonary tuberculosis. Predictably, as the cut-
ff is moved to larger reactions, sensitivity decreases and
peciﬁcity increases. More estimates are needed to identify
he accurate cut off point of PPD in tuberculosis patients.
oi:10.1016/j.ijid.2010.02.2161
9.006
hallenges in the case detection of sputum smear-positive
uberculosis in Rwanda: A lowressource setting
. Muvunyi
National University of Rwanda/Faculty of Medicine, Butare,
wanda
Background: The use of smear microscopy in patients sus-
ected of tuberculosis presenting to health services is of
reat value in case detection and in reducing the spread
f the infection throughout the population by treatment of
uch cases. The TB diagnosis using Smear microscopy places
burden on the patient. A patient with suspected TB typi-
ally has to visit the clinic at least twice before a diagnosis
an be made, and then has to return again for the results. In
he present study, we aimed to evaluate the performance of
he sputum smear microscopy and its public implication with
eference to recommendations for the number of specimen
hat have to be collected from TB suspect.
Methods: This study was conducted at the department of
icrobiology, University of Butare Teaching Hospital after
btaining clearance from the ethical committee. In this
tudy, using TB register and laboratory sputum register, we
eview laboratory records of seven hundred and forty six
atients who were TB suspect during the period from Jan-
ary 2007 to December 2008. Data processing and statistical
nalysis were performed using SPSS software (Windows ver-
ion 16.0). The results were expressed as percentage, with
igniﬁcance at 5%.
Results: During the study period, 741 new TB suspects
ubmitted sputum specimens for AFB smear. Among the sus-
ects, 46% (341) of patients submitted sputum specimens
n accordance with the guidelines (i.e., three sputum sam-
les), 14.3% (106 of 741) had two sputa submitted for AFB
mear and 39.7% (294 of 741) submitted only one sputum
pecimen. Of the 39.7% of TB suspects who did not show up
fter submitting the ﬁrst on-spot specimen, 6.5% (19) had a
mear-positive ﬁrst. Of 341 patients submitting three spu-
um samples, 55 (16.1%) suspects were found to have at least
ne positive smear. Of these, 47 (85.5%) were detected from
he ﬁrst specimen and 8 (14.5%) were positive on the second
pecimen but not the ﬁrst. The third specimen did not have
ny additional diagnostic value for the detection of AFB as
hown in Fig. 2.
Conclusion: In conclusion, our result show that examining
wo sputa smears was sufﬁcient for the detection of AFB in
ur laboratory. Further research involving different labora-
ories from all of the regions of Rwanda is needed to reassess
hese ﬁndings.
oi:10.1016/j.ijid.2010.02.2162
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59.007
Predictive factors for the indeterminate result on the
QuantiFERON-TB Gold In-Tube test
S.H. Han ∗, B.S. Chin, H. Choi, S.Y. Shin, Y.T. Chae, S.J. Jin,
J.-H. Baek, C.O. Kim, J.Y. Choi, Y.G. Song, J.M. Kim
Yonsei University College of Medicine, Seoul, Korea, Repub-
lic of
Background: QuantiFERON-TB Gold In-Tube (QFT-G IT)
test is recommended for screening of latent tuberculosis.
However, this can reveal the indeterminate results, espe-
cially in the immunocompromised patients. Therefore, we
investigated the predictive factors that can inﬂuence the
indeterminate results on QFT-G IT.
Methods: We performed a retrospective case-control
study with 144 cases with the indeterminate results on
QFT-G IT from October 2006 to March 2009 at Severance
Hospital. The controls with the positive or negative results
were selected by matching 1:1 with the case for date of QFT-
G IT assay. An indeterminate result was considered when
the level in both the tuberculosis antigen and mitogen tube
was less than 0.35 IU/ml, or the level in the nil tube was
higher than 8.0 IU/ml. Through retrospective review of med-
ical records, age, gender, total lymphocyte count at the
QFT-G IT assay, underlying diseases, and medical conditions
which can inﬂuence the immune function were collected
as covariates. The predictive factors for the indeterminate
results on QFT-G IT were assessed by multivariate logistic
regression models.
Results: Age and gender did not show the signiﬁcant dif-
ferences between case and control patients (p = 0.105 and
0.906). The percentage of patients with hematologic malig-
nancy (19.4% vs. 11.1%, p = 0.049), chronic renal disease
(22.2% vs. 9.7%, p = 0.004), and autoimmune disease (16.0%
vs. 6.3%, p = 0.009) in the case group were the signiﬁcantly
higher than those in the control group. Also, the case group
had the signiﬁcantly higher percentage of steroid use (16.0%
vs. 8.3%, p = 0.047) and solid organ transplantation (11.1%
vs. 2.1%, p = 0.002) than the control group. The total lym-
phocyte count was the signiﬁcantly lower in the case group
than in the control group (median [interquartile range], 540
[220—1,030] vs. 1,370 [870—1,970], p < 0.001). In the ﬁnal
regression model, clinical factors associated with the inde-
terminate results were chronic renal disease (odds ratio [OR]
2.26, 95% conﬁdential interval [CI] 1.03—4.94, p = 0.041),
autoimmune disease (OR 3.99, 95% CI 1.65—9.66, p = 0.002),
and solid organ transplantation (OR 5.06, 95% CI 1.30—19.73,
p = 0.020).
Conclusion: The patients with lower lymphocyte counts
or immunosuppressive condition showed the higher pos-
sibility of the indeterminate results on QFT-G IT assay.
Therefore, the combined assay such as tuberculin skin test
and T-SOPT TB with QFT-G IT may be helpful to screen the
latent tuberculosis in the patients with these conditions.
doi:10.1016/j.ijid.2010.02.2163
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retrospective study to assess treatment outcomes
mong TB patients taking DOTS treatment in South India
. Narasimhan1,∗, R. Peter2, A. Manoharan2, J. Wood1, R.
acIntyre1, D. Mathai2, K. John2
University of New South Wales, Sydney, Australia
Christian Medical College and Hospital, Vellore, India
Background: In spite of the wide implementation of
irectly Observed Treatment Short course (DOTS) strategy in
ndia, Tuberculosis (TB) still remains a major public health
roblem in the country. There is a considerable doubt about
he effectiveness of DOTS program in TB control in the coun-
ry; a retrospective analysis was conducted to assess the
esponse to treatment among individuals who take TB med-
cations through the DOTS program in South India.
Methods: Retrospective chart review of 136 consecutive
B cases who sought care at the DOTS clinic in Christian
edical College and Hospital, Vellore, South India during the
eriod October 2008 to October 2009.
Results: Of 136 patients who sought care there were 85
ales (63%), median age was 39 years, 15 tested positive
or HIV, 68 negative for HIV and 52 of them had no HIV sta-
us revealed. Of the total, 91 (67.4%) had pulmonary TB and
3 (32%) had extra pulmonary TB. Almost 104 (77%) of them
ere new cases of TB, 7 (5%) were defaulters from prior
B treatment. 99 of them had their sputum tested for AFB
f which, 76 tested positive for AFB and the rest had nega-
ive smear results. There were no reports available for the
est. At the end of intensive phase of treatment there were
early 18 (27%) of them who remained smear positive in
pite of supervised treatment. Similarly at the end of two
onths continuous phase there were 2 (8%) of them who still
emained smear positive. There were a total of 6 patients
ho were completing 6 month DOTS therapy, among which
ne person had converted from smear negative to smear
ositive at the end of treatment.
Conclusion: Nearly one fourth of the cases remained
mear positive at the end of intensive phase, in spite of
upervised treatment, in our study sample. Cases which do
ot respond to treatment should be tested for drug resis-
ance and susceptibility at the earliest. Unless there is rapid
iagnosis and treatment of treatment failure and relapse
ases there won’t be any progress in our efforts to control
B.
oi:10.1016/j.ijid.2010.02.2164
9.009
opulation-based investigation on molecular characteri-
ation of Fluoroquinolones resistance of Mycobacterium
uberculosis in rural area of eastern China
. Xu ∗, Y. Hu, W. Jiang, W. Wang
School of Public Health, Fudan University, Shanghai, China
Background: Extensive use of ﬂuoroquinolones in treat-
ng numerous bacterial infections might select for resistant
trains of Mycobacterium tuberculosis (M.TB), especially in
hina where uses of ﬂuoroquinolones in treating TB have
ot been standardized yet. The present study was to investi-
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ate the prevalence of ﬂuoroquinolones resistant TB and its
olecular characterization in rural areas of eastern China.
Methods: Deqing and Guanyun, two rural Chinese coun-
ies in neighboring provinces (zhejiang and Jiangsu), were
elected as the ﬁeld site, where 164 and 187 isolates were
ollected from the pulmonary TB patients registered in local
B dispensaries during 2004/2005. The susceptibility to 1st
ine anti-TB drug and Fluoroquinolones was determined by
he proportion methods. IS6110 restricted fragment poly-
orphism (RFLP) was performed for genotyping and DNA
equencing on hotspot region of gyrA gene was performed
s well.
Results: Fluoroquinolones resistance was detected in 31
f 351 isolates including 24(6.8%), 11(3.1%) and 10(2.8%)
esistant to ciproﬂoxacin, oﬂoxacin and levoﬂoxacin respec-
ively. Fluoroquinolones resistance was equally distributed
n MDR-TB(15.8% and 11.8%), other combination(8.5% and
.1%) and 1st line drug susceptible group(6.3% and 7.7%)
oth in Deqing and Guanyun. And the similar proportion of
uoroquinolones resistance has also been observed in groups
f subjects with different social-demographic, clinical and
acteriological features. Mutations in the quinolone resis-
ance determining regions (QRDRs) of gyrA were found in 17
f 31 ﬂuoroquinolones resistant isolates in codon 94(45.2%),
0(12.9%) and 74(3.2%). IS6110-RFLP identiﬁed 2 clusters
ithin ﬂuoroquinolones resistant isolates and 3 clusters
omposed by both ﬂuoroquinolones resistant isolates and
uoroquinolones susceptible isolates. The geographic distri-
ution of the ﬂuoroquinolones resistant TB patients noted
heir mainly distributed in central town areas of rural coun-
ies both in two counties, with 6(42.9%) from Deqing and
(47.1%) from Guanyun respectively.
Conclusion: Fluoroquinolones resistance has emerged in
.TB circulating in rural China and mainly related to the
utation in QRDR region of gyrA. The selective growth of
uoroquinolones resistant strain might be the main cause
or the epidemic of ﬂuoroquinolones resistant TB in rural
hina. And the TB patients from central town areas deserve
he special concern for the development of ﬂuoroquinolones
esistance.
oi:10.1016/j.ijid.2010.02.2165
9.010
sefulness of PCR in the differential diagnosis of tubercu-
osis in parafﬁn embedded tissues
. Montenegro1, C. Delgado1, S. Pineda2, M. Pinilla1,∗, D.
uinez1, M. Garrido1, C. Cabezas3, F. Mucientes1
Universidad de Concepcion, Concepcion, Chile
Hospital Guillermo Grant Benavente, Concepcion, Chile
Hospital Guillermo Grant Benavente, Concepcion, Chile
Background: Conﬁrmation of differential diagnosis of
ycobacterium tuberculosis (MTB) is important on the ﬁnd-
ng of granulomatous inﬂammation that may or may not be
ssociated with infectious agents. Conventional microbio-
ogical methods are suboptimal for samples formalin-ﬁxed
nd parafﬁn-embedded (FFPE) for histological analysis. The
sefulness of PCR for the diagnosis of MTB have been demon-
trated with fresh samples, but still requires validation for
FPE. The aim of this study was to compare the diagnos-
c
t
Aternational Congress on Infectious Diseases (ICID) Abstracts
ic efﬁcacy of a nested IS6110 PCR for MTB in FFPE and its
orrelation with histopathology ﬁnding and auramine/Ziehl-
eelsen stains.
Methods: We analyzed 110 FFPE (44 lymph nodes, 12
kin, 10 pleura, 10 lung, 5 breast, 4 intestine and 21
ther tissues (brain, prostate, uterus, bone marrow, kid-
ey, synovial ﬂuid, larynx, mouth, appendix, among others).
FPE Histologic Groups. According to histologic diagnostic
f granulomatous lesion. 1. Granuloma with caseous necro-
is (n = 52); 2. Granuloma without caseous necrosis (n = 25);
.Granuloma tuberculoid-sarcoidal (n = 9); 4. Suppurative
ranuloma (n = 7); 5.Foreign body granuloma/chronic non-
peciﬁc inﬂammation (n = 17). FFEP Processing. 2-5 sections
f 5m of identiﬁed lesion were deparafﬁnized, rehydrated
nd digested with proteinase K and DNA extracted with
Qiagen-Puregene commercial kit following manufacturer
nstructions. Quality of DNA was assessed by ampliﬁcation of
110 bp beta globin segment. Only FFPE beta globin positive
amples were utilized for analysis. Nested IS6110 PCR. Outer
nd inner primers were utilized to amplyfy a 123 bp segment
f IS6110 repetitive insertion of MTB complex genome.
Results: Sensitivities of PCR versus staining for MTB
or FFPE were: for granulomas with caseous necrosis, PCR
7.6%, auramine/ZN 19%. For granulomas without caseous
ecrosis: PCR 24.%, auramine/ZN 12.5%. No positives were
ound in the other histologic groups for PCR and stains.
linical validity for PCR was estimated considering as most
robable TB granulomas with caseous necrosis and those
ositive for stains. PCR had: 62% sensitivity, 93% speciﬁcity,
8% positive predictive value and 70% negative predictive
alue.
Conclusion: PCR is a useful complementary technique
or diagnosing MTB in FFPE, with sensitivity and speciﬁcity
onsiderably greater than auramine/ZN. Nested IS6110 PCR
ncreased the accuracy of histological diagnoses associated
ith granulomatous tissue response.
oi:10.1016/j.ijid.2010.02.2166
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eneticdiversity and population structure of M. tubercu-
osis strains circulating in Central Russia
. Shemyakin ∗, V.N. Stepanshina
Applied Microbiology and Biotechnology, Obolensk, Russian
ederation
Background: All of 1200 collected strains with a unique
poligotype (57 of a total 72 spoligotypes) were included
nto the sample. Among the strains with shared spoligotypes,
wo to eight epidemiologically unlinked strains were cho-
en for analysis. The resulting panel of 107 strains should
e representative of the diversity of M. tuberculosis strains
irculating in the Central region of Russian Federation.
Methods: The genetic relatedness of the isolates in
he sample was assessed using ﬁve genotyping methods:
S6110-RFLP, spoligotyping, MIRU-VNTR typing, SNP-based
dentiﬁcation of principal genetic groups, PGGs, and SNP
lustered groups.
Results: Members of 4 from 6 SCG were identiﬁed in
he study sample. SCG6/PGG3 strains formed two groups.
ccording to the IS6110 ﬁngerprint patterns, SCG3/PGG2
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tuberculosis disease. Additional studies are needed to fur-
ther assess the utility of the QuantiFERON-TB In-Tube test in
the children with high risks of exposure to M tuberculosis.
doi:10.1016/j.ijid.2010.02.216914th International Congress on Infectious Diseases (ICID) Abs
was divided on at least 5 groups, including Haarlem strains
and all strains with low IS6110 copy number. MIRU copy num-
ber was identiﬁed in 12 microsatellite loci. A total of 58
distinct proﬁles were recognized with 38 unique proﬁles and
20 clusters comprising from 2 to 23 isolates. Phospholipases
C (PLC), have been shown to be involved in M. tuberculo-
sis virulence. In this study, we analyzed the frequency of
IS6110 insertions into the phospholipase C operon (plcABC
genes) among clinical isolates of M. tuberculosis from Cen-
tral Russia. Of the 107 isolates analyzed, 47 contained an
IS6110 insertion. In 45 of the 47 isolates, the IS6110 element
was inserted at the same position and in the same orienta-
tion within the plcA gene as determined by sequencing. The
stable association of the Ins2 IS6110 insertion in the plcA
gene with the group supports the hypothesis of their clonal
expansion from the common progenitor. The MDR TB level
in previously treated patients in prison hospital approaches
to 100% and exceeds 50% among civilians. Rate of M tuber-
culosis strains resistant to RIF INH and KAN was extremely
high.
Conclusion: These data support the assumption that a
parental strain had been circulating in the environment for
a prolonged period of time and had been split into a num-
ber of variant strains after acquisition of resistance to many
antituberculosis drugs.
doi:10.1016/j.ijid.2010.02.2167
59.012
Evaluation of IS6110 PCR, BACTEC and conventional meth-
ods in rapid diagnosis of extra pulmonary tuberculosis
cases attending two tertiary care hospitals in North India
A.K. Maurya1,∗, V. Nag2, S. Kant1, R.A.S. Kushwaha1, M.K.
Rana3, W. Rahman4, T. Dhole4
1 C.S.M Medical University UP, Lucknow (Erstwhile King
George Medical College), Lucknow, Uttar Pradesh, India
2 Sanjay Gandhi Postgraduate Institute of Medical Sciences,
Lucknow, UP, India
3 Sanjay Gandhi Postgraduate Institute of Medical Sciences,
Lucknow, India
4 Sanjay Gandhi Postgradute Insistute of Medical Sciences,
Lucknow, India
Background: In developing countries the diagnosis of
extra pulmonary tuberculosis (EPTB) with conventional diag-
nostic tools is a major challenge. EPTB encounters many
problems like pauci-bacillary nature, inadequate sample
volume. All the limitations reﬂect in the poor contribution of
conventional bacteriological technique in the establishment
of diagnosis of EPTB. The objective was to evaluate IS6110
PCR for detection of Mycobacterium tuberculosis complex
for diagnosis of Extra Pulmonary Tuberculosis cases attend-
ing tertiary care hospitals.
Setting: Department of Pulmonary Medicine, C.S.M Med-
ical University, Lucknow (Erstwhile King George Medical
University) and Department of Microbiology, Sanjay Gandhi
Postgraduate Institute of Medical Sciences, Lucknow, India.Methods: Specimens from sixty clinically suspected cases
of EPTB were processed for Mycobacteria by conventional
and BACTEC culture for M. tuberculosis complex. All the
samples were also processed for PCR ampliﬁcation withts e307
rimers targeting 123 bp fragment of insertion element
S6110 of M. tuberculosis complex.
Results: Out of 60 cases, 47 (79%) were newly diagnosed;
3 (21%) cases were previous treated cases. Forty ﬁve (75%)
ere male and ﬁfteen were (25%) female. 11/60 (18.3%)
ere positive for AFB by ZN staining. BACTEC culture was
ositive in 23/60 (38.8%) and IS6110 PCR was positive in
7/60 (61.6%) cases.
Conclusion: IS6110 PCR can be highly useful in establish-
ent of diagnosis of EPTB.
oi:10.1016/j.ijid.2010.02.2168
9.013
iagnosis of latent tuberculosis infection by using the
uantiFERON-TB Gold in-tube test in children whose
ousehold contact has contagious pulmonary tuberculosis
isease
. Lee ∗, N. Kim, J. Kim
CHA Bundang Medical Center, Seongnam, Korea, Republic
f
Background: The QuantiFERON-TB Gold In-Tube test
Cellestis, Carnegie Victoria, Australia) was approved for the
iagnosis of latent tuberculosis infection. Although it has
een shown to be sensitive and speciﬁc in adults, limited
ata are available on its performance in children.
Methods: This was a case-control study of BCG-
accinated children younger than 15 years of age in
eongnam, South Korea. We compared tuberculin skin test
nd QuantiFERON-TB In-Tube test results in children who
ad exposed to household with contagious pulmonary tuber-
ulosis disease within the past 3 months. Controls with
o known exposure history for Mycobacterium tuberculosis
ere matched in a 1:1 ratio to cases according to age and
ender.
Results: Among the 27 children with a history of expo-
ure to a household with contagious pulmonary tuberculosis
isease, 21 (78%) had positive results for the tuber-
ulin skin test, whereas 8 (30%) had positive results for
he QuantiFERON-TB In-Tube test. Among the 27 chil-
ren with no known exposure history for M tuberculosis,
one had positive results for both tuberculin skin test and
uantiFERON-TB In-Tube test. There was moderate concor-
ance between tuberculin skin test and QuantiFERON-TB
n-Tube test results ( = 0.43).
Conclusion: The QuantiFERON-TB In-Tube test is a spe-
iﬁc test for diagnosis of latent tuberculosis infection in
hildren whose household contact has contagious pulmonary
e th International Congress on Infectious Diseases (ICID) Abstracts
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tive serology for HIV and high protein levels. Cryptococcosis
meningitis, possible partnership in areas of high prevalence
of TB and HIV. Evolution depended on the stage and the time
when treatment was started. Lethality: 30%. The fatality
rate in HIV + 40% vs. 0% of HIV-. HIV infection was associated
with poor prognosis.
doi:10.1016/j.ijid.2010.02.2170
59.015
Serum proteins in patients with pulmonary tuberculosis
and controls in Nigeria
M. Garbati 1,∗, A. Danburam2, H. Yusuph3, D. Mshelia4
1 King Fahad Medical City, Riyadh, Riyadh, Saudi Arabia
2 Federal Medical Centre, Yola, Nigeria
3 University of Maiduguri, Maiduguri, Peru
4 University of Maiduguri, Maidugiri, Nigeria
Background: Tuberculosis (TB) remains an important
communicable disease especially in the developing world.
The complex relationship that exists between TB and
poverty, homelessness, Human Immunodeﬁcieny Virus and
Acquired Immune Deﬁciency Syndrome (HIV/AIDS) and mal-
nutrition has made the devastating effects of TB well known.
We therefore undertook to evaluate this complex relation-
ship.
Methods: A total of 420 subjects were studied, compris-
ing 210 newly diagnosed sputum smear positive Pulmonary
TB (PTB) patients (aged 18 years and above from Lagos
metropolis) and 210 controls. We determined serum total
proteins levels in the study population colorimetrically using
the Biuret method, while serum albumin was measured by
the bromocresol green method. Screening for HIV-1 and
HIV-2 antibodies was done using ELISA (Wellcome Diagnos-
tics, pasteur, Marnes-la-cognetee, France). Positive samples
were subjected to Western Blotting (Dupont de Nemours,
USA) for conﬁrmation.
Results: Hypoalbuminaemia was found in 184 (87.60%)
of the cases vs. 26 (12.38%) of the controls (P = 0.001) (see
Table 1). The protein sub-fraction, gammaglobulin was how-
ever, much higher in the cases than in the controls [mean
41.45± 11.21% vs. 29.42± 6.76% (p = 0.005)] (see Table 2).
HIV antibody test was positive in 11/153 (7.19%) of those
who accepted to be screened for HIV co-infection.
Conclusion: PTB cases had lower total serum proteins
and lower serum albumin but higher plasma gammaglobu-
Table 1 Distribution of serum protein pattern in the study
population
Protein fraction g/L Cases n = 210 (%) Controls n = 210 (%) P value
Total Protein 73.25±10.51 82.09±63.57 0.04
Albumin 29.37±9.22 40.18±6.23 0.001
Globulin 45.63± 8.71 36.09± 6.43 0.001
Hypoalbuminaemia 184 (87.62) 26 (12.38) 0.001
Hypergammglobulinaemia 189 (90.00) 90 (42.86) 0.001
Hypoalbuminaemia: Albumin < 35 g/L; Hypergammglobulinaemia: Globulin > 35 g/L.308 14
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linical and epidemiological features of tuberculous
eningitis
.E. Ferreira ∗, N.E. Frassone
Hospital Rawson, Córdoba, Córdoba, Argentina
Background: Tuberculosis is common in people with HIV
AIDS, the main risk factor for tuberculous meningitis (TM)
mong individuals aged 25 to 45 years. It has a high fatality
ate and serious neurologic sequelae.
Methods: Retrospective analytic study on patients over
5 years with TM assisted at the Hospital Rawson (Cór-
oba, Argentina) from 01/01/2001 to 01/01/2008, reviewing
edical records. Inclusion Criteria:-High suspicion of TM:
ompatible clinical manifestations associated with CSF cyto-
hemical parameters characteristic -TM conﬁrmed: positive
ulture for M. tuberculosis CSF or brain tissue biopsy.
Results: We analyzed 21 medical records. Average age:
5 years. Sex: 90% male. Headache 95%, fever and stiff
eck 67%. Stage 1 (S1) 48%, S2 38%, S3 14%. Hyponatremia
ccurred in 75% of those left with neurological sequelae
nd 50% of those who died. Chest Rx: 33% pathological
86% had positive culture of CSF). Neuroimaging: 43% hydro-
ephalus, cerebral edema 33%, stroke 29%, tuberculomas
4%, basilar arachnoiditis 5%. CSF: 95% hypoglycorrhachia,
0% high protein levels and hypercellular (89% had lympho-
ytic predominance). 100% smear negative. Positive culture:
5% (73% positive serology for HIV and 82% high protein lev-
ls). Associated cryptococcosis meningitis 29%. HIV + 71%.
D4 low, 100%. On 82% of patients who progressed to com-
lete healing began tuberculostatic treatment in the 1st
eek of hospitalization. Complete healing 52%, neurologi-
al sequelae 19%, death 29%. Lethality 30% (100% aged 25 to
5). Lethality: 40% HIV +, 0% HIV-. Complete healing 80% of
1 and 0% of E3.
Conclusion: TM occurred most often in young men, where
IDS was more frequent and more lethal. Clinical: fever,
eadache and stiff neck. Hyponatremia was associated
ith worse evolution. Abnormal Rx, was associated with
ositive CSF cultures. Hydrocephalus, brain edema and cere-
ral infarction, more frequent injuries. Hypoglycorrhachia
as characteristic. CSF culture positive: most had posi-
14th International Congress on Infectious Diseases (ICID) Abstrac
Table 2 The Relative Sub-fractional Composition of Serum
Proteins by densitometry in study subjects
Subfraction Cases n = 21 (%) Controls n = 21 (%) P Value
Albumin 28.41± 10.88 42.55± 5.13 0.013
Globulins:
Alpha 1 8.03± 5.04 11.19± 2.84 0.098
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gAlpha 2 11.18± 3.15 11.46± 2.03 0.810
Beta 10.26± 6.61 10.54± 5.41 0.810
Gamma 41.45± 11.21 29.42± 6.67 0.005
lins than controls. This study therefore, tried to highlight on
the interrelationship between poverty and disease.
doi:10.1016/j.ijid.2010.02.2171
59.016
High ethionamide resistance in Mycobacterium tubercu-
losis strains isolated in Kenya
V. Asiko
Kenya Medical Research Institute (KEMRI), NAIROBI, KENYA,
Kenya
Background: Increasing development of tuberculosis (TB)
resistance to the currently available drugs including second-
line anti-TB drugs that are being used for treatment of Multi-
Drug Resistant TB (MDR-TB) patients has frustrated efforts
to control TB worldwide. Ethionamide (Eth) is one of the
drugs used in the regimen for treatment of these patients.
Methods: A total of 216 MTB strains with pre-determined
ﬁrst-line drug susceptibility testing (DST) results were used
including 78 ﬁrst-line resistant to individual and combined
drugs, and 138 susceptible to streptomycin, rifampicin, iso-
niazid and ethambutol. The strains were subjected to DST
to ethionamide among other second-line.
Results: Thirty two [32/216 (14.8%)] strains showed resis-
tance to second-line drugs. Resistance to Eth was the highest
[18/32 (56.3%)] including co-resistance with isoniazid [8/18
(44.4%)]. Nine [9/18 (50%)] strains were fully resistant and
9 [9/18 (50%)] were intermediate resistant to Eth.
Conclusion: Unexplainable high levels of Eth resistance is
a cause for concern. This will impact negatively on the out-
come of management of MDR-TB especially in Kenya where
the use of this drug is almost mandatory. Close monitoring
of Eth before initiating individual patient management may
be necessary.
doi:10.1016/j.ijid.2010.02.2172
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ulmonary TB among elderly patients: Higher rates, difﬁ-
ulties for diagnosis and poorer prognosis
.P. Cruz Hervert ∗, R.A. Baez-Saldan˜a, L.D. Ferreyra-
eyes, E.E. Ferreira-Guerrero, B. Cano-Arellano, L. Juarez-
andino, M.D. L. García-García
Instituto Nacional de Salud Publica de México, Cuernavaca,
orelos, Mexico
Background: Tuberculosis (TB) rates among the elderly
>65 yrs) in Mexico (31/100,000) are two-fold those among
eneral population representing a major challenge to health
ystems. Complicating factors include immunosenescence,
hronic diseases, and other infectious diseases.
Methods: Objective: To describe clinical and epidemio-
ogical consequences of pulmonary TB among the elderly.
e screened persons with more than 2 weeks cough in
outhern Mexico from March, 1995 to December, 2008.
e collected clinical and mycobacteriological informa-
ion (isolation, identiﬁcation, drug-susceptibility testing and
S6110-based genotyping and spoligotyping) from individu-
ls with bacteriologically conﬁrmed pulmonary tuberculosis.
atients were treated in accordance with ofﬁcial norms and
ollowed to ascertain treatment outcome, retreatment, and
ital status. We present data for two age groups (45 to 64
ears and 65 and more). We compared TB incidence and
ortality rates. We used Cox proportional hazards models
o assess the association of elderly age with death due to
B.
Results: 526 TB patients were older than 45 years of age;
f these, 173 (33%) were 65 yrs of age or older. Individuals
65 yrs had higher rates of recently transmitted TB rates,
ewer symptoms and fewer bacilli in sputa as compared with
5 to 64 year old adults. Elderly age was associated to death
ue to TB (HR = 3.41; IC95% 1.4—8.3.; p = 0.007) adjusting by
ender, drug resistance, re-treatment and diabetes.
Graph 1 Kaplan-Meier survival estimates for death by
B between age groups.
Conclusion: Although high, TB rates among the elderly
re most probably underestimated. Pulmonary TB among
65 years entails difﬁculties for timely diagnosis and poses
higher risk of mortality due to TB. Speciﬁc strategies to
chieve timely diagnosis and treatment are needed for vul-
erable group (Graph 1).
oi:10.1016/j.ijid.2010.02.2173
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9.018
leural effusion of patients with tuberculosis is character-
zed by accumulation of  T lymphocytes that expresses
istinct surface markers
.H. Okamura1, D.A. Oliveira2, R.F.S. Moreira2, F.
igueroa1, J.B. Aﬁune1, L.F.R. Medici 1, F.A.F. Melo1,
. Rivero2, D. Rodrigues2,∗
Instituto Clemente Ferreira, Sao Paulo, Brazil
Universidade Federal de Sao Paulo, Sao Paulo, Brazil
Background: Tuberculosis (TB) causes about 3 million of
eath per year. It is very important to elucidate the precise
echanism of defense against Mycobacterium tuberculosis.
he role of gamma-delta (/9) T lymphocytes in adaptative
mmunity in tuberculosis remains uncertain. We addressed
he distribution of these T subsets at diagnosis of tuber-
ulosis patients and suggest they must be involved in the
athogenesis of the disease.
Methods: The frequency of /9 T lymphocytes was eval-
ated in both pleural effusion and peripheral blood of 33
atients with pleural tuberculosis before treatment. Frozen
BMCs were surface stained for CD3, V91, and V92. Analyze
f memory and naive subsets were performed by expression
f CD11a and CD27 on /9 T cell. Also, the percentage of
FN-/- producing V91 and V92 cells after IPP stimulation was
valuated. Latently infected contacts and healthy subjects
ere used as controls.
Results: The latent infection group presented the high-
st proportion of V91 T cells (12.9%, p < 0.05) compared to
ealthy control (4.29%, p < 0.05) and tuberculosis patients
6.2%, p < 0.05). It was observed higher percentage of mem-
ry cells in latent infection than the other groups (p < 0.05).
leural effusion was characterized by higher frequency of
emory phenotype cells than blood (p = 0.0342). These sub-
ets produced more IFNg (7.05% in memory versus 3.62% in
aïve cells, p < 0.05) conﬁrming that they are memory cells.
e found that in tuberculosis the frequency of V91T cells
re higher when compared with V92 (5.07% versus 1.1%,
< 0.05). These numbers reﬂected an inverted V91:Vd2 ratio
ssociated with tuberculosis. The latent infection group pre-
ented higher frequency of V92 T cells than healthy control
2.76% versus 1.29%, p = 0.03), and than TB (p < 0.001).
Conclusion: Marked accumulation of V91 and V92 in
leural effusion is seen in active tuberculosis, and /9 T lym-
hocytes are expanded in pleural effusion, and this site is
ainly composed by memory subsets. Our date further indi-
ate that /9 T cells participate in the immune response
gainst Mycobacterium tuberculosis.
oi:10.1016/j.ijid.2010.02.2174
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iagnostics of resistance mycobacterium tuberculosis (MR
T) to isoniazid (H) and rifampicin (R) by simultaneous
dentiﬁcation of mutations in rpoB, katG, inhA and ahpC
enes with use biological microchips (TB-biochip)
. Zhuravlev
The Research Institute of Phthisiopulmonology,
t.Petersburg, Russian Federation
Background: TB-biochip can simultaneously identify
utations in four MBT genes associated with MR to (R) and
H): rpoB, katG, inhA, ahpC.
Methods: We have studied opportunities of use of the TB-
iochip for express diagnostic of genetic characteristic of
R MT in clinical samples (sputum) from 186 patients with
isseminated tuberculosis.
Results: Mutations in rpoB gene were revealed in
25(67.2%) cases. Thus the replacement of codon 531 in
3(50.4%), including (Ser531-Leu) in 26(41.3%) was most
ften. This mutation is mostly distributed among R resis-
ance strains in the world and commonly connected to
eijing genotype. This replacement causes resistance to
igh concentration R in vitro and does not affect MBT
iability. Other variants of mutations in this codon were
ery seldom: Ser531-Cys(10), Ser531-Gln(19), Ser531-Trp(8)
atients. Replacements in other codons: 511(12), 512(13),
13(9), 516(8), 526(15) and 533(5) cases. Drug resistance
o H, caused by mutations in katG gene, was revealed in
5(51.0%) cases. Replacement in codon prevailed: isolated
ariant - in 41(43.2%) patients, combination with 328 codon
eplacement - 8(8.4%) or combination with 335 codon -
(2.1%). We have revealed the replacement of nucleotides
f inhA gene in 43(23.1%) patients. The ahpC gene has low-
st number of mutations - 11(5.9%). Among the studied MBT
e have revealed only 3(1.6%) with mutations in all studied
ene. In 3 gene the mutations were - 16(8.6%) strains, in 2
ene - 59(31.7%), in 1 gene - 28(15.1%). The strains without
ny mutations revealed were only 37(19.9%). Our results had
good correlation with microbiological investigation of the
ame samples.
Conclusion: The prevalence of the strains with the com-
ination of mutations of rpoB531 and katG315 once again
onﬁrms the presence of pool of drug resistant and mul-
idrug resistant strains of Beijing genotype at territory of
orth-West region of Russia in conditions of wide applica-
ion of R and H. This the method of biological microchips
s high sensitive and speciﬁc for express detection of MR
T. It allows detection of resistance MT to R and H with in
4 hours that is very important for choosing the adequate
nti-tuberculosis chemotherapy.
oi:10.1016/j.ijid.2010.02.2175
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mitogen response was lower in H-HD than in healthy staff
and travellers (7.56 IU/mL vs 20.15 IU/mL, p < 0.001).
Conclusion: The IGRA test gives fewer indeterminate and
positive results than we expected from overseas reports.14th International Congress on Infectious Diseases (ICID) Abs
59.020
Fast identiﬁcation of Mycobacteria from positive Mb/Bact
bottles using a multiplex PCR
E.P.A. Bensi 1, C.E. Levy2, M. Ramos3,∗, P.C. Panunto1
1 Universidade Estadual de Campinas, Campinas, SP, Brazil
2 Universidade Estadual de Campinas, Campinas, Brazil
3 Universidade Estadual de Campinas - UNICAMP, Campinas,
SP, Brazil
Background: The rapid identiﬁcation of mycobacteria
from culture-positive Mb/Bact bottles is an important clini-
cal issue. Furthermore, the availability of a non-expensive,
technically simple, and accurate method also would beneﬁt
mycobacterial laboratories in developing countries. In this
study, we aimed to develop an assay allowing the identiﬁ-
cation of the Mycobacterium tuberculosis complex (MTBC)
and other frequently isolated nontuberculous mycobacte-
ria (NTM) directly from positive Mb/Bact (Organon-Teknika)
bottles. A multiplex PCR focusing the hsp65 gene, and the
IS6110 was done and evaluated for its efﬁciency compared
to PRA identﬁcation, and PNB inhibition.
Methods: Mycobacterial strains were grown from clin-
ical samples and preserved in solid media (LJ). A panel
of 91 M. tuberculosis strains, and 26 Non-Tuberculous-
Mycobacteria were submitted to the following identiﬁcation
techniques: a) hsp65 gene ampliﬁcation followed by restric-
tion (PRA); b) p-Nitrobenzoic acid (PNB) growth inhibition
in liquid media (Mb/Bact); 3) Multiplex-PCR, using two sets
of primers: TB284/TB850 (IS6110 MTC spciﬁc primers), and
TB11/TB12 (65 kD antigen, Mycobacterium genus speciﬁc
primers). The mycobacteria was inactivated being heated at
80oC for 20min before DNA extraction. DNA was extracted
by the freezing and thawing method. 50l of the the super-
natant was used for ampliﬁcation. Identiﬁcation using hsp65
restriction was done according to international protocols
(Telenti et al, 1993), and considered the gold-standard. PNB
was added to liquid Mb/Bact bottles to a ﬁnal concentration
of 500g/ml. p-aminobenzoic acid, and the Mycobacterial
concentration was adjusted to the MacFarland 1 standard.
Results: The hsp65 restriction analysis identiﬁed all
Mycobacteria tested as: M.tuberculosis (61 strains),
M.avium, M.intracellulare, M.fortuitum, M.abscessus,
M.gordonae, M.szulgai. There was 100% agreement
between the tests performedts e311
Conclusion: A simple and inexpensive Multiplex-PCR as
escribed here, can readly distinguish among M. tuberculo-
is Complex strains, and Non-Tuberculous Mycobacteria.
oi:10.1016/j.ijid.2010.02.2176
9.021
dentiﬁcation and treatment of latent tuberculosis infec-
ion in haemodialysis patients in New Zealand
. Verrall, M. Leikis, J. Hildreth, N. Raymond, T.
lackmore ∗
Capital and Coast DHB, Wellington, New Zealand
Background: International and local reports indicate that
uberculosis (TB) is a major issue in haemodialysis units
ecause of high rates, difﬁcult and late diagnosis, high
orbidity and mortality. Moreover, there is potential for
osocomial spread. The Mantoux test is unreliable in renal
isease, and appears to have lead to diagnostic nihilism
ith respect to latent TB infection (LTBI): no treatment of
TBI had been employed previously in our unit. The aims of
his study were to describe the epidemiology of active TB
ithin renal patients in the greater Wellington Region and
o develop a LTBI testing and treating algorithm using an
nterferongamma release assay (IGRA)
Methods: A ten year review of notiﬁcation data and clin-
cal records was used to identify and describe renal patients
ith active TB. All patients receiving hospital haemodialysis
H-HD) were screened using QUANTIFERON-Gold (Cellis-
is, Australia). Chest radiographs and clinical notes were
eviewed.
Results: Seven cases of active TB in H-HD patients were
dentiﬁed, approximating an incidence of 1.2/100 new dial-
sis patients. The overall annual incidence in New Zealand is
0.3/100,000. Six patients died (86% mortality), but mostly
his was not directly due to TB. All 65 H-HD patients were
creened for LTBI, 66% of whom were born outside NZ. Over-
ll 6 (9%) were positive and all but one were from overseas,
igh prevalence, countries. Three results were repeatedly
ndeterminate due to weak mitogen test results. The mean
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treatment with tuberculous drugs is effective, however the
early diagnosis is important to avoid clinical complication or
even association to malignance tumors.312 14
hose identiﬁed as having LTBI have all been commenced
n isoniazid therapy, apart from two patients who are not
xpected to survive long term. Treatment has been sim-
liﬁed by using directly observed therapy when patients
eceive dialysis. Those with negative and indeterminate
GRA results will be carefully followed, enabling further clin-
cal validation of the test. Most importantly, the IGRA test
as given greater conﬁdence to the renal unit staff and has
esulted in active management of LTBI in a high risk group.
oi:10.1016/j.ijid.2010.02.2177
9.022
he role of a whole blood interferon- releasing assay for
he tracing of tuberculosis infection in bacilli Calmette
uerin vaccinated children
.-K. Chun ∗, E. Soon, H.M. Kim
Wonju Christian Hospital, Wonju, Korea, Republic of
Background: There are limited data about new
nterferon-/ releasing assay (IGRA) in pediatric ages.
aradoxically the screening of latent tuberculosis infection
LTBI) and the selection for isoniazid (INH) preventive
reatment have signiﬁcance in this age group. The high
peciﬁcity of IGRA has a merit in younger children under
CG effects. The aim of this study was to evaluate the role
f IGRA for the tracing of tuberculosis infection in BCG
accinated children.
Methods: For 24 months, between Jul. 1, 2007 and Jul.
1, 2009, data were collected from children who visited
or tuberculosis evaluation in Wonju Christian Hospital. The
rst group was composed of children who had close contact
o active tuberculosis patients, the second group was the
atients undergoing evaluations of tuberculosis with various
iseases. Tuberculin skin test (TST) and QuantiFERON®-TB
old In-Tube (QFT-G IT, Cellestis, Victoria, Australia) test
ere performed.
Results: A total of 70 children were evaluated and their
edian age was 5 year of age (range: 7 days — 16 years).
here were 24 patients who had history of contact to active
uberculosis but no symptoms. Among them, 5 patients were
FT-G IT positive and 10 patients were TST positive when the
utoff value is ≥5mm ( = 0.53), 5 patients were TST posi-
ive when the cutoff value is ≥10mm ( = 0.74). Fourty six
atients were evaluated to be ruled out tuberculosis infec-
ion and 16 patients were diagnosed as active tuberculosis
nd improved by antituberculosis medications. In 2nd group,
ST was positive in 9/16 (56.2%) and QFT-G IT was positive
n 11/16 (68.7%).
Conclusion: The results of IGRA seemed to be concordant
ith TST in pediatric age also in diagnosing LTBI and active
uberculosis. In BCG vaccinated children, using both meth-
ds would be useful for highly selective anti-tuberculosis
reatments.
oi:10.1016/j.ijid.2010.02.2178
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n unusual case of esophageal tuberculosis in immuno-
ompetent female patient
.F. Brito1,∗, R.F. Arbex1, C.M.S. Messina1, M.H. Froes2,
.B. Aﬁune3, C.M.F. Paradela2, F.A.F. Melo3, D. Rodrigues1
Universidade Federal de Sao Paulo, Sao Paulo, Brazil
Instituto de Infectologia Emilio Ribas, Sao Paulo, Brazil
Instituto Clemente Ferreira, Sao Paulo, Brazil
Background: Esophageal tuberculosis is an extremely
are entity, totaling 3% of total patients with gastroin-
estinal tuberculosis (TB). Clinically these patients may be
istakenly diagnosed as esophageal carcinoma because dys-
hagia and weight loss are the more frequent symptoms.
sophageal TB involvement generally affects the middle-
hird of the esophagus around the carina. This usually is
aused by direct extension and spread from mediastinal
tructures, the previous mechanism of spreading the inocu-
ation of swallowed sputum, as well as by hematogenous or
ymphatic spread. The goal of this case presentation is order
o emphasize the importance of tuberculosis infection in the
ifferential diagnosis of gastrointestinal symptoms because
his form of TB can be successfully treated by antitubercu-
ous chemotherapy.
Methods: A 31-year-women was admitted to Clemente
erreira Institute, a reference center for tuberculosis in
razil, with complains of dysphagia and postprandial epi-
astria pain. It was associated with non-productive cough,
eight loss and weakness. She otherwise was in good health,
linical examination appeared normal and, she reported no
ther relevant symptoms. No TB contacted informed prior
istory of tuberculosis. She had no immunosuppressive con-
itions.
Results: The barium swallow ﬁlm revealed an extrinsic
ompression and erosion in the esophagus. She was submit-
ed to esophagogastroduodenoscopy showing large ulcers in
he esophagus, and the histopatological examination the
ucous biopsy showed ulcerative inﬂammation and pres-
nce of granulomatous inﬂammation, but a negative staining
or acidfast bacilli. She had a positive tuberculin skin test
13mm). Chest X-ray showing inﬁltration image at right hilar
egion. Tubercle bacilli were isolated on Lowenstein-Jensen
edium from sputum. Treatment with rifampin, isoniazid
nd pyrazinamide was initiated, having the patient shown
avorable clinical response during a follow-up period of 6
onths.
Conclusion: Esophageal tuberculosis is rare, and the diag-
ostic may be mistakenly considered as malignancy. Theoi:10.1016/j.ijid.2010.02.2179
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introduction, and increasing reliance on molecular methods
to detect non-vaccine types from cases of meningitis and
empyema.
doi:10.1016/j.ijid.2010.02.218214th International Congress on Infectious Diseases (ICID) Abs
59.024
Pott’s Spine in a 3-year-old child
N. Bhumbra1, R. Arrouk2,∗
1 University of Toledo College Of Medicine, Toledo, OH, USA
2 University of Toledo College of Medicine, Toledo, OH, USA
Background: Less than 1% of pediatric tuberculosis
is associated with spinal disease. The infection is via
hematogenous or lymphatic spread from a primary focus in
the lungs.
Methods: A 3 year-old recently adopted Ethiopian girl
presented with kyphosis. Imaging studies showed signiﬁcant
erosive defect in the lower thoracic spine, multiple eroded
vertebral bodies, 30-degree kyphotic deformity, and a pre-
vertebral abscess. The patient had a normal chest x-ray and
a positive PPD test (17x14mm induration). The patient had
no constitutional symptoms, no lung disease and minimal
elevation of ESR.
Results: Pott’s Disease (Tuberculous Spondylitis) was sus-
pected and conﬁrmed by obtaining a specimen from the
prevertebral abscess through interventional radiology. The
specimen was positive for acid-fast bacilli, and the culture
grew mycobacterium tuberculosis.
Conclusion: This case report highlights the patient’s ini-
tial presentation, diagnostic work-up, and the management.
Pott’s Disease, relatively rare in children, will be discussed.
doi:10.1016/j.ijid.2010.02.2180
59.025
Status of HIV/TB co-infection in Cuba and strategies
followed in the health care of patients with active tuber-
culosis and AIDS in the Institute of Tropical Medicine
‘‘Pedro Kourí’’
M. Diaz Jidy
Instituto Pedro Kouri, La Lisa, Cuba
Background: There is a tendency to the reduction of
tuberculosis cases in Cuba. However, an increase of tb cases
in the HIV/AIDS population has been observed.
Methods: The data supplied by the Cuban Public Health
Ministry were compiled in relation to the number of cases
with tb and HIV/AIDS diagnosed during the last 8 years,
and diagnostic and treatment procedures in the Institute of
Tropical Medicine ‘‘Pedro Kourí’’ were reviewed.
Results: The number of tb patients with HIV/AIDS
increased from 13 (1.2%) of 1133 tb patients reported for
year 2000 in Cuba, to 50 (6.6%) of 754 tb patients reported
for 2007. Forty-one cases were diagnosed in the IPK hos-
pital in 2007, 21 were conﬁrmed by bacteriology tests,
and 24 already had previous antiretroviral treatment. The
procedure followed with inpatients was to keep them in
respiratory isolation until 3 smears were performed with cul-
tures and antibiograms. In case these smears were positives,
the tb treatment was given priority over the antiretroviral
treatment. For up to 60% of tb patients, negative smears
have been reported even for sick patients. Therefore, given
the evidence that a patient had an active tb even with a
negative smear, the case is analyzed in a staff meeting con-
sidering aspects such as previous contacts with tb patients,ts e313
ersistent respiratory symptoms, weight loss, and radiology
tudies compatible with the disease, among others, where
t can be decided to report and start the tb treatment.
Conclusion: The number of patients with TB and HIV/AIDS
n Cuba has increased with the years. Even in patients with
egative smears, the disease cannot be ruled out and spe-
iﬁc strategies are needed for its diagnosis and prompt
reatment.
oi:10.1016/j.ijid.2010.02.2181
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neumococcal infection and colonization in children and
ts impact on pneumococcal disease in adults
. Klugman
Emory University, Atlanta, GA, USA
The introduction of 7 valent pneumococcal conjugate
accine in children in the USA in the year 2000 has been
ollowed by evidence not only of direct protection from
nvasive pneumococcal disease, meningitis and pneumonia
n immunized infants, but also by a reduction in serotype
peciﬁc infections in adults, particularly the elderly. The
ecrease in disease in adults is due to the induction of herd
mmunity through the vaccine impact on acquisition of vac-
ine serotypes in the nasopharynx of immunized children.
he extent of herd immunity is such that the impact on
arriage has been responsible for a greater reduction in mor-
idity and mortality through herd immunity, than has been
he reduction in disease due to direct protection. These data
uggest that impact on carriage should be an important com-
onent in the evaluation of future pneumococcal vaccines
uch as 10 and 13 valent conjugates as well as candidate
rotein vaccines. Replacement disease has occurred, partic-
larly among Alaska natives, HIV infected adults, and adults
ith underlying chronic diseases. The replacing serotypes
re less invasive and therefore the replacement has not
liminated the beneﬁts of vaccination in most groups.
Antibiotic resistant infections have diminished, but resis-
ance is emerging among important serotypes such as 19A
nd 6C. In other countries, there are emerging data sug-
esting similar protection and herd immunity. In a trial of
valent conjugate, including types 1 and 5 in South Africa,
IV infected children have been protected by this vaccine
rom invasive disease and pneumonia. Temporal shifts in epi-
emic prone serotypes may mask vaccine impact if these
ypes are increasing at the time of vaccine introduction.
ther factors that may mask vaccine effect are increas-
ng submission of strains to reference centers post vaccine
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1.001
xtreme Drug Resistance (XDR) in Nosocomial Pathogens
. Pasteran
Instituto Nacional de Enfermedades Infecciosas INEI ANLIS
r. Carlos G. Malbran, Buenos Aires, Argentina
The implacable increase in the prevalence of antimi-
robial resistance among gran negative bacilli (BGN) is
f great concern. Several highly resistant gram-negative
athogens, namely Acinetobacter, Pseudomonas aerugi-
osa, and Klebsiella pneumoniae sensitive to a small number
f drugs, if not any, are emerging as signiﬁcant pathogens.
he mechanisms of this resistance are often complex
ut include outer-membrane impermeability, up-regulated
fﬂux pumps, target-site mutation and, not surprisingly,
he production of carbapenemases, in addition to several
nzymes. Given the frequency of worldwide reports now
escribing infection with carbapenemase-producing BGN, in
ddition to the intercontinental spread of hyper-epidemic
lones, such as KPC-3-possesing K. pneumoniae ST258, it is
ossible that any institution on the globe could be beset
y multi-resistant BGNs. Proﬁcient methods are needed for
arly detection and conﬁrmation in clinical microbiology
aboratories of multidrug resistant bacteria, specially those
roducing carbapenemases, in any attempt aimed for tar-
eting optimal antimicrobial therapy and controlling their
pread. Therapeutic options for these pathogens are so
xtremely limited. Even now, resistance to new ‘‘salvage’’
herapy, such as tigecycline and colistin is being observed.
everal new terms deﬁnitions have been introduced in the
edical literature to describe this complex scenario: pan-
esistance, extreme-resistance, extensively-resistant.
Although there is no international harmonization of this
erminology, their adequately capture the public awareness
or the desperate need for attention to this problem. As
xpected, mortality rates among patients with infections
ue to these organisms are signiﬁcantly higher than those
aused by sensitive germs. The urgency of the problem is
ompounded by the recognition that fewer new antimicro-
ial agents are introduced each year. Thus, clinicians are
orced to use older drugs for which there is a lack of robust
ata about their effectiveness. The complex nature of this
cenario requires the coordinated efforts of all sectors
nvolved, in any attempt to curb antimicrobial resistance.
oi:10.1016/j.ijid.2010.02.2183
1.002
asic Principles of Implementing an Antibiotic Optimiza-
ion Program
. Cortes
Bogota, Colombia
Antimicrobial stewardship is an important and evolving
spect of patient care and safety programs in hospitals
round the world. A team of involved specialists, including
nfectious diseases physicians, clinical microbiologists, hos-
ital epidemiologists and others, is needed to address this
omplex problem. In United States a clinical pharmacist has
een also claimed to collaborate in this kind of program,
E
i
p
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ut in Latin America and other limited-resources areas, lack
f appropiate personnel are part of the limitations to imple-
entation. Two strategies, not to be exclusively applied, are
roposed. Prospective audit with intervention and feedback
s an option, while the use of formulary restriction and pre-
uthorization might be also used. The ﬁrst strategy might be
ime consuming and requires a series of tools to succed. The
mplementation of the program requires administrative and
conomic support and the use of education, development of
uidelines, antimicrobial order forms, de-escalation therapy
which requires an active participation of the microbiology
aboratory), dose optimization, and switch to oral therapy.
ffective use of antimicrobials but also prevention of resis-
ance are the goals to achive in the individualised care of
atients and new targets are being currently deﬁned (phar-
acodynamic objectives). Up to the moment more research
s required to ﬁnd the best ways to achieve these goals.
oi:10.1016/j.ijid.2010.02.2184
1.003
nfection Control Program as an Additional Tool to Control
acterial Resistance
. Cornejo
Instituto Nacional de Cancerologia, Mexico City, Mexico
The combination of effective antimicrobial steward-
hip with a comprehensive infection control program has
een shown to limit the emergence and transmission of
ntimicrobial-resistant bacteria, reducing health care costs.
There are multiple mechanisms postulated by which
ntimicrobial resistance may appear and disseminate within
ospital organisms:
1) Introduction of a resistant organism to a previously
usceptible population; 2) Acquisition of resistance by a sus-
eptible strain: spontaneous mutation or genetic transfer;
) Expression of regulated resistance already present in the
opulation; 4) Selection of resistant subpopulations; and, 5)
issemination or spread of resistant organisms
There have been proposed ﬁve strategic goals to optimize
ntimicrobial use: 1) Optimize antimicrobial prophylaxis
or surgery 2) Optimize choice and duration of empirical
herapy; 3) Improve prescribing by education; 4) Monitor
nd feedback information on antimicrobial resistance rates,
nd, 5) Produce protocols for antibiotic usage. Also the
trategies must include optimal selection, dose, and dura-
ion of treatment, as well as control of antibiotic use, for
revention or slowing the emergence of resistant among
icroorganisms.
An effective Antimicrobial Control Program Infection
ust prevent or reduce antimicrobial resistance. Speciﬁc
oals related to this program are:
1) A determination of who will be responsible for main-
aining control. 2) A determination of which antimicrobial(s)
o control. 3) Precise deﬁnitions of antimicrobial resistance
or antimicrobials and organisms. 4) A system for monitoring
he frequency of resistance (clinical and environmental). 4)
ducation. It is an essential element to inﬂuence prescrib-
ng behavior. 5) A method to determine antimicrobial use
er geographic area per unit time. 6) Ability to distinguish
ommunity from nosocomial isolates. 7) A method to assure
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that clinical care will not be harmed by control measures
such as: de-escalation of therapy, dose optimization, and
parenteral to oral conversion of antimicrobials with excel-
lent bioavailability can decrease the length of hospital stay
and health care costs.
doi:10.1016/j.ijid.2010.02.2185
61.004
New Antibiotics: Which Role in a Antimicrobial Steward-
ship Program?
D. Curcio
Hospital de Infecciosas F.J. Muniz, Buenos Aires, Argentina
Infections caused by multidrug-resistant bacteria con-
tinue to challenge physicians in the daily practice. We
face growing resistance among Gram-positive and Gram-
negative pathogens that cause infection in the hospital
and in the community. Rice recently reported these as
the ‘‘ESKAPE’’ pathogens (Enterococcus faecium, Staphy-
lococcus aureus, Klebsiella pneumoniae, Acinetobacter
baumanii, Pseudomonas aeruginosa, and Enterobacter
species) to emphasize that they currently cause the majority
of world-wide hospital infections and effectively ‘‘escape’’
the effects of antibacterial drugs.
In this context, controlling antibiotic use and bacterial
resistance trough an antibiotic stewardship program (ASP)
is of major importance to all professionals involved in infec-
tious diseases.
A critical need to develop new antimicrobial compounds
and to use the recently approved agents appropriately are
components of all ASP. Unfortunately, most of the agents
which are in the late stage of develop have activity only
against Gram-positives and none is active for treatment of
infections caused by the Gram-negative ESKAPE pathogens.
We have analized the body of the literature with the aim
to deﬁne, within a ASP, the opportunity of use and the poten-
tial advantages of new antibiotics in order to reduce the
emergence and selection of resistant pathogens.
Related with the role of the new antibiotics in a Asp, it is
possible to consider the following points: i-the use of tige-
cycline instead of carbapenems in clinical settings with high
rates of carbapenems-resistant pathogens (ie. in nosocomial
peritonitis), ii-the use of doripenem in extended-infusion
(ie. in severe infections due to Pseudomonas aeruginosa);
iii-the use of daptomycin at high doses (ie. in infections
due to methicillin-resistant Staphylococcus aureus) and iv-
the use of ceftobiprole as empiric monotherapy (ie. in some
suspected mixed infections).
The use of the new antibiotics in the daily practice
based on the individual patient characteristics, causative
organism, site of infection, and pharmacokinetic and phar-
macodynamic characteristics of the drug is an important
part of an ASP.
doi:10.1016/j.ijid.2010.02.2186
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urrent challenges in HIV care (Invited Presenta-
ion)
2.001
tate of the Art on ARV Therapy: How Many Standards of
are?
. Cahn
Foundation Huesped, Buenos Aires, Argentina
Albeit nobody would support the idea of ‘‘ﬁrst and second
lass medicine’’, in real life we confront AIDS with at leat
wo standards of care. When to start ARV therapy remains a
atter of debate. No disagreement exists for symptomatic
atients, as well as for asymptomatic individuals with CD4
ounts of 350/ mm3 or below. In resource-poor settings,
HO recommended until late 2009 that adolescents and
dults should start HAART when they have advanced HIV
isease, mildly symptomatic and asymptomatic disease,
HO Stage II or I HIV disease with CD4 counts <200/mm3
These recommendations were updated in November 2009
nd look now closer to those released by other interna-
ional bodies. Some Western countries guidelines panels,
ike the DHHS recommends now treatment initiation in
symptomatic patients when the CD4 count falls below
50/mm3, and have shown a divided opinion regarding the
f treatment should be considered in patients with CD4
ell counts <500/mm3, particularly if the patient has high
iral load, age above 50 and/or comorbidities like HBV or
CV coinfections, among others. Increasing amount of data
uggest that by starting earlier, the so called ‘‘non-AIDS’’
iseases driving to mortality in the HAART era might be dra-
atically reduced. On top of the beneﬁts at the individual
evel, ART has been shown as a prevention tool by reduc-
ng the median viral load at the community level.Currently
vailable co formulations are the best options for ARV back-
one in naive patients. Issues such as childbearing potential
nd baseline resistance need to be taken into consideration
hen selecting a regimen. Controversies remain on whether
o use a PI or an NNRTI as the third drug in initial therapy,
articularly important in the presence of advanced disease.
he bottom line is that one size does not ﬁt for all in this
hallenging ﬁeld.
oi:10.1016/j.ijid.2010.02.2187
2.002
rug Resistance and Other Laboratory Monitoring Assays
n HIV infection
. Hirsch
Harvard Medical School, Boston, MA, USA
Although CD4 cell counts and plasma viral load assays
re the principal laboratory tests used to monitor the
rogress of HIV-1 infections, several other assays are assum-
ng increasing importance to adequately assess the beneﬁts
f antiretroviral therapy (ART) in infected individuals. The
ccessibility of such assays will vary greatly, depending on
he resources available to treat HIV infections.
Where testing capability exists, HIV drug resistance test-
ng is useful when patients enter care prior to initiating
herapy and again when considering change of regimens
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uring virologic failure. Genotypic assays are generally pre-
erred because of cost and rapidity, except in situations
here multiple ART regimens have been used, when phe-
otypic assays may be of value.
When abacavir is being considered as part of an ART
egimen, genetic screening for HLAB* 5701 is helpful to
educe the risk of severe abacavir hypersensitivity reac-
ions. These reactions, reported in 5-8% of white and 2-3%
f black patients occur primarily in individuals with the MHC
lass I allele HLA-B*5701. Individuals who screen positive for
LA-B*5701 should not receive abacavir.
When a CCR5 antagonist (e.g., maraviroc) is being con-
idered as part of an ART regimen, a coreceptor tropism
ssay is useful, since an agent of this class will only suppress
iruses that utilize this receptor (R5 viruses). CCR5 antago-
ists should not be used in individuals who carry primarily X4
r dual/mixed tropic viruses. Currently, the principal assay
vailable to measure HIV-1 tropism is phenotypic, though
enotypic tests are under study.
Although therapeutic drug monitoring is recommended
y some, its use remains controversial, and no clear-cut
ecommendations can be made regarding its utility.
oi:10.1016/j.ijid.2010.02.2188
2.003
pportunistic Infections and IRIS in the Era of HAART
. Miro
Hosp. Clinic - IDIBAPS. University of Barcelona, Barcelona,
pain
Despite the important advance that cART represents for
he prognosis of the HIV-1 infection, OIs continue to be an
mportant cause of morbidity and mortality in developed
ountries. This is due to late presentation (up to one-third
f new HIV-1 infections), lack of adherence to cART and
rophylaxis or virological failure of cART. In addition, OIs
re very common in developing countries, being tubercu-
osis (TB) the most common one. The ACTG A5164 results
ecommended to start cART during the ﬁrst 2 weeks after
tarting antimicrobial treatment for the OI (patients with
B were not included in this RCT). Some of these patients,
espite having an excellent viral and immune response to
ART, will present a paradoxical worsening of the OI known
s the immune reconstitution inﬂammatory syndrome (IRIS).
he microorganisms most commonly associated with IRIS are
ycobacteria, fungi, and herpes group viruses. The IRIS has
lso been reported in tumors, such as Kaposi sarcoma, and
auses autoimmune diseases. The percentage of patients
ho develop IRIS is variable. In cohort studies of patients
tarting cART, IRIS affects between 15% and 25%. In OIs series
ike TB the frequency is higher, and can reach 50%. Clini-
al effects of IRIS range from a mild, self-limiting illness to
evere morbidity and mortality. The lack of evidence-based
reatment guidelines poses challenges in the management
f these patients. Patients are generally recommended to
ontinue with cART and speciﬁc treatment against OIs.
djuvant nonsteroid anti-inﬂammatory drugs (NSAIDs) and
orticosteroids are commonly used. Corticosteroids have
emonstrated their usefulness in a recent clinical trial in
B patients. Surgery is necessary to debride abscesses.
s
o
dternational Congress on Infectious Diseases (ICID) Abstracts
n life-threatening cases, the possibility of interrupting
ART should be considered until the patient’s situation has
mproved. Clinical experience with immunosuppressors or
NF-alpha inhibitors is very limited.
oi:10.1016/j.ijid.2010.02.2189
2.004
hy are patients dying in the HAART Era?
. Katabira
Makerere University, Kampala, Uganda
NO ABSTRACT RECEIVED
oi:10.1016/j.ijid.2010.02.2190
iomarkers in infectious diseases (Invited Presenta-
ion)
3.001
linical Use of Biomarkers in the Diagnosis and Manage-
ent of CAP
. Ramirez
Hospital Universitario la Fe, Valencia, Spain
Community-acquired pneumonia (CAP) is a serious health
roblem worldwide with an annual incidence of 0.3-0.5%
n the adult population. Besides, CAP remains the leading
ause of death from infectious diseases. This justiﬁes the
nterest in studying all clinical aspects affecting CAP. A new
pproach is to evaluate biological markers of infection and
nﬂammation, as an expression of the hostˇıs inﬂammatory
esponse against the microorganism, in order to achieve
iagnosis, aetiology, progonosis and treatment informa-
ion. The most widely studied biomarkers have been C
eactive protein (CRP), procalcitonin (PCT) and cytokines.
ther biomarkers are now obtaining promising results. Most
uthors conclude that biomarkers can help in the diagno-
is of CAP. Fewer data analyse the capacity of biomarkers
n identiﬁying the potential causative agent and the best
esults have been settled down in children. Linked with the
bove mentioned, biomarkers, mainly PCT, have been used
uccesfully guiding antibiotic prescription in patients with
uspected CAP. Treatment guided by serum PCT was a safe
ay to avoid antibiotics, although economic savings were
vershadowed by PCT analysis costs. Approximately 10-15%
f patients hospitalised for CAP develop treatment failure
nd almost 6% may manifest rapidly progressive pneumonia,
t has been demonstrated that serum levels of biomarkers
an identify patients at risk of treatment failure and there-
ore could guide treatment handling. Clinical data scoring
ystems have been recognized as a useful tool to assess sta-
ility and prognosis of patients with CAP. Analysis of systemic
iomarkers in adition to clinical scores has shown to improve
ither the prediction of absence of severe complications
nd the 30-day mortality prediction by PSI or CURB65/CRB65
cales. Current data from literature seem to support the use
f biomarkers in the daily medical practice concerning CAP.
oi:10.1016/j.ijid.2010.02.2191
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63.002
Biomarkers for Sepsis
S. LaRosa
Rhode Island Hospital, Providence, USA
Manifestations of the Systemic Inﬂammatory Response
Syndrome (SIRS) (leukocytosis, hyperthermia, tachycardia
and tachypnea) can be present in both non-infectious and
infectious conditions and do not predict those subjects at
high risk for death. Readily available biomarkers can help
the practicing ID physician predict the likelihood of infection
and a poor outcome. Unexplained hypophosphatemia and
eosinopenia are common ﬁndings in the setting of bacterial
infection. Coagulation abnormalities including elevated D-
dimer, unexplained thrombocytopenia, Protein C deﬁciency
and prolonged prothrombin time (PT) are present to a
greater extent in patients with a deﬁnite focus of infection
or bacteremia than in those without. Protein C deﬁciency
occurs early in the setting of infection and the severity
predicts outcome. Lactic acidemia is present in the set-
ting of sepsis and the inability to clear it after appropriate
antibiotics and aggressive ﬂuid resuscitation predicts a poor
outcome.
Newer approved biomarkers for sepsis include serum pro-
calcitonin (PCT) and the Endotoxin Activity Assay (EAA).
Serum PCT has been shown to have better sensitivity and
speciﬁcity than the more commonly ordered C-reactive pro-
tein (CRP) in distinguishing SIRS from sepsis. PCT levels have
also been used to shorten the duration of antibiotic therapy.
The EAA assay is elevated in 85% of patients with severe sep-
sis and levels >0.6 are associated with the highest mortality.
A number of additional biomarkers for sepsis are actively
being investigated. In a clinical trial of a biomarker panel,
a score composed of neutrophil-gelatinase —associated
lipocalin (NGAL) in concert with IL-1 receptor antagonist
(IL-1ra) and Protein C had the highest diagnostic accu-
racy for severe sepsis. Levels of the biomarkers gelsolin,
angiopoietin 2 and inter-alpha inhibitors are associated with
sepsis severity and could potentially serve as theragnostics.
Sepsis-induced immunosuppression and propensity towards
secondary infection may be predicted by decreased mono-
cytic HLA-DR expression and reversed with treatment with
GM-CSF.
doi:10.1016/j.ijid.2010.02.2192
63.003
Biomarkers for the Diagnosis of TB
J. Friedland
Imperial College London, London, United Kingdom
Many patients with tuberculosis are treated empirically
and failure to diagnose infection is a cause of morbidity and
mortality. Tuberculosis is a great mimic of other infectious
and non-infectious medical conditions. It may be difﬁcult
to distinguish active disease from latent infection from pre-
vious and even treated tuberculosis. There is also a major
problem in knowing if prophylactic therapy and new vac-
cination programmes are effective since the time course
of the development of active infection is measured over
o
h
b
its e317
ecades. For all these reasons, there is great interest in the
evelopment of novel biomarkers in tuberculosis. To date,
he main biomarkers used in infection are skin tests which
ely on delayed hypersensitivity reactions and interferon
ssays. All these tests have limitations in terms of sensi-
ivity and ability to distinguish different forms of infection.
nitial interest in biomarkers focused on single markers such
s adenosine deaminase. It has become apparent that such
arkers do not provide sufﬁcient speciﬁcity. After brieﬂy
eviewing the topic, I shall focus on the current interest in
eﬁning multiple biomarkers for the diagnosis of tuberculo-
is. There has been interest in transciptomics, metabolomics
nd proteomics to deﬁne disease. Proteomics is particu-
arly attractive as there is the potential to develop tools
uch as dipsticks which are suitable for use in resource-
oor areas from such studies. Some data will be presented
rom our unpublished studies using proteomics to distin-
uish active and latent infection. An alternative, interesting
pproach that will be considered is the development of spe-
iﬁc immune proﬁles that reﬂect either latent or active
nfection with tuberculosis. The potential and current appli-
ation of biomarkers for tuberculosis is an exciting area and
eems likely to provide a future step-change in the diagnosis
f this global infection
oi:10.1016/j.ijid.2010.02.2193
3.004
linical Utility of Biomarkers in Fungal Infection
. Patterson
University of Texas Health Science Center at San Antonio,
an Antonio, TX, USA
Biomarkers are important means for the diagnosis of
nvasive mycoses as cultures may not be positive even in
he setting of signiﬁcant infection. Furthermore, invasive
rocedures which may be necessary to establish deﬁnitive
vidence of infection are often reluctantly undertaken in
everely immunosuppressed patients. For some mycoses,
uch as Cryptococcus and Histoplasma, the detection of
irculating polysaccharide antigen has proven a very use-
ul target for both diagnosis and response to therapy. More
ecently biomarkers have been used to diagnose opportunis-
ic pathogens such as Candida and Aspergillus. A major focus
as been on measurement of Aspergillus galactomannan
rom serum and other body ﬂuids to establish a diagnosis of
nvasive aspergillosis. Serial measurements of galactoman-
an have been shown to correlate with progressive infection
r with successful outcomes of therapy in both pre-clinical
odels as well as in human infections. A number of fac-
ors signiﬁcantly reduce levels of circulating galactomannan
ncluding the use of mould-active antifungal therapy or pro-
hylaxis, immune status of the host and importantly extent
f infection. The test may not be positive despite invasive
nfection, particularly if localized to the lung or if anti-
ould agents are administered. PCR based-methods have
een developed for Aspergillus and Candida but the lack
f standardization and limited external validation have also
ampered utility of that approach. A non-speciﬁc fungal
iomarker, 1,3-beta, D-glucan, that it detected using a mod-
ﬁcation of the limulus lysate assay, is present in many
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ungi, including both yeasts and many moulds (Zygomycetes
eing a major exception). Detection of 1,3-beta, D-glucan
s approved for clinical use though cost and technical issues
ave limited its clinical acceptance for routine use. These
ethods are aimed at providing non-invasive and rapid
ethods for establishing a diagnosis of these often lethal
nfections.
oi:10.1016/j.ijid.2010.02.2194
urden of Plasmodium vivax malaria in Latin Amer-
ca (Invited Presentation)
4.001
pidemiology of P. vivax Malaria in the World and Latin
merica
.J. Rodriguez-Morales
Universidad Central de Venezuela, Caracas, DC, Venezuela
Morbidity and mortality burden of malaria, particu-
arly in children, represents a public health threat also in
hose countries from regions such as South East Asia and
atin America with moderate to low levels of transmis-
ion. Between them epidemiological patterns are similar,
ower malaria inoculation rates sustained with a predom-
nant prevalence of Plasmodium vivax infection. Malaria
ortality in these areas has been mainly attributed to P.
alciparum, but its direct and indirect burden has not well
eﬁned. These patterns are increasingly causing concern
n some countries. Globally, ∼250 million clinical episodes
ccur annually (2.7 in Latin America); most of these are
aused by infection with P. falciparum and P. vivax. Although
. falciparum is justiﬁably regarded as the greater menace
ecause of its high mortality, widespread antimalarial drugs
esistance and its dominance on Africa, malaria due to P.
ivax has also placed signiﬁcant burdens on health, longevity
nd general prosperity of large sections of the human pop-
lation. The debilitating impact of P. vivax malaria remains
igh, unacceptable and preventable for well over one billion
nhabitants of the planet. Complicated and even fatal cases
f malaria due to P. vivax have been increasingly reported
n the medical literature. Plasmodium vivax can cause both
equestration-related and non-sequestration-related com-
lications of severe malaria, including cerebral malaria,
enal failure, circulatory collapse, severe anemia, abnormal
leeding, ARDS and jaundice. In Latin America the burden of
ortality due to malaria, although decreasing, is still signiﬁ-
ant. Powerful antimalarial campaigns in the region directed
ainly to P. falciparum achieved a signiﬁcant reduction of
ortality in the last century. Evidence suggests that P. vivax
an imposes a signiﬁcant burden of mortality that may have
esulted from its interaction with other diseases and con-
itions. These and other epidemiological issues are herein
iscussed at a global level and focused in Latin America.
oi:10.1016/j.ijid.2010.02.2195
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4.002
olecular Epidemiology of P. vivax: tools for Malaria Con-
rol
. Escalante
Arizona State University, Tempe, AZ, USA
Plasmodium vivax is the most prevalent human malarial
arasite in several areas of Asia and South-Central America.
lthough Plasmodium genomics is improving our knowledge
f the organism’s complex biology, population-based inves-
igations are needed to explore the extent of the parasites’
enetic variation, how the observed variation is geograph-
cally distributed, and how such diversity affects or can
e used to assess the success of control measures. Unfor-
unately, the lack of suitable in vitro culturing methods
or P. vivax imposes the use of ﬁeld specimens for popu-
ation studies. Such circumstances have limited molecular
pidemiologic and genetic diversity studies to a handful of
ntigens and few genetic markers that could be considered
eutral, that is, that are not expected to be under natu-
al selection by the immune response or antimalarial drugs.
irst, I will discuss the emerging patterns on the genetic
iversity of P. vivax using neutral markers and explore
he value of comparative approaches to assess potential
ntigenic regions using closely related Plasmodium species
ound inmacaques. I will show an example with genes encod-
ng a well known antigen, AMA-1. Then, I will review the
urrent status of our knowledge on the genetic diversity of
his parasite in Latin-America. Overall, P. vivax populations
n the new world have low levels of genetic diversity and
ndergo clonal expansions. Such low genetic polymorphism
hould be considered while using genetic markers in epi-
emiologic investigations that aim to assess, for example,
he frequency of recrudescent infections or the reintroduc-
ion/expansion of the parasite in a given geographic area in
he context of control efforts.
oi:10.1016/j.ijid.2010.02.2196
4.003
evere and complicated Malaria due to P. vivax
. Murillo
University of Miami, Miami, FL, USA
NO ABSTRACT RECEIVED
oi:10.1016/j.ijid.2010.02.2197
4.004
reatment, Prophylaxis and Resistance in P. vivax Malaria
. Torres
Tropical Medicine Institute, Caracas, Venezuela
The burden of malaria caused by Plasmodium vivax
emains under-appreciated to a great extent, both in terms
f its clinical spectrum and incidence of disease. Con-
rol measures are hampered by both the emergence of
hloroquine (CQ) resistance and the presence of dormant
ypnozoite stages in the liver, which result in relapse infec-
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tions weeks after the cure of the initial episode. Although
CQ remains the ﬁrst line of treatment for patients with vivax
malaria in most of the world, CQ monotherapy is now vir-
tually ineffective in Papua Indonesia with signiﬁcant clinical
resistance apparent throughout the Indonesian archipelago.
Sporadic cases have been reported from South America and
Asia. Unfortunately, the mechanism of P. vivax CQ resistance
is largely unknown and as yet no genetic markers have been
identiﬁed.
Since clinical studies are difﬁcult to carry out in this
species due to factors such as individual variations in patient
immune status, reinfections and frequent relapses, and in
vitro susceptibility assays applicability is limited by lack of
culture methods, the global prevalence of CQ resistance to
P. vivax continues to be poorly deﬁned.
Primaquine, an 8-aminoquinoline compound, is the only
commercially available drug with hypnozoitocidal activity
against P. vivax and is widely used for terminal prophy-
laxis; yet, little is known about how the drug works, if it
works, or how it fails. Reports of true PQ failure and subse-
quent P. vivax relapse are unusual. Most suspected cases can
be ascribed to poor patient adherence. The lack of effec-
tive alternatives to PQ against hypnozoites represents an
important drawback in clinical practice andmay be as opera-
tionally crippling to control efforts against P. vivax, as having
no access to insecticides, bed nets, reliable diagnostics, or
chemoprophylaxis.
Plasmodium vivax malaria will linger as a persistent
and severe challenge to public health as long as our
drug armamentarium remains limited and substantial areas
of our knowledge on its biology, epidemiology, genetics,
metabolism, and mechanisms of resistance to antimalarials,
remain obscure.
doi:10.1016/j.ijid.2010.02.2198
Inﬂuenza (Oral Presentation)
65.001
Mixed infection of inﬂuenza A viruses is common
Y. Furuse1,∗, A. Suzuki1, N. Nukiwa2, N. Fuji 1, H. Oshitani1
1 Tohoku University Graduate School of Medicine, Sendai,
Japan
2 Tohoku University School of Medicine, Sendai, Japan
Background: Reassortment, which is the rearrangement
of viral gene segments in a host cell infected with two
different viruses, is an important mechanism for the evo-
lution of inﬂuenza viruses. A mixed infection of more than
one virus could lead to reassortment. To better understand
the occurrence of quasispecies in one host, we investigated
mixed infection in individual isolates for seasonal inﬂuenza
A viruses using amantadine sensitivity as a marker.
Methods: We cultured viruses with amantadine, and per-
formed sequencing, RFLP, cloning, and quantitative PCR to
detect mixed population in clinical samples.Results: Culturing with amantadine shows evidence of a
high number of mixed populations. When sensitive isolates,
whose M genes were in a certain lineage, were cultured in
medium with amantadine, the viruses with M genes from
a different lineage appeared after several passages. In con-
t
i
h
its e319
rast, the other assays can hardly detect mixed populations.
he proportion of minor viruses in the mixed population may
e too small to be identiﬁed by these assays. We showed
considerably higher proportion (at least 6/11) of mixed
opulations in analyzed samples.
Conclusion: The existence of quasispecies in each isolate
s common. However, the proportion of these, which can be
ess than 1%, is too low to be detected by conventional meth-
ds. Such mixed populations, in which reassortment occurs,
ay have a signiﬁcant role in the evolution of viruses.
oi:10.1016/j.ijid.2010.02.2199
5.002
nﬂuenza vaccine delivery to adolescents: Assessment of
wo multicomponent interventions
.M. Gargano1,∗, K. Pazol2, J.E. Painter3, J.M. Sales3,
. Murray4, C. Morfaw5, L.M. Jones3, P. Weiss3, W.A.
renstein6, R.J. DiClemente3, J.M. Hughes1
Emory University, Atlanta, GA, USA
Centers for Disease Control and Prevention, Atlanta, GA,
SA
Emory University, Rollins School of Public Health, Atlanta,
A, USA
Medical College of Georgia, Department of Pediatric Infec-
ious Disease, Augusta, GA, USA
Richmond County Health Department, Augusta, GA, USA
Bill and Melinda Gates Foundation, Seattle, WA, USA
Background: Despite efforts to enhance inﬂuenza vac-
ination among persons at highest risk of complications,
nﬂuenza remains a health burden in the United States.
vidence indicates that vaccination of elementary school
hildren protects them from inﬂuenza, and reduces trans-
ission. However, there are no published intervention trials
emonstrating the impact of strategies designed to enhance
nﬂuenza vaccination rates speciﬁcally among adolescents.
Objective: Assessing the efﬁcacy of twomulti-component
nterventions designed to enhance inﬂuenza vaccination
ates among adolescents attending middle- and high-schools
n three rural counties in Georgia, U.S.A.
Methods: This study employs a non-randomized, three-
rmed controlled design across 2 years. The three arms
onsist of: 1) a multi-component school-based inﬂuenza
accination intervention condition (County 1), 2) a multi-
omponent provider-based inﬂuenza vaccination condition
County 2), and 3) a standard of care condition (County
). The multi-component interventions each consisted of
structural component (school-based or provider-based
rovision of inﬂuenza vaccination) and an educational com-
onent (a brochure and a school skit), designed to enhance
accine education among adolescents and their parents.
Results: During the 2008 to 2009 inﬂuenza season in
ounty 1, there were 70 students vaccinated out of 370 stu-
ents (18.9%). During the same year in County 2, there were
10 out of 736 students vaccinated (14.9%). In the ﬁrst year,
tudents in County 1 were 25% more likely to be vaccinated
han students in County 2 (RR = 1.26, 95% CI: 0.96-1.66). Dur-
ng the current 2009-2010 inﬂuenza season, in County 1 we
ave vaccinated 114 out of 375 students (30.4%), a 62.2%
ncrease from the previous inﬂuenza vaccination season.
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urrently, in County 2 we have vaccinated 10.5% of students
70 out of 663). For the current inﬂuenza season, students
n County 1 are almost 200% more likely to get vaccinated
han students in County 2 (RR = 2.88, 95% CI: 2.20-3.77).
Conclusion: We have observed a greater percentage of
tudents vaccinated in the school-based intervention than
n the provider-based intervention during the previous and
urrent inﬂuenza seasons (p = 0.0912 and p < 0.0001, respec-
ively). This study has implications for best practices for
ass campaigns during an inﬂuenza pandemic, such as the
urrent H1N1 inﬂuenza pandemic. This study is funded by
DC 5 R18 IP000166.
oi:10.1016/j.ijid.2010.02.2200
5.003
randomized intervention trial of mask use and hand
ygiene to reduce seasonal inﬂuenza-like illness and
nﬂuenza infections among young adults in a university
etting
.E. Aiello1,∗, R.M. Coulborn1, V. Perez1, B.M. Davis1, M.
ddin1, G.F. Murray2, D.K. Shay3, S.H. Waterman3, A.S.
onto1
University of Michigan School of Public Health, Ann Arbor,
I, USA
University of South Alabama, Mobile, AL, USA
Centers for Disease Control and Prevention, Atlanta, GA,
SA
Background: Early efforts to decrease transmission of
andemic inﬂuenza will likely rely on nonpharmaceuti-
al interventions (NPIs), because of delays in availability
f suitable vaccines and limited stock of antiviral med-
cations. We conducted a randomized trial to estimate
eductions in inﬂuenza-like illness (ILI) and laboratory-
onﬁrmed inﬂuenza infection associated with use of face
asks combined with hand hygienemeasures and facemasks
lone in a university setting.
Methods: During the 2007-08 inﬂuenza season, 1,111
tudents residing in university residence halls were cluster-
andomized by residence house (N = 37) to either face mask
nd hand hygiene, face mask only, or control arms. Discrete-
ime survival analysis using generalized models estimated
ate ratios, according to study arm, each week and cumu-
atively over the 6-week intervention period, for clinically
eriﬁed ILI and laboratory-conﬁrmed inﬂuenza A or B.
Results: In the mask and hand hygiene group com-
ared with the control group, adjusting for covariates, we
bserved signiﬁcant reductions in ILI incidence during weeks
(RR, 52%, [95% CI, 6%-76%]) and 5 (RR, 62%, [CI, 6%-85%]),
nd a borderline signiﬁcant reduction during week 6 (RR,
0%, [CI, 2%-91%]). For laboratory-conﬁrmed inﬂuenza, both
he face mask only and the face mask and hand hygiene
roups compared to the control showed a reduction in cumu-
ative incidence, however results did not reach statistical
igniﬁcance; polymerase chain reaction (PCR) conﬁrmed
nﬂuenza A or B in 11 out of 49 samples (22%) in the face
ask and hand hygiene group, 16 out of 58 samples (28%) in
he face mask only group, and 18 out of 68 samples (26%) in
he control group.
w
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Conclusion: These ﬁndings suggest that in shared living
nvironments, the use of face masks and hand hygiene may
educe inﬂuenza-like illnesses.
Trial registration: www.clinicaltrials.gov, Identiﬁer:
CT00490633
oi:10.1016/j.ijid.2010.02.2201
5.004
opulation-based surveillance for 2009 pandemic
nﬂuenza A H1N1 Virus in Guatemala, 2009
. Arvelo1,∗, L. Reyes2, A. Estevez3, J. Gray3, S.
indstrom1, A. Fry1, S. Olsen1, F. Ardon2, G. Frenkel3, B.
ordillo2, K. Lindblade1
Centers for Disease Control and Prevention, Atlanta, GA,
SA
Ministry of Public Health and Social Assistance, Guatemala
ity, Guatemala
Universidad del Valle de Guatemala, Guatemala City,
uatemala
Background: Worldwide >414,000 cases of pandemic
nﬂuenza H1N1 2009 (2009 H1N1) and nearly 5000 deaths
ave been reported. The 2009 H1N1 was ﬁrst identiﬁed in
exico in April 2009, but spread into neighboring Guatemala
ccurred weeks later. We describe the clinical and epidemi-
logic characteristics of patients with 2009 H1N1 infection
n two sites in Guatemala.
Methods: We analyzed data from an active population-
ased surveillance for clinical pneumonia and inﬂuenza-like
llnesses (ILI) in hospitals and ambulatory clinics, respec-
ively, in the departments of Santa Rosa and Quetzaltenango
n Guatemala from February through September 2009. Clin-
cal and epidemiological information, and nasopharyngeal
wabs were collected from enrolled patients. Specimens
ere tested for inﬂuenza with real-time reverse transcrip-
ase polymerase chain reaction.
Results: We identiﬁed 198 persons with 2009 H1N1 infec-
ion between May and September 2009; 61 (31%) were
ospitalized with pneumonia and six died (case fatality pro-
ortion: 2.7%, 95% conﬁdence interval 0.9%-6.3%). Among
nﬂuenza cases identiﬁed between February and May, the
roportion caused by 2009 H1N1 rose from 0% in February
o 67% in May. By July in any given week 80% to 100% of
nﬂuenza A viruses were 2009 H1N1. The median age of per-
ons with 2009 H1N1 infection was nine years, and among
atients hospitalized with pneumonia six years. Fever >38 ◦C
as documented in 37 (60%) pneumonia patients, 53 (85%)
ersons self-reported fever. Adjusted hospitalization rates
ere highest for children <5 years old (154.9 per 100,000) in
anta Rosa. Fourteen (23%) hospitalized patients with 2009
1N1 were admitted to the intensive care unit (ICU) and
ve (8%) requiredmechanical ventilation. Among children <5
ears, nine (28%) were admitted to the ICU and three (10%)
ied. Underlying chronic conditions were noted in <20% of
atients hospitalized with 2009 H1N1 infection.
Conclusion: Although seasonal inﬂuenza A (H1N1/H3N2)
as circulating prior to widespread 2009 H1N1 transmis-
ion, it was quickly replaced by the 2009 H1N1 virus. The
pidemiology was similar to reports elsewhere except for
he low frequency of underlying disease among hospitalized
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patients. Surveillance for H1N1 requiring documented fever
will underestimate burden of disease. Children <5 years old
in Guatemala should be prioritized for vaccination.
doi:10.1016/j.ijid.2010.02.2202
65.005
Adjuvanted inﬂuenza vaccines and their potential role for
vaccination of travelers
T. Tsai 1,∗, N. Groth2, M. Pellegrini 2, D. O’Hagan1, A.
Hilbert3
1 Novartis Vaccines and Diagnostics, Cambridge, MA, USA
2 Novartis Vaccines and Diagnostics, Sienna, Italy
3 Novartis Vaccines and Diagnostics, Marburg, Germany
Background: Trivalent seasonal inﬂuenza vaccine (TIV)
adjuvanted with the emulsion adjuvant MF59® (FLUAD®)
is licensed in 29 countries worldwide for adults over 65
years of age. Compared with unadjuvanted TIV, the adju-
vanted vaccine provides higher hemagglutination inhibition
(HI) antibody titers not only against vaccine strains, but also
against drift-variant strains. Usually inﬂuenza is transmitted
in a single epidemic seasonal epidemic in temperate cli-
mates, but it may appear in two epidemics during the year
or may be transmitted throughout the year, in subtropical
and tropical locations. Although persons travelling from the
Northern Hemisphere (NH) to the tropics or antipodes may
not have access to the TIV made with strains used in the
Southern Hemisphere (SH) formulation, they are neverthe-
less recommended to receive available NH formulation-TIV
because one or more of the strains may overlap and because
some degree of protection may be elicited, even by an
imperfectly matched vaccine.
Methods: The following data from recent clinical
trials highlight the cross-protection elicited by the MF59-
adjuvanted vaccine. Sera from 222 children, 6-36 months of
age, vaccinated with the 2006/07 formulations of FLUAD or
unadjuvanted TIV were tested against the H1N1 strain in the
2007/08 formulation (A/Solomon Islands/3/2006 (H1N1)-
like). Sera from adults with chronic illnesses and elderly
adults (> 65 years) were similarly tested.
Results: In the children geometric mean titer (GMT) HI
responses, geometric mean ratios (GMR), and seroprotec-
tion (SP) rates were signiﬁcantly higher in FLUAD recipients.
Similar signiﬁcant differences were seen among 349 adults
with chronic illnesses with increased risk for inﬂuenza mor-
bidity who were vaccinated with either FLUAD or with an
undajuvanted subunit vaccine. Finally, 56 elderly adults who
received the 2007/08 FLUAD formulation displayed postvac-
cination responses against strains in the 2008/09 formulation
which met the European Committee for Human Medicinal
Products criteria for GMR, SP and SC for the mismatched
H1N1 and H3N2 strains.
Conclusion: Altogether these results suggest that the
greater degree of cross-variant immunity elicited by MF59-
adjuvanted inﬂuenza vaccine may offer an advantage in
circumstances where travelers may be exposed to antigeni-
cally mismatched viruses.
doi:10.1016/j.ijid.2010.02.2203
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easonal inﬂuenza vaccine may be associated with
ncreased risk of illness due to the 2009 pandemic A/H1N1
irus
.M. Skowronski 1,∗, G. De Serres2, N. Crowcroft3, N.
anjua1, N. Boulianne2, T.S. Hottes1, L.C. Rosella3, J.A.
ickinson4, G. Rodica2, P. Sethi 3, N. Ouhoummane2,
.J. Willison3, I. Rouleau2, K. Fonseca5, S.J. Drews6, A.
ebbapragada3, H. Charest7, M.-E. Hamelin7, G. Boivin7,
. Gardy1, Y. Li 8, P. Martin1
BC Centre for Disease Control, Vancouver, BC, Canada
Institut national de santé publique du Québec, Québec,
C, Canada
Ontario Agency for Health Protection and Promotion,
oronto, ON, Canada
University of Calgary, Alberta, AB, Canada
Alberta Provincial Laboratory, Calgary, AB, Canada
University of Calgary, Calgary, AB, Canada
CHUQ research Center, Laval University, Canada, Quebec,
C, Canada
National Microbiology Laboratory, Public Health Agency of
anada, Winipeg, MB, Canada
Background: In late spring 2009, concern was raised in
anada that prior receipt of the 2008-09 trivalent inacti-
ated inﬂuenza vaccine (TIV) was associated with increased
isk of pandemic H1N1 (pH1N1) illness. Several epidemio-
ogic investigations were urgently conducted through the
ummer to assess this putative association.
Methods: Studies included: (1) test-negative case-control
esign based on Canada’s ongoing sentinel vaccine effective-
ess monitoring system in British Columbia, Alberta, Ontario
nd Quebec; (2) conventional case-control design using pop-
lation controls in Quebec; (3) testnegative case-control
esign in Ontario and (4) prospective household transmis-
ion (cohort) study in Quebec. Logistic regression estimated
dds ratios for TIV effect on community- or hospital-based
aboratory-conﬁrmed seasonal or pH1N1 inﬂuenza cases
ompared to controls with restriction, stratiﬁcation and
djustment for covariates including combinations of age,
ex, comorbidity, timeliness of medical visit, prior physician
isits, and/or health care worker status. For the prospective
tudy relative risks were computed.
Results: Based on the sentinel study of ∼700 cases and
00 controls, 2008-09 TIV provided statistically signiﬁcant
rotection against seasonal inﬂuenza (OR 0.44;95% CI 0.33-
.59). Conversely, estimates from the sentinel and several
ther study designs involving ∼1200 laboratory-conﬁrmed
H1N1 cases and 1500 controls consistently showed that
rior recipients of 2008-09 TIV were at statistically sig-
iﬁcant 1.5-2.5-fold increased risk of medically-attended
H1N1 illness during the spring/summer 2009 with upper
imit of the 95% conﬁdence interval spanning 3-4-fold
ncrease. There was non-signiﬁcant increase in the strength
f the association with more TIV doses received in the prior
ve years. Risk of pH1N1 hospitalization was not further
ncreased among vaccinated people when comparing hos-
italized to community cases.
Conclusion: Prior receipt of 2008-09 TIV was associ-
ted with increased risk of medicallyattended pH1N1 illness
uring the spring/summer 2009 in Canada. Possible biologi-
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al mechanisms and immuno-epidemiologic implications are
onsidered.
oi:10.1016/j.ijid.2010.02.2204
5.007
onitoring for avian inﬂuenza in wild birds on the Far East
n 2008
. Sayfutdinova1,∗, J. Runstadler2, M. Kulak1, M. Sivay3
State Research Center of Virology and Biotechnology
‘Vector’’, Koltsovo, Russian Federation
Institute of Arctic Biology, Fairbanks, AK, USA
State Research Center of Virology and Biotechnology ‘Vec-
or’, Koltsovo, Russian Federation
Background: Waterbirds are natural reservoirs for low-
athogenic avian inﬂuenza and have been implicated as the
rimary source of infection in outbreaks of highly pathogenic
vian inﬂuenza. An understanding of the movements of birds
nd the ecology of avian inﬂuenza viruses within the wild
ird population is essential in assessing the risks to human
ealth and production industries. The purpose of this inves-
igation was surveillance for avian inﬂuenza in migratory
horebirds at the East Asian-Australasian Flyway. Sample
ollection was on Kamchatka, on the Kuril islands, at the
mursky region, on Sakhalin and on Chukchi Peninsula.
Methods: Viral RNA was isolated from virus-containing
llantoic ﬂuid with the RNeasy Mini kit (QIAGEN, Valencia,
A, USA) as speciﬁed by the manufacturer. Uni12 primer was
sed for reverse transcription. PCR was performed with a
et of primers speciﬁc for each gene segment of inﬂuenza
virus (18). PCR products were puriﬁed with the QIAquick
CR puriﬁcation or QIAquick gel extraction kit (QIAGEN). The
mplicons were sequenced on an automated Applied Biosys-
ems 3130 system using BigDye terminator cycle sequencing
eady reaction kit» (Applied BioSystems).
Results: In the Far East in the 2008 from birds
f 127 spices and 32 families were collected 4248
amples and 16 inﬂuenza viruses were isolated and
nalyzed. No highly pathogenic avian inﬂuenza viruses
ere identiﬁed. The hemagglutinin genes of stains
/Larus/Kamchatka/521/08(H13N6) isolated in Kamchatka
egion and A/Teal/Tinda/6114/08(H10N6) (bankit1288867 in
enebank) isolated in Amursky region were analyzed genet-
cally. The analysis shows homology with the strains which
ere isolated in the Astrahansky region and on Hokkaido
sland.
Conclusion: Surveillance activities for avian inﬂuenza in
ild birds should be continued to provide further epidemio-
ogical information about circulating viruses and to identify
ny changes in subtype prevalence.This work was supported by Russian Government and Bio
ndustry Initiative (BII) USA (ISTC#3436) and was done in
ollaboration with Novosibirsk State University.
oi:10.1016/j.ijid.2010.02.2205ternational Congress on Infectious Diseases (ICID) Abstracts
5.008
nﬂuenza surveillance contributions from South and
outheast Asia
. Jarman1, K.S.A. Myint1, S. Shrestha1, J. Gaywee1,
.M. Velasco1, I.-K. Yoon1, D. Saunders1, A. Timmermans1,
. Ungchusak2, T. Wongstitwilairoong1, C.J. mason1, R.V.
ibbons1, J.A. Pavlin1,∗
Armed Forces Research Institute of Medical Sciences,
angkok, Thailand
Ministry of Public Health, Bangkok, Thailand
Background: On-going, comprehensive inﬂuenza surveil-
ance is critical to detect and monitor inﬂuenza outbreaks.
he Armed Forces Research Institute of Medical Sciences
AFRIMS) has established 45 inﬂuenza sentinel sites in
outh and Southeast Asia in 4 countries (Thailand, Nepal,
hilippines, Bhutan) and an additional 9 countries with par-
icipating US Embassies.
Methods: Patients who present with a history of fever
nd cough or sore throat can participate. Samples are tested
ith a rapid test for inﬂuenza A and B and realtime PCR for
nﬂuenza A (H1, pH1, H3, H5) and B. Some positive samples
ndergo virus isolation, characterization and sequencing at
FRIMS or in the US at the Centers for Disease Control and
revention (WHO Collaborating Center for Surveillance, Epi-
emiology and Control of Inﬂuenza).
Results: From October 2005 through September 2009,
FRIMS sites collected samples from 7,713 patients with
,239 taken since the H1N1 outbreak started in May 2009.
or the entire surveillance period, 42.2% of the samples
ere positive for inﬂuenza A or B by PCR. Since June 2009,
9.1% of the positive inﬂuenza samples have been pH1N1
ositive. Our surveillance system was the ﬁrst to detect
he presence of pH1N1 in Nepal and Bhutan. Evaluation of
nﬂuenza rapid tests compared to PCR differed by site but
ad overall 60% sensitivity and 97% speciﬁcity, and pH1N1
ad a 68% sensitivity and 98% speciﬁcity. Sequences from
ecent seasonal H1N1 viruses demonstrated greater than 97%
omology at the amino acid level with the 08/09 H1N1 vac-
ine strain. Samples from Bhutan and the Philippines had a
ery similar strain in circulation with 98.9-99.6% homology
t the amino acid level. A/Nepal/NP06C-017/2008 showed
he greatest divergence with the other strains (96.6-97.5%
omology). Seven pandemic H1N1 HA genes were sequenced
nd compared to other circulating viruses and were very sim-
lar. To date, all seasonal H1N1 and H3N2 viruses that have
een screened have genetic markers for M2 blocker resis-
ance and all pH1N1 demonstrate NA inhibitor resistance.
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Conclusion: An extensive inﬂuenza surveillance program
in Asia can document virus movement and genetic changes,
and is well positioned to provide assistance during pan-
demics and prevention efforts.
doi:10.1016/j.ijid.2010.02.2206
65.009
H1N1 experience at the Institute for Infectious Diseases
Emilio Ribas, Sao Paulo, Brazil. The role of a travel clinic
as sentinel for emerging diseases
J. Alves, C.E. Guarnieri, T.S. Chaves ∗
Institute for Infectious Diseases Emilio Ribas, Sao Paulo,
Brazil
Background: According to WHO ﬁgures, by November 8
more than 503,536 cases of pandemic inﬂuenza had been
conﬁrmed and more than 6,260 deaths had been reported.
Most cases came from the Americas which also presented
the highest number of deaths. South America was severely
affected by the transmission of H1N1 and big efforts made to
control its dissemination and assist severe cases. Before July
16, when sustained transmission of pandemic inﬂuenza H1N1
was recognized in Brazil, most cases were travel related. By
late November, 22,565 cases had been reported in the coun-
try with a total of 1,528 deaths. The Institute for Infectious
Diseases Emilio Ribas (IIDER), a reference hospital for infec-
tious diseases in Sao Paulo city, was responsible for reporting
a signiﬁcant number of the entire state’s cases. As H1N1
was initially related to travelers, a number of patients were
referred to the clinic to be followed.
Methods: To evaluate the role of the travel clinic during
the ﬁrst months of the pandemic, we analyzed 53 report
care forms, broken down by gender, age, symptoms, history
of travel, diagnosis and treatment.
Results: Of the 53 patients evaluated, 21 were male
(39.6%) and 32 female (60.4%). The mean age was 38.7
and the most common symptoms were cough (90.5%), fever
(83%), headache (79%), coryza (64.1%), myalgia (73.5),
shortness of breath (49%) and diarrhea (16.9%). Oseltamivir
was prescribed to 35 (66%) of all patients. H1N1 was con-
ﬁrmed in 18 patients and Sazonal Inﬂuenza was isolated in
6 patients. Out of 17 patients who had traveled internation-
ally, only 3 tested positive for H1N1 and they had come from
Argentina (2) and Mexico (1).
Conclusion: Since the begining of the Inluenza pandemic,
IIDER had reported a total of 1,924 ﬂu-like cases by October
1, 2009. Because H1N1 transmission was initially associated
with travelers, travel clinics were able to provide ﬁrst warn-
ing. In our report, we include the ﬁrst case of H1N1 infection
in Sao Paulo city, a patient returning from Mexico who pre-
sented symptoms 2 days before the WHO global alert, which
demonstrates the high sensitivity of post-travel evaluations
in a pandemic scenario.
doi:10.1016/j.ijid.2010.02.2207
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5.010
s a mass immunization program for pandemic (H1N1)
009 good value for money? Early evidence from the
anadian experience
. Sander1,∗, C. Bauch2, R.A. Fowler3, D. Fisman1, J.
wong4, A. McGeer5, M. Zivkovic Gojovic6, M. Krahn1
University of Toronto, Toronto, ON, Canada
University of Guelph, Guelph, ON, Canada
Sunnybrook Health Sciences Center, Toronto, ON, Canada
Institute for Clinical Evaluative Sciences, Toronto, ON,
anada
Mount Sinai Hospital, Toronto, ON, Canada
York University, Toronto, ON, Canada
Background: Since the H1N1 vaccine approval on October
1, 2009 in Canada, the largest vaccination program in the
ountry’s history has been rolled out. This work contributes
nformed estimates to the current debate about the pan-
emic (H1N1) 2009 mass immunization program’s economic
erits.
Methods: We performed a cost-utility analysis of the
H1N1) 2009 mass immunization program in Ontario,
anada’s most populous province. We utilize a previ-
usly developed model to simulate the current pandemic
nﬂuenza (H1N1) outbreak in Ontario to compare no inter-
ention to mass immunization of 10% of the population
er week, starting 40 days into the pandemic and last-
ng until 30% vaccine coverage is reached. Data for health
are resource use (ofﬁce visits, emergency department vis-
ts, hospitalizations, intensive care unit admissions, use of
xtracorporeal membrane oxygenation (ECMO)) and deaths
ere based on pandemic (H1N1) surveillance data in Ontario
nd Australia, and Ontario administrative data. Program
nd other costs were drawn from Ontario sources (Ontario
ealth Insurance Plan (OHIP), Ontario Case Costing Initiative
OCCI)). Utility weights were obtained from the literature
nd annualized. Years of life lost were calculated using
verage life expectancy adjusted for quality of life. Main
utcome measures were quality adjusted life-years (QALYs),
osts in 2009 Canadian dollars, and cost per QALY gained.
Results: Ontario’s H1N1 immunization program is esti-
ated to cost $118 million ($30 per person vaccinated).
mmunizing 30% of the population prevents approximately
.4 million cases, 850 hospitalizations and 35 deaths. This
educes healthcare cost due to illness from $154 million to
77 million and is associated with 24,864 additional quality-
djusted life-years for the population. The incremental
ost-effectiveness ratio (ICER) is $1,645 per QALY gained.
esults are sensitive to immunization program effectiveness
nd cost. In all sensitivity analyses the ICER remains well
elow established thresholds, which determine the cost-
ffectiveness of a program.
Conclusion: The pandemic (H1N1) 2009 mass immu-
ization program in Ontario is highly costeffective under
onservative assumptions on health care resource use, costs,
nd mortality. This conclusion is supported by extensive
ensitivity analyses and is consistent with the economic
ttractiveness demonstrated for seasonal inﬂuenza pro-
rams.
oi:10.1016/j.ijid.2010.02.2208
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5.011
apid real time surveillance and monitoring of pandemic
nﬂuenza associated pneumonia & risk factors using pri-
ary care electronic medical records (EMR)
. Wong1, J.G. Mercer2, S. Mukhi1, S. Totten1,∗, K. El
man3, G. Jayaraman1, C. Babin1, R. Saginur3, R. Kropp1,
. Rodin1, G. Garber3
Public Health Agency of Canada, Ottawa, ON, Canada
Canadian Medical Association, Ottawa, ON, Canada
University of Ottawa, Ottawa, ON, Canada
Background: The arrival of the inﬂuenza pandemic
pH1N1) highlights gaps in surveillance. This pilot project
everages EMR to rapidly detect changes in the severity of
nﬂuenza-like-illness (ILI) and associated risk factors to sup-
ort public health actions.
Methods: The sentinel primary care clinics use their
MR with minimal operational disruption to transmit de-
dentiﬁed surveillance information daily to the secure
anadian Network for Public Health Intelligence (CNPHI)
erver at the Public Health Agency of Canada. The Canadian
luWatch ILI case deﬁnition is used:
fever (T > 38 0C) and
cough and
myalgia or arthralgia or sore throat or fatigue.
Chi-Square, Fisher Exact and Mann-Whitney tests, with
< 0.05 (2-sided) denoting statistical signiﬁcance are used.
Results: During the initial phase of the 12 month study
Oct 4-Nov 19, 2009), 237 medicallyattended ILI (MA-ILI)
ases arising from 12,581 patient visits were reported from
articipating Canadian sentinel sites. Children under 10
ears accounted for 33.8% of these cases. Pneumonia was
eported in 8.4% of the MA-ILI cases, increasing from none
n early October to 22.2% in the second week of Novem-
er. Comparing ILI cases with pneumonia to those without,
he median age was 30 years vs 21 years (p = 0.5); 50.0% vs
4.5% were females (p = 0.2); 0% vs 0.9% were health care
orkers (p = 1.0); median time from symptom onset to pri-
ary care visit was 5 days vs 2 days (p = 0.02); 0% vs 2.3%
eceived the current season’s inﬂuenza vaccine (p = 1.0),
.0% vs 0.5% received the pH1N1 inﬂuenza vaccine (p = 0.2),
5.0% vs 39.4% received a pneumococcal vaccine (p = 0.2);
% vs 3.3% had diabetes (p = 1.0) and 20.0% vs 23.4% had
sthma (p = 1.0).
Conclusion: Children under 10 years were disproportion-
tely affected but most cases were not life threatening. EMR
as able to rapidly detect the shifts in the pandemic severity
n real time. The proportion of ILI cases with pneumonia was
scalating during the initial phase of this study. Pneumonia
as associated with a longer time from symptom onset to
rimary care visit. With increasing sample size in this ongo-
ng study, statistical power to assess vaccine effectiveness
nd severity risk factors is anticipated to increase greatly.
oi:10.1016/j.ijid.2010.02.2209
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RSA: The clinical challenge (Invited Presentation)
6.001
ystemic MRSA infections
. Rubinstein
Faculty of Medicine, Winnipeg, Canada
Systemic Staphylococcal infections were always a
readed complication of various injuries and for many
enturies meant amputation or death for the unfortunate
atient. MRSA has become since the 60’s a major cause for
ystemic infections and in various settings are responsible to
80% of all nosocomial bacteremias. In other settings, MRSA
s responsible ∼50% and in a recent survey of ICU infections
mong ∼14.000 patients the infection rate had decreased to
7% (Vincent et al JAMA 302;2323:2009). MRSA infections are
haracterized by various clinical presentations from mild-
o rapidly progressing and frequently with involvement of
ultiple organs includ. heart valvaes, bones, joints and
mplanted foreign bodies. Those locations, with the partic-
lar resistance pattern of MRSA, and only a few effective
ntibiotics to choose from, make MRSA infections partic-
larly difﬁcult to treat with a frequent need for surgery.
he frequent use of foreign bodies in therapy (IV catheters,
mplants,dialysis catheters, CNS shunts etc’) and the bio-
ogical avidity of this organism to these foreign materials
dd to the complexity of the infection. Quorum sensing and
he ability of the organism to create a bioﬁlm and to detach
rom the adherent colony add also to the complexity of these
nfections. Understanding of these biological mechanisms
nd being able to interfere should allow for some future
herapeutic measures. Evidently, meanwhile, hospital infec-
ion control and a possible future staphylococcal vaccine are
olutions to peruse. CA MRSA can be controlled by hyginic
easures as well as vaccine as this organism despite its low
otential to cause systemic infections is likely to stay for
any years.
oi:10.1016/j.ijid.2010.02.2210
6.002
reatment of severe MRSA infections: Beyond Vancomycin
. Karchmer
Beth Israel Hospital, Boston, MA, USA
Vancomycin, as the gold standard for therapy of severe
RSA infections, particularly pneumonia, bacteremia, and
ndocarditis, has been questioned. In recent years reduced
ancomycin susceptibility of MRSA has been noted: minimum
nhibitory concentrations (MIC) have increased, isolates with
ntermediate susceptibility (MIC 4 to 16 $g/ml) [VISA] and
vertly resistant (MIC ‘‘32 $g/ml) [VRSA] have been noted,
nd importantly isolates of apparently vancomycin sus-
eptible MRSA with subpopulations exhibiting intermediate
usceptibility to vancomycin (survival at vancomycin con-
entrations’’ 4 $g/ml) so called heteroVISA [hVISA] have
een encountered. VISA and hVISA isolates may emerge
hen vancomycin therapy is suboptimal. Severe MRSA infec-
ions caused by isolates with vancomycin MIC’’ 1.5-2.0 $g/ml
nd hVISA have been associated with poor clinical outcome
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when treated with vancomycin compared with infections
caused by more susceptible MRSA. Aggressive vancomycin
dosing to achieve trough concentrations 15 to 20 $g/ml has
been used to improve outcome when treating infections
caused by MRSA. The clinical utility of this strategy has not
been established; however, aggressive dosing is associated
with nephrotoxicity especially in patients weighing > 101 kg,
with reduced renal function and in intensive care settings.
Using vancomycin in combination with other antimicrobials
has not proven more effective either.
Treatment with other antimicrobials to which MRSA are
susceptible is increasingly used to address concerns regard-
ing the inefﬁcacy of vancomycin therapy for severe MRSA
infections. Clinical trials suggest that linezolid is at least
comparable to vancomycin for treatment of MRSA pneumo-
nia and for pharmacokinetic-pharmacodynamic reasons may
be preferable in selected patients. Daptomycin (6mg/kg/d)
was non-inferior to comparator regimens (low-dose gentam-
icin plus nafcillin or vancomycin) in a clinical trial treating
S. aureus bacteremia and right sided endocarditis; cure
rates were higher with daptomycin compared to vancomycin
(not statistically signiﬁcant) in trial patients with MRSA
bacteremia. Doses of daptomycin (10mg/kg/d) higher than
approved by the FDA are preferred by some experts when
treating MRSA bacteremia or endocarditis. Linezolid has
appeared effective in selected patients with persistent MRSA
bacteremia. Televancin, with dual mechanisms of cidality
versus MRSA, has recently been approved by the FDA for
treatment of complicated skin/soft tissue infection due to
MRSA and may offer additional options for treating severe
infections. New cephalosporins that bind to PBP2’ and to
which MRSA are susceptible are under development and
fusidic acid is attracting increasing interest as an agent for
combination therapy against severe MRSA infections.
doi:10.1016/j.ijid.2010.02.2211
66.003
The potential for a staphylococcal vaccine
O. Schneewind
University of Chicago, Chicago, IL, USA
Staphylococcus aureus is a frequent cause of bac-
teremia, pneumonia, skin and soft tissue infection as
well as osteomyelitis and septic arthritis. The remarkable
pathogenic potential of this microbe has been demon-
strated over the past decade, with the rapid spread of
highly virulent, drug (methicillin)-resistant S. aureus strains
(MRSA). The search for protective immunity against inva-
sive S. aureus disease has been a research goal since the
discovery of this microbe, however this pursuit has not
yet been successful and a staphylococcal vaccine is cur-
rently not available. To identify protective antigens for a
staphylococcal vaccine, three models systems for S. aureus
infections in mice were developed - pneumonia, lethal sep-
ticemia and persistent abscess model. Using a combination
of molecular genetic tools, the genetic requirements of the
pathogen for each of the three disease complexes were char-
acterized. Genes encoding secreted products that proved
to be necessary for the pathogenesis in any one of three
disease models were examined further, subjecting the puri-
p
P
sts e325
ed products to vaccine trials for protective immunity.
ene products that generated protection were also tested
or cross-protection in other disease models or examined
or speciﬁc animal or human immune responses follow-
ng infection. Taken together these studies revealed that
taphylococci elicit only moderate host immune responses
o infection owing to their expression of several differ-
nt immune-suppressive molecules, in particular adenosine
ynthase AdsA. a-hemolysin was the sole protective anti-
en for staphylococcal lung infection. Antibodies against
eme-iron scavenging factors provided protective immunity
gainst staphylococcal abscess formation, whereas combi-
ations of different antibodies generated protection against
ethal septicemia in mice. These studies therefore suggest
hat the generation of a successful vaccine against S. aureus
nfection requires a combination of different antigens, but
annot be accomplished by a single factor.
oi:10.1016/j.ijid.2010.02.2212
6.004
RSA in Latin America: special considerations
. Guzman-Blanco
Hospital Privado, Caracas, Venezuela
Until the year 2000, epidemiological surveillance in Latin
merica was conducted in only a few countries, includ-
ng Venezuela and Argentina. Since then, with the support
f the Pan American Health Organization (PAHO), a net-
ork for surveillance of bacterial resistance has been
rganized, which includes the majority of Latin American
ountries: the Monitoring/Surveillance Network for Resis-
ance to Antibiotics. Criteria for admission of surveillance
enters to the network include concepts of standardization,
uality control, supervision visits and regular data report-
ng. Results are published each year on the PAHO web site
www.paho.org) .The data are collected during the daily
ork of selected laboratories in the region, with strong sup-
ort from national and regional reference laboratories.
The Resistance Group of the Panamerican Infectious Dis-
ases Asociation, under the leadership of Dr. Jose Maria
asellas has kept surveillance on the incidence of MRSA and
pdated reports are published on the API journal.
The methodology used for deﬁnition of a given strain as
RSA is different in each country. Some countries work with
he Bauer and Kirby method using the oxacillin or cefoxitin
isks, and others use automated methods like VITEK 1 or 2
bioMérieux) and/or MicroScan (Dade Behring).
Conﬁrmation tests such as the methicillin screen plate
est are not widely used. The high cost of E-test strips does
ot permit their routine use in laboratories in the region,
nd rapid methods of mecA gene detection are not available
or the majority of laboratories. Molecular analysis of MRSA
trains is restricted to some centers in Brazil, Argentina,
hile, Mexico and Colombia. In cases of nosocomial out-
reaks, the identity of MRSA strains is usually assumed from
he phenotypic pattern of antibiotic resistance.Nosocomial, multidrug-resistant MRSA is a growing
roblem in Latin America. Information gathered by the
AHO-sponsored program on nosocomial infections demon-
trated that for the year 2004, MRSA prevalence was as
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ollows: Argentina, 42% (n = 5851 isolates); Bolivia, 36%
n = 1167); Chile, 80% (n = 246); Colombia, 47% (n = 4214);
osta Rica, 58% (n = 674); Cuba, 6% (n = 80); Ecuador,
5% (n = 1363); Guatemala, 64% (n = 1483); Honduras, 12%
n = 393); Mexico, 52% (n = 497); Nicaragua, 20% (n = 296);
araguay, 44% (n = 980); Peru, 80% (n = 1407); Uruguay, 59%
n = 1431) and Venezuela, 25% (n = 2114).
Similarly, data submitted to the Pan-American Associa-
ion of Infectious Diseases for the year 2006 showed the
ollowing rates of HA-MRSA: Argentina 51%; Bolivia 55%;
razil 54%; Chile 29%; Ecuador 25%; Mexico 32%; Panama
8%; Paraguay 30%; Uruguay 24%; and Venezuela 27% The
rst published report of CA-MRSA infections in Latin Amer-
ca came from Brazil, where three wellcharacterized strains,
solated from patients with SSTIs or septic arthritis in 2003,
arbored SCCmec type IV, PVL, enterotoxin and #-hemolysin
enes. A further report followed of a large outbreak of CA-
RSA infection that affected inmates in jails and people
rom the community in Montevideo, Uruguay, beginning in
anuary 2002. At the end of the outbreak, more than 1000
atients had been affected and 12 deaths had occurred.
STIs accounted for more than 65% of the cases, but severe
orms of pneumonia were reported, including 4 deaths. In
his outbreak, TMP-SMX was very active in the treatment of
kin infections.
Since those ﬁrst reports, MRSA has been identiﬁed as
he cause of community-acquired infections in several more
ountries across South America. In Lima, 27% resistance
o methicillin was reported in isolates collected from 30
ommunity-acquired infections in 2002. Two cases of SSTI
aused by CA-MRSA strains were reported from Bogotá in
006, and a report from the Colombian network of resistance
urveillance showed an increase in CA-MRSA from 1% of S.
ureus isolates in 2001 to 5.4% in 2006 [21]. The PAHO pro-
ram has also included surveillance of community-acquired
RSA infections since 2005, and in Venezuela, 12.4% of 845
solates of S. aureus from the community were resistant to
xacillin. However, no clinical information is available for
hese cases. A few isolated cases of CA-MRSA infection have
een reported in Chile, but some of these were in peo-
le returning from cities in Uruguay or Brazil with a high
ncidence of MRSA.
MRSA is an increasing problem in Latin America, both
n the healthcare environment and in the community. In
osocomial S. aureus infections, the frequency of methi-
illin resistance has surpassed 50% in over half of the
atin American countries for which data were identiﬁed.
ommunity-acquired-MRSA has been reported in Latin Amer-
ca and even though large outbreaks such as the one that
ccurred in Uruguay — causing 12 deaths — have not been
eported elsewhere, this example highlights the problem.
urveillance programs are only recently beginning to record
A-MRSA, and the true incidence of MRSA in the community
s still largely unknown in the region.
oi:10.1016/j.ijid.2010.02.2213
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7.001
icrobial chemical ecology and the future of antibiotics
. Kolter
Harvard Medical School, Boston, MA, USA
When it comes to cell-to-cell communication the pre-
ominant language is that of small signaling molecules. The
icrobial world is no exception - microbes are known to
xchange messages both within and across species by secret-
ng and recognizing small molecule natural products. Among
uch compounds can be found many of the antibiotics that
ave been extensively used in medicine since the middle
f the last century. Concomitant with their use has been
he evolution of antibiotic resistance. In order to under-
tand the phenomenon of antibiotic resistance and to devise
etter strategies for future antibiotic discovery and use it
s useful to consider this topic from an ecological perspec-
ive. In this sense, it is important that to recognize that we
emain largely ignorant of the role that antibiotic substances
lay in environmental settings. Work that I will discuss in
his lecture supports the idea that antibiotics can serve
on-lethal signaling functions in bacteria - both within and
cross species. In addition, I will discuss instances in which
nterspecies interactions mediated by small molecule natu-
al products lead to narrow spectrum action of antibiotics in
cological settings. These results suggest new ways to look
or and use antibiotics in the future.
oi:10.1016/j.ijid.2010.02.2214
uberculosis: Tools for the Future (Invited Presen-
ation)
8.001
nlocking the Mycobacterial Cell Wall: Insights into
irulence, Biosynthetic Pathways and systems-based
pproach to drug discovery
. Verma1, A. Goyal2, R. Sankaranarayanan2, R. Gokhale3,∗
National Institute of Immunology, Delhi, India
Centre for Cellular and Molecular Biology, Hyderabad,
ndia
Institute of Genomics & Integrative Biology, Delhi, India
Biosynthetic machinery of complex lipids in Mycobac-
erium tuberculosis (Mtb) includes a family of FadD proteins,
hich are otherwise universally involved in fatty acid degra-
ation. Mtb produce several exotic lipids, many of which
re important for its virulence as well as survival in the
ost. By combination of structural, genetic and biochem-
cal studies, we have identiﬁed several novel mechanisms
nd pathways that generates complex cell envelope lipids.
e show that polyketide synthase in conjunction with a
ew family of fatty acyl AMP ligases (FAALs) in Mtb are
nvolved in biosynthesis of lipids. Based on the structure
f a FAAL homologue and by generating loss- as well as
ain-of-function mutants, we show that an insertion motif
ictates the synthesis of acyl-adenylates or acyl-CoA, and
hus bifurcates metabolic fate of fatty acids. Since FAALs
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Brazilian criteria for LTBI treatment strongly suggests that a
change on these criteria could have a direct impact on TB
control.14th International Congress on Infectious Diseases (ICID) Abs
are focal nodes in biosynthetic network of virulent lipids,
inhibitors directed against these proteins provide a unique
multi-pronged approach of simultaneously disrupting several
pathways in lipid metabolism. Our study illustrate how obli-
gate pathogens like Mtb have evolved such novel themes
of functional versatility to generate unusual metabolites.
We also reveal possible evolutionary path traced by FAALs
from omnipresent fatty acyl CoA ligases. Furthermore, our
study also provide credence to the ‘systems pharmacology’
approach for drug discovery.
doi:10.1016/j.ijid.2010.02.2215
68.002
Diagnosing Drug Resistance in Low-Resource Settings:
Practical Approaches
A. Umubyeyi Nyaruhirira1,∗, T. Martine2, F. Portaels3, V.
Greet4
1 Corunna, Rwanda
2 TB Program, Kigali, Rwanda
3 Tropical Institute of Medicine, Brussels, Belgium
4 ICAP, Columbia University, Rwanda, Kigali, Rwanda
Tuberculosis (TB) remains one of the major causes of
death from a single infectious agent worldwide. Of great
concern for TB control is the emergence of drug resistance.
Since there is no cure for some multidrug-resistant strains of
Mycobacterium tuberculosis, there is concern that they may
spread around the world, stressing the need for additional
control measures, such as new diagnostics, better drugs for
treatment, and a more effective vaccine. Pulmonary TB can
be diagnosed by its symptoms, chest radiography, sputum
smear microscopy and by cultivation of M. tuberculosis,
which is considered as the gold standard. Recent advances
in molecular biology and molecular epidemiology, and a bet-
ter understanding of the molecular basis of drug resistance
in TB, have provided new tools for rapid diagnosis; how-
ever, the high cost of most of these techniques, and their
requirement for sophisticated equipment and skilled person-
nel have precluded their implementation on a routine basis,
especially in low-income countries. Other nonconventional
diagnostic approaches proposed include the search for bio-
chemical markers, detection of immunological response and
early detection of M. tuberculosis by methods other than
colony counting. In the present mini review, some of these
approaches will be reviewed and the feasibility for their
implementation in diagnostic laboratories will be discussed.
However, with the resurgence of interest in the develop-
ment of new tools for TB control, and the recent inﬂux of
funding and political support, it is likely that the next few
years will see the introduction of new diagnostic tools into
routine TB control programs and particularly in high disease
burden, and resource-poor countries.
doi:10.1016/j.ijid.2010.02.2216
dts e327
8.003
pplicable Insights from Pharmacokinetic and Pharmaco-
ynamic Modeling of Antituberculosis Chemotherapy
. Nuermberger
Johns Hopkins University, Baltimore, USA
Current chemotherapy for tuberculosis leaves consid-
rable room for improvement. Major objectives include
hortening the duration of therapy necessary for cure,
mproving the efﬁcacy of intermittent treatment regimens,
nd preventing the development of drug resistance. Bet-
er understanding of the pharmacodynamic relationship
etween drug exposure and drug effect will identify strate-
ies for optimizing drug effect in order to achieve these
bjectives, thereby informing pre-clinical drug develop-
ent, clinical trial design and clinical practice. Recent work
n in vitro and animal models involving both new and exist-
ng antituberculosis drugs will be reviewed and discussed in
his context.
oi:10.1016/j.ijid.2010.02.2217
8.004
ddressing Latent TB in Areas with High TB Burden: Impli-
ations for Control
. Conde
Hospital Universitario Clementino Fraga Filho, Rio de
aneiro, Brazil
Brazil is a country in South America with a total popu-
ation of 191 million of people (81% urban; 19% rural) with
n estimated incidence of 92,000 new cases of tuberculo-
is (TB) yearly (data from 2007). Treatment of latent TB
nfection (LTBI) in Brazil is currently recommended only
n the case of contacts of pulmonary smear-positive TB
atients aged % 15 years with a tuberculin skin test (TST)
‘10mm and no previous bacilli Calmette-Guérin (BCG) vac-
ination or with a TST’’ 15mm regardless of previous BCG
accination. However, a recent retrospective cohort study
valuating contacts aged ‘‘15 years who did not meet the
razilian criteria for LTBI treatment shown a TB incidence
f 3.2% (22/667), with an estimated TB rate of 1,649 per 100
00 population. The risk of TB was greater among the 349
ontacts with TST’’ 5mm (5.4%) compared to the 318 con-
acts with TST < 5mm (0.9%; RR 6.04, 95%CI 1.7—20.6). The
igh incidence of TB among contacts who did not meet theoi:10.1016/j.ijid.2010.02.2218
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<200 cells/ml) when they are diagnosed with a URI caused
by inﬂuenza or RSV to prevent progression to pneumonia and
possible death.328 14
pdate on infections in transplant recipients
Invited Presentation)
9.001
ropical Infections in Solid Organ Transplant Recipients
. Cuellar
National Institute of Allergy and Infectious Diseases,
ethesda, MD, USA
Tropical infections in solid organ transplant recipients
re an increasing problem worldwide. This increase is the
esult of several factors. Firstly, the number of coun-
ries with transplantation programs is increasing and now
ncludes countries in the tropics. Secondly, there has been an
ncrease in immigration and international travel worldwide.
nd ﬁnally, commercial transplantation is a growing emer-
ent problem. Chagas disease, strongyloidiasis and less so
uberculosis, are only a few of the infections that have tra-
itionally been considered to be limited to tropical regions,
ut that are common enough to pose a challenge in the
anagement of transplant recipients or candidates world-
ide. Evidence based recommendations on the prevention
nd treatment of these diseases in the transplant popula-
ion is scarce, and usually the result of small retrospective
tudies.
oi:10.1016/j.ijid.2010.02.2219
9.002
olyoma Virus Infection, Replication, and Disease after
idney Transplantation
. Hirsch
University of Basel, Basel, Switzerland
Six polyomaviruses (PyV) infect humans, but show dif-
erent seroprevalence rates i.e. BK 82%, JC 58%, KI 69%,
U 55%, MC 42% and SV40 <5%. BK and JC PyV are known
o persist in the renourinary tract with asymptomatic uri-
ary shedding in 7% and 19% of healthy adults, respectively.
I and WU PyV can be detected in less than 2% of res-
iratory secretions, but may cause bronchitis/pneumonia
n immuno-compromized patients. MC PyV integration has
een linked to Merkel carcinoma in immunocompromized,
ut MC genomes can also be detected in 38% of healthy
kin swabs. BK PyV is linked to two major complications in
ransplant recipients, polyomavirus-associated nephropathy
PyVAN) and polyomavirus-associated hemorrhagic cystitis
PyVHC). PyVAN and PyVHC have been encountered in a vari-
ty of immunodeﬁcient patients, but most cases of PyVAN
rise in kidney transplant patients at rates of 1-10%, while
yVHC preferentially affects allogeneic hematopoietic stem
ell transplant patients at rates of 5-15%. BKV has been
ess frequently associated with other pathologies such as
reteric stenosis, pneumonitis, hemophagocytic syndrome,
ncephalitis, retinitis, and polyomavirus-associated multi-
ocal leukoencephalopathy (PyVML), a complication of the
entral nervous system mostly caused by the closely related
C PyV. PyVAN is rare in non-kidney transplant recipients,
espite similar or even higher intensity of immunosuppres-
ion. The objective of this presentation is to provide an
dternational Congress on Infectious Diseases (ICID) Abstracts
pdate on PyV in kidney transplantation and highlight the
urrent recommendations of the AST-ID and KDIGO focussing
K and PyVAN regarding screening, diagnosis and manage-
ent.
Hirsch HH, Randhawa P and AST-ID CPG. Am J Transplant
009; 9 (Suppl 4): S136-S146 Kasiske BL et al. and the Kid-
ey Disease: Improving Global Outcomes (KDIGO) Transplant
ork Group. Am J Transplant 2009; 9 (Suppl 3):S1-155
oi:10.1016/j.ijid.2010.02.2220
9.003
espiratory Viral Infections in Hematopoietic Stem Cell
ransplant Recipents
. Chemaly
University of Texas MD Anderson Cancer Center, Houston,
SA
Inﬂuenza, parainﬂuenza, respiratory syncytial virus and
icornavirus infections are common causes of upper respi-
atory infection. For many years these viral infections were
onsidered to be of minimal concern in patients with can-
er. However, during the past 20 years, these viruses have
een recognized as a possible cause of serious infections
n patients undergoing hematopoietic stem cell transplan-
ation (HSCT) or therapy for hematologic malignancies,
specially acute leukemia. Some of these patients have only
RIs from which they recover uneventfully, but others have
nfections that progress to pneumonia, which can be fatal.
mportant advances have been made in recent years in the
anagement of these infections, including the development
f rapid diagnostic tests and the discovery of therapeu-
ic agents for some of these infections. Many studies from
ifferent institutions, including ours, looked at their experi-
nce with these infections to determine their impact on this
roup of patients, most of who were immunocompromised
nd acquired their infections in the community. Several
mportant predisposing factors for these infections have
een identiﬁed in HSCT recipients and patients with hema-
ological malignancies. These include age >65 years, severe
eutropenia, severe lymphopenia, allogeneic transplanta-
ion, transplant conditioning regimen, graft versus host
isease and adrenal corticosteroid therapy. HSCT recipients
re at greatest risk within the ﬁrst 100 days post-transplant.
everal studies have suggested that aerosolized ribavirin is
ffective for the therapy of RSV pneumonia in HSCT recip-
ents, especially when administered with immunoglobulins,
lthough the number of cases has been small. In summary,
here is some evidence to suggest that it may be beneﬁ-
ial to administer therapy routinely to HSCT recipients and
atients with hematologic malignancies who have known
redisposing factors for pneumonias (i.e. age>65 years, ALCoi:10.1016/j.ijid.2010.02.2221
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cheaper, pose less risks to patients, and offer greater ben-
eﬁt by reducing infections due to many pathogens, not just
those due to MRSA.
doi:10.1016/j.ijid.2010.02.222414th International Congress on Infectious Diseases (ICID) Abs
69.004
Prevention of Cytomegalovirus Infection after
Hematopoietic Stem Cell Transplantation: Preemptive
Therapy Vs Universal Prophylaxis
S. Mossad
Cleveland Clinic Foundation, Cleveland, OH, USA
Blood products administered to all HSCT recipients;
particularly those who are CMV seronegative, should be
leukocyte depleted, or obtained from CMV seronegative
donors.
Allogeneic HSCT recipients should be managed under
a CMV prevention strategy; either universal prophylaxis
or preemptive therapy for the ﬁrst 100 days. There are
advantages & disadvantages to both strategies. Intravenous
ganciclovir (GCV) or oral valganciclovir (VGCV) are the most
commonly used agents. Foscarnet & cidofovir are alterna-
tives, but both require prehydration & may be nephrotoxic.
Acyclovir & valacyclovir are much less active against CMV.
Universal prophylaxis with IV GCV or VGCV may cause neu-
tropenia, which can usually be managed with G-CSF and
temporary suspension of drug. Preemptive therapy requires
the ready availability of a sensitive test for early detec-
tion of asymptomatic CMV replication, such as antigenemia
or PCR. Such test should be done at least once weekly,
and treatment promptly initiated when test is positive, and
continued for at least for 2 weeks; longer if test is still
positive. Weekly surveillance testing should be continued
to detect recurrence. Patients who are CMV seropositive,
whose donors are CMV seronegative, or whose donors are
unrelated, haploidentical, cord blood, or T cell depleted, or
who develop CMV viremia < 100 days after HSCT, or steroid-
requiring chronic GVHD, or with CD4 counts < 50/mm3 are
at a higher risk for late CMV viremia occurring > 100 days
after HSCT. Such patients should be monitored with CMV
antigenemia or PCR for preemptive therapy.
Autologous HSCT who are CMV seropositive, and who are
at a higher risk for CMV reactivation due to total body irra-
diation, CD34+ selected T cell depleted grafts, or receipt
of alemtuzumab, ﬂudarabine, or 2-chlorodeoxyadenosine
in the 6 months preceding HSCT, should be monitored by
weekly CMV antigenemia or PCR for preemptive therapy for
60 days after HSCT.
doi:10.1016/j.ijid.2010.02.2222
International perspectives on infection control
(Invited Presentation)
70.001
Engaging Nations in a Commitment to Infection Control
D. Pittet
University of Geneva Hospitals, Geneva, Geneva, Switzer-
landHealth care-associated infection is a major, global issue
for patient safety and its prevention was chosen by WHO
Patient Safety as the theme of its First Global Patient Safety
Challenge ‘‘Clean Care is Safer Care’’ launched in Octo-
ber 2005. Since then, a formal statement has been signedts e329
y over 120 ministries of health as a pledge of support to
mplement actions to reduce health care-associated infec-
ion, corresponding to more than 85% coverage of the world
opulation. The Challenge has focused on raising global
wareness of the importance of health care-associated
nfection as a priority patient safety issue with the promo-
ion of hand hygiene as the cornerstone.
The main output of the Challenge has been the devel-
pment of the WHO Guidelines on Hand Hygiene in Health
are and the design of an implementation strategy to trans-
ate the guidelines into practice. These have been tested
n eight pilot sites and used in over 350 healthcare settings
orldwide with very promising results. Over 40 countries
ave also established hand hygiene promotion campaigns
t national level. In August 2009, around 50 participants of
he ‘‘campaigning nations’’ network met in Geneva to share
nowledge, experiences and concerns, including approaches
o take account of cultural diversity.
The SAVE LIVES: Clean Your Hands initiative was also
aunched by WHO Patient Safety on 5 May 2009 to encour-
ge health-care workers to be part of a global movement
o improve and, importantly, sustain hand hygiene. More
han 5500 health-care facilities have already registered their
ommitment to the initiative with a target to achieve 10,000
egistrations by 5 May 2010. The ultimate aim of SAVE LIVES:
lean Your Hands is to demonstrate that hand hygiene is the
ssential basis for the reduction of health care-associated
nfection and to engage nations in a ﬁrm and ongoing com-
itment to infection prevention.
oi:10.1016/j.ijid.2010.02.2223
0.002
nternational Controversies: Bare Below the Elbow and
he Incremental Value of MRSA Screening
. Edmond
Medical College of Virginia Campus, Richmond, VA, USA
This presentation will summarize the relevant data for
wo of the most controversial interventions to reduce
ealthcare associated infections. The ﬁrst half of the pre-
entation will lay out the arguments for why elimination
f white coats and adoption of a bare below the elbows
pproach should be considered for implementation. The sec-
nd half of the presentation will review problems associated
ith a MRSA search and destroy strategy and demon-
trate that horizontal strategies for infection prevention are
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0.003
ith Limited Resources: How to begin and How to Sustain
n Infection Control Program
. Wey
University of Sao Paulo, Sao Paulo, Brazil
Infection control (IC) efforts may encounter greater
bstacles in developing countries. However, progress
ppears to have been made composed of designated
nd trained doctors, nurses, and others. E-learning is an
mportant tool to bring health care professionals updated
nformation, especially where teaching resources are lim-
ted. It allows the exchange of experiences between
rofessionals, promotes simultaneous knowledge acquisi-
ion, and reaches some remote areas. Trained IC personnel
re a scarce resource and their job is to prevent and
ontrol infection; their time and expertise must not be dis-
roportionately utilized in counting infection only. Basic
urveillance is an essential component of IC Programs and
hould be tailored for each institution. The data should be
sed to identify preventable infections so that resources
re targeted in high priority areas requiring minimum
esources. In addition, surveillance data can be used to com-
are infection rates between healthcare facilities, convince
dministrators, clinical teams and health care professionals
o adopt recommended practices and help evaluate IC mea-
ures. For this last purpose one can easily ﬁnd Guidelines
ssued by international health institutions or professional
ocieties that indicate the basic requirements for an effec-
ive IC. The IC team should take into account to implement
easures that are more cost-effective, and use all effort
nd creativity to adopt tools that could improve compliance.
ositive Deviance method that is a social and behavioral
hange process based on the premise that in most organiza-
ions and communities there are people or groups of people
ho solve problems better than colleagues who have exactly
he same resources. Another important concern in develop-
ng countries is integrating epidemiology and microbiology.
espite its relevance, knowledge about the status of antibi-
tic resistance in the developing world remains on the whole
acking. Regional special laboratories could provide a good
mount of information about resistance and help in outbreak
ontrol.
oi:10.1016/j.ijid.2010.02.2225
0.004
he Future Hospital Epidemiologist’s Portfolio for Success
. Wenzel
VCU Medical Center, Richmond, VA, USA
It is understood that a successful Hospital Epidemiologist
ill need skills in clinical medicine, especially infectious dis-
ases, and in microbiology, epidemiology and informatics.
et that is only the beginning. Success builds on a platform
f skill sets that include Becoming Articulate and Persua-
ive and Becoming Inspiring. These skills can be taught. In
ddition a still more successful Hospital Epidemiologist will
eed to know more: How to Manage Something New; How to
anage Intimidation; and How to be Creative.
o
b
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The presentation will be accompanied by examples from
he experiences of the speaker as well as examples from
eaders in other ﬁelds.
oi:10.1016/j.ijid.2010.02.2226
acterial meningitis: Prevention and cure (Invited
resentation)
1.001
he Global Impact of Bacterial Meningitis
. Heath
St. George’s University of London, London, United Kingdom
Background: Bacterial meningitis is an important cause of
ortality and morbidity in neonates, infants, children and
dults worldwide.
Methods.
Review of published literature.
Results: Streptococcus pneumoniae, Haemophilus
nﬂuenzae type b, and Neisseria meningitidis are the most
mportant causes of acute bacterial meningitis worldwide.
number of other bacteria are capable of causing menin-
itis, often associated with speciﬁc population groups; for
xample, Streptococcus suis is a common cause of acute
acterial meningitis in southeast Asia but occurs rarely
lsewhere, Group B streptococcus is the leading cause
f neonatal meningitis in developed countries but less
requent in developing countries where Gram negative
acteria are more commonly implicated, while in HIV-
nfected patients, S pneumoniae is the commonest cause
f acute bacterial meningitis but meningitis caused by
ycobacterium tuberculosis and Cryptococcus neoformans
s also common. However, surveillance, especially in high
ortality developing countries usually under ascertains
acterial meningitis and sepsis due to the low sensitivity
f diagnostic tests and limited access to care. Furthermore
he long term sequelae of meningitis, a particular concern
ollowing neonatal meningitis, is poorly described. Finally,
ost reported estimates of meningitis incidence and
ase fatality ratios come from hospital-based surveillance
tudies only.
Conclusion: The global burden of bacterial meningitis is
ubstantial. Better standardisation and reporting of methods
nd limitations for surveillance studies are needed and more
esearch is required. Expanded use of established and new
accines could signiﬁcantly reduce both bacterial meningitis
nd overall mortality, especially in children.
oi:10.1016/j.ijid.2010.02.2227
1.002
athophysiology of bacterial meningitis
. Nau
Evangelisches Krankenhaus Göttingen-Weende & University
f Göttingen, Göttingen, Germany
Bacterial meningitis is characterized by the entry of
acteria into the cerebrospinal ﬂuid (CSF) and bacterial
rowth in this compartment leading to inﬂammation within
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the CSF and the adjacent brain tissue. Long-term neu-
rological sequelae and death are caused jointly by the
following factors: (1) The systemic inﬂammatory response
of the host leads to leukocyte extravasation into the sub-
arachnoid space, an increased CSF outﬂow resistance, and
brain edema. The resulting elevated intracranial pressure
is an important cause of death in the acute phase and
of long-term sequelae. Systemic inﬂammation can also
cause vasculitis, cerebral venous thrombosis and secondary
ischemia. (2) Immune cells within the brain parenchyma,
in particular microglia, can be stimulated by proinﬂam-
matory bacterial compounds, which can directly lead to
neuronal injury. (3) Some bacterial compounds, e.g., pneu-
molysin, possess direct toxicity on neurons. Neuronal injury
is mediated by the release of reactive oxygen intermedi-
ates, proteases, cytokines and excitatory amino acids, the
activation of transcription factors, caspases, matrix metal-
loproteases and other proteases.
Rapid initiation of effective antibiotic therapy sterilizes
the CSF and reduces mortality of bacterial meningitis. In
industrialized countries, dexamethasone as an adjunctive
therapy to antibiotic treatment, improves outcome of bac-
terial meningitis, particularly of Streptococcus pneumoniae
meningitis. In experimental meningitis, dexamethasone as
an adjunct to antibiotic treatment causes an increase of
neuronal injury in the dentate gyrus of the hippocampal
formation, suggesting that corticosteroids might not be the
ideal adjunctive therapy. Several approaches that inter-
fere selectively with the mechanisms of neuronal injury,
including the use of non-bacteriolytic bactericidal protein
synthesis-inhibiting antibiotics, antioxidants and inhibitors
of transcription factors, matrix metalloproteinases, and cas-
pases, are effective in animal models. However, adequate
clinical studies are lacking. A recent randomized clinical
study points to a beneﬁcial effect of adjunctive oral glyc-
erol.
doi:10.1016/j.ijid.2010.02.2228
71.003
Vaccination Against Bacterial Meningitis
H. Peltola
Helsinki, Finland
Thanks to conjugate vaccines specially against
Haemophilus inﬂuenzae (Hib) and Streptococcus pneu-
moniae (Pnc), bacterial meningitis has become disease
whose global importance is no more realized in the afﬂuent
countries. However, more than 1 MI individuals a year,
proportionally more often children than adults, fall down;
one-third succumb, and one-third of survivors are left
with moderate-to-severe sequelae. In the world where the
meningitis problem is greatest, only a fraction of people
are vaccinated. The main (though not only) reason is the
too high cost of conjugates for those populations.
Years ago, inexpensive polysaccharide vaccines were
developed against Hib, Pnc, and Neisseria meningitidis
(Mnc). The Hib, polysaccharide is rightly gone, but all poten-
tial of polysaccharides against Pnc and Mnc has not been
used. The reasoning is that polysaccharides are not suf-
ﬁciently immunogenic in small children (in greatest risk).
o
o
g
tts e331
owever, convincing clinical efﬁcacy data are lacking to
rove this statement. It is unlikely that those data will ever
e produced, because people are too convinced of the supe-
iority of conjugates to support any major ﬁeld trial with a
nc or Mnc polysaccharide.
At present, variable conjugate vaccines are available
gainst Hib, 7-13 serotypes of Pnc, and up to 4 serogroups of
nc. Hib vaccination is indicated in all countries. So is also
nc conjugate, albeit its effect speciﬁcally against meningi-
is depends on local epidemiology (serotype distribution).
n case of Mnc meningitis, the main problem is the lack
f sufﬁciently good vaccine against serogroup B, the most
ommon group in many countries. Fortunately, encouraging
esults have been obtained recently regarding a new-type
f vaccine.
Group A Mnc is a special problem of Africa. Monovalent
onjugate has been used there, and luckily, its price is tol-
rable because of its manufacturing outside Big Farma. This
pproach would be welcome to cover other causative agents
f meningits as well.
oi:10.1016/j.ijid.2010.02.2229
1.004
ffective Adjuvant Therapies for Meningitis
. Singhi
Post-graduate Institute of Medical Education and Research,
handigarh, India
Objective: To review advances in adjuvant therapy of
acterial meningitis.
Data Sources: Work published within past 5 years
etrieved from personal knowledge and the U.S. National
ibrary of Medicine for terms: central nervous system infec-
ions, meningitisbacterial; therapy; corticosteroids; ﬂuids;
nti-inﬂammatory; glycerol, and pediatrics.
Study Selection, Data Extraction and Synthesis: Promis-
ng articles were reviewed and data used based on clinical
elevance and signiﬁcance.
Results: Corticosteroid therapy: Results from clinical
rials of adjuvant steroid therapy are conﬂicting. What
merges from meta-analysis is that in high-income countries
teroids reduce the risk of hearing loss in immunocompetent
atients with H. inﬂuenzae-b or pneumococcal meningitis;
here is no survival beneﬁt. In low-income countries utility
f corticosteroids is unclear.
Fluids: Evidence supports normal maintenance intra-
enous ﬂuids rather than restricted ﬂuids in the ﬁrst 48 hours
n settings; it reduces risk of spasticity and severe neurologic
equelae.
Oral glycerol therapy during ﬁrst 48 hours of treatment
an prevent severe neurologic sequelae. Within 6 hours of
dministration oral glycerol increased plasma osmolality by
%, which is known to reduce secretion of CSF and enhance
ovement of water back to plasma, and thus improve cere-
ral blood ﬂow.
Management of raised ICP is not easy because a variety
f mechanisms. Neuroimaging may be helpful in selection
f appropriate treatment. Cerebral perfusion pressure tar-
eted therapy to maintain CPP >50mmHg is likely to improve
he outcome.
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aged 4 months to 16 years. Arco is a suitable ACT in the332 14
New Adjunct Therapies: Endogenous inﬂammatory medi-
tors, chemokines and chemo attractant cytokines are
elieved to contribute to neurologic injury. Agents aimed
t blocking these mediators offer future therapeutic hopes:
hese have been shown to reduce brain edema, postmenin-
itic hearing loss and cochlear and brain cell injury in
xperimental meningitis. and Conclusions: In acute bac-
erial meningitis use of glycerol and maintenance instead
f restricted ﬂuids improve the outcomes; however, role
f dexamethasone in prevention of hearing loss needs re-
valuation.
oi:10.1016/j.ijid.2010.02.2230
arasitology (Oral Presentation)
2.001
ne year impact of a single dose of Praziquantel in ﬁve
chistosomiasis endemic districts in Rwanda
. Denise1,∗, R. Eugene1, S. Jackson2, K. Blaise3, M.
dette2, K. Michee3, K. Michael2, R. Josh4
Access Project, KIGALI, Rwanda
Ministry of Health, Kigali, Rwanda
Access Project, Kigali, Rwanda
Earth Institute, Columbia University, New York, NY, USA
Background: Schistosomiasis is one of the most prevalent
arasitic diseases in developing countries and has a negative
mpact on the health of the population and consequently
he economics of those countries. In Rwanda, the mapping
urvey of schistosomiasis (and soiltransmitted helminths)
onducted in 2007 by the Neglected Tropical Disease (NTD)
ontrol program have shown that only S. mansoni was preva-
ent at 2.7% in the whole country with a variation per district
rom 0 to 69.5%. The disease was more localized near lakes
urera, Ruhondo, Muhazi and Kivu. In total, height endemic
istricts were identiﬁed and a mass drug administration with
raziquantel and albendazole was implemented.
Methods: The impact of the treatment programme was
onitored through a cohort of 2,166 school children aged 7-
6 years in ﬁve most infected districts. Their infection status
ith S. mansoni was determined by clinical and parasitologi-
al examination at baseline and at year one after treatment.
he prevalence and intensity of S. mansoni before and after
he treatment were analyzed.
Results: After one round of treatment, the prevalence of
. mansoni infection have been reduced signiﬁcantly in all 5
istricts from 11.2% [95% CI 9.8%-12.5%] at baseline to 2.0%
95% CI 1.4%-2.6%] at year one follow up. On the intensity,
he median number of eggs in the 5 districts decreased by
wo from 72 eggs per gram (epg) of stool to 36 epg. The
roportion of children with heavy S. mansoni infection was
igniﬁcantly reduced as well. Signs of early clinical morbidity
f S. mansoni infection like bloody diarrhea, abdominal pain
ecreased signiﬁcantly.The rate of hepatomegaly, which is a
ate clinical sign for S.mansoni was very low in that cohort.
t
dternational Congress on Infectious Diseases (ICID) Abstracts
Conclusion: One single dose of praziquantel in school age
hildren in schistosomiasis endemic districts can decrease
igniﬁcantly the prevalence and intensity of the infection
nd can contribute to the reduction of the morbidity due to
. mansoni in Rwanda.
oi:10.1016/j.ijid.2010.02.2231
2.002
comparative study of Arco and Coartem in the treatment
f uncomplicated malaria in patients aged 4 months to 16
ears attending Mulago hospital, Kampala, Uganda
. Rujumba1, E.A. Mworozi 1,∗, A.K. Maganda2, R. Kiguba1,
. Rwakimali 3, S. Nsobya4
Makerere University College of Health Sciences, Kampala,
ganda
Mulago National Referral Hospital, kampala, Uganda
Ministry of Health, Kampala, Uganda
Mulago Hospital, kampala, Uganda
Background: Malaria is a major cause of child morbidity
ndmortality in Uganda. It accounts for 24-45% of outpatient
isits in Uganda. The situation is worsened by the devel-
pment of drug resistance and lengthy anti-malaria drug
reatment which pose problems of compliance to medica-
ion. Both Arco and Coartem are Artemisinin Combination
herapies (ACTs). We conducted a study to compare the efﬁ-
acy and safety of Arco a single dose drug and Coartem in
he treatment of uncomplicated malaria in children aged
months — 16 years attending Mulago Hospital, Kampala
ganda.
Methods: A phase II single blinded randomized clinical
rial was carried out between November 2007 and June 2008.
e screened 3344 patients with fever for malaria of whom
53 had positive blood smear, 225 fulﬁlled the inclusion cri-
eria and were randomized into the two study arms i.e. Arco
nd Coartem arms. The study patients were followed up for
2 days.
Results: There was 100% parasite clearance by day 2 in
oth the ARCO and Coartem arms of the study. The overall
ure rate on day 42 of follow up was 98% for both Arco and
oartem. Recrudescence occurred in 2 patients in the Arco
rm of the study by day 42 and in 2 patients on Coartem
y day 21 of follow up. No statistically signiﬁcant differ-
nce in resolution of fever, vomiting, dizziness and back
ain was observed throughout the follow up period of the
tudy. No difference was observed in the clinical presenta-
ion between the two treatment arms. No serious adverse
vents were reported/observed in either of the study arms.
Conclusion: Arco and Coartem are equally effective andreatment of uncomplicated malaria in children.
oi:10.1016/j.ijid.2010.02.2232
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72.003
The effect of malaria on the outcome of Lassa Fever
P. Okokhere1,∗, D. Asogun2, S.A. Okogbenin1
1 Irrua Specialist Teaching Hospital, Irrua, Nigeria, Irrua,
Edo, Nigeria
2 Irrua Specialist Teaching, Hospital, Irrua, Edo, Nigeria
Background: Lassa fever (LF) and malaria can co-exist in
patients in countries endemic for both infections and thus
lead to delay in diagnosis of LF, with consequent adverse
effect on outcome. This study was aimed at addressing the
paucity of data on the prevalence of malaria as a comorbid-
ity in patients with LF and the effect on outcome.
Methods: The clinical presentation and outcome of
patients with RT-PCR conﬁrmed LF seen at the Irrua Spe-
cialist Teaching Hospital, Nigeria between January 2008 and
August 2009 were reviewed. RT-PCR for Lassa virus and blood
smear for malaria parasites were done using standard tech-
niques. Treatment was with ribavirin.
Results: 102 patients with RT-PCR conﬁrmed LF were
managed during the period. 27 (37%) of 73 patients were
LF and malaria smear positive while 46 (63%) were LF pos-
itive and malaria smear negative; malaria parasite smear
was not examined in 29 (28.4%) of the 102 patients. Malaria
positive LF patients had a signiﬁcantly shorter duration
of fever (7.6 + 4.93 versus 10.2 + 5.96 days; p < 0.05) but
a signiﬁcantly lower mean temperature (37.54 + 1.09 ver-
sus 38.04 + 1.2 oC; p < 0.05) on admission. Central nervous
system (CNS) features were signiﬁcantly more frequent in
malaria positive patients (51.9% versus 26.8%; p < 0.01), but
there was no signiﬁcant difference in case fatality rates
(36.4% versus 54.5%; p > 0.1). Overall, patients with CNS
manifestations had a signiﬁcantly higher CFR than those
without (54.8% versus 9.4%; p < 0.001), irrespective of the
presence or absence of malaria parasites. The mortality
rate among patients with severe CNS manifestations (coma
and/or seizure) was also signiﬁcantly higher than among
those with milder CNS features (80% versus 31.8%; p < 0.001).
Conclusion: There is a high prevalence (37%) of co-
infection with malaria in patients with LF, thus emphasizing
a high index of suspicion for diagnosis and testing for LF even
in the presence of malaria parasitaemia in endemic areas.
Our study could not demonstrate a major effect of malaria
on outcome. Severe CNS manifestations such as coma and/or
seizures were associated with excess mortality.
doi:10.1016/j.ijid.2010.02.2233
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2.004
linical analysis and eco-epidemiology data of pediatric
isceral leishmaniasis (VL) in Argentina
. Ruvinsky1,∗, O. Salomon2, L. Arce3, D. Jozami4, J.
ltcheh5, R. Cappellini 6, S. Lopez Papucci7, A. Riarte8,
. Gomez9, L. Borchichi 3, R. Bologna1, P. Paulin1, R.
ividori 9, G. Moscatelli 10, H. Freilij 5, R. Chiabrando6, A.
entile6, A. Aletti 7, A. Gajo Gane11, T. Orduna12
Hospital de Pediatria Dr. Juan P. Garrahan, Buenos Aires,
rgentina
CENDIE, Buenos Aires, Argentina
Hospital F. Barreyro, Posadas, Argentina
Hospital Viano, Santiago del Estero, Argentina
Hospital Dr.R. Gutierrez, Buenos Aires, Argentina
Sanatorio Franchin, Buenos Aires, Argentina
Hospital Vilela, Rosario, Argentina
Insituto Fatala Chaben, Buenos Aires, Argentina
Hospital Viano, Santiago del Estero, Argentina
0 Hospital Dr.R. Gutierrez, Buenos, Argentina
1 Hospital Juan Pablo II, Corrientes, Argentina
2 Hospital Dr. F. Mun˜iz, Buenos Aires, Argentina
Background: The ﬁrst Argentinian human VL
utochthonous case, with concurrent canine VL, Lu.
ongipalpis, and L.infantum typiﬁed from human and dogs,
as reported from Posadas (Misiones 5/2006)
Methods: The objective was to describe clinical char-
cteristics and eco-epidemiological data of VL in pediatric
atients in Argentina Following method was used: Retro-
pective multicentre study. Data from children with VL
onﬁrmed (2006-2009) were collected by a surveillance
atabase and review of medical records. Data from eco-
pidemiology study from Argentina were included.
Results: The screening of vectors in Posadas (3/2007)
ound Lu.longipalpis in 42% of 314 sites, but only 5.2% with
31 vector/trap, with spatial auto-correlation. The highest
aptures were associated with peridomestic chicken habi-
ats, and dog closeness to humans. Posadas up to 9/2008
eported more than 5000 infected dogs. La Banda (Santi-
go del Estero) reported 8 dogs with VL from 10/2007 to
/2008 within an area of 1.5 km2. This focus was sam-
led in 11/2007 and 4/2008, and none Lu. longipalpis was
ound but Lu. migonei were concurrent with the cases (10
). Lu. longipalpis and canine VL was reported in Corri-
ntes province since 12/2008 Eighteen pediatric patients
ith conﬁrmed VL were included, median age was 12.5
onths (IQR: 8-68 m.), 78% was from Misiones province,
6.6% from Santiago del Estero province, whereas 5.6% was
rom Corrientes province. Male-female ratio: 3.5:1Clinical
eatures included fever and hepato-splenomegaly (100%),
eight loss (66.6%), diarrhea (44.4%), and bleeding disorders
27.7%).VL children were positive by parasitological and/or
k39 studies. Laboratory ﬁndings were hypoalbuminemia
83.3%), leucopenia (80%), anemia (83.3%) and thrombocy-
openia (72%). Three patients had congenital co-infections
2 Chagas disease and 1 HIV infection) Five children (27.7%)
eveloped secondary bacterial infections. Twelve patients
ere treated with amphotericin B (10 lipid complex and
deoxicolate) and 6 with antimony. One child with severe
leeding and hepatic failure died. No relapse was observed
n the survivors.
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Conclusion: In Argentina Lu. longipalpis colonized
ecently urban environments showing high spatial hetero-
eneity (hot spots), and a dispersion trend to southern
atitudes.VL should be considered in patients with prolonged
ever that live or visit an endemic region. Early diagnosis
s essential to avoid severe complication and mortality in
hildren.
oi:10.1016/j.ijid.2010.02.2234
2.005
ovel molecular detection of drug resistance markers in
lasmodium falciparum from Papua New Guinean chil-
ren with uncomplicated malaria
. Wong1,∗, H. Karunajeewa1, I. Mueller2, P. Siba2, E.P.
arnevale3, P. Zimmerman3, T. M.E. Davis1
University of Western Australia, Perth, WA, Australia
Institute of Medical Research, Madang, Papua New Guinea
Case Western Reserve University, Cleveland, OH, USA
Background: Parasite drug resistance is a major obstacle
o effective malaria control.
Surveillance for parasite drug resistance mutations is
ecoming an established tool in assessing treatment effec-
iveness, especially as it overcomes challenges associated
ith in vivo testing. In Madang Province, Papua New Guinea
PNG), conventional treatments such as chloroquine (CQ)
nd sulfadoxine-pyrimethamine (SP) are associated with
ncreasing failure rates.
Methods: To investigate underlying molecular mecha-
isms, we used a post-PCR, multiplexed ligase detection
eaction-ﬂuorescent microsphere assay (LDR-FMA) to detect
ingle nucleotide polymorphisms (SNPs) in Plasmodium fal-
iparum drug resistance genes in 402 ﬁeld isolates from
hildren with falciparum malaria. This technique enables
imultaneous identiﬁcation of 18 SNPs in pfcrt, pfdhfr,
fdhps and 10 allelic variants in pfmdr1. We also assessed
ssociations between drug resistance genotypes and in
ivo treatment failure rates (PCR-corrected at Day 42) for
QSP, artesunate-SP, piperaquine-dihydroartemisinin and
rtemether-lumefantrine.
Results: There was a high prevalence of multiple muta-
ions across these genes. Eighty-eight percent of the isolates
ith complete haplotypes were characterised by the quin-
uple mutation SVMNT+NRNI + KAA +YYSND in the codons
2-76 for pfcrt, 51, 59, 108, 164 for pfdhfr, 540, 581, 613
or pfdhps, and 86, 184, 1034, 1042, 1246 for pfmdr1. The
resence of the pfmdr1 1246Y mutation was associated
ith treatment failure in all groups combined and in the
iperaquinedihydroartemisinin group (Fisher’s exact test,
= 0.006 and 0.004, respectively). Four isolates also carried
he 540E pfdhps allele in addition to the quintuple mutation.
f other minor haplotypes, NFSDD was found in four iso-
ates but has been associated with artemetherlumefantrine
reatment failure in Africa.
Conclusion: We found ﬁxation of pfcrt 76T, pfdhfr 59R
nd 108N and pfmdr1 mutations (at 92%, 93%, 95% and
1%, respectively), consistent with previous PNG studies.
DR-FMA is costeffective, enables high-throughput suitable
or large-scale epidemiological studies and extends current
CR-based methods. Our ﬁndings are consistent with the
T
a
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revious widespread use of 4-aminoquinolines and SP in PNG
nd support a change to alternative ﬁrst-line treatment
or uncomplicated falciparum malaria. Since introduction
f artemether-lumefantrine treatment in PNG is imminent,
onitoring changes in the pfmdr1 gene and the NFSDD hap-
otype appears a high priority.
oi:10.1016/j.ijid.2010.02.2235
2.006
dentiﬁcation of intestinal parasites from naturally con-
aminated hands of people living in low socio-economic
reas of Dhaka, Bangladesh
.K. Ijaz1, J.R. Rubino2, K.A. Talukder3, A. Nur-E-Kamal4,∗
1Reckitt Benckiser Inc., Montvale, NJ, USA
Reckitt Benckiser Inc, Montvale, NJ, USA
ICDDR, B, Mohakhali, Bangladesh
Medgar Evers College, Brooklyn, NY, USA
Background: Intestinal parasitic infections are global
roblem with more than an estimated one billion infected
ersons mostly in underdeveloped countries. Children are
ost effected by these infections. This is predominantly
ue to poor hygienic conditions, low parenteral health edu-
ation, and absence of safe drinking water. The scientiﬁc
vidence describing intestinal parasite and bacterial con-
amination on paper currency from a developing country
ighlight the role of poor hand hygiene practices promoting
issemination of infectious diseases including intestinal par-
sitic egg / (oo)cysts. As a part of parasitological survey to
ssess the intestinal parasites amongst low socio-economic
ommunities of Indian sub-continent stool and hands were
nalyzed for evidence of parasite eggs / (oo)cysts from chil-
ren living in slums of Dhaka, Bangladesh.
Methods: A total of 215 stool samples have been analyzed
or intestinal parasitic eggs /(oo)cysts using conventional
icroscopic assay.
Results: The general prevalence in this part of the survey
f intestinal parasitic egg / (oo)cysts were 37% (79 positive
ut of 215 stool samples). Of these 79 stool-positive chil-
ren, to date hands of 65 were sampled in order to screen for
ny intestinal parasitic egg / (oo)cyst. Three different types
f parasitic egg / cysts were recovered from hands of these
hildren. Amongst the helminths, Ascaris 11%, and Trichuris
.5% were recovered where as the protozoan parasite, Giar-
ia recovery was 5% of hand samples. Over all, 1117% of the
hildren examined carried intestinal parasitic egg / cysts
n their hands and 37% in their stool samples, indicating
he perpetuation of fecal-hand-mouth cycle of helminths
nd protozoan infections in these children. To our knowl-
dge this the ﬁrst report where intestinal parasites have
een recovered from naturally-contaminated hand samples
f children.
Conclusion: Our study highlights the need to include
roper hand hygiene practices (washing hands with soap and
ater) including health hygiene educational promotion pro-
rams in order to sustain any chemotherapeutic programs.
he data being generated in this survey will be presented
nd its implications on public health will be discussed.
oi:10.1016/j.ijid.2010.02.2236
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72.007
Training in fever case management and use of malaria
rapid diagnostic testing kits improved fever case manage-
ment in Uganda
U. Ssekabira
Infectious Diseases Insitute,Makerere University, Kampala,
Uganda
Background: In Africa, there is poor access to diagnos-
tic tests; malaria is typically diagnosed clinically, though
presumptive treatment results in signiﬁcant overuse of anti-
malarials and delayed treatment of actual causes of fever.
The WHO currently recommends antimaralial treatment for
only laboratory conﬁrmed malaria. Malaria rapid diagnostic
tests (RDTs) may offer a reliable alternative, but effective
training for health workers is a key challenge in RDT imple-
mentation. We tested the effectiveness of the training on
use of RDTS in fever case management.
Methods: Clinicians at peripheral health centers with-
out microscopy in two districts in a low endemic zone in
Uganda were trained for two days and immediately followed
up in their health facilities to observe performance and offer
additional targeted on site training. Training covered clinical
evaluation, selection of patients for RDT testing, perform-
ing and interpretation of RDT tests and treatment of patients
with negative and positive RDT results. Data on practices in
management of patients with suspected malaria before and
after the training were collected and compared.Data on out
patient consultations for 10 consecutive days in the pre and
post training period was compared.
Results: Data revealed appropriate use of RDTs and
improved fever case management; there was a reduction
in proportion of patients; diagnosed as Malaria [61% to 26%
(p = 0.000)] amongst the under ﬁves and from 52.3% to 14.5%
(p = 0.000)amongst adults above 5yrs, prescribed antimalar-
ials from 97% to 80% (p = 0.000) among the under ﬁves and
from 94% to 86% (p = 0.000) among the above 5yrs, with
malaria treated with antibiotics among those above 5yrs
from 55% to 40% (p = 0.000), with malaria given both anti-
malarials and antibiotics from 63% to 47% (p = 0.000) amongst
the under ﬁves and from 46% to 29% (p = 0.000) amongst
those above 5yrs. The training contributed to rational use
of antimalarials; the proportion of patients with a nega-
tive RDT who received antimalarials in the two facilities
12% compared to 50-70% who receive antimalarials despite
a negative blood smear in sites with microscopy.Conclusion: The training in use of Malaria RDTs in fever
case management substantially lead to rational use of anti-
malarials and antibiotics.
doi:10.1016/j.ijid.2010.02.2237
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ntibacterial effects of Humulus lupulus L. extract on top-
cal staphylococcal infection in BALB/c Mice cornea
. Hadipour Jahromy1,∗, S. Khakpour1, M. Hadipour
ahromy2, A. Najaﬁ1
Islamic Azad University, Tehran, Iran, Islamic Republic of
Shahid Beheshti University of Medical Sciences, Tehran,
ran, Islamic Republic of
Background: Staphylococcus aureus is an opportunistic
athogen and the most common cause of bacterial keratitis
hat can result in irreversible corneal scarring, a pathologic
ffect that reduces visual acuity and can lead to blindness.
umulus lupulus L. ﬂower complex has multiple therapeu-
ic properties such as antibiotic effects against some gram
ositive bacteria and fungi. In the present research, topical
nti-staphylococcus aureus effects of hydroalcoholic extract
f Humulus lupulus L. ﬂowers in corneal infection induced
y staphylococcus aureus were investigated in mice.
Methods: At ﬁrst, staphylococcus aureus were inoculated
nto right cornea of animals under anesthesia by mak-
ng parallel scars. One, three, ﬁve, seven and nine days
ost-inoculation, the eyes were observed carefully under
icroscope. In observations, eyes were scored according to
he area and the degree of opacity. In order to assess the
ntibacterial effects of Humulus lupulus L., the extract was
dministered in form of eye drop at 1%, 5% and 10% con-
entrations. Treatments were started twice daily as soon as
he ﬁrst opacity was observed and continued for one week.
he ﬁrst sign of corneal infection with opacity was observed
fter three days of bacterial inoculation as compared with
he normal eye.
Results: The intensity of opacity was progressed time
ependently in a manner that maximum opacity of the whole
ornea was obvious in more than half of animals, after
ine days. Administration of the Humulus lupulus L. extract
0% topically, reduced corneal opacity and consequently the
nfection. Introducing animal models of ocular diseases such
s bacterial infection in cornea has special importance in
cular research.
Conclusion: Effective components existing in Humulus
upulus L. ﬂower extract aremainly resins and essence which
mong them, resins has special importance and seems to be
esponsible for its antibiotic effects.
oi:10.1016/j.ijid.2010.02.365
3.002
p regulation of IRF-2 in West Nile Virus infection: Impli-
ations for establishment of viremia in the brain leading
o encephalitis
.L. Yeo ∗, M.L. NgNational University of Singapore, Singapore, Singapore
Background: A proportion of patients afﬂicted with
NV can develop neuromuscular degenerative diseases
nd potentially fatal encephalitis. However, host immuno-
